{"chunk_id": "SSUs_v1_p013_txt_00_f4c219", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 13, "page_end": 13, "section_path": ["HEAD & NECK / ENT", "Rhinological Surgery", "Head & Neck / ENT"], "specialty_tags": ["HEAD & NECK / ENT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Head & Neck / ENT", "keywords": [], "text": "Head & Neck / ENT\nMost important consideration: usually a shared airway, and often a difficult airway", "citations": [{"type": "pdf_page", "page": 13, "label": "p13"}]}
{"chunk_id": "SSUs_v1_p013_txt_01_99188c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 13, "page_end": 13, "section_path": ["HEAD & NECK / ENT", "Rhinological Surgery", "Rhinological Surgery"], "specialty_tags": ["HEAD & NECK / ENT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Rhinological Surgery", "keywords": [], "text": "Rhinological Surgery\nOperations: FESS, polypectomy, septorhinoplasty\nMost vascular part is anterior inferior septum – Little’s area / Kiesselbach’s\nplexus – most common source of epistaxis\nInnervation:\n•\nV1: → nasociliary nerve → anterior ethmoidal n. (int + ext)\no\nSupplies: septum, nasal tip, anterior lateral walls, sinuses\n•\nV2: maxillary →\no\nPterygopalatine ganglia\n▪\nGreater + lesser palatine n.: septum, lateral walls\n▪\nLateral posterior superior / inferior n.\no\nInfraorbital nerve: maxillary sinus, skin lateral / under nose\n•\nVII: post-ganglionic parasympathetic – secretory\n•\nOlfaction: CNI\nTopical vasoconstrictors:\n•\nTopical cocaine solution (2mg/kg, peak levels 30-60mins)\n•\nTopical cocaine paste\n•\nEphedrine\n•\nDirect injection of LA + adr\nPre-op:\n•\nAssess:\no\nCI to cocaine\no\nAppropriateness for: hypotensive anaesthesia\n▪\nCI hypotensive anaesthesia: poorly controlled HTN, CVA, IHD/CAD, CKD, advanced liver dz\n•\n?OSA + other resp disease (2/3 of pts with chronic sinusitis have lower airway inflammation or COPD)\nIntra-op:\n•\nPossible difficult BVM 2’ nasal obstruction\n•\nAirway: shared, reinforced flexi-LMA (benefit of spont vent) or south rae ETT (controlled CO2)\no\nNo routine throat pack\n•\nRemi +/- GTN for cocaine/adrenaline injection\n•\nSurgeons may request eyes uncovered to inspect for globe / orbital damage – use lube\n•\nBloodless field:\no\nNon-pharmacological: reverse trendelenberg\no\nVasoconstrictors + TXA + steroids + a2 agonists\no\nHypotensive anaesthesia: 20-30% reduction from baseline OR sBP 90-100/MAP 60-70, HR 60, TIVA + a2 agonist\no\nAvoid obstruction to venous drainage:\n▪\nHead as neutral as able\n▪\nTape tube cf tie\n▪\nHead slightly up\n▪\nPPV (low-normal CO2, low PEEP)\no\nSphenopalatine block\n•\nRegional (analgesia): infraorbital nerve block\n•\nIntra-op severe hypertension management: manage w/\nalpha blocker first if akin to a phaeo presentation\n(unopposed alpha will cause heart failure)\n•\nPrior to extubation: Valsalva, suction coroner’s clot,\nanalgesia\n•\nRemi extubation to cough\nPost-op:\n•\nDay only unless comorbid / OSA\nThroat Packs\n•\nNo robust evidence to show \n•\nPotentially catastrophic – routine use not\nrecommended\nManagement:\n•\nDiscuss at TIME OUT\n•\nInserted by surgeons + included in scrub count\n•\nVisual reminder i.e. fluorescent sticker on patient\nforehead\n•\nTied to airway to ensure cannot be left behind\n•\nClear documentation", "citations": [{"type": "pdf_page", "page": 13, "label": "p13"}]}
{"chunk_id": "SSUs_v1_p014_txt_00_b13ab5", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 14, "page_end": 14, "section_path": ["HEAD & NECK / ENT", "Middle Ear Surgery", "Middle Ear Surgery"], "specialty_tags": ["HEAD & NECK / ENT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Middle Ear Surgery", "keywords": [], "text": "Middle Ear Surgery\nInclude: cochlear implant, myringoplasty, tympanoplasty, ossicular chain reconstruction, mastoidectomy, stapedectomy\nPre-op:\n•\nQuery hearing – may need quiet place, allow lip reading\n•\nAssess: congenital syndromes (?difficult airway)\n•\nIx: ECG (congenital sensorineural hearing loss associated with long QT)\nIntra-op:\n•\nProp + remi TIVA:\no\nFacial n. monitoring\no\nGood for PONV – very emetic surgery\no\nAllows smooth extubation on remi\n•\nAvoid nitrous (non-compliant middle ear cavity)\n•\nBloodless field:\no\nNon-pharmacological: reverse trendelenberg\no\nVasoconstrictors + TXA + steroids + a2 agonists\no\nHypotensive anaesthesia: 30% reduction from baseline OR sBP 90-100/MAP 60-70, HR 60, TIVA + a2 agonist\no\nAvoid obstruction to venous drainage:\n▪\nHead as neutral as able\n▪\nTape tube cf tie\n▪\nHead slightly up\n▪\nPPV (low-normal CO2, low PEEP)\n•\nPONV prophylaxis +++\n•\nAnalgesia: simple + LA (w/ adr) by surgeons\nPost-op:\n•\nOften discharged DOS\nComplications:\n•\nChange in taste\n•\nTransient facial palsy\n•\nRare: CSF leak, meningitis, persistent facial n. palsy", "citations": [{"type": "pdf_page", "page": 14, "label": "p14"}]}
{"chunk_id": "SSUs_v1_p015_txt_00_372d71", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 15, "page_end": 15, "section_path": ["HEAD & NECK / ENT", "Oropharyngeal/H&N Cancer Surgery", "Oropharyngeal/H&N Cancer Surgery"], "specialty_tags": ["HEAD & NECK / ENT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Oropharyngeal/H&N Cancer Surgery", "keywords": [], "text": "Oropharyngeal/H&N Cancer Surgery\nOropharyngeal: tongue, tonsils, pharynx\nPre-op:\n•\nASSESS:\no\nHistory:\n▪\nModifiable RFs: EtOH, smoking, iron deficiency\n▪\nNutrition (may be  2’ EtOH, dysphagia, cancer anorexia, chemo, radiation mucositis)\n•\nBMI <18.5 or >10% weight loss → dietician, monitor for refeeding\n•\n+ thiamine + vit B, trace elements\n▪\n4Ms: chemo/RTx effects\n▪\nFunctional capacity\no\nExam:\n▪\nAIRWAY ASSESSMENT\no\nIx:\n▪\nImaging ?airway\n▪\nNasendoscopy\n▪\nFlow vol loops ?upper airway obstruction v COPD\n▪\nCPET may aid in risk – value not fully elucidated\no\nRisk: RCRI\n•\nMANAGE:\no\nNutrition\no\nIron deficiency\n•\nREFER:\no\nMDT management: anaesthetics, surgery, ICU +/- dietician\no\nResp for COPD management\no\n?Ceiling of care – rescue ECMO candidate\no\nPost-op disposition ?need for flap management, trache + ICU\nIntra-op: shared airway procedure\n•\nMonitoring: ANZCA standard + art line + UO + bladder temp\n•\nAirway plan + difficult airway equipment\no\nMaxilla / nasal ca: oral intubation\no\nOral ca: nasal intubation\no\nSubmental intubation CI due to risk of fistula / false tract\n•\nSpecial considerations:\no\nFlap management if indicated\no\nLong procedure, pressure care\n•\nAvoid casual vandalism\n•\nDocument laryngoscopy at end\n•\nExtubation:\no\nIf extubating:\n▪\nSuction +++ whilst deep w/ laryngoscope, avoid flaps and suture lines, Y suction nose + tube\no\nIf ‘at risk’: planned tracheostomy or delayed extubation\n▪\nRemain intubated if resection near vallecula or epiglottis\nPost-op:\n•\nHead elevated\n•\nTrache care: emergency box\no\n+/- nebulised lignocaine for comfort\no\nPONV ++\no\nSteroids\n•\nNutritional support\n•\nFree flap care\n•\nFASTHUGS\nH&N cancers most commonly\nmetastasise to cervical nodes\nTypes of neck dissection:\n•\nRadical: removes LN levels I-V\nalong with the SCM, IJV, and CN\nXI\n•\nModified radical: removes LN\nlevels I-V but spares at least one\nnon-lymphatic structure (SCM,\nIJV, or CN XI)\n•\nSelective: removes any of LN\nlevels I-V based on patterns of\ncervical mets\nAccessory nerve monitored closely if", "citations": [{"type": "pdf_page", "page": 15, "label": "p15"}]}
{"chunk_id": "SSUs_v1_p016_txt_00_284eb9", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 16, "page_end": 16, "section_path": ["HEAD & NECK / ENT", "Laryngectomy", "Laryngectomy"], "specialty_tags": ["HEAD & NECK / ENT", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Laryngectomy", "keywords": [], "text": "Laryngectomy\nLaryngeal cancer: 30% supraglottic, 65% glottic, transglottic, subglottic 5%\nPre-op:\n•\nASSESS:\no\nHistory:\n▪\nModifiable RFs: EtOH, smoking, iron deficiency\n▪\nNutrition (may be  2’ EtOH, dysphagia, cancer anorexia, chemo, radiation mucositis)\n•\nBMI <18.5 or >10% weight loss → dietician, monitor for refeeding\n•\n+ thiamine + vit B, trace elements\n•\nConsider admission for controlled EtOH withdrawal + feeding\n▪\n4Ms: chemo/RTx effects\n▪\nFunctional capacity\no\nExam:\n▪\nAIRWAY ASSESSMENT – middle column pathology\no\nIx:\n▪\nImaging ?airway\n▪\nNasendoscopy\n▪\nFlow vol loops ?upper airway obstruction v COPD\n▪\nCPET may aid in risk – value not fully elucidated\no\nRisk: RCRI, P-POSSUM\n•\nMANAGE:\no\nNutrition\no\nIron deficiency\n•\nREFER:\no\nMDT management: anaesthetics, surgery, ICU +/- dietician\no\nResp for COPD management\no\n?Ceiling of care – rescue ECMO candidate\no\nPost-op disposition ?need for flap management, trache + ICU\nIntra-op: shared airway procedure\n•\nMonitoring: ANZCA standard + art line + UO + bladder temp\n•\nIntubation: ideally trache end of case to avoid tracheostomal recurrence but may have to do elective if grave concerns\nfor airway – consultant anaesthetist + ENT scrubbed\no\nPLAN + PLAN FOR FAILURE\no\nLA front of neck before starting +/- cannula if below cancer\no\nTHRIVE + CASH (stridor: CPAP, adrenaline, steroids, heliox)\no\nSpont breathing videolaryngoscopy + small reinforced tube\n▪\nFOB useful for supraglottic but laryngeal can be subglottic also must avoid ‘cork in bottle’\no\nTrachea resected → tracheostome → change to J tube\n•\nAccessory n. monitoring by surgeons\n•\nTrache end of case (tracheostomal recurrence)\nPost-op:\n•\nICU\n•\nTrache care: emergency box\no\n+/- nebulised lignocaine for comfort\no\nPONV ++\no\nSteroids\n•\nHead elevated\n•\nNutritional support\n•\nFASTHUGS\n•\nBarium swallow test", "citations": [{"type": "pdf_page", "page": 16, "label": "p16"}]}
{"chunk_id": "SSUs_v1_p017_img_9591faad", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 17, "page_end": 17, "section_path": ["HEAD & NECK / ENT", "Tracheostomy Emergency Post-Laryngectomy", "Tracheostomy Emergency Post-Laryngectomy"], "specialty_tags": ["HEAD & NECK / ENT", "crisis", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "algorithm_image", "modality": "image", "title": "Tracheostomy Emergency Post-Laryngectomy", "keywords": [], "text": "Emergency laryngectomy management Call for airway expert help Look, listen & feel at the mouth and laryngectomy stoma ‘A Mapleson C system (e.g. ‘Waters circuit’) may help assessment if available Use waveform capnography whenever available: exhaled carbon dioxide indicates a patent or partially patent airway Is the patient breathing? Call Resuscitation Team CPR if no pulse / signs of life Assess laryngectomy stoma patency| Most laryngectomy stomas will NOT have a tube in situ Remove stoma cover (if present) Remove inner tube (if present ) Some inner tubes need re-inserting to connect to breathing circuits Do not remove a tracheoesophageal puncture (TEP) prosthesis Can you pass a suction catheter? ‘Apply high flow oxygen to laryngectomy stoma If any doubt whether patient has a laryngectomy, apply oxygen to face also* The laryngectomy stoma is patent Perform tracheal suction Consider partial obstruction Ventilate via stoma if not breathing Continue ABCDE assessment Deflate the cuff (if present) Look, listen & feel at the laryngectomy stoma or tube Use waveform capnography or Mapleson C if available Continue ABCDE assessment | | Is the patient stable or improving? REMOV", "image": {"paths": ["p017_img662.png"], "ocr_text": "Emergency laryngectomy management\n\nCall for airway expert help\nLook, listen & feel at the mouth and laryngectomy stoma\n‘A Mapleson C system (e.g. ‘Waters circuit’) may help assessment if available\nUse waveform capnography whenever available: exhaled carbon dioxide indicates a patent or partially patent airway\n\nIs the patient breathing?\nCall Resuscitation Team\nCPR if no pulse / signs of life\n\nAssess laryngectomy stoma patency|\nMost laryngectomy stomas will NOT have a tube in situ\n\nRemove stoma cover (if present)\nRemove inner tube (if present )\n\nSome inner tubes need re-inserting to connect to breathing circuits\n\nDo not remove a tracheoesophageal puncture (TEP) prosthesis\n\nCan you pass a suction catheter?\n\n‘Apply high flow oxygen to laryngectomy stoma\nIf any doubt whether patient has a\nlaryngectomy, apply oxygen to face also*\n\nThe laryngectomy stoma is patent\nPerform tracheal suction\n\nConsider partial obstruction\nVentilate via stoma if not breathing\nContinue ABCDE assessment\n\nDeflate the cuff (if present)\nLook, listen & feel at the laryngectomy stoma or tube\nUse waveform capnography or Mapleson C if available\n\nContinue ABCDE assessment\n\n|\n|\n\nIs the patient stable or improving?\n\nREMOVE THE TUBE FROM THE LARYNGECTOMY STOMA if present\nLook, listen & feel at the laryngectomy stoma. Ensure oxygen is re-applied to stoma\n\nUse waveform capnography or Mapleson C if available\nAten Tear cone Bee\nIs the patient breathing?\nCPR if no pulse / signs of life ce 3 assessment\n\nPrimary emergency oxygenation ‘Secondary emergency oxygenation\n\nAttempt intubation of laryngectomy stoma\n‘Small tracheostomy tube / 6.0 cuffed ETT\n\nLaryngectomy stoma ventilation via either\nPaediatric face mask applied to stoma\nLMA applied to stoma\n\nConsider Aintree catheter and fibreoptic\n‘scope / Bougie / Airway exchange catheter\n\nLaryngectomy patients have an end stoma and cannot be oxygenated via the mouth or nose\n‘Applying oxygen to the face and stoma is the default emergency action for all patients with a tracheostomy\n\nNational Tracheostomy Safety Project. Review date 1/4/16. Feedback & resources at www.tracheostomy.org.uk"}, "citations": [{"type": "pdf_page", "page": 17, "label": "p17"}]}
{"chunk_id": "SSUs_v1_p018_txt_00_27c5e2", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 18, "page_end": 18, "section_path": ["HEAD & NECK / ENT", "Microlaryngoscopy", "Parotidectomy"], "specialty_tags": ["HEAD & NECK / ENT", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Parotidectomy", "keywords": [], "text": "Parotidectomy\nIndications: parotid mass (mostly benign)\nPre-op:\n•\nAirway: MO, ?distortion – consider pre-op nasendoscopy if unsure\n•\nNutrition assessment\nIntra-op:\n•\nIntubation: south RAE\n•\nMaintenance: prop + remi TIVA (remi helps with movement)\no\nFacial nerve monitoring:\n▪\nLow dose NMBA (roc +/- sugammadex)\n▪\nSurgeon may request eye exposed: use lube\n•\nEnsure good access: malignant tumours have high bleeding risk\n•\nBloodless field:\no\nNon-pharmacological: reverse trendelenberg\no\nVasoconstrictors + TXA + steroids + a2 agonists\no\nHypotensive anaesthesia: 20-30% reduction from baseline OR sBP 90-100/MAP 60-70, HR 60, TIVA + a2 agonist\no\nAvoid obstruction to venous drainage:\n▪\nHead as neutral as able + up\n▪\nTape tube cf tie\n▪\nPPV (low-normal CO2, low PEEP)\n•\nLikely Valsalva at end of case\n•\nExtubate on remifentanil to avoid hypertension + coughing + bucking", "citations": [{"type": "pdf_page", "page": 18, "label": "p18"}]}
{"chunk_id": "SSUs_v1_p018_txt_01_2d6dd0", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 18, "page_end": 18, "section_path": ["HEAD & NECK / ENT", "Microlaryngoscopy", "Microlaryngoscopy"], "specialty_tags": ["HEAD & NECK / ENT", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Microlaryngoscopy", "keywords": [], "text": "Microlaryngoscopy\nPre-op:\n•\nImaging\n•\nConsider nasendoscopy\n•\nDiscuss with surgeons:\no\nPlan ?laser\no\nRisk of bleeding: MLT versus tubeless airway\n•\nConsider using jet ventilation\n•\nIf large lesion consider placing pre-op subglottic cannula\nIntra-op: shared airway procedure\n•\nSpont vent TIVA", "citations": [{"type": "pdf_page", "page": 18, "label": "p18"}]}
{"chunk_id": "SSUs_v1_p019_txt_00_dffd74", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 19, "page_end": 19, "section_path": ["HEAD & NECK / ENT", "Airway Stenting", "Airway Stenting"], "specialty_tags": ["HEAD & NECK / ENT", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Airway Stenting", "keywords": [], "text": "Airway Stenting\nTreats obstruction of central airways i.e. trachea and main bronchi\nIndications: malignancy (palliative), stricture, tracheomalacia\nPre-op:\n•\nASSESS:\no\nHistory: 4Ms, functional assessment\no\nExam:\n▪\nObstruction: ability to lie flat, rescue position, ?stridor (rest v exertion), hypoxia\n▪\nDental for rigid bronch\no\nIx:\n▪\nCT: extent of obstruction, involvement of carina → risk\n•\nMANAGE:\no\nDocument ceiling of care\n•\nREFER:\no\n?ECMO candidate if airway obstructs – severe = >50% obstruction\nIntra-op: shared airway procedure\n•\nFlexibronch (sedation): aim to maintain spont ventilation\n•\nRigid bronch: requires GA\no\nJet ventilation: FiO2 100%, CPM 100, I time 50%, pressure 1.5 barr, pause pressure (mPAP) 25mBar, PP 25mBar\n•\nEmergency equipment for bleeding", "citations": [{"type": "pdf_page", "page": 19, "label": "p19"}]}
{"chunk_id": "SSUs_v1_p020_txt_00_6b1618", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 20, "page_end": 20, "section_path": ["HEAD & NECK / ENT", "Tonsillectomy / Adenoidectomy", "Tonsillectomy / Adenoidectomy"], "specialty_tags": ["HEAD & NECK / ENT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Tonsillectomy / Adenoidectomy", "keywords": [], "text": "Tonsillectomy / Adenoidectomy\nPre-op:\n•\nAssess OSA\nIntra-op: shared airway procedure\n•\nIntubation: south RAE\no\nBoyle-Davis ‘gag’: monitor airway pressures\n•\nAnalgesia:\no\nNSAIDs: no evidence for bleeding\no\nDexamethasone\no\nDexmed / clonidine (limited evidence)\no\nInconsistent evidence for: LA infiltration, magnesium\n•\nInconsistent evidence for antibiotics\n•\nSuction coroner’s clot\nPost-op:\n•\nAnalgesia: above + honey, acupuncture, opioid rescue\nPost-Tonsillectomy Haemorrhage\nIncidence 6%.\n•\nPrimary <24hr\n•\nSecondary >24hr (often D5 – 14)\nPre-op:\n•\nResuscitate\n•\nGroup + hold + alert blood bank\nIntra-op:\n•\nResuscitate prior to induction as best able, wide bore access\n•\nIntubation: RSI with cricoid (aspiration risk)\no\nPosition: head down or lateral decubitus\no\nDifficult airway equipment available\no\nSUCTION x2\no\nMcIntosh laryngoscope for direct laryngoscopy (blood can make VL difficult)\n•\nBlood management bundle\n•\nTXA\n•\nSend ROTEM if ongoing bleeding\n•\nPONV management +++ (blood is highly emetogenic)\n•\nExtubation:\no\nCompletely awake\no\nDrain stomach via NGT/OGT\nPost-op:\n•\nCan consider ICU for close monitoring", "citations": [{"type": "pdf_page", "page": 20, "label": "p20"}]}
{"chunk_id": "SSUs_v1_p021_txt_00_2438f8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 21, "page_end": 21, "section_path": ["HEAD & NECK / ENT", "Thyroid Surgery", "Thyroid Surgery"], "specialty_tags": ["HEAD & NECK / ENT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Thyroid Surgery", "keywords": [], "text": "Thyroid Surgery\nSee thyroid disease + thyroid storm elsewhere\nIndications:\n•\nThyroid surgery: nodules, hyperthyroid, goitre, cancer\n•\nParathyroid surgery: hyperparathyroidism (primary / tertiary)\nPre-op:\n•\nASSESS:\no\nHistory:\n▪\nAirway obstruction: stridor, sleeping, voice change, positional\n+/- RLN involvement\no\nExam: thyroid disease\n▪\nAirway ?obstruction, safe position\n▪\nConsider nasendoscopy\no\nIx:\n▪\nAim euthyroid last 3-6mo: TFTs, PTH, Ca2+, phosphate, vit D levels\n▪\nECG +/- TTE\n▪\nImaging:\n•\nAirway obstruction + extension of disease (retropharyngeal rare → laryngeal deviation +\nfailed intubation +/- surgical airway)\n•\nSVC obstructon\n•\nMANAGE: thyroid disease, arrhythmias\n•\nREFER:\no\nMDT management with ENT, endocrine\n▪\n?extent of disease ?requirement for neck dissection\nIntra-op:\n•\nLA: superficial cervical plexus + local infiltration\n•\nGA:\no\nIntubation: awake / spont vent intubation if airway risk\n▪\nNIM tube (in line with VC – monitors RLN) + low dose roc\n▪\nTIVA with reminfentanil\n•\nPositioning: shoulder roll, neck extended, arms tucked, head up\n•\nIntra-operative\n•\nMonitor for:\no\nThyroid storm\no\nPTH monitoring: short ½ life – PTH drop >50%\nconfidence all tissue excised\no\nCarotid vagal stimulation\no\nVAE\n•\nValsalva at end to check for haemostasis in trendelenberg\n•\nExtubation:\no\nAvoid BP + coughing / straining (remifentanil)\no\nRisk of tracheomalacia: consider AEC\nPost-op:\n•\nMonitor:\no\nHaematoma/airway: emergency equipment @ bedside\n▪\nDESATS ACRONYM\no\nRLN palsy: stridor, weak voice (unilateral okay, bilateral – airway emergency)\no\nTracheomalacia\no\nHypocalcaemia\n•\nRare complications:\no\nPneumothorax\no\nMyxoedema coma: extremely rare, DDx for unconsciousness (Rx IV thyroxine)\nTRH (hypothalamus, inhibited by\nsomatostatin) → TSH (anterior pituitary)\nThyroid fx: iodine → thyroid hormones\n•\n80% T4 (prohormone)\n•\n20% T3 (bioactive) – majority\nformed from conversion of T4\nParathyroid fx: produces PTH ( 1/Ca2+)\n•\nCa2+\nThyroid storm: acute + life-threatening -\nhypertension, HR, febrile, atrial fibrillation\n•\nSend TSH + T4 + T3 but do not wait for result\n•\nRx:\no\nFiO2, hyperventilate\no\nBP: beta-blockers\no\nBenzos for convulsion\no\nCooling: active + paracetamol\no\nBlock thyroid synthesis: PTU, carbimazole\no\nBlock release: iodine\no\nBlock T4 → T3: steroids, propranolol\no\nAF: amiodarone", "citations": [{"type": "pdf_page", "page": 21, "label": "p21"}]}
{"chunk_id": "SSUs_v1_p022_txt_00_0adeb5", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 22, "page_end": 22, "section_path": ["HEAD & NECK / ENT", "Post-Thyroidectomy Bleed / Airway Emergency", "Post-Thyroidectomy Bleed / Airway Emergency"], "specialty_tags": ["HEAD & NECK / ENT", "crisis", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Post-Thyroidectomy Bleed / Airway Emergency", "keywords": [], "text": "Post-Thyroidectomy Bleed / Airway Emergency\nLikely to be laryngeal oedema from venous congestion even if sutures released\nMajority <24 hr; 50% within 6hr post-op – no evidence incidence with drains\nDAS recommendations:\n•\nObs: q1 hourly first 6hr, vigilance for subsequent 18hr – includes wound + pain scoring\n•\nPost-thyroidectomy emergency box + grab bag at bed space\n•\nMonitor: DESATS acronym –\no\nDifficulty swallowing / discomfort\no\n(n)EWS – early warning score charts i.e. BTG\no\nSwelling\no\nAnxiety\no\nTachypnoea\no\nStridor\nIf ≥1\n▪\nFiO2 100% 15L NRB\n▪\nHead up 45 degrees\n▪\nImmediate senior review – if surgeons not available → anaesthetics\n▪\nAny signs of haematoma → EVACUATE superficial + deep layers – SCOOP\n•\nSkin exposure\n•\nCut sutures\n•\nOpen skin\n•\nOpen muscle\n•\nPack\n▪\nDexamethasone + TXA\n•\nIntubation if deterioration regardless of location:\no\nConsider flexible bronch\no\nAvoid multiple attempts\no\nEarly progression to FONA (needle cric preferred method)\n•\nDebrief\n•\nPsychological follow-up for patient\n•\nPreparation + ongoing training", "citations": [{"type": "pdf_page", "page": 22, "label": "p22"}]}
{"chunk_id": "SSUs_v1_p023_txt_00_01479b", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 23, "page_end": 23, "section_path": ["HEAD & NECK / ENT", "Surgical Tracheostomy", "Surgical Tracheostomy"], "specialty_tags": ["HEAD & NECK / ENT", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Surgical Tracheostomy", "keywords": [], "text": "Surgical Tracheostomy\nPatients are usually intubated and ventilated but can be awake under LA\nPre-op:\n•\nASSESS:\no\nHistory:\no\nExamination:\n▪\nAirway if not intubated\n▪\nVentilation requirements i.e. requiring O2 or just prolonged intubation / critical illness myopathy\n▪\nHaemodynamic requirements\no\nIx:\n▪\nCoags\n•\nMANAGE:\no\nCorrect coagulopathy\no\nAspirate NGT\n•\nREFER\nIntra-op: elective should be done in hours\n•\nPrepare for need to intubate from above\no\nDifficult airway, 2nd skilled assistant, ENT on standby throughout\no\nIf airway ≥2b consider placing bougie in case ENT loses airway\n•\nAirway:\no\nPre-oxygenate then minimise FiO2\n▪\nFiO2 <30%, cease for diathermy\no\nAdvance ETT prior to stoma formation – cuff distal to incision (between tracheal rings 2-3)\no\nWhen ready to exchange for trache tube withdraw ETT\no\nTrache tube inserted + connected to circuit – confirm ETCO2 prior to ETT removal\n▪\nAny doubt of false passage check with fibreoptic scope\nPost-op:\n•\nICU/HDU\n•\nEmergency trache equipment at bedside including appropriate signage\n•\nHumidified inspired gases\nFeatures of different trache tubes:\n•\nInner cannula: permits cleaning\n•\nAdjustable flange: useful in obese patients\n•\nFenestrations / speaking valve\nComplications:\n•\nEarly:\no\nBleed\no\nDislodgement +/- obstruction\no\nSubcut emphysema\no\nInfection\n•\nLate:\no\nStenosis\no\nPressure necrosis\no\nPersistent tracheocutaneous fistula\no\nTracheooesophageal fistula\no\nTracheoinnominate fistula", "citations": [{"type": "pdf_page", "page": 23, "label": "p23"}]}
{"chunk_id": "SSUs_v1_p024_img_6f85242a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 24, "page_end": 24, "section_path": ["HEAD & NECK / ENT", "Tracheostomy Emergency", "Tracheostomy Emergency"], "specialty_tags": ["HEAD & NECK / ENT", "crisis", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "algorithm_image", "modality": "image", "title": "Tracheostomy Emergency", "keywords": [], "text": "Emergency tracheostomy management - Patent upper airway Call for airway expert help Look, listen & feel at the mouth and tracheostomy ‘A Mapleson C system (e.g. ‘Waters circuit’) may help assessment if available Use waveform capnography when available: exhaled carbon dioxide indicates a patent or partially patent airway No Is the patient breathing? Call Resuscitation Team Apply high flow oxygen to BOTH CPR if no pulse / signs of life the face and the tracheostomy Assess tracheostomy patency Remove speaking valve or cap (if present) Remove inner tube ‘Some inner tubes need re-inserting to connect to breathing circuits The tracheostomy tube is patent Can you pass a suction catheter? Perform tracheal suction No Consider partial obstruction Ventilate (via tracheostomy) if Deflate the cuff (if present) not breathing Look, listen & feel at the mouth and tracheostomy Continue ABCDE assessment Use waveform capnography or Mapleson C if available Tracheostomy tube partially obstructed or displaced Is the patient stable or improving? Continue ABCDE assessment REMOVE THE TRACHEOSTOMY TUBE Look, listen & feel at the mouth and tracheostomy. Ensure oxygen re-applied to face and stoma Use", "image": {"paths": ["p024_img689.png"], "ocr_text": "Emergency tracheostomy management - Patent upper airway\n\nCall for airway expert help\nLook, listen & feel at the mouth and tracheostomy\n‘A Mapleson C system (e.g. ‘Waters circuit’) may help assessment if available\nUse waveform capnography when available: exhaled carbon dioxide indicates a patent or partially patent airway\n\nNo Is the patient breathing?\nCall Resuscitation Team Apply high flow oxygen to BOTH\nCPR if no pulse / signs of life the face and the tracheostomy\n\nAssess tracheostomy patency\n\nRemove speaking valve or cap (if present)\nRemove inner tube\n‘Some inner tubes need re-inserting to connect to breathing circuits\n\nThe tracheostomy tube is patent\nCan you pass a suction catheter? Perform tracheal suction\nNo\n\nConsider partial obstruction\nVentilate (via tracheostomy) if\nDeflate the cuff (if present) not breathing\nLook, listen & feel at the mouth and tracheostomy Continue ABCDE assessment\nUse waveform capnography or Mapleson C if available\n\nTracheostomy tube partially\n\nobstructed or displaced\nIs the patient stable or improving? Continue ABCDE assessment\n\nREMOVE THE TRACHEOSTOMY TUBE\nLook, listen & feel at the mouth and tracheostomy. Ensure oxygen re-applied to face and stoma\nUse waveform capnography or Mapleson C if available\n\nCall Resuscitation team Continue ABCDE\nCPR if no pulse / signs of life assessment\n\nPrimary emergency oxygenation ‘Secondary emergency oxygenation\n\nStandard ORAL airway manoeuvres Attempt ORAL intubation\n\nCover the stoma (swabs / hand). Use: Prepare for difficult intubation\nBag-valve-mask Uncut tube, advanced beyond stoma\nOral or nasal airway adjuncts\nSupraglottic airway device e.g. LMA\n\nAttempt intubation of STOMA\n\nTracheostomy STOMA ventilation ‘Small tracheostomy tube / 6.0 cuffed ETT\nPaediatric face mask applied to stoma Consider Aintree catheter and fibreoptic\nLMA applied to stoma ‘scope / Bougie / Airway exchange catheter\n\nNational Tracheostomy Safety Project. Review date 1/4/16. Feedback & resources at www.tracheostomy.org.uk"}, "citations": [{"type": "pdf_page", "page": 24, "label": "p24"}]}
{"chunk_id": "SSUs_v1_p025_txt_00_2c71ad", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 25, "page_end": 25, "section_path": ["HEAD & NECK / ENT", "Transoral Robotic Surgery", "Transoral Robotic Surgery"], "specialty_tags": ["HEAD & NECK / ENT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Transoral Robotic Surgery", "keywords": [], "text": "Transoral Robotic Surgery\nPreviously restricted “line of sight” has limited transoral surgery → transfacial or transmandibular approach (overcome by TORS)\nIndications: oral cavity, larynx, pharynx, tongue base, radical tonsillectomy, other complex oral lesions\nCI: trismus / limited MO, macroglossia, mandibular or maxillary invasion, carotid or bone involvement\nPre-op:\n•\nDentition\n•\nAirway\n•\nNeed for trache: often in salvage surgery + excessive resections\nIntra-op: shared airway procedure\n•\nAirway: reinforced nasal tube (6/6.5) on contralateral side to operation, or north RAE – check cuff pressure\n•\nMeticulous padding + positioning\n•\nGag used – stimulating\n•\nDeeply paralysed – LL NM monitoring + full reversal end of case\n•\nLaser safety\n•\nDocument airway details\n•\nValsalva at end to check bleeding\nPost-op:\n•\nAirway details at patient bedside\n•\nGenerally remain intubated in immediate post-op period\n•\nDexamethasone (pain, LOS, swallowing)\nComplications: bleeding + aspiration most common, then lacerations, dental damage, mandibular #, cervical spine #, ocular\ninjury, dysphagia, dehydration, PEG dependency, nerve injuries (hypoglossal, lingual)", "citations": [{"type": "pdf_page", "page": 25, "label": "p25"}]}
{"chunk_id": "SSUs_v1_p026_txt_00_905bf4", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 26, "page_end": 26, "section_path": ["HEAD & NECK / ENT", "Obstructing Organic Lesions", "Obstructing Organic Lesions"], "specialty_tags": ["HEAD & NECK / ENT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Obstructing Organic Lesions", "keywords": [], "text": "Obstructing Organic Lesions\nFor all:\n•\nTHRIVE / FiO2 100%\n•\nDifficult intubation trolley\n•\nSkilled anaesthetic assistant\n•\nBronchoscope\n•\nENT on standby +/- ECMO\n•\nNasendoscopy very useful tool\nPre-OT management of stridor: CASH\n•\nCPAP (including HFNP)\n•\nAdrenaline\n•\nSteroids\n•\nHeliox\nAirway: must remain spont venting\n•\nTopicalisation\n•\nProcedure:\no\nSupraglottic: AFOI with topicalization\no\nGlottic / subglottic:\n▪\nNasendoscopy:\n•\nIf likely able to intubate:\no\nVL\no\nNeck marked + LA infiltrated +/- cannula + ENT on standby\n•\nIf risk of ‘cork in bottle’ → awake tracheostomy\nENT scrubbed on standby\nRemoval of Inhaled Foreign Body\nMust ascertain exact location of FB from imaging.\nFor all:\n•\nFiO2 100% 15L NRB - do not use THRIVE or positive pressure\n•\nDifficult intubation trolley\n•\nSkilled anaesthetic assistant\n•\nBronchoscope\n•\nENT on standby +/- ECMO\n•\nNasendoscopy very useful tool\nManagement:\n•\nTIVA spont vent induction\n•\nIf using rigid bronch to retrieve object aim to deliver O2 down side arm of rigid bronch\nFractured Nose Reduction\nAnaesthesia:\n•\nLA: bilateral infraorbital blocks + topical LA to septum and nasal floor\n•\nGA: associated with better patient satisfaction, improved appearance and function of nose, reduced need for corrective\nsurgeries (septoplasty, septorhinoplasty, rhinoplasty)", "citations": [{"type": "pdf_page", "page": 26, "label": "p26"}]}
{"chunk_id": "SSUs_v1_p027_txt_00_4dbcd0", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 27, "page_end": 27, "section_path": ["HEAD & NECK / ENT", "Head and Neck Infections", "Head and Neck Infections"], "specialty_tags": ["HEAD & NECK / ENT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Head and Neck Infections", "keywords": [], "text": "Head and Neck Infections\nSpread of infection via fascial planes - neck contains 2x fascial layers in communication with each other:\n•\nSuperficial fascia\n•\nDeep fascia\no\nCervical / superficial fascia\no\nPre-tracheal fascia\n▪\nContains danger space: extends to mediastinum (located\nposterior to retropharyngeal, anterior to prevertebral\nfascia)\no\nPrevertebral fascia\nSpaces:\n•\nSubmandibular e.g. Ludwigs angina (mainly 2’ to dental extraction /\ninfection)\n•\nParapharyngeal\n•\nRetropharyngeal\nPre-op:\n•\nASSESS:\no\nHistory: worsening or improved with abx, able to lie flat\no\nExam:\n▪\nDysphagia, dysphonia, trismus (interdental distance), positional changes, tracheal deviation\n•\nTrismus 2’ infection often doesn’t relax with anaesthesia cf trismus 2’ trauma\n▪\nTongue protrusion – suggests sublingual involvement\n▪\nDrooling + stridor are late signs\n▪\nSubcut emphysema\no\nIx:\n▪\nImaging\n▪\nNasendoscopy\n•\nMANAGE:\no\nCASH\n•\nREFER:\no\nENT, ICU\nIntra-op:\n•\nIntubation: no universal agreement – pathology dependent\no\nENT team scrubbed on standby\n•\nExtubate with caution: drainage does not = swelling\nPost-op:\n•\nHDU/ICU\nComplications:\n•\nPeriorbital cellulitis\n•\nCavernous sinus thrombosis\n•\nFacial vein thrombosis\n•\nLemierres (IJ thrombus 2’ infection)\n•\nMediastinitis\n•\nRupture into airway\n•\nAirway obstruction\n•\nHaematogenous spread", "citations": [{"type": "pdf_page", "page": 27, "label": "p27"}]}
{"chunk_id": "SSUs_v1_p028_txt_00_60d43f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 28, "page_end": 28, "section_path": ["HEAD & NECK / ENT", "Facial Trauma", "Maxillofacial Surgery"], "specialty_tags": ["HEAD & NECK / ENT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Maxillofacial Surgery", "keywords": [], "text": "Maxillofacial Surgery\nSame considerations as oropharyngeal surgery+\nPre-op:\n•\nASSESS:\no\nSame as oropharyngeal sx\no\nPrevious airway\no\nNasendoscopy if multiple procedures +/- radiotherapy\n•\nMANAGE:\n•\nREFER:\no\nMDT: maxfacs + ICU\nIntra-op:\n•\nIntubation: likely nasal intubation\n•\nThroat pack if indicated\n•\nTwo-stage operations (resection, reconstruction) very long surgery: pressure points\n•\nHypotension for bone work: difficult to stop bone bleeding, helps with surgical conditions\no\nAvoid if: carotid stenosis, AS/MS, stage 4 kidney disease\n•\nFree flap considerations (if applicable)\n•\nIf considerable bleeding empty stomach of blood with OGT + suction with laryngoscope\n•\nExtubation position:\no\n30 degrees head up if risk of bleeding from venous congestion\no\nLeft lateral and head down if risk of airway soiling\n•\nSmooth extubation: can use remifentanil or switch ETT for LMA and wake slowly if safe\no\nSuction via tube as withdrawing\no\nCan withdraw nasal ETT to 15cm and cut to form NPA – place safety pin to prevent unwanted insertion", "citations": [{"type": "pdf_page", "page": 28, "label": "p28"}]}
{"chunk_id": "SSUs_v1_p028_txt_01_52654f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 28, "page_end": 28, "section_path": ["HEAD & NECK / ENT", "Facial Trauma", "Facial Trauma"], "specialty_tags": ["HEAD & NECK / ENT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Facial Trauma", "keywords": [], "text": "Facial Trauma\nBeware associated injuries: brain, C-spine, mandible / maxilla / orbit, base of skull, epistaxis, airway oedema, neck, chest /\nabdominal, bleeding (blood in stomach → aspiration risk), dental injury\nAnatomy:\n•\nLower third:\no\nBilateral anterior mandible: tongue falls back\no\nSublingual haematoma\no\nTeeth loss\n•\nMiddle third: maxilla, zygoma, lower half orbit\no\ni.e. le fort fractures\n•\nUpper third: frontal, sphenoid, orbit – consider skull base\nPre-op:\n•\nKnow details of injury + planned mode of repair i.e. arch bars versus fixation screws versus Ivy loops\n•\nAssess for trismus and evidence of TMJ injury – may require awake nasal intubation\n•\nMust assess for possible base of skull # or CSF leak precluding nasal intubation\nIntra-op: as above+\n•\nMay require nasal intubation\n•\nThroat pack\n•\nPrepare for bradycardia when zygoma/mid-face fracture reduced i.e. “Gillies lift”\n•\nMay require controlled hypotension\n•\nBlood loss management\nPost-op:\n•\nIntermaxillary fixation rare these days, usually removable bands, but if used wire cutters must\nbe immediately available + surgeons present for extubation\n•\nProlonged stay in recovery before ICU / appropriate ward\n•\nConsider delayed extubation – must check for cuff leak", "citations": [{"type": "pdf_page", "page": 28, "label": "p28"}]}
{"chunk_id": "SSUs_v1_p029_txt_00_21020b", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 29, "page_end": 29, "section_path": ["HEAD & NECK / ENT", "Electroconvulsive Therapy", "Electroconvulsive Therapy"], "specialty_tags": ["HEAD & NECK / ENT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Electroconvulsive Therapy", "keywords": [], "text": "Electroconvulsive Therapy\nIndications: medication resistant depression, bipolar/mania, schizophrenia/schizoaffective, catatonia, NMS\nMOA: GCTS under GA\nCI:\n•\nMI or CVA within 3/12\n•\nICP\n•\nUncontrolled HF\n•\nDVT\n•\nUntreated cerebral aneurysm\n•\nUnstable major fracture/osteroporosis\n•\nPhaeochromocytoma\n•\nRetinal detachment / glaucoma\nMethod:\n•\n2x electrodes\no\nUnilateral: cochlear implants, less cognitive adverse effects (if non-dominant)\no\nBilateral: faster effect\n•\nTwice weekly ~10-12 treatments (maintenance thereafter not recommended) or until lack of improvement\nEvidence:\n•\nSome recent narrative reviews debating efficacy – low level evidence\n•\nMeta-analyses and systematic reviews:\no\nNo evidence for ECT over pharmacotherapy if used alone, supports superior outcomes in conjunction with\npharmacotherapy – however many limitations\no\nNo difference in MMSE between ECT and no ECT\nPhysiological effects:\n•\nCVS:\no\nInitially parasympathetic response: salivation, bradycardia, hypotension, asystole\no\n→ sympathetic response: BP 30-40%, HR 20%, CO (myocardial VO2)\n•\nCerebral: CMRO2, CBF, ICP\n•\nOther: IOP, intragastric pressure, headache, myalgia, dental damage, hypersalivation\nComplications:\n•\nCVS: MI/MACE\n•\nNeuro: ICH, TIA, cortical blindness, prolonged seizures, cognitive (memory, disorientation, retro- + antegrade amnesia)\no\nMinimised by: altered stimulus intensity/waveform, unilateral electrodes, longer inter-ECT interval\n•\nMortality 1/10,000\nAgent\nAdvantages\nDisadvantages\nPropofol\n•\nPONV\n•\nRapid onset, offset\n•\nShortest seizure duration\n•\nPain on injection\nThiopentone\n•\nBetter seizure quality\n•\narrhythmias\n•\nShort seizure duration\n•\nPrecipitates with sux\nKetamine\n•\nEffective in resistant\nseizures\n•\nduration\n•\nEmergence phenomenon\n•\nCVS stability\n•\nICP\nSevoflurane\n•\nDifficult IV access\n•\nTocolytic in pregnancy\n•\nSlow induction\nDexmed\n•\nNo effect on seizure\nduration\n•\nMAP, HR", "citations": [{"type": "pdf_page", "page": 29, "label": "p29"}]}
{"chunk_id": "SSUs_v1_p030_txt_00_ae7fcf", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 30, "page_end": 30, "section_path": ["HEAD & NECK / ENT", "Electroconvulsive Therapy"], "specialty_tags": ["HEAD & NECK / ENT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Electroconvulsive Therapy", "keywords": [], "text": "Pre-op:\n•\nASSESS:\no\nMust know if voluntary or involuntary: capacity / consent\no\nHistory: poor historians, elderly, comorbid\n▪\nAspiration risk\no\nExam: cardiac, airway\no\nIx:\n▪\nECG + bloods first time\no\nMedications: d/w psych\n▪\nMAOis: hypertension if indirection sympathomimetics used\n▪\nLithium: risk of delirium, prolonged seizures, toxic lithium levels, neuromuscular blockade\n•\nAvoid if possible, if cannot be discontinued omit day prior or monitor closely\n▪\nBenzos: seizure threshold, withhold prior if able\n▪\nEnsure PPI + anti-hypertensives taken prior\n•\nMANAGE:\no\nSpecial populations:\n▪\nPPM switch to fixed rate, ICD will require magnet\n▪\nPregnancy: pre-procedure tocolysis (otherwise safe)\n▪\nDBS: disable device via manufacturer\n•\nREFER:\no\nAny CI\nIntra-op: often remote anaesthesia + high turnover – check all emergency equipment\n•\nPre-ECT: empty bladder, glycol if previous bradycardia\n•\nMonitoring: routine + 5-lead ECG if CVS dz\n•\nGoals: rapid onset + offset, muscle relaxation for safety, manage physiological effects\n•\nInduction:\no\nBite block\no\nPropofol 1mg / kg, sux 0.5mg/kg\no\nHyperventilate to seizure threshold (ETCO2 ~30mmHg) + hyperoxia\no\nAdjuncts:\n▪\nBeta-blockers for HR/BP\n▪\nCan use low dose remi/alfentanil at induction to reduce anaesthetic agent\no\nAvoid:\n▪\nIndirect sympathomimetics if on TCA, MAOi\n▪\nOndans, fentanyl, metoclopramide if on SSRI\n•\nTerminate seizure if >2 mins\n•\nSupport airway whilst waking\nPost-op:\n•\nSide effects: confusion, agitation, violence, amnesia, headache, myalgia, PONV\n•\nComplications: MACE 1/50\n•\nPost-op agitation: IV benzo, dexmed, antipsychotic", "citations": [{"type": "pdf_page", "page": 30, "label": "p30"}]}
{"chunk_id": "SSUs_v1_p031_txt_00_2d9f5f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 31, "page_end": 31, "section_path": ["CARDIAC SURGERY", "Cardiac Surgery"], "specialty_tags": ["CARDIAC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Cardiac Surgery", "keywords": [], "text": "Cardiac Surgery\nIx:\n•\nECG, TTE, CXR, +/- spiro +/- CT chest +/- RH cath\n•\nIx: Hb, HbA1c, albumin (vent, infection, mortality), EUC, coags, G&H x-match x2, plt count\no\nAnaemia → iron studies → treat (anaemia independent RF, end up requiring more transfusions)\n•\nCardiac cath\no\nLCx → OM\no\nLAD (is actually a branch of LCx) → diagonals + septal perforators\n*intermediates occur at a trifurcation\no\nRCA → acute marginals + posterior descending artery (may join LAD) + posterior branch to LV\nAssess dominance i.e. PDA (80% right, 20% left)\nAssess CI to TOE:\n•\nAbsolute: perf, stricture, tumour, diverticulum, active bleed\n•\nRelative: neck radiation, GI surgery, recent bleed, Barrett’s, dysphagia, restricted neck ROM, varices, hiatus hernia,\ncoagulopathy, oesophagitis\nUnsure: gastroscopy start of case\nExamination: routine +dental health (valves), skin integrity\nOptimisation:\n•\nModifiable RFs\n•\nPre-op CEA for carotid stenosis\n•\nTarget HbA1c <6.5%\n•\nIntra-nasal muciprocin (Staph aureus sternal wound infection)\n•\nRehabilitation\nMedication:\n•\nContinue: beta blocker, statin, aspirin (ATACUS)\n•\nWithhold:\no\nClopidogrel/prasugrel/ticagrelor 5 – 7 days\no\nWarfarin 5 days\no\nDOACs 3 – 5 days\nConsent:\n•\nMortality: EUROSCORE II\n•\n1-2% permanent handicap\n•\nPost-op analgesia challenging\n•\nPost-op depression frequent (generally self-limiting)\n•\nPOCD\n•\nAwareness: 1/8600\n•\nRisks of TOE: consent\n•\nGeneral risk of GA: dental damage (ETT + TOE), risk of allergy / adverse drug reactions", "citations": [{"type": "pdf_page", "page": 31, "label": "p31"}]}
{"chunk_id": "SSUs_v1_p032_txt_00_ba2b92", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 32, "page_end": 32, "section_path": ["CARDIAC SURGERY", "Fast Track Cardiac Surgery", "ERAS Cardiac Surgery"], "specialty_tags": ["CARDIAC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "ERAS Cardiac Surgery", "keywords": [], "text": "ERAS Cardiac Surgery\nPre-op:\n•\nEUROSCORE – risk\n•\nHbA1c <6.5% (myocardial injury and infections)\n•\nAlbumin + nutrition (low albumin associated with prolonged ventilation, AKI, infection, LOS, mortality)\n•\nAnaemia: Hb <100 → 5x mortality\n•\nPrehabilitation: education + patient engagement tools, exercise, lifestyle modification\no\nStopping smoking + hazardous alcohol consumption for 4/52 prior to surgery\n•\nPre-op carb loading (24g complex carbs night prior + 2hr pre-op)\n•\nInfection reduction care bundle (see below)\nIntra-op:\n•\nUse of TXA on pump\n•\nGoal directed fluid therapy\n•\nMultimodal, opioid sparing analgesia\n•\nAvoiding T >37.9 whilst re-warming on CPB\n•\nRigid sternal fixation\n•\nPONV prophylaxis\nPost-op:\n•\nAim extubation within 6hr post-op\n•\nAvoidance of T <36 (bleeding, infection, LOS, mortality)\n•\nInsulin infusions to treat hyperglycaemia\n•\nPost-op delirium screening once per nursing shift post-op (CAM-ICU)\n•\nVTE prophylaxis\n•\nMaintenance of chest tube patency\n•\nAvoid breaking sterile field of chest drains to remove clots\nSurgical infection:\n•\nLevel I recommendation:\no\nIntranasal decolonisation prior to surgery\no\nCephalosporin 30-60 min prior to surgery\no\nClipping > shaving prior to surgery\n•\nLevel II recommendation:\no\nChlorhex based skin prep\no\nRemove operative wound dressing after 48 hours", "citations": [{"type": "pdf_page", "page": 32, "label": "p32"}]}
{"chunk_id": "SSUs_v1_p032_txt_01_f833d8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 32, "page_end": 32, "section_path": ["CARDIAC SURGERY", "Fast Track Cardiac Surgery", "Fast Track Cardiac Surgery"], "specialty_tags": ["CARDIAC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Fast Track Cardiac Surgery", "keywords": [], "text": "Fast Track Cardiac Surgery\nFast track: extubated and transferred from ICU to step down unit on same day as surgery\nAssociated with:\n•\nICU and total LOS\n•\nSimilar 30-day post-op outcomes (all-cause mortality, stroke, renal failure, infection, AF, and readmission)\nFast tracking appropriate patients may reduce resource utilisation whilst maintaining patient safety", "citations": [{"type": "pdf_page", "page": 32, "label": "p32"}]}
{"chunk_id": "SSUs_v1_p033_txt_00_58b480", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 33, "page_end": 33, "section_path": ["CARDIAC SURGERY", "On Pump", "Coronary Artery Bypass Surgery"], "specialty_tags": ["CARDIAC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Coronary Artery Bypass Surgery", "keywords": [], "text": "Coronary Artery Bypass Surgery\nIndications: left main >50%, TVD >70% +/- prox LAD, two vessel dz (LAD + other major), ≥one stenosis >70% w/ sig SSx, ≥one\nstenosis >70% w/ cardiac arrest or ischaemia related tachycardia", "citations": [{"type": "pdf_page", "page": 33, "label": "p33"}]}
{"chunk_id": "SSUs_v1_p033_txt_01_866aa1", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 33, "page_end": 33, "section_path": ["CARDIAC SURGERY", "On Pump", "On Pump"], "specialty_tags": ["CARDIAC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "On Pump", "keywords": [], "text": "On Pump\nPre-op:\n•\nASSESS:\no\nCI to bypass: e.g. porcelain aorta or TOE\n•\nMANAGE: consent / optimise\n•\nREFER/DISCUSS: CTSx, ICU +/- ECMO\nIntra-op:\n•\nMonitoring: sats, 5-lead ECG, art line, CVC + PAC, temp x2, BIS, NIRS\n•\nDrugs: TXA, abx\n•\nMaintenance: sevo (ischaemic pre-conditioning)\n•\nTOE post-induction: 5% changes op course\n•\nSternotomy: lungs off\n•\nHarvesting of internal mammary: VT\nOn pump: HAD2SAVE\n•\nHeparin: 300-400 units / kg\n•\nACT >480s\n•\nDrugs: paralysis, volatile via CBP or TIVA\n•\nDrips: turn off inotropes, fluids\n•\nSwan: pull PA catheter back 5cm to avoid pulmonary arterial occlusion / rupture when pulmonary arteries collapse\n•\nAlarms: disable\n•\nVentilator: off when bypass “full flow”\n•\nEmboli: check arterial cannula for bubbles\nBypass: RA venous, arch arterial return (arterial first in last out – sBP <100 dissection risk)\nBypass components: venous cannula → reservoir → pump → combined filter / oxygenator / warmer → arterial\nCardioplegia: temp: 25 - 32C (gradient <10C)\n•\nAntegrade: aortic root (requires competent AV)\n•\nRetrograde: coronary sinus (risk missing some veins – incomplete)\nFlow:\n•\nRate: BSA x CI (~2.4L/min/m2)\n•\nVO2: (CaO2 – CvO2) x CO\nMonitoring:\n•\nPump flow: SvO2 <75% → flow\n•\nBlood: ABQ q30 min (pH, iCa), ACT, SvO2, Hb, Hct >25%, K, BSL\no\nHCT on CPB = blood volume x Hct / total circuit volume\n•\nHeparin re-dosing: based on ACT\nWean from CPB: TRAVEL\n•\nTemp: re-warm 0.5C/min to >36.5, temp gradient <4C, TOE\n•\nRate, rhythm, reversal ready (protamine – 0.6x initial heparin bolus volume)\n•\nAir, acid-base, ABG, anaesthesia, alarms on\n•\nVentilation (oxygenation), vasopressors (aim SVR 1000-1200)\n•\nElectrolytes (K+, Ca2+)\n•\nLevel (bed + volume in reservoir)\nProtamine after venous decannulation, prior to arterial decannulation – sBP <100\nCheck pacemaker settings\nPost-bypass TOE + re-check ACT", "citations": [{"type": "pdf_page", "page": 33, "label": "p33"}]}
{"chunk_id": "SSUs_v1_p034_txt_00_3b6373", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 34, "page_end": 34, "section_path": ["CARDIAC SURGERY", "Off Pump", "Off Pump"], "specialty_tags": ["CARDIAC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Off Pump", "keywords": [], "text": "Off Pump\nIndications: porcelain aorta\nConsiderations:\n•\nWarming patient more difficult (as pump helps to warm)\n•\nNeed to keep well filled\n•\nControl HR and rhythm throughout\n•\nPatient is still heparinised (?ACT target)\n•\nLIMA to LAD first to optimise perfusion to pericardium (cf on pump)\nTrials have shown no benefit to on pump surgery – ROOBY trial:\n•\nNo difference in composite 30-day outcome: death & complications\n•\n1 year follow-up: patients with off-pump had worse outcomes + poorer graft patency cf on-pump\n•\nNo significant differences in neuropsychological outcomes", "citations": [{"type": "pdf_page", "page": 34, "label": "p34"}]}
{"chunk_id": "SSUs_v1_p035_txt_00_42552e", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 35, "page_end": 35, "section_path": ["CARDIAC SURGERY", "Deep Hypothermic Circulatory Arrest", "Deep Hypothermic Circulatory Arrest"], "specialty_tags": ["CARDIAC SURGERY", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Deep Hypothermic Circulatory Arrest", "keywords": [], "text": "Deep Hypothermic Circulatory Arrest\nIndications:\n•\nCardiac: aortic arch/thoracic aorta, pulmonary thrombo-endarterectomy, congenital surgery\no\nAortic arch: assess for compression of tracheobronchial tree i.e. stridor or oesophagus i.e. dysphagia\n•\nNeuro: aneurysm, complex AVM\n•\nOther: RCC with caval invasion, other tumours\nAim:\n•\nCirculatory arrest → optimises operating conditions\n•\nDeep hypothermia → neuroprotection (CMRO2 7%/1C <37C at 18C 60% will have isoelectric EEG)\nPre-op: CAGS +\n•\nDocument neuro exam\nIntra-op:\n•\nAs for CPB → full flows\n•\nNeuromonitoring: EEG, NIRS, SSEPs, jugular venous bulb sats\n•\nCooling: temp gradient <10C (to avoid air bubbles)\no\nMonintor temp @ 2 sites: NPA (best measure of brain temp) + bladder\n•\nNeuroprotection:\no\nPropofol + steroids prior to flow arrest\no\nExtremely tight BSL control\no\nHct 20% / Hb 75 to improve microcirculation\n•\nAt 18-20C → partial exsanguination, heparinised blood in stasis\no\nSafe period:\n▪\n~30mins of arrest at 18°C\n▪\n40min: marked brain injury\n▪\n60min majority will have brain injury\n•\nMaintenance: no evidence for TIVA v volatile via circuit\n•\nAdjuvant perfusion strategies i.e. cerebroplegia:\no\nSelective antegrade cerebral perfusion\no\nRetrograde cerebral perfusion\n•\nRewarming: temp gradient <5C, T <37C, rewarming rate <0.5C/min, core temp <36.5C\nBlood gas measurements:\n•\nAlpha stat: measure at <37C – not temp corrected\n•\npH stat: target normal pH, pCO2 regardless of actual temp\nNo evidence of benefit for either technique\nRecommendations for DHCA:\n•\nAdults: alpha-stat\n•\nPaeds: pH stat during cooling and alpha stat during rewarming\nConsequences:\n•\nCVS: arrhythmia, blood viscosity, vasoconstriction, impaired microcirculation\n•\nHaem: coagulopathy, plt fx, RBC rigidity\n•\nMetabolic: acidosis, hyperglycaemia, altered PK and PD\n•\nRenal: GFR\n•\nNeuro: hyperthermia during warming risk of brain injury, post-op cognitive dysfunction, stroke ~10%", "citations": [{"type": "pdf_page", "page": 35, "label": "p35"}]}
{"chunk_id": "SSUs_v1_p036_txt_00_9a41bc", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 36, "page_end": 36, "section_path": ["CARDIAC SURGERY", "Minimally Invasive Cardiac Surgery", "Minimally Invasive Cardiac Surgery"], "specialty_tags": ["CARDIAC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Minimally Invasive Cardiac Surgery", "keywords": [], "text": "Minimally Invasive Cardiac Surgery\nAdvantages:\n•\nPost-op pain\n•\nCosmetics\n•\nEarly mobilsation + LOS\n•\nBlood loss\nVATS Surgery\nMost common is MV surgery. Right antero-lateral approach or minithoracotomy + ports.\nRequirements:\n•\nOLV\n•\nNIRS\n•\nTOE\n•\nPeripheral CPB – more dangerous than central cannulation\no\nVacuum drainage can lead to airlocks or haemolysis\n•\nAortic occlusion for cardioplegia: either clamp or endoballoon (endoballoon technically difficult)\nPre-op:\n•\nAs for sternotomy – must be prepared to convert if needed\nIntra-op:\n•\nUsual cardiac / sternotomy\n•\nDLT\n•\nTOE: check endoballoon\n•\nIn contrast to sternotomy femoral venous cannulation first?\nComplications:\n•\nConversion to sternotomy (main reason is bleeding)\n•\nPost-op bleeding: 2’ incomplete opening of pericardium, difficult assessment via TOE\n•\n2’ retrograde / peripheral CPB: neurological complications, stroke, aortic dissection\n•\nNerve injury: positioning, phrenic nerve, pressure points\n•\nHarlequin syndrome: hemicerebral ischaemia (improved by ventilation of L lung with 100% FiO2 until diastolic arrest)\n•\nOLV complications\n•\nRe-expansion pulmonary oedema", "citations": [{"type": "pdf_page", "page": 36, "label": "p36"}]}
{"chunk_id": "SSUs_v1_p037_txt_00_5056d9", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 37, "page_end": 37, "section_path": ["CARDIAC SURGERY", "Transcatheter Mitral Valve Repair", "Transcatheter Mitral Valve Repair"], "specialty_tags": ["CARDIAC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Transcatheter Mitral Valve Repair", "keywords": [], "text": "Transcatheter Mitral Valve Repair\nIndications: severe primary MR + high surgical risk, if secondary MR optimise HF / CAD first\nCI:\n•\nValve: area <3cm2, leaflet length <6mm, mean pressure gradient >5mmHg, calcification at grasping area, thrombus,\nregurg at commissure\n•\nAtrial access: unable to achieve >35mm above MV on intra-atrial septum, very small LA\nPre-op: cardiac+\n•\nLV function: LVEF <40% risk of afterload mismatch and worsening LV – not CI, just be aware\n•\nFavourable anatomy + access\n•\nCI to TOE\n•\nMedications: continue BB, anti-arrhythmics, antiplt + diuretics; WH warfarin / DOACs\n•\nRhythm: SR if able\n•\nCIED check\n•\nRisk of conversion < TAVI (rare)\nIntra-op:\n•\nMonitoring: routine + art line\n•\nInduction: prop, remi, roc; avoid benzos\n•\nUsual MR goals: high normal HR, euvolaemia, reduced afterload, SR\no\nAF: treat, no thrombus on TOE can cardiovert\n•\nAid procedure / coaptation gap:\no\nVentilation: PEEP 5 – 10 (can aid device placement), Vt 3-6mL/kg reduces movement\no\nLV size: diuretics\nProcedure:\n•\nFemoral v. puncture → heparin (ACT 250 – 300) → atrial septal puncture\n•\nClips placed\n•\nAfter clips placed must normalise BP to patient awake state and assess for MR prior to deployment → deployed\n•\nAssessment, aiming mean diastolic gradient ≤6mmHg\n•\nSubjective closure of atrial defect based on shunting\n•\n+/- heparin reversal\n•\nFemoral access closure device – 1hr bed rest\n•\nIf oropharangeal topicalization used must wear off prior to PO intake\nTTE within 24hr: ?residual MR +/- new MS, assess ASD if not closed\nRx: antiplatelet only (only anti-coagulate if already taking for other reason)\nComplications:\n•\nBleeding (retroperitoneal is rare but possible)\n•\nTOE complications\n•\nAKI\n•\nDelayed tamponade\n•\nArrhythmia\n•\nPulmonary oedema +/- hypoxia (possible if new MS, excess fluids)", "citations": [{"type": "pdf_page", "page": 37, "label": "p37"}]}
{"chunk_id": "SSUs_v1_p038_txt_00_30fa5f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 38, "page_end": 38, "section_path": ["TAVI", "TAVI"], "specialty_tags": ["TAVI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "TAVI", "keywords": [], "text": "TAVI\nIndications: severe AS not suitable for sAVR (consider comorbidity, age, porcelain aorta, previous surgery)\n•\nIndications for surgery: EUROSCORE <10%, anatomy not suitable for TAVI, endocarditis, LV thrombus, other cardiac\ncondition that requires surgical intervention\nAbsolute CI: endocarditis\nRelative CI: life expectancy <2y + anatomical adverse features\nTrials have shown equivalence and superiority to sAVR in high- and intermediate- risk patients\nPre-op: cardiac+\n•\nFavourable anatomy\n•\nAssess for conversion\nIntra-op:\n•\nMonitoring: routine + art line\n•\nAnaesthetic: no difference in outcomes with GA v LA (usually LA + conscious sedation)\no\nSedation: must be able to breath hold, benefit of neuro examination\no\nGA required if TOE needed\n•\nAccess: usually femoral artery → retrograde implantation\n•\nHeparin ~5000iu → ACT 250s\n•\nType of valve:\no\nCore: self-expanding, can be repositioned\no\nSapien: balloon expanding, once deployed is stuck\n•\nValve deployment: rapid ventricular pacing 200bpm → sBP <50mmHg for 5 – 10s – avoid misplacement\n•\nPost-deployment: must check for leaks +/- need for reintervention + check coronaries for obstruction\nPost-op: 3-6mo of DAPT followed by aspirin only (if already anticoagulated recommence and add clopidogrel for 3mo)\nComplications:\n•\nVascular injury\n•\nEmbolisation\n•\nParavalvular regurgitation\n•\nOstial obstruction\n•\nTamponade\n•\nAV block\n•\nPEA\n•\nAsystole\n•\nStroke\n•\nAKI", "citations": [{"type": "pdf_page", "page": 38, "label": "p38"}]}
{"chunk_id": "SSUs_v1_p039_txt_00_8ebc7a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 39, "page_end": 39, "section_path": ["TAVI", "Pericardial Effusion / Tamponade", "Pericardial Effusion / Tamponade"], "specialty_tags": ["TAVI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pericardial Effusion / Tamponade", "keywords": [], "text": "Pericardial Effusion / Tamponade\nDefinitions:\n•\nEffusion: fluid in pericardial space\n•\nTamponade: when pericardial effusion → pressure → ventricular filling and CO\nCauses:\n•\nEffusion:\no\nInfectious: viral, bacterial, TB, fungal, parasitic\no\nNon-infectious: idiopathic, trauma, uraemia, neoplastic, autoimmune, Dressler’s syndrome (i.e. sterile\npericarditis post-MI), hypothyroidism, radiation\nCommon causes of tamponade: pericarditis, tuberculosis, trauma, malignancy, iatrogenic (e.g. cardiac surgery, invasive\nprocedures)\nPathophysiology:\n•\nIntra-pericardial pressure usually equals intrathoracic pressure\no\npericardial pressure → ventricular filling pressures, chamber compression, CO\n•\nPericardial volume is fixed → in tamponade IV septum shifts to left in inspiration → ventricular filling\nAccentuation of normal variation in spont breathing\nTamponade worsened by mechanical ventilation\nClinical presentation:\n•\nPulsus paradoxus: sBP by 10mmHg on spontaneous inspiration (due\nto left shift of IV septum)\n•\nDyspnoea, orthopnoea, chest discomfort\n•\nElevated JVP\n•\nMarkers of CO: UO, lactic acidosis, cool peripheries, hypotension\n•\nSympathetic tone\nIx:\n•\nBloods\n•\nCXR: enlarged cardiac silhouette\n•\nECG: sinus tachycardia, small QRS voltage, electrical alternans\n•\nTTE/TOE: size, location, haemodynamic consequences\n•\nCT/MRI\nManagement:\n•\nPericardiocentesis: 16-18G needle inferior / left xiphisternum, 45 angle towards left shoulder, ideally US guided\no\nComplications (1.5%): cardiac arrest, cardiac laceration, arrhythmia, lung / oesophageal injury, pulmonary\noedema, acute ventricular dilation\n•\nSurgical drainage i.e. pericardial window\nAnaesthesia:\n•\nGoals: “fast, full, tight”\no\npreload, HR normal-high, SR, maintain SVR, maintain contractility\n•\nInduction: consider pre-induction pericardiocentesis under LA\no\nPrep + drape + surgeon scrubbed and ready\no\nInvasive monitoring, CVC, large bore IV, defib pads attached and ready + emergency drugs\no\nDrugs: ketamine 0.5mg-1mg/kg, rocuronium 1.2mg/kg, metaraminol 1mg chaser\no\nVentilation: low PEEP + large volumes, consider spont venting + spray chords\no\nMaintenance: volatile + opioids, NMBA, intra-op TOE\no\nPrepare for rebound hypertension post-drainage → deepen anaesthesia, cease vasopressors\nPost op → ICU\nSize: measured during diastole\n•\nSmall: <10mm\n•\nMod: 10 – 20mm\n•\nLarge: >20mm + “swinging heart” –\nwith electrical alternans\nTTE/TOE:\n•\nCollapse of cardiac chambers\n•\nIVC dilatation\n•\nLeft shift IV septum\n•\nLV diastolic pseudohypertrophy\n•\nTricuspid: 30% in inspiratory peak E-\nwave velocity\n•\nMitral: 30% in inspiratory peak E-\nwave velocity", "citations": [{"type": "pdf_page", "page": 39, "label": "p39"}]}
{"chunk_id": "SSUs_v1_p040_txt_00_c4deaa", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 40, "page_end": 40, "section_path": ["TAVI", "Re-Do Sternotomy", "Re-Do Sternotomy"], "specialty_tags": ["TAVI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Re-Do Sternotomy", "keywords": [], "text": "Re-Do Sternotomy\nMortality 2-6x cf primary sternotomy)\nMain risk: blood loss 2’ prolonged dissection of adhesions +/- direct injury to heart on sternal entry\nSubsequent risks:\n•\nProlonged bypass times\n•\nCoagulopathy\nHighest risk period: 3 weeks – 6mo (density of adhesions)\nPre-op:\n•\nRisk/consent: NYHA, EUROSCORE II\n•\nTTE\n•\nShould have coronary angiogram to assess mobility & patency of grafts\n•\nCT/MRI high risk injury findings:\no\nGrafts crossing midline\no\nRV/major vasculature adherent to or within 1cm of sternum in AP direction\n•\nTreat anaemia\n•\nRe-program implantable devices to asynchronous mode\no\nCRT: may need to be in sensing mode – d/w surgeons, will require diathermy for 1-2s with 10s pauses\n•\nPre-med for anxiety\nIntra-op:\n•\nBlood products available prior to starting + 14G x2 – set up cell salvage\no\nRapid infuser + 4 units pRBC\no\nPlatelet line\n•\nMonitoring: sats, art line, 5-lead ECG + CVC prior to induction if able\n•\nDefib pads in situ (cannot easily mobilise heart for internal pads)\n•\nPeripheral CPB: reserved for high-risk pts\no\nBenefits: still + empty heart for entry, cooling for organ protection\no\nRisks: stroke, heparinisation may blood loss during dissection\nConsider pre-emptive sheath insertion → rewired in event of major haemorrhage\n•\nDrugs: TXA, heparin must be drawn up prior to incision\n•\nTrendelenberg: heart away from sternum\nManagement of catastrophic haemorrhage during resternotomy:\n•\nDirect pressure to sternal edges\n•\nImmediate heparin and institution of CPB\no\nIf no peripheral cannulas in situ commence MTP aiming to match losses\nPost-bypass:\n•\nCa2+, TEG, warm, normal pH\nPost-op:\n•\nICU\n•\nRe-do sternotomies risk sternal wound infections & mediastinitis", "citations": [{"type": "pdf_page", "page": 40, "label": "p40"}]}
{"chunk_id": "SSUs_v1_p041_txt_00_9340d9", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 41, "page_end": 41, "section_path": ["ECMO", "ECMO"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "ECMO", "keywords": [], "text": "ECMO\nIndications:\n•\nVV: respiratory failure with predicted mortality ≥50%\n•\nVA: eCPR or refractory cardiogenic shock with maximum medical therapy\no\nCentral: return cannula in aorta\no\nPeripheral: return cannula in femoral artery\n▪\nRisk of Harlequin syndrome: 2’ impaired pulmonary function + recovering LV i.e. poorly oxygenated\nblood → heart and brain, well oxygenated blood from circuit → LL – must have R sats / art line + NIRS\nMust have reasonable expectation of recovery or be a bridge to definitive management\nCI: age >75yo, severe other organ failure, severe brain injury, advanced malignancy, non-reversible pathology, aortic dissection\n(VA)\nComponents:\n•\nAccess cannula\n•\nPump\n•\nMembrane oxygenator\n•\nHeater\n•\nReturn cannula\nVA-ECMO Indications\nVV-ECMO Indications\n•\nGraft failure (heart/lung)\n•\nCardiogenic shock / arrest\n•\nPost-cardiac surgery\n•\nSepsis\n•\nDrug OD e.g. beta blocker\n•\nMyocarditis\n•\nBridge to VAD\n•\nOE\n•\nMajor heart / vessel trauma\n•\nMassive pulmonary haemorrhage\n•\nAnaphylaxis\n•\nProcedural support\n•\nSevere pneumonia\n•\nARDS/COVID\n•\nPulmonary contusion\n•\nAcute graft failure\n•\nSmoke inhalation\n•\nAsthma\n•\nAirway obstruction\n•\nAspiration\n•\nBAL for alveolar proteinosis\nCI: cardiac arrest without ROSC (unless ECMO-CPR), advanced age, active / terminal malignancy, chronic end stage organ failure,\nirreversible neurological condition, recent ICH\nSpecific CI:\n•\nVV: mechanical ventilation >7 days, severe pHTN mPAP >50\n•\nVA: severe AR, aortic dissection\nDaily investigations on ECMO:\n•\nCXR\n•\nBloods: ABG, EUC, CMP, LFT, LDH, FBC\n•\nPre- & post-membrane ABG\n•\nCoags: INR, aPTT, fibrinogen, anti-Xa level, D-dimer\n•\nPlasma free Hb\nMonitoring:\n•\nPump flow rate\n•\nCircuit lines: chattering, swinging\n•\nPre- and post-membrane pressures  transmembrane pressure\no\nNormal <50mmHg – increased may indicate clot on oxygenator\n•\nTemp\n•\nRPM\n•\nVascular obs\n•\nNIRS", "citations": [{"type": "pdf_page", "page": 41, "label": "p41"}]}
{"chunk_id": "SSUs_v1_p042_txt_00_881729", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 42, "page_end": 42, "section_path": ["ECMO"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "ECMO", "keywords": [], "text": "Anticoagulation:\n•\nUFH: aPTT, anti-Xa levels, AT level\no\nComplications: HITS, heparin resistance\n•\nBivalirudin: aPTT\nTroubleshooting VV-ECMO:\n•\nWorsening hypoxia/hypercapnoea:\no\nEnsure pump flow >2/3 CO\no\n100% O2 at oxygenator\no\nPost-membrane O2 >150mmHg (i.e. oxygenator is functioning)\no\nTreatment: flow, ventilation, cool patient / O2 requirement\n•\nWorsening hypercapnoea:\no\nAs above\no\nsweep gas\n•\nCheck for recirculation: take venous PO2 – if higher than patient’s venous PO2 then withdraw access line\nTroubleshooting VA ECMO:\n•\nDifferential hypoxia:\no\nModify lung ventilation / oxygenation\no\nConsider R subclavian return line\n•\nFlow not maintained:\no\nA\n▪\nAccess: tip position, kink, clot\n▪\nAirway: coughing, moving\no\nB: oxygenation check TMP, plasma free Hb\no\nC: ensure adequate preload\nComplications:\nPatient\nCircuit\n•\nBleeding: ICH, GIT, pulmonary, access site\n•\nCoagulopathy, thrombosis\n•\nInfection\n•\nDifferential hypoxia (VA)\n•\nLimb ischaemia\n•\nVascular injury\n•\nHITS (if heparin as anticoagulant)\n•\nHaemolysis: plasma free Hb >70, bili, LDH,\nfibrinogen, potassium\n•\nAccess insufficiency\n•\nRecirculation (VV)\n•\nCircuit breach: haemorrhage, air embolism\n•\nThrombus / clot\n•\nPump or oxygenator failure\n•\nCannula malposition or decannulation", "citations": [{"type": "pdf_page", "page": 42, "label": "p42"}]}
{"chunk_id": "SSUs_v1_p043_txt_00_536cfa", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 43, "page_end": 43, "section_path": ["ECMO", "Protamine Reactions", "Heparin"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Heparin", "keywords": [], "text": "Heparin\nBinds to ATIII → conformational change → potentiates effect (AT3 inhibits factors Xa and IIa)\nMeasured via ACT intra-op (aPTT inaccurate at higher doses, requires dilution + takes longer)\nACT:\n•\nProlonged by: haemodilution, hypothermia, plt, plt inhibitors\n•\nShortened by: surgical stress, plt lysis\nHeparin Resistance\nDefinition: requiring >500units / kg to give ACT 400-480 (whole blood → activated with kaolin → time to clot is measured)\nHeparin resistance mechanisms (3):\n•\nExcessive binding of heparin to protein, platelets, surfaces\n•\nAT3 deficiency:\no\nDisease (liver failure, sepsis, DIC)\no\nAsparaginase / CPB / ECMO\no\nRecent sig heparin exposure (not LMWH)\no\nHereditary AT3 deficiency\n•\nStates that effect ACT independently of heparin (e.g. coag factor deficiency, platelet impairment)\nRx:\n•\nHigher dose of heparin\n•\nAT3 supplementation (fractionated human-derived AT3 > FFP)\nHeparin Induced Thrombocytopaenia (HITS)\nPlatelet: <100 or <50% baseline. 4Ts: thrombocytopaenia, timing, thrombosis, other causes for thrombocytopaenia\nDiagnosis: via functional HIT assay\nHeparin risk 1/200 therapeutic:\n•\nType 1 (non-immune): 10 – 20%, within 4 days of UFH, usually nil thrombosis, self-limiting → observe\n•\nType 2 (i.e. HITTS, immune): 1-3%, IgG mediated (forming IgG-pltF4-heparin complexes), usually 5-14 days after\nstarting heparin, marked thrombocytopaenia, associated with thrombosis requires alternative anticoagulation\nProtamine Reactions\nProtamine\nMOA/Class\n+ve protamine binds -ve heparin → forms stable inactive protamine-heparin salt complex → prevents heparin\nbinding to AT3 → reversal of heparin effect\nEffect: UFH 100%, LMWH (60%), fondaparinux (0%)\nDerived from salmon sperm\nPharmacokinetic\nDose: IV 1mg reverses 100IU of heparin (reversal within 5 minutes)\nAt end of CPB dose protamine 0.6 vol ratio to initial dose of heparin\nElimination\nComplex cleared by reticuloendothelial system, t1/2β 60 mins (risk of re-heparinisation)\nPharmacodynamic\nCVS\no\nVasodilation 2’ histamine/unknown (especially when given rapidly) → hypotension + flushing\no\nPulmonary hypertension (2’ compliment action + thromboxane release)\no\nDirect myocardial depressant\nRESP\no\nNon-cardiogenic pulmonary oedema (thromboxane mediated) → pulmonary vasoconstriction\no\nBronchospasm (histamine)\nHAEM\no\nParadoxical anticoagulation if dose exceeds required dose to reverse heparin → reacts with platelets and\nfibrinogen\nIMMUNO\no\nAnaphylactoid / anaphylaxis – possible cross-reactivity as some insulins contain protamine (slows absorption) –\ndo not exceed initial 1:1 reversal ratio of initial heparin bolus\nOTHER\no\nIncompatibility with some antibiotics\no\nMay increase duration of non-depolarising MBs\nReactions:\n•\nType I: isolated hypotension\n•\nType II: hypotension + features of anaphylactoid reactions e.g. bronchoconstriction\n•\nType III: 2’ large heparin-protamine complexes in pulmonary circ → may lead to acute RHF (rare)\nSpecial populations:\n•\nAPLS: no guidelines, difficult monitoring of\nheparin/ACT, no evidence for IVIg\n•\nFVL: heparin + protamine reversal\n•\nProtein C & S deficiency: no guidelines – may\nneed higher heparin dosing, + protamine\nreversal", "citations": [{"type": "pdf_page", "page": 43, "label": "p43"}]}
{"chunk_id": "SSUs_v1_p044_txt_00_f5a5dc", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 44, "page_end": 44, "section_path": ["ECMO", "Epicardial Pacing", "Epicardial Pacing"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Epicardial Pacing", "keywords": [], "text": "Epicardial Pacing\nTemporary pacing wires: atrium + ventricle\n1. Pacing\n2. Sensing\n3. Response\n4. Programmability (i.e. rate)\nPaced ventricle is not preferred as electrical activity does not flow like intrinsic activity\nModes:\n•\nFixed/asynchronous: paces over intrinsic rhythm, useful for intra-op diathermy etc however risk of R on T should only\nbe used post-op in emergencies\n•\nDemand/synchronous: allows inhibition when normal conduction present and triggering of ventricular pacing when\natrial activity is sensed\nCommon modes:\n•\nAAI: atrial pacing beneficial if normal AV conduction - atrial pacing in early post-op risk of AF\n•\nVVI: RV before LV → broad QRS. LV ejection.\n•\nDDD/DDI: both chambers paced with a predetermined AV interval\n•\nVOO/DOO: emergency setting (usually 80bpm), asynchronous – risk of R on T\nTemporary pacing usually initiated at time of weaning from bypass. AOO or DOO. AOO > DOO if AV conduction is <200ms.\nUsually not possible to check the pacemaker intra-op as patient dependent when hypothermic and coming off bypass.\nCapture threshold (should be checked prior to chest closure):\n•\n<5mA: good\n•\n5 – 10mA: d/w surgeon – may need repositioning or replacement\n•\n>10mA: unacceptable – will likely fail in early post-op period\nPacemaker check (in ICU):\n•\nPhysiological: T >36, normal K\n•\nIf pausing to check intrinsic rhythm ECG\nand arterial line should be continuously\nmonitored\n•\nIf intrinsic rhythm present:\no\n1st: measure sensing threshold\no\n2nd: measure capture threshold\nPacing issues:\n•\nFailure to pace: systematic check ?wire\nmigration ?improper wire connection\n•\nFailure to capture: check\n•\nIntermittent pacing: check\n•\nR on T induced VT/VF: pause pacemaker\n→ external defib\n•\nPacemaker mediated tachycardia\nMust withhold heparin prior to pacing wire\nremoval + observation for at least 24hr.", "citations": [{"type": "pdf_page", "page": 44, "label": "p44"}]}
{"chunk_id": "SSUs_v1_p045_txt_00_77c889", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 45, "page_end": 45, "section_path": ["ECMO", "Pulmonary Artery Catheter", "Pulmonary Artery Catheter"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pulmonary Artery Catheter", "keywords": [], "text": "Pulmonary Artery Catheter\nIndications:\n•\nEvaluation / diagnosis of pulmonary hypertension (gold standard) – measure at end expiration\n•\nShock evaluation: MvO2, volume status\n•\nCardiac illness e.g. tamponade\n•\nAssessment of right-sided valvular disease, congenital disease, shunts, when surgical repair is planned\nContra-indications: no consent, infection over insertion site, presence of RVAD\nRelative CI:\n•\nLBBB – risk of RBBB on insertion, must have external pacing available\n•\nSevere arrhythmia\n•\nSevere right sided valve stenosis\n•\nTOF\nRisks:\n•\nGeneral: infection, bleeding, damage to local structures\n•\nSpecific: arrhythmia, PA rupture, thrombosis, air embolism, pneumothorax\nRight Atrium\nRight Ventricle\nPulmonary Artery\nPA Wedge\nWaveform\nNormal values\nCVP ~0-6mmHg\n15/2 – 30/8mmHg\n15/8 – 30/15mmHg\n8-12mmHg\nPoints of Waveform\na wave: atrial contraction\nc wave: closure of TV /\nventricular contraction\nx descent: TV pulled during\nventricular ejection\nv wave: atrial filling during\nventricular systole\ny descent: opening of TV,\ndiastolic filling\nAtrial systole: small\nupstroke\nSystolic upstroke:\nisovolumic contraction,\nrapid ejection\nDiastole: isovolumic\nrelaxation, rapid filling\nSystole – same pressure\nas RV systole\nDiastole step up\nDicrotic notch: due to\nreflection and resonance\nWedge = balloon inflated\nto occlude a pulmonary\nartery branch\nVery similar to CVP!\na: atrial contraction\nx descent: MV pulled\nduring ventricular\nejection\nv wave: atrial filling\nduring ventricular systole\ny descent: opening of\nMV, diastolic filling\nc wave absent because\nLA pressure transmitted -\ndampened\nPathology\n↑ if:\n•\n↑venous return / blood\nvolume\n•\nRHF\n↓if:\n•\n↓venous return\n•\nPPV\n↑ if:\n•\npulmonary\nhypertension\n•\npulmonary stenosis\n↑ if:\n•\nleft heart failure\n•\nChronic hypoxia\n•\nPE\n•\nIdiopathic\nMeasures LA pressure –\nindicates LH failure\nSVO2 Monitoring", "citations": [{"type": "pdf_page", "page": 45, "label": "p45"}]}
{"chunk_id": "SSUs_v1_p046_txt_00_af7cc1", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 46, "page_end": 46, "section_path": ["ECMO", "TOE / Aortic Doppler"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "TOE / Aortic Doppler", "keywords": [], "text": "PAC sample. Normal 65 – 70%.\nHIGH SVO2\nLOW SVO2\nO2 delivery\nIncreased:\n•\nFiO2\n•\nHyperoxia\n•\nHyperbaric\n•\nHigh flow states: sepsis, hyperthyroid,\nsevere liver dz\nDecreased:\n•\nAnaemia\n•\nHypoxia\n•\nLow flow state: shock, arrhythmia\nO2 demand\nDecreased:\n•\nHypothermia\n•\nAnaesthesia\n•\nNeuromuscular blockade\n•\nHistotoxic (e.g. cyanide)\n•\nShunting (e.g. sepsis)\nIncreased:\n•\nHyperthermia\n•\nShivering\n•\nPain\n•\nSeizure", "citations": [{"type": "pdf_page", "page": 46, "label": "p46"}]}
{"chunk_id": "SSUs_v1_p046_txt_01_ac594e", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 46, "page_end": 46, "section_path": ["ECMO", "TOE / Aortic Doppler", "Pulse Contour Analysis"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pulse Contour Analysis", "keywords": [], "text": "Pulse Contour Analysis\nSVV: <10% unlikely to be fluid responsive, >15% likely to be fluid responsive\nPiCCO\nPiCCO catheter: arterial line with thermistor (usually in femoral artery)\nMethod: CVC → injectate administered → produces temperature time curve via PiCCO catheter (attached to pressure\ntransducer + PiCCO monitor)\nThermodilution:\nClearance = dose / AUC\n∴ CO = clearance = volume x (Tinjectate – Tblood) / area under temp-time curve (Stewart Hamilton eqn for thermodilution)\nDerives: CI (+ others)\nPulse contour analysis:\nBeat-to-beat parameters derived from shape of arterial wave\nDerives: SVV (fluid responsiveness), slope\nFloTrac\nSensor on arterial line (radial).\nParameters:\n•\nCI/CO\n•\nSV/SVI\n•\nSVR/SVRI\n•\nSVV\nConnects to Vigileo.\nTOE / Aortic Doppler\nM mode of AV\nCO = SV x HR\n•\n= CSA (aortic cross sectional area) x VTI (i.e. stroke distance) x HR\nCorrect for 70% if using descending aorta as only 70% CO passes through descending aorta", "citations": [{"type": "pdf_page", "page": 46, "label": "p46"}]}
{"chunk_id": "SSUs_v1_p047_txt_00_ad339f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 47, "page_end": 47, "section_path": ["ECMO", "Three-Bottle Suction Drains", "Chest Drains"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Chest Drains", "keywords": [], "text": "Chest Drains\nThree essential components:\n•\nPleural tube (large diameter, non-kinking, non-compressible)\n•\nOne-way valve\n•\nCollection chamber\nRequires pressure gradient between pleural space and collection system. Drain placed below level of chest (aim 100cm)\nThree-Bottle Suction Drains\nSafest method.\nComponents:\n1. Trap: blood, fluid\n2. Underwater seal w/ one way valve: prevents backflow of air to patient if disconnection occurs\n3. Manometer: degree of suction (increases pressure difference)\nAdding a fourth bottle ‘vents’ system to relieve any pressure if failure of suction occurs\nConsiderations:\n•\nBellows (labelled E) will expand to the arrow, the suction regulator at A adjusts the suction pressure applied\n•\nPatient intrathoracic pressure equals suction control setting + float ball water column level\no\nIf no suction equals float ball level only\n•\nOnly drain 1000 – 1500mL at a time then clamp to prevent re-expansion pulmonary oedema\n•\nClamping: can cause tension pneumothorax\no\nNever clamp during transfer or if on PPV\no\nIndications: large volume drained, post-pneumonectomy, on removal, sample fluid, change bottle/tubing,\nassess for air leak, if bottle must be lifted above patient chest", "citations": [{"type": "pdf_page", "page": 47, "label": "p47"}]}
{"chunk_id": "SSUs_v1_p048_txt_00_1d7010", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 48, "page_end": 48, "section_path": ["ECMO", "Intra-aortic Balloon Pumps", "Intra-aortic Balloon Pumps"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Intra-aortic Balloon Pumps", "keywords": [], "text": "Intra-aortic Balloon Pumps\nAnatomy + procedure:\n•\nSausage-shaped balloon sits in descending thoracic aorta\n•\nUpper part distal to L subclavian, lower part cephalad to coeliac trunk\n•\nInflated with helium\nIndications - as a bridge to therapy in: severe ischaemic MR, VSD, high risk CAGS / PCI (left main >70%), post-CAGS off bypass,\ncardiogenic shock (LVEF <40%), pulmonary oedema, pre-transplant, pre-reoperation\nCI: AR, aortic aneurysm/dissection, severe sepsis, coagulopathy, LVOT obstruction, futile, AAA, tachyarrhythmia, severe PVD\nCounter-pulsation: i.e. balloon inflation in diastole and deflation in systole →\n•\nVolume displacement proximally and distally\n•\nAugments intrinsic Windkessel effect\n•\nImproved coronary and systemic perfusion\nPrinciple: improved ventricular performance by →\n•\nmyocardial O2 supply\n•\nmyocardial O2 demand\nVariable\nDiastole\nSystole\nBalloon\nInflation at start of diastole\nDeflation at start of systole\nECG timing\nMiddle of T wave\nMiddle of R wave\nHaemodynamic\neffects\n•\nDBP / aortic root pressure\n→ coronary flow (note: in\nsevere CAD autoregulation\nis lost so flow entirely\ndependent on pressure\ngradient)\n•\nDPTI\n•\nEDP and LV volume\n•\nafterload → CO\n•\nPressure/work required to\nopen AV\n•\nsystemic blood flow →\nrenal blood flow by 25%\n•\nLV afterload also improves\nRV\n•\nregurg fraction in MR and\nVSD\nInsertion:\n•\nDouble-lumen 8 – 9.5Fr catheter\n•\n25 – 50mL balloon <80-90% aortic diameter\n•\nSized on height\n•\nTip: 2-3cm distal to L subclavian artery at the\nlevel of the carina\nLess iABPs now in use due to ECMO\nTriggers: ECG (see table) or pressure\nAbnormal waveforms:\nEarly\nLate\nInflation\n• Incomplete LV\nemptying\n• No diastolic\naugmentation\n• LV demand\n• LV supply\n• diastolic\naugmentation →\nbenefit on coronary\nperfusion\nDeflation\n•\nEDP\nbaseline\n•\nNo\nimprovement in\nafterload\n• afterload", "citations": [{"type": "pdf_page", "page": 48, "label": "p48"}]}
{"chunk_id": "SSUs_v1_p049_txt_00_7c1ae7", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 49, "page_end": 49, "section_path": ["ECMO", "Cardiac Patient Handover", "Cardiac Patient Handover"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Cardiac Patient Handover", "keywords": [], "text": "Cardiac Patient Handover\nPhase 1: equipment and technology\n•\nMonitoring\n•\nVentilator initiated\n•\nInfusions and fluids checked\n•\nChest drains secured and on suction\n•\nAbove checked including vitals\n•\nConfirm ready for handover\nPhase 2: information handover\n•\nAnaesthetist\no\nPatient-specific information\no\nAnaesthetic-specific information\n•\nSurgeon\no\nSurgical course\no\nBlood loss, complications\no\nPlan / goals for next 6 – 12 hr\nPhase 3: discussion\nAnaesthetist should remain until haemodynamic stability", "citations": [{"type": "pdf_page", "page": 49, "label": "p49"}]}
{"chunk_id": "SSUs_v1_p050_txt_00_3588c7", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 50, "page_end": 50, "section_path": ["ECMO", "Cardiac Arrest After Cardiac Surgery - CALS", "CALS"], "specialty_tags": ["ECMO", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "CALS", "keywords": [], "text": "CALS\nFor 10 days post-op; >10 days not helpful\nIncidence 1-3% post-op\nInitial management based on initial rhythm.\nMain differences:\n•\nDelayed compressions unless PEA\n•\nAim for re-sternotomy <5 mins\n•\nAvoid full dose adrenaline\n•\n3 stacked shocks / external pacing / internal pacing\nCauses:\n•\nBleeding:\no\nMedical: heparin (?rebound), platelets,\nfactors, fibrinolysis – do ROTEM\n▪\nAim Hb >80, HCT >25\no\nSurgical: chest drain output – must check\ndrain is not occluded\n▪\n>400mL in 1 hour\n▪\n>200mL/hr in 2 consecutive hours\n▪\n>100mL/hr in 4 consecutive hours\n•\nLow CO:\no\nInotropic / mechanical support\no\nMyocardial stunning, preload, afterload,\nrate, rhythm\no\nGraft/valve failure\no\nIschaemia\n•\nTamponade\n•\nTension pneumothorax\n•\nArrhythmia: ensure Mg >1, K >4.5\n•\nVasodilation\no\nTemperature\no\nSepsis\no\nAnaphylaxis\no\nAdrenal insufficiency\no\nPost-bypass vasoplegia\no\nInodilators\nIx:\n•\nFull bloods + ABG + coags / fibrinogen + ROTEM + consider multiplate\n•\nIx: ECG, CXR, TOE, CI: <2.2\nManagement:\n•\nDelay external chest compressions initially up to 1 min (unless PEA) to allow:\no\n3x stacked shocks\no\nPacing\nIf PEA start compressions immediately, if above unsuccessful start also\n•\nAirway + breathing: FiO2 100%, no PEEP, confirm ETT, exclude tension PTx\n•\nCirc:\no\nAnti-arrhythmics (amio, lignocaine 1mg/kg), internal defib 20J\no\nPressure: sBP >60, internal cardiac massage\no\nSwitch iABP to pressure trigger 1:1 ratio 100bpm\no\nPacing to DDD or asynchronous 80 – 100bpm max ouput\nWill need full arrest team", "citations": [{"type": "pdf_page", "page": 50, "label": "p50"}]}
{"chunk_id": "SSUs_v1_p051_txt_00_70dbe1", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 51, "page_end": 51, "section_path": ["ECMO", "Difficult Weaning from Cardiac Bypass", "Difficult Weaning from Cardiac Bypass"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Difficult Weaning from Cardiac Bypass", "keywords": [], "text": "Difficult Weaning from Cardiac Bypass\nAim: HR 70-100 (correct either side), MAP 70-90 (if <70 optimise)\nMust ensure preload optimised and adequate surgical repair (no valve dysfunction, graft failure or LVOT obstruction)\nOngoing inability to wean →\nTOE:\n•\nLV impaired\n1. Inotropes and pressors (i.e. dobutamine, norad, levosimenden, milrinone)\n▪\nInotropes:\n•\nUnsure cause consider adrenaline\n•\nMilrinone: must add norad to offset vasodilation\n•\nLevosimenden: mainly pre-op\n•\nDobutamine\n2. Stepwise reduction of VR and pump flow\n3. Cardiac pacing\n4. Inhaled NO if pulmonary hypertension or RH failure\n•\nLV appropriate i.e. vasoplegia\n1. Vasopressors (norad)\n2. Vasopressin\nOngoing inability to wean i.e. MAP <70, CI <2.0, SvO2 <70%, elevated lactate → mechanical circulatory support\nMechanical support:\n•\nIABP (CI: AR, severe aortic disease)\n•\nLeft heart assistance e.g. impella available\n•\nECMO\nRisk factors for RV failure on CPB wean:\n•\nRV dysfunction\n•\nPulmonary hypertension\n•\nLong CPB time\n•\nLVAD\n•\nHeart transplant\n•\nInadequate myocardial protection", "citations": [{"type": "pdf_page", "page": 51, "label": "p51"}]}
{"chunk_id": "SSUs_v1_p052_txt_00_6c7f55", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 52, "page_end": 52, "section_path": ["ECMO", "Cardioversion", "Interventional Cardiology"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Interventional Cardiology", "keywords": [], "text": "Interventional Cardiology\nConsiderations:\n•\nPatient: properly assessed, appropriate for procedure, ACD formalised\n•\nAnaesthetic: plan, personnel (AN/AT), equipment (piped gas? scavenging?), equipment absent (US, MH box,\nanaphylaxis box)\n•\nProcedure: communication with teams (cardiology not always used to working with anaesthetics), times of high risk,\nplan if things go wrong (OT +/- CPB / ECMO)\n•\nEnvironment: isolation, space allocation, radiation, sterile field, movement / table if ii used\n•\nRecovery: where? Specialist care i.e. monitoring, pacing wires, ICU\nCath Lab\nRadiation safety:\n•\nPPE: lead apron, thyroid shield, leaded glass screen, eyewear\n•\nExposure: shots > screening\n•\nALARA\n•\nMaximise distance from source\n•\nDosimeter\nComplications:\n•\nVascular: access site (vessel injury, pseudoaneurysm), thrombus, air embolus, stroke\n•\nArrhythmia: induced, accidental, 2’ pathology (heart block, ischaemia, re-entrant)\n•\nBleeding: access site, retroperitoneal, vessel rupture, tamponade\n•\nEquipment: embolisation, malposition\n•\nCardiac arrest", "citations": [{"type": "pdf_page", "page": 52, "label": "p52"}]}
{"chunk_id": "SSUs_v1_p052_txt_01_1c57f7", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 52, "page_end": 52, "section_path": ["ECMO", "Cardioversion", "Cardioversion"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Cardioversion", "keywords": [], "text": "Cardioversion\nIndications: tachyarrhythmia (+/- haemodynamic compromise), resistant to medical Rx, deemed reversible, HF 2’ AF, new onset\nCI: digoxin toxicity, AF >48hr without anticoagulation\nUnlikely successful if catecholamine driven or multifocal atrial tachycardia (address underlying cause)\nComplications: worse arrhythmia, asystole, stroke, cutaneous burns, ischaemia, APO\nPre-op:\n•\nAnticoagulation for >48 hr (regardless of thrombus)\n•\nIx: routine bloods, ECG, TFTs, TTE, coags, digoxin level\n•\nWH antihypertensives\n•\nConsent for sedation, warn for potential procedural recall\nIntra-op:\n•\nDefib pads anterolateral or AP (AP useful for pacing if asystole occurs)\n•\nTOE prior to cardioversion:\no\nThrombus → abandon + recheck 4/52\n•\nPropofol bolus / infusion\n•\nBiphasic, sync (unsync if VF occurs and defib required)\no\nAF: 150J → 200J\no\nFlutter, SVT: 100J usually adequate\no\nCease O2 just prior to shock\nPost-op:\n•\nAnticoagulation 4/52 (prothrombotic + atrial stunning)\no\nAtrial stunning: supportive care\nEmergency cardioversion:\n•\nMay be safer to stay and play (CCU etc) than to transfer unstable patient + allows earlier CV\n•\nConsiderations for remote anaesthesia\n•\nUnfasted: RSI v sedation – tailor to individual circumstance i.e. risk of aspiration versus haemodynamic collapse\n•\nSafe in pregnancy if unstable (do FHR + facility with availability of emergency C-section if required)", "citations": [{"type": "pdf_page", "page": 52, "label": "p52"}]}
{"chunk_id": "SSUs_v1_p053_txt_00_b50e03", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 53, "page_end": 53, "section_path": ["ECMO", "AF Ablation", "EP Studies +/- Ablation"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "EP Studies +/- Ablation", "keywords": [], "text": "EP Studies +/- Ablation\nEP studies are rare in isolation – usually +/- ablation\nSide of study:\n•\nRight: R venous entry (usually R femoral pain), no anticoagulation\n•\nLeft: more invasive, trans-septal crossing, requires anticoagulation\nTypes of mapping software:\n•\nCARTO (magnets)\n•\nNavX (electrical field – interferes with ECG so makes it difficult to pick up ischaemic events)\nAnaesthetic considerations:\n•\nRemote GA:\no\nFigure out where equipment + crisis access\no\nLimited access: C arms, fluoroscopy screens, dimmed lights\n•\nSpecific:\no\nTable doesn’t tilt: risk in aspiration\no\nSide:\n▪\nR side: similar to coronary cath: sedation + local versus GA\n▪\nL side: GA, trans-septal puncture (TOE guidance)\n•\nACT >300\n•\nLonger procedure\n•\nThrombus burden/sicker heart\no\nRadiation exposure\n•\nCrisis:\no\nPerforation/effusion/tamponade\no\nStenosis\no\nRegurgitation\nSides:\n•\nAVNRT: right\n•\nAVRT: right or left\n•\nFlutter: right (usually cavotricuspid isthmus in RA)\n•\nAF: left (usually PV isolation)\n•\nVT ablation: left\nAF Ablation\nGA + trans-septal puncture for pulmonary vein isolation\n•\nMonitoring: sats, 5-lead ECG, art line, temp probe for catheter ablation, BIS\n•\nVentilation: low vol, high freq\n•\nNo paralysis (phrenic n monitoring) – immobilise with remifentanil\n•\nHeparin: ACT 300 pre-septal puncture\n•\nLimit IVF (large irrigation)\n•\nStop ablation if temp >38\nPost-op:\n•\nLie flat 4 hours post groin puncture\n•\nOvernight telemetry\n•\nAnticoagulation for 8/52\n•\nPPI for 6/52\nComplications:\n•\nEarly: tamponade, groin bleeding, groin aneurysm, oesophageal injury, CVA/TIA/air embolism, phrenic n injury, failed\nprocedure\n•\nLate: PV stenosis, radiation exposure / malignancy, recurrence", "citations": [{"type": "pdf_page", "page": 53, "label": "p53"}]}
{"chunk_id": "SSUs_v1_p054_txt_00_655a76", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 54, "page_end": 54, "section_path": ["ECMO", "Device Lead Removal", "Device Insertion"], "specialty_tags": ["ECMO"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Device Insertion", "keywords": [], "text": "Device Insertion\nPacemaker Insertion\nFailure of automaticity (i.e. SA node) – this is benign (sick sinus, Mobitz 1)\nFailure of conduction (i.e. block) – not benign (Mobitz 2, complete heart block)\nUsually L subclavian access (if right sided ask why – usually either L side already used, or congenital)\nii guided +/- L venogram\nSubmuscular versus subcut\nAnaesthetic is proceduralist / location / patient dependent – local versus GA\nAICDs\nPathology:\n•\nPrimary prevention\n•\nSecondary prevention\nAnaesthetic same as PPM, usually subcut – ICD box sits in pocket between SA and latissimus dorsi between anterior and mid\naxillary line at level of the apex. Has 8cm shocking coil + 2x sensing electrodes → tunnelled subcut:\n•\nSensing electrodes:\no\nDistal: manubrium sternum\no\nProximal: xiphoid process\n•\nShocking electrode: substernal notch\nCRT\nIndication: NYHA III or IV, LVEF <35%, QRS >130ms + LBBB\nPPM: cause R → L septal depolarisation → filling of right heart first → reduced LV filling → SV and CO\nCRT: both ventricles paced simultaneously mimicking normal physiology with L→R depolarisation\nDevice – 3 leads (cf PPM with only RA & RV):\n•\nRA\n•\nRV\n•\nCoronary sinus (paces LV)\nBox is sub-pectoral.\nAnaesthetic: R sided procedure, very sick patients, usually have diastolic dysfunction/orthopnoea/LHF, longer case (difficult to\nfind coronary sinus)\nImplanted CRT can lead to positive remodelling of the heart\nDevice Lead Removal\nIndications: infection, recall/malfunction, venous access issues, severe TR, chronic pain, MRI/radiotherapy\nPre-op:\n•\nTTE: cardiac function, course of the leads, presence of PFO, vegetations, severity of TR\n•\nIx: routine + cross match\n•\nBe prepared for haemorrhage (+ difficult re-sternotomy if previous surgery)\n•\nRisk: EROS category, overall major complications 2-4%, mortality 1%\n•\nConsider: crisis management plan +/- availability of CTSx + CPB (perfusionist)\nIntra-op:\n•\nGA + TOE\n•\nCVC + mode of temporary pacing\n•\nMay need SVC balloon\n•\nDepends on ease of extraction – prepare for haemorrhage / inversion of RA / TV damage\nPost-op:\n•\nRoutine+\n•\nCXR ?PTx/haemothorax", "citations": [{"type": "pdf_page", "page": 54, "label": "p54"}]}
{"chunk_id": "SSUs_v1_p055_txt_00_71a7b0", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 55, "page_end": 55, "section_path": ["THORACIC SURGERY", "Thoracic Surgery"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Thoracic Surgery", "keywords": [], "text": "Thoracic Surgery\nRight Lung\nLeft Lung\nRUL\n•\nApical\n•\nPosterior\n•\nAnterior\nRML (or more correctly - just middle lobe)\n•\nLateral\n•\nMedial\nRLL\n•\nApical . superior\n•\nMedial\n•\nAnterior\n•\nLateral\n•\nPosterior\nPNEMONIC: APALM APALM\nLUL\n•\nApical\n•\nPosterior\n•\nAnterior\nLingula:\n•\nSuperior\n•\nInferior\nLLL:\n•\nApical\n•\nPosterior\n•\nAnterior\n•\nLateral\nPNEMONIC: APAL(SI) APAL\nFlexible bronchoscopy physiological effects:\n•\nResp: airway resistance, gas exchange/Vt, lung compliance, intrinsic PEEP\no\nRisk of hypoxia, hypercapnia, coughing, broncho/laryngospasm\n•\nCVS: SNS (CO, HR), pulmonary artery pressure, venous return\n•\nNeuro: ICP", "citations": [{"type": "pdf_page", "page": 55, "label": "p55"}]}
{"chunk_id": "SSUs_v1_p056_txt_00_53e613", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 56, "page_end": 56, "section_path": ["THORACIC SURGERY", "Bronchial Blockers", "Lung Isolation"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Lung Isolation", "keywords": [], "text": "Lung Isolation\nAbsolute indications:\n•\nPrevent damage / contamination of healthy lung (e.g. lung abscess, pulmonary haemorrhage)\n•\nControl distribution of ventilation (e.g. bronchopleural fistula, traumatic bronchial disruption)\n•\nSingle lung lavage (e.g. CF)\nRelative indications:\n•\nImproved surgical access:\no\nStrong evidence: thoracic AA, pneumonectomy, lung reduction, minimally invasive cardiac surgery, upper\nlobectomy, VATS\no\nWeaker evidence: oesophageal surgery, middle & lower lobectomy, mediastinal mass reduction\nMethods of OLV:\n•\nDLT\n•\nBronchial blockers\n•\nSingle lumen tube advanced endo-bronchially\nMust review relevant imaging pre-op + discuss with surgeons", "citations": [{"type": "pdf_page", "page": 56, "label": "p56"}]}
{"chunk_id": "SSUs_v1_p056_txt_01_db123d", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 56, "page_end": 56, "section_path": ["THORACIC SURGERY", "Bronchial Blockers", "Bronchial Blockers"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Bronchial Blockers", "keywords": [], "text": "Bronchial Blockers\nOptions:\n•\nCoaxial: within SLT lumen\n•\nIndependent: adjacent to SLT\nSlight variations but mostly size of\nbronchial blocker matches size of ETT.\nUnivent ETT is an all-in-one single\nlumen ETT with an enclosed, moveable\nbronchial blocker\n3 way connector:\n•\nBronchial blocker\n•\nFOB\n•\nVentilator port on the side\nTube exchange:\n•\nMuscle relaxant\n•\n100% FiO2\n•\nBigger AEC down TRACHEAL lumen – 14Fr", "citations": [{"type": "pdf_page", "page": 56, "label": "p56"}]}
{"chunk_id": "SSUs_v1_p057_txt_00_8900cd", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 57, "page_end": 57, "section_path": ["THORACIC SURGERY", "Double Lumen Tubes", "Endobronchial Single Lumen Tube"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Endobronchial Single Lumen Tube", "keywords": [], "text": "Endobronchial Single Lumen Tube\nRarely used unless emergency or extremely difficult DLT placement.", "citations": [{"type": "pdf_page", "page": 57, "label": "p57"}]}
{"chunk_id": "SSUs_v1_p057_txt_01_832355", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 57, "page_end": 57, "section_path": ["THORACIC SURGERY", "Double Lumen Tubes", "Double Lumen Tubes"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Double Lumen Tubes", "keywords": [], "text": "Double Lumen Tubes\nFeatures of DLT:\n•\nBifurcated w/ 2 lumens:\no\nTracheal: above carina\no\nEndobronchial (blue cuff + pilot): main stem bronchus\n▪\nRight DLT: shorter, straighter, wider\n•\nMurphy’s eye - right UL bronchus\n▪\nLeft DLT\nChoosing DLT:\n•\nSide:\no\nUsually L unless surgery involving L main bronchus i.e.\npneumonectomy\no\nDependent lung easier to ventilate with endobronchial lumen\n•\nSize: best chosen based on CT sizing however\no\nDefault for 170cm – female 37 Fr, male: 39 Fr\no\nChange a size per 10cm height from 170cm (i.e. female 160cm 35Fr)\no\n11Fr 100cm AEC fits 35Fr bronchial lumen and bigger\n•\nInsertion: check integrity + lubricate -\no\nStylet in endobronchial lumen\no\nRemove stylet once cuff through cords\no\nRotate 90 degrees depending on side\no\nPass tracheal cuff beyond glottis until resistance felt\no\nDepth: 12 + (patient height / 10) @ teeth\n•\nConfirmation:\no\nThree-step auscultation: sufficient for L DLTs\n▪\nInflate tracheal cuff (high vol, low pressure): auscultate to confirm bilateral air entry\n▪\nClamp tracheal limb, inflate bronchial lumen (low vol, high pressure), ventilate, auscultate\n▪\nRelease tracheal clamp, and ventilate – confirm resumption of bilateral ventilation\no\nFibreoptic scope: essential for R DLTs\n▪\nTracheal lumen: visualise carina\n▪\nEndobronchial lumen: blue cuff in bronchus\n▪\nCheck murphy’s eye is aligned with RUL bronchus (R DLT only)\nIssues with DLTs:\n•\nMalposition: overinflated cuff, movement with neck extension, surgical manipulation\n•\nAirway trauma: may rupture membranous airway → airleaks, subcut emphysema, massive bleeding\n•\nTension pneumothorax\nLung Isolation with DLT\nPrior to lung isolation:\n•\nPre-oxygenation 100% FiO2 to de-nitrogenatate\n•\nCheck 2 things on ventilator:\no\nPeak airway pressure: expected post-OLV peak pressure ~5cmH2O higher\no\nCheck leak\nLung isolation:\n•\nClamp appropriate tube and allow passive deflation via circuit disconnection\no\nIf required later can use low suction\n•\nCheck Paw\n•\nCheck leak (should still be zero) – if not:\no\nFurther inflate bronchial cuff\no\nRe-check with bronch\nCauses of failed lung collapse: misplaced airway, pleural adhesions, gas trapping, poor lung elasticity, airway compression", "citations": [{"type": "pdf_page", "page": 57, "label": "p57"}]}
{"chunk_id": "SSUs_v1_p058_txt_00_b0ed6c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 58, "page_end": 58, "section_path": ["THORACIC SURGERY", "Double Lumen Tubes"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Double Lumen Tubes", "keywords": [], "text": "Special scenarios:\n•\nTracheostomy: DLT or BB through stoma, DL trache tubes exist, orotracheal intubation + stoma coverage\n•\nAnticipated difficult airway: awake SLT + bronchial blocker (airway exchange catheter + DLT is an option but riskier)\n•\nRequirement for post-op ventilation: (risk of trauma + upper airway oedema)\no\nShort procedure: DLT → SLT via airway exchange catheter\no\nLong procedure: deflate endobronchial cuff and ventilate through tracheal lumen\nIsolation Technique\nAdvantages\nDisadvantages\nDouble Lumen Tube\n•\nQuick\n•\nCan suction + bronch isolated lung\n•\nCPAP to operated lung\n•\nEither lung ventilation\n•\nCan confirm without scope if needed\n•\nLimited sizes\n•\nDifficult in abnormal airways\n•\nNot ideal for post-op ventilation\n•\nPotential airway trauma risk\n•\nRisk of intra-op displacement\nBronchial Blockers\n•\nEasy size selection\n•\nEasily used with standard ETT\n•\nEasier placement in difficult airways\n•\nSelective lobar isolation is possible\n•\nPost-operative dual lung ventilation easy\n•\nTakes longer to insert than DLT\n•\nMust confirm with fibreoptic scope\n•\nSlow + incomplete lung collapse\n•\nSuction + bronch of isolated lung impossible\n•\nDifficult alternate OLV (unless Rusch EZ\nBifid)\nEndobronchial Tube\n•\nEasiest in emergencies\n•\nSuction + bronch of isolated lung impossible\n•\nDifficult for L OLV", "citations": [{"type": "pdf_page", "page": 58, "label": "p58"}]}
{"chunk_id": "SSUs_v1_p059_txt_00_eb79ec", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 59, "page_end": 59, "section_path": ["THORACIC SURGERY", "Hypoxaemia with OLV", "Hypoxaemia with OLV"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Hypoxaemia with OLV", "keywords": [], "text": "Hypoxaemia with OLV\nHypoxaemia with OLV:\n•\nNo definition but generally accepted as sats <90% on FiO2 100% - must alert surgeons\n•\nExpect immediate in arterial oxygenation after starting OLV, improves as HPV increases (biphasic) – aim sats ≥90%\nImmediate management: FiO2 to 100% (except previous bleomycin – however titrate FiO2 to sats >90 briefly if needed)\nLikely cause depends on timing:\n•\nImmediately following lung isolation:\no\nLikely atelectasis and de-recruitment\no\nCheck airway pressure & leak\no\nRe-check tube position with bronch\n•\nIntra-op:\no\nCheck position of DLT / BB\no\nCheck cuff pressures + vent pressures\no\nOptimise haemodynamics\no\nRecruitment maneouvre of ventilated lung (anticipate transient worsening)\no\nTreat bronchospasm (auscultate if able)\no\nTherapeutic suctioning\no\nAdjust PEEP to ventilated lung (if EEP > set PEEP + obstructive trace consider gas trapping → passive\nexpiration)\no\nOxygen insufflation + 1-5cmH2O to non-ventilated lung\no\nIntermittent reinflation of non-ventilated lung (HPV reflex improves with repeated hypoxic exposure)\no\nClamp non-ventilated lung\no\nSevere sudden desaturation → two-lung ventilation + consider:\n▪\nMajor haemorrhage (discuss with surgeon, Hb)\n▪\nTension pneumothorax (turn supine, drain)\n▪\nGas embolism (head down, inotropic support)\n▪\nAcute right heart failure (TOE, correct resp acidosis)\nLung re-expansion:\n•\nSustained inflation at low pressure i.e. 20-30cmH2O for 10 – 15s\n•\nRepeat as necessary\nPost-op:\n•\nLPV\n•\nHigh FiO2 → VILI (lowest FiO2 for sats 90-94%)\nLateral decubitus position:\n•\nCompliance:\no\nAwake: dependent lung > non-dependent lung\no\nAnaesthetised: non-dependent lung > dependent lung → ventilation of non-dependent lung\n OLV in lateral decubitus V:Q matching (further aided by HPV)", "citations": [{"type": "pdf_page", "page": 59, "label": "p59"}]}
{"chunk_id": "SSUs_v1_p060_txt_00_8c34c8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 60, "page_end": 60, "section_path": ["THORACIC SURGERY", "Anterior Mediastinal Masses", "Anterior Mediastinal Masses"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Anterior Mediastinal Masses", "keywords": [], "text": "Anterior Mediastinal Masses\nAnatomy: between two pleural cavities, from thoracic inlet → diaphragm\nSuperior and inferior divided by thoracic plane (imaginary line from sternal angle to T4 vertebrae)\n4Ts:\n•\nThymoma\n•\nThyroid\n•\nTeratoma\n•\nTerrible lymphoma\nPre-op:\n•\nHistory:\no\nMass effect: ?positional effect - must know position of greatest comfort\n▪\nAirway: stridor, dyspnoea, SOB\n▪\nVasculature: pre-syncope / syncope\no\nOther 4Ms: metabolic (paraneoplastic syndromes, medication (chemo), mets)\n•\nExam:\no\nAirway: ability to lie flat, stridor, wheeze, sitting + lying sats\no\nVascular obstruction: Pemberton’s, facial plethora – do BP sitting + lying\n•\nIx:\no\nRoutine bloods, G&H, TFTs\no\nCT Imaging: airway diameter <50%, carina involvement, vascular obstruction\no\nUpright + supine PFTs: usually insp + exp curves, a disprop in max exp flow consider tracheomalacia\no\nHigh risk: supine PEFR <40%\n•\nCandidate for salvage VV-ECMO\n•\nAvoid pre-med if concerns for tracheal obstruction\n•\nRefer: CTSx, ICU – consider location\nResection: robotic (requires CO2 insufflation – may preload), VATS,\nopen / sternotomy\nIntra-op:\n•\nMonitoring:\no\nRight arm: sats probe (will alert to brachiocephalic compression)\no\nLeft arm: art line (will give true BP reading even if brachiocephalic compression)\n•\nVenous access LL (if bleeding from vessels draining into SVC)\n•\nSurgeons present / scrubbed on induction\n▪\nRescue:\n•\nObstruction above carina: rigid bronch\n•\nCarinal involvement: VV ECMO\n+/- sternotomy\n•\nSurgical method:\no\nSternotomy: SLT – consider spont vent induction, pass ETT beyond obstruction prior to paralysing\no\nThoracotomy: DLT → OLV (DLT requires paralysis)\no\nRisk of non-cardiogenic pulmonary oedema with airway obstruction\n•\nBlood management\n•\nRegional:\no\nPVB by surgeons\no\nSA block: chest drain\nPost-op: HDU, drain management, FASTHUGS, APS\n•\nPre-op tracheal diameter <50% - high risk tracheomalacia – keep reintubation equipment at bedside\nDiagnostic Procedure\n•\nLocal +/- sedation\n•\nEBUS + needle: spont vent LMA\n•\nMediastinoscopy: 3cm incision at suprasternal notch - spont vent LMA – rigid bronch rescue\no\nCI: previous procedure (scarring), prev radiation, thoracic aneurysm, SVC syndrome, severe tracheal deviation\no\nMust be prepared for bleeding + thoracotomy\nParaneoplastic syndromes:\n•\nEndocrine: hyper-PTH, cushing’s, SIADH, carcinoid\n•\nNeuromuscular: MG, Eaton-lambert, neuropathy\n•\nHaem: anaemia, plt, thrombosis\n•\nOther: amyloidosis, nephrotic", "citations": [{"type": "pdf_page", "page": 60, "label": "p60"}]}
{"chunk_id": "SSUs_v1_p061_txt_00_2bb15c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 61, "page_end": 61, "section_path": ["THORACIC SURGERY", "Lung Resection", "Lung Resection"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Lung Resection", "keywords": [], "text": "Lung Resection\nAssessment domains/risk:\n•\nOperative mortality: THORASCORE – not very accurate\n•\nPeri-op myocardial events:\no\nRCRI 6 Cs: refer to cardiology if ≥3\no\nTTE: ?pulmonary hypertension (esp if pneumonectomy)\n•\nRisk of post-op dyspnoea: must do within last 6-12mo\no\nPredicted post-op FEV1: pre-op FEV1 x remaining % lung segments\n▪\n>40% low risk, 30 – 40% mod, <30% high risk\n•\nVQ scan: consider for pneumoectomies or if ppoFEV1 <40%\no\nDLCO\no\nFunctional assessment\n▪\nShuttle walk test:\n•\n>400m = VO2 >15mL/kg/min\n•\n<400m → refer for CPET\n4% SpO2 during exercise = risk\n▪\nCPET:\n•\nVO2 max >20mL/kg/min – safe for pneumonectomy\n•\nVO2 <10mL/kg/min contra-indicated – high risk of\ndyspnoea\n•\n+ Cancer staging: PET-CT\n•\nTreatment side effects i.e. chemo and radiotherapy\nNOTE: all guidelines differ on exact cut offs – broadly all follow the 3-legged stool\n•\nLung mechanics: FEV1\n•\nPulmonary parenchymal function: DLCO\n•\nCardiopulmonary reserve: VO2 max\nRisk stratification:\n•\nLow risk: <1% mortality\no\nLow cardiac risk\no\nFEV1 / DLCO >80%\no\nVO2 max >20mL/kg/min\n•\nIntermediate risk: 2-9% mortality\no\nPredicted post-op FEV1 and DLCO >30%\no\nOR ≥1 is <30% but predicted post-op VO2 is >10mL/kg/min (or >35%)\n•\nHigh risk: mortality >10%\no\nPredicted post-op VO2 is <10mL/kg/min (or <35%)", "citations": [{"type": "pdf_page", "page": 61, "label": "p61"}]}
{"chunk_id": "SSUs_v1_p062_txt_00_c41fe7", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 62, "page_end": 62, "section_path": ["THORACIC SURGERY", "Lung Resection"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Lung Resection", "keywords": [], "text": "Operation\nIndication\nSurgical Technique\nAnaesthetic\nConsiderations\nPneumonectomy\n•\nBronchial carcinoma (85% NSCLC) not\namenable to sleeve lobectomy\n•\nUncontrollable haemorrhage\nThoracotomy in lateral decubitus\nSee\npneumonectomy\nSleeve lobectomy\n•\nLocally advanced carcinoma involving the\nmain bronchus with sufficient tissue for\nre-anastomosis (must achieve complete\nexcision)\nThoracotomy in lateral decubitus\n– more challenging surgically\nthan pneumonectomy due to\nreconstruction\nLobectomy\n•\nPrimary lung cancer with curative intent\nTake entire blood supply to lobe\n+ bronchus + LNs\nSegmentectomy\n•\nLung nodule (TB etc)\n•\nPrimary lung cancer with\ncardiopulmonary reserve (i.e.\nparenchymal preservation)\n•\nBronchiectasis\n•\nRarely for lung metastases – only if\nwedge resection not suitable\nMore challenging surgically than\nlobectomy – no defined fissures\nBronchus and blood supply to\nsegment ligated → systemic\ninjection if ICG → resection of un-\ndyed portion\nWedge resection\n•\nMetastatic nodule\n•\nFocal lung disease\nResection of diseased portion of\nlung\nLateral decubitus: hypotension common in and out of position.\nHead-to-toe check:\n•\nDependent eye\n•\nDependent ear pinna\n•\nCervical spine (in line with thoracic spine)\n•\nDependent arm (compression brachial plexus + circ)\n•\nNon-dependent arm (stretch brachial plexus + circ)\n•\nBilateral suprascapular n\n•\nDependent leg (peroneal n + circ)\n•\nNon-dependent leg sciatic nerve (avoid tight strapping)\nMonitoring:\n•\nArt line: non-dependent arm – will be accurate, not altered by compression\n•\nSats probe: dependent arm – will alert to decreased perfusion from lateral decubitus positioning", "citations": [{"type": "pdf_page", "page": 62, "label": "p62"}]}
{"chunk_id": "SSUs_v1_p063_txt_00_80d2bf", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 63, "page_end": 63, "section_path": ["THORACIC SURGERY", "Cardiac Herniation", "Pneumonectomy"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pneumonectomy", "keywords": [], "text": "Pneumonectomy\nIndications:\n•\nBronchial carcinoma (85% NSCLC) – must be unsuitable for sleeve resection\n•\nUncontrolled haemorrhage\nCI: significant pulmonary hypertension\nMortality:\n•\nRight > left (+ bronchopleural fistula rate)\n•\n1 year mortality 25% (strongly  age - ability of RV to tolerate PVR)\nPre-op:\n•\nAs per lung resection assessment\n•\nSleeve lobectomy must be ruled out as possible option\n•\n4M’s of cancer\n•\nModifiable RFs: smoking, infection, nutrition, pulmonary rehabilitation,\nexercise\nIntra-op:\n•\nRoutine monitoring + art line, CVC, temp, IDC, ABG monitoring +/- TOE\n•\nVolatile or TIVA – TIVA easier for rigid bronch\n•\nInitial rigid bronch (confirms sufficient length free of tumour to proceed)\n•\nDLT: bronchial lumen for side not being resected → lung isolation\n•\nPosition: lateral with table break\n•\nOLV targets: sats 94-98, peak pressure <35, plateau pressure <25, PEEP 5 – 8, Vt 6mL/kg, normal CO2\no\nOLV prior to thoracotomy\no\nTEST OLV prior to starting resection – must have good ventilation / O2\n•\nPosterolateral thoracotomy (5th intercostal space)\n•\nTest clamp of ipsilateral PA (if cardiac collapse / CVP rise ++ predicts post-op cardiac complications)\n•\nVessel ligation + bronchus stapled / cut\n•\nLeak test to confirm stump patency\n•\nAnalgesia: TEA / paravertebral block (by surgeons under vision)\n•\nFluid:\no\nRestrictive i.e. <20mL/kg in first 24hr to reduce risk of pulmonary oedema\no\nUO aim 0.5mL/kg/hr – not more\n•\nThoracostomy tube + closure\nPost-op: ICU\n•\nEarly extubation if possible\n•\nRespiratory physiotherapy\n•\nSingle chamber chest drain without suction\nComplications:\n•\nHaemorrhage\n•\nPost-pneumonectomy pulmonary oedema (50% mortality)\n•\nSecretions\n•\nArrhythmia: 40% new AF\n•\nCardiac herniation (mortality 50%)\n•\nBronchopleural fistula (up to 20%): R > L SSx cough, continuous air leak, empyema, air fluid levels\nFollowing pneumonectomy: volume of hemithorax 2’ mediastinal shift, elevation of diaphragm, contraction of chest wall,\nreplacement of air with pleural fluid +/- neovascularisation in younger patients\nCardiac Herniation\nR > L. Usually within 24 hours post-op. SSx hypotension, shock, cyanosis.\nRight side worse due to torsion of the heart → acute SVC syndrome.\nManagement: full lateral position with operated side up, intubation with SLT + pressors and inotropes to support whilst\nexploration takes place\nType of pneumonectomy:\n•\nStandard: removal of affected lung only,\nbronchial stump closed + vessels ligated\n•\nIntrapericardial pneumonectomy: if main\nPA involved, or division close to atrium\n•\nExtrapleural pneumonectomy: radical –\nlung, ipsilateral pleura, hemidiaphragm,\nhemipericardium\n•\nCompletion pneumonectomy: remaining\ntissue from prior resection", "citations": [{"type": "pdf_page", "page": 63, "label": "p63"}]}
{"chunk_id": "SSUs_v1_p064_txt_00_d9756a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 64, "page_end": 64, "section_path": ["THORACIC SURGERY", "VATS/Robotic Assisted Lung Resection Surgery", "VATS/Robotic Assisted Lung Resection Surgery"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "VATS/Robotic Assisted Lung Resection Surgery", "keywords": [], "text": "VATS/Robotic Assisted Lung Resection Surgery\nBenefits cf open:\n•\nMorbidity/mortality\n•\nLOS\n•\nImproved functional recovery (VIOLET trial)\nRobotic versus VATS: overall very comparable results\n•\nRATS has significantly longer operating time\n•\nVATS has blood loss\n•\nNo significant difference:\no\nDuration of chest tubes\no\nLOS\no\nLow- and high-grade complications\no\nReadmissions\no\n30-day mortality\nIndications:\n•\nDiagnostic: biopsy, thoracocentesis, staging\n•\nTherapeutic:\no\nPleural: pleurodesis, decortication\no\nParenchymal: wedge resection, segmentectomy, lobectomy, bullae resection, volume reduction\no\nMediastinal: tumour, thymectomy, chylothorax, pericardial window\no\nOesophageal: vagotomy, myotomy\no\nSympathectomy\nCI:\n•\nSurgical: adhesions, extensive disease, anatomical location, tumour >6cm\n•\nAnaesthetic: CI to OLV\nIntra-op for both:\n•\nTIVA > volatile (unplanned admission to ICU)\n•\nPosition: lateral + table break (padding or bean bag)\n•\nLung isolation + OLV (DLT or BB) – L side less likely to dislodge\n•\nRegional block + LA by surgeons\nRobotic surgery considerations:\n•\nRobotic surgery requires CO2 insufflation (cf VATS open to air) – this is essentially a tension pneumothorax\no\nMust watch for CVS effects + ETCO2: ensure inflation pressure ~8cmH2O (if insufflation > RA pressure will\nlose CO)\n•\nEmergency: requires safe removal of robot + lead surgeon to scrub (can cause delay to management)", "citations": [{"type": "pdf_page", "page": 64, "label": "p64"}]}
{"chunk_id": "SSUs_v1_p065_txt_00_501e0c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 65, "page_end": 65, "section_path": ["THORACIC SURGERY", "Bronchoscopic LVRS", "Lung Volume Reduction Surgery"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Lung Volume Reduction Surgery", "keywords": [], "text": "Lung Volume Reduction Surgery\nPalliative procedure for severe COPD caused by emphysema – excision of emphysematous lung tissue\nAim: improvement of elastic recoil of remaining lung → hyperinflation → improved resp muscle efficiency and reduced\nintrathoracic pressure improving LV filling\nLVRS not shown to improve survival cf maximum medical therapy, but can improve QoL, dyspnoea, exercise tolerance\nNETT trial: FEV1 or DLCO <20% predicted pre-op – unacceptably high peri-op mortality rate\nMethod: median sternotomy, thoracotomy or VATS (usually VATS)\nPre-op:\n•\nQuantify risk and ensure FEV1 or DLCO not <20%\n•\nNo pre-med\nIntra-op:\n•\nRoutine + art line\n•\nDLT\n•\nMonitor for airway pressures/hypotension – high risk of pneumothorax with PPV, avoid gas trapping\n•\nPermissive hypercapnia unless pH <7.2 – may need intermittent 2-lung ventilation\n•\nRegional anaesthesia + post-op extubation\nBronchoscopic LVRS\nAims to achieve similar effect as LVRS but with less morbidity\nMethods:\n•\nOne-way endobronchial valves\n•\nBiologic sealants\n•\nThermal ablation of bronchi\n•\nBronchial blockers\nAnaesthetic: GA or sedation\n•\nFlexi bronch amenable to sedation\n•\nRigid bronch or thermal ablation – GA", "citations": [{"type": "pdf_page", "page": 65, "label": "p65"}]}
{"chunk_id": "SSUs_v1_p066_txt_00_315458", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 66, "page_end": 66, "section_path": ["THORACIC SURGERY", "Post-Thoracotomy Pain", "Post-Thoracotomy Pain"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Post-Thoracotomy Pain", "keywords": [], "text": "Post-Thoracotomy Pain\n65% of patients post-thoracotomy (2nd only to amputation)\nPhysiology:\n•\nNociceptive: T4 – T10 somatic, vagal/phrenic visceral\n•\nNeuropathic\n•\nReferred: i.e. ipsilateral shoulder\nReducing risk of chronic pain:\n•\nThoracic epidural and paravertebral block are comparable\n•\nVATS > open\nPre-op / intra-op:\n•\nParavertebral block: preferred, less SE + safety profile, chest infection, confusion, hypotension, N&V / itching,\nurinary retention\n•\nThoracic epidural (T5/T6)\n•\nSpinal morphine (4.5mcg/kg)\n•\nOperative technique: VATS > open, muscle sparing\nPost-op:\n•\nParacetamol\n•\nNSAIDs: unless CI, or pleurodesis\n•\nIV PCA\n•\nThoracic epidural or paravertebral catheter for 2-3 days\n•\nTopical LA for drain removal\n•\nSuprascapular n. block for shoulder tip pain\nChronic pain management:\n•\nPharmacological: NSAIDs, amitriptyline, gabapentin, opioids, ketamine\n•\nNon-pharmacological: TENS, spinal cord stimulator", "citations": [{"type": "pdf_page", "page": 66, "label": "p66"}]}
{"chunk_id": "SSUs_v1_p067_txt_00_728820", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 67, "page_end": 67, "section_path": ["THORACIC SURGERY", "Bronchopleural Fistula", "Bronchopleural Fistula"], "specialty_tags": ["THORACIC SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Bronchopleural Fistula", "keywords": [], "text": "Bronchopleural Fistula\nSinus tract between main stem, lobar or segmental bronchus + pleural space\nMany risk factors, highest post-op risk after pneumonectomy or R lower lobectomy 2’:\n•\nIschaemic necrosis\n•\nInfection\nSSx: dyspnoea, hypotension, subcut emphysema, cough +/- expectorated purulent pleural fluid, tracheal or mediastinal shift,\npersistent air leak\nEvaluation:\n•\nBronchography + methylene blue\n•\nBronchoscopic exploration\nIf cause not due to lung resection e.g. malignancy or infection → bronchoscopic treatment\nPre-op:\n•\nPleural drainage: affected side dependent – thoracostomy + drain\no\nSend: FBC, pH, protein, LDH, glucose, cytology, TGs, gram stain, culture\nIntra-op:\n•\nMeticulous pre-oxygenation\n•\nInduction: RSI with small VT and low airway pressures until lung isolation confirmed\n•\nVATS → muscle flap\no\nOther options: decort, complete pneumonectomy\n•\nAim to extubate if able – ongoing PPV can reduce healing\no\nIf remaining ventilated: minimal PEEP, low mean airway pressures\nOther options:\n•\nAwake intubation: patient likely already hypoxaemic\n•\nSpont vent: risk of aspiration into healthy lung, technically difficult with DLT", "citations": [{"type": "pdf_page", "page": 67, "label": "p67"}]}
{"chunk_id": "SSUs_v1_p068_txt_00_0941c2", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 68, "page_end": 68, "section_path": ["THORACIC SURGERY", "Tracheobronchial Mass", "Tracheobronchial Mass"], "specialty_tags": ["THORACIC SURGERY", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Tracheobronchial Mass", "keywords": [], "text": "Tracheobronchial Mass\nAirway Stenting\nIndications for stenting:\n•\nMalignancy: (adenocarcinoma, carcinoid, adjacent, mets)\no\n4Ms\n•\nNon-cancer: consider tracheal resection\no\nStrictures\no\nStenosis\no\nTracheomalacia\nComplications:\n•\nEarly: dental damage, airway damage + bleeding, barotrauma, airway obstruction\n•\nJet vent: gas embolism, tension pneumothorax, tension pneumomediastinum, subcut emphysema\n•\nLate: erosion, stent migration, bacterial infection, granuloma +/- stenosis, fistula\nPre-op:\n•\nASSESS:\no\nMedical comorbidities\n▪\nFunctional assessment\no\nTracheobronchial lesion:\n▪\nMass effect: ?positional effect - must know position of greatest comfort\n•\nAirway: stridor, dyspnoea, SOB\n•\nVasculature: pre-syncope / syncope\n▪\nMetabolic: paraneoplastic syndromes\n▪\nMedication, mets\no\nExam:\n▪\nAbility to lie flat, stridor, wheeze, sitting + lying sats\n▪\nVascular obstruction: Pemberton’s, facial plethora\n•\nBP sitting + lying\no\nIx:\n▪\nRoutine bloods, ECG\n▪\nTTE: ?pulmonary hypertension +/- RH dysfunction (apnoeic O2 + jet vent)\n▪\nCT Imaging: airway diameter <50%, carina involvement (risk), vascular obstruction\n▪\nUpright + supine PFTs: uusually insp + exp curves, a disproportionate in max exp flow consider\ntracheomalacia\n▪\nHigh risk: supine PEFR <40%\n•\nMANAGE:\no\nACD documented\no\nOptimise where able\n•\nREFER/DISCUSS: ENT + cardiothoracics + ICU + ECMO team\no\nHigh risk: tertiary centre\no\nType of stent / need for GA\n▪\nFlexible bronch versus rigid bronch\no\n?Need for laser\no\nRescue interventions - candidate for salvage VV-ECMO?\no\nLimits of care ?palliative procedure\nIntra-op:\n•\nTopicalization\n•\nAnaesthetic: TIVA +/- NMBA\n•\nProcedure:\no\nFlexi bronch: spont vent HFNP +/- LMA\no\nRigid bronch: HFNP + jet ventilation\nPost-op:\n•\nHDU", "citations": [{"type": "pdf_page", "page": 68, "label": "p68"}]}
{"chunk_id": "SSUs_v1_p069_txt_00_cec32d", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 69, "page_end": 69, "section_path": ["GENERAL SURGERY", "General Surgery"], "specialty_tags": ["GENERAL SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "General Surgery", "keywords": [], "text": "General Surgery\nRELIEF trial: elective major abdo surgery, no difference in disability free survival between liberal and restrictive fluid strategies,\nAKI in restrictive group\nLaparotomy\nPre-op:\n•\nResus +++\n•\nACS-NSQIP / NELA\n•\nAspiration risk\n•\nREFER: ICU\nIntra-op:\n•\nSuction NGT\n•\nMonitoring: 5-lead, art line, CVC, UO\n•\nRSI\n•\nBlood management\n•\nGoal directed fluid therapy\nPost-op:\n•\nERAS / FASTHUGS", "citations": [{"type": "pdf_page", "page": 69, "label": "p69"}]}
{"chunk_id": "SSUs_v1_p070_txt_00_648720", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 70, "page_end": 70, "section_path": ["GENERAL SURGERY", "Splenectomy", "Splenectomy"], "specialty_tags": ["GENERAL SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Splenectomy", "keywords": [], "text": "Splenectomy\nCoeliac → splenic a. → spleen → splenic v. → SMV → PV\nFunction:\n•\nSecondary lymphoid (white pulp): process + present antigens, adaptive immunity\n•\nHaematological (red pulp): RBC destruction + haem lifecycle, phagocytosis, haematopoeisis\n•\nStorage: 250mL RBC, 30% platelets\nDisorders:\n•\nAccessory spleen 10%\n•\nSplenic artery aneurysm (may rupture in pregnancy)\n•\nSplenomegaly: infection, cancer, congestive, functional, immune, storage\n•\nHyposplenism: functional (EtOH, sickle cell, BMT, coeliac, IBD), surgical/trauma\no\nPresentation: encapsulated organism infection (S pneumoniae, N meningitides, I influenzae)\no\nBlood film: acanthocytes, target cells, Howell-Jolly bodies\n•\nSplenic infarct: haematological, embolic, traumatic\n•\nTrauma: grades 1 – 5\nSplenectomy indications:\n•\nTrauma\n•\nHaematological: ITP, hereditary spherocytosis, thalassemia, Hodgkin’s disease, leukaemia, Felty syndrome (RA)\nPre-op:\n•\nCancer 4Ms\n•\nSteroids\n•\nVaccination: 2 weeks pre-op (2 weeks post-op if emergency)\n•\nPre-op splenic artery embolisation\n•\nITP: platelets >20, IVIg, steroids\n•\nSurgical approach: laparoscopic v open\n•\nREFER: haematology\nIntra-op:\n•\nMonitoring: art line, temp\n•\nNeuraxial safe: platelet >100 (cf pregnancy >70 – procoagulant)\n•\nPrevent sickling: normal O2\n•\nStress dose steroids\n•\nBlood: irradiated products\n•\nBlood management bundle\nPost-op:\n•\nPenicillin prophylaxis\n•\nVaccination at 2 weeks if emergency\n•\nMonitor for complications: PV thrombosis, VTE, overwhelming sepsis", "citations": [{"type": "pdf_page", "page": 70, "label": "p70"}]}
{"chunk_id": "SSUs_v1_p071_txt_00_9d559f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 71, "page_end": 71, "section_path": ["GENERAL SURGERY", "Oesophagectomy", "Oesophagectomy"], "specialty_tags": ["GENERAL SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Oesophagectomy", "keywords": [], "text": "Oesophagectomy\nIndications: adenocarcinoma 80%, SCC 20%\nPre-op:\n•\nFunctional, RCRI\n•\nCancer 4Ms\no\nWait several weeks after neo-\nadjuvant chemo\no\n5FU (bone marrow\nsuppression), cisplatin\n(cardiotoxic, nephrotoxic, hepatotoxic)\n•\nFrailty\n•\nNutrition\n•\nAnaemia\n•\nModifiable RFs\n•\nPlanned surgical approach:\no\nThoracotomy: Ivor-Lewis, Mckeown, trans-diaphragmatic, minimally invasive\no\nNo thoracotomy: trans-hiatal\n•\nSurgical risk (mortality 5%, morbidity 30%)\n•\nREFER: ICU\nIntra-op:\n•\nPre-med: PPI, sodium citrate\n•\nMonitoring: art line, CVC, temp, UO, BIS\no\nMediastinal manipulation → cardiac instability\n•\nRSI + DLT if thoracotomy (+/- lateral decubitus)\n•\nGoal directed fluid (too much – anastomotic oedema, too little – anastomotic ischaemia)\n•\nAnalgesia: TEA, PVB, ESP\n•\nLong operation: pressure care\nPost-op:\n•\nEarly extubation\n•\nCPAP / BiPAP CI\n•\nERAS + FASTHUGS - early enteral feeding\n•\nAPS\nComplications: resp (50%), RLN palsy, anastomotic leak, MACE, AF, sepsis", "citations": [{"type": "pdf_page", "page": 71, "label": "p71"}]}
{"chunk_id": "SSUs_v1_p072_txt_00_e0ea37", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 72, "page_end": 72, "section_path": ["GENERAL SURGERY", "Gastrectomy", "Gastrectomy"], "specialty_tags": ["GENERAL SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Gastrectomy", "keywords": [], "text": "Gastrectomy\nIndication: gastric ca.\nRFs: age, genetic, H pylori, smoking, previous gastric surgery, pernicious anaemia, low SES\nPre-op:\n•\nStaging laparoscopy + CT\n•\nCancer 4Ms:\no\n5FU (bone marrow suppression), cisplatin (cardiotoxic, nephrotoxic, hepatotoxic) + epirubacin\n•\nFrailty\n•\nNutrition\n•\nAnaemia\n•\nModifiable RFs\n•\nGORD\n•\nMDT + refer ICU\nIntra-op:\n•\nRSI + ETT\n•\nTEA\nPost-op:\n•\nICU / HDU\n•\nComplications\no\nAnastomotic leak\no\nMalabsorption", "citations": [{"type": "pdf_page", "page": 72, "label": "p72"}]}
{"chunk_id": "SSUs_v1_p073_txt_00_b428b6", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 73, "page_end": 73, "section_path": ["GENERAL SURGERY", "Liver Resection", "Liver Resection"], "specialty_tags": ["GENERAL SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Liver Resection", "keywords": [], "text": "Liver Resection\nIndications: benign mass (haemangioma, adenoma) and malignant masses (primary or mets)\nAnatomy:\n•\n8 functional segments – each consist of a portal triad\n•\nRegenerates – starts within 24 hrs of resection, original size by 6mo (functional\nrecovery 2-3 weeks)\n•\nSafe liver remnant:\no\n20% in healthy liver\no\n40% in cirrhosis\nCI:\n•\nChild Pugh C\n•\nChild Pugh B with remnant <40%\n•\nNASH with remnant <30%\nComplications - 40% (20% major): bile leak, pulmonary, ascites, thrombotic, post-op liver failure, mortality 1-3%\nPre-op:\n•\nAs for liver disease\n•\nFuture remnant:\no\nAssess size: CT/MRI\no\nPortal vein embolisation → remnant hypertrophy\n•\nCancer 4Ms\no\nChemo: wait 4-6 weeks, risk of cardiotoxicity\n•\nModifiable risk: nutrition, anaemia\n•\nOptimise:\no\nCorrect coagulopathy\no\nNutrition\no\nDiabetes (operative mortality higher)\n•\nX-match 4 units\n•\nRisk score: Child Pugh, MELD, VOCAL-PENN\n•\nMinimise fasting + carb load\n•\nMDT\n•\nAvoid long-acting pre-med\nIntra-op:\n•\nPringle manoeuvre: 10-20 mins → 5 mins reperfusion, ischaemia + induces ischaemic preconditioning\n•\nBlood management bundle\no\n+ aim CVP <5mmHg: main source of bleeding is backflow from valveless hepatic veins\n▪\nbleeding + transfusion but no difference in outcomes\n▪\nPosition: steep head up + arms out (risk of VAE)\n▪\nintrathoracic pressure\n▪\nIVF until parenchymal resection complete\n•\nAnalgesia: TEA or spinal with morphine + PCA\nPost-op:\n•\nEarly mobilisation\n•\nAnalgesia + APS\n•\nPONV\n•\nERAS\nPost-op Liver Failure:\n•\nRFs: diabetes, obesity, metabolic syndrome, malnutrition, cholangitis, age >65\n•\nSurgical: blood loss >1200mL, transfusion, associated resection, FLR <20%, extended liver resection (>50%), operation\ntime >240min, other post op complications\n•\nPre-op liver dysfunction\nManagement same as ALF.\nPringle manoeuvre:\n•\nPortal vein\n•\nHepatic artery\n•\nBile duct\n•\n“Hepatoduodenal ligament”\n•\nEffect:\no\nSVR 20-30%\no\nCO 10%", "citations": [{"type": "pdf_page", "page": 73, "label": "p73"}]}
{"chunk_id": "SSUs_v1_p074_txt_00_324a24", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 74, "page_end": 74, "section_path": ["GENERAL SURGERY", "Nephrectomy", "Nephrectomy"], "specialty_tags": ["GENERAL SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Nephrectomy", "keywords": [], "text": "Nephrectomy\nIndications: live donor transplant, tumour (RCC, TCC, Wilms), trauma, non-functioning chronically infected\nPre-op:\n•\nCancer: 4Ms\no\nRCC: IVC invasion\n•\nRenal function + complications of disease (HTN, anaemia, electrolyes)\n•\nSurgery: partial / total / radical, laparoscopic v open\n•\nFunctional capacity + RCRI\n•\nIx:\no\nIsotope renography: predicted post-op renal fx\no\nCT/MRI: caval infiltration\n▪\nHeparin\n▪\nArterial embolisation\n▪\nMDT: vascular, CTSx, UGI\n▪\nCPB\nIntra-op:\n•\nPosition: lateral w/ table break (preload, FRC)\n•\nPressure care\n•\nMonitoring: 5-lead, art line, CVC, temp, UO\n•\nBlood management bundle + cell salvage\n•\nTOE if IVC disease\n•\nLocal renal hypothermia (if WIT estimated >30mins)\n•\nRegional: TEA, PVB, ESP\n•\nDeep neuromuscular blockade: post-op pain\nPost-op:\n•\nMonitor EUC", "citations": [{"type": "pdf_page", "page": 74, "label": "p74"}]}
{"chunk_id": "SSUs_v1_p075_txt_00_64989d", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 75, "page_end": 75, "section_path": ["GENERAL SURGERY", "Prostatectomy", "Prostatectomy"], "specialty_tags": ["GENERAL SURGERY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Prostatectomy", "keywords": [], "text": "Prostatectomy\nOpen or robotic.\n•\nBoth: paracetamol, NSAIDs, opioid rescue\n•\nOpen: TEA, IV lignocaine, LA wound infiltration\n•\nRobot: TAP blocks\nRobotic Prostatectomy\nBenefits: smaller incision, pain, blood loss / transfusion, faster recovery, shorter LOS\nRisks: vision loss, AKI, atelectasis, air embolism, retroperionteal haematoma, aspiration / regurg, raised ICP, endobronchial\nintubation, insidious major haemorrhage, acid injury to eyes, pressure area\nNo difference:\n•\nCancer outcome\n•\nIncontinence\n•\nSexual function\nAnaesthetic robotic considerations:\n•\nPoor access to patient\n•\nComplete immobility\n•\nPneumoperitoneum\n•\nSteep trendelenberg → ICP, IOP\nfacial oedema, orbital oedema,\nregurg\n•\nVentilation: PCV > VCV – greater\ndynamic compliance\nPre-op:\n•\nAssess ICP / IOP\n•\nCardiorespiratory function (effects SVR, oxygen consumption, hypercapnoea, airway pressures, V/Q mismatch)\n•\nEmergency undocking procedure must be known to staff\nIntra-op:\n•\nIntubation: tape (not tie)\n•\nVentilation: LPV, higher PEEP, permissive hypercapnoea but beware with ICP, recruitment\n•\nPosition + pressure care check prior to drape\no\nEnsure lube + TEG secured + gauze over\no\nNerve palsy: common peroneal, brachial plexus\n•\nAnalgesia: include spinal morphine\n•\nRestrict IVF until urethral anastomosis complete\n•\nParalysis + NM monitoring\n•\nAvoid N2O\n•\nExtubation:\no\nUpright\no\nLeak test\nPost-op:\n•\nRisk of cerebral irritation → early neuro assessment", "citations": [{"type": "pdf_page", "page": 75, "label": "p75"}]}
{"chunk_id": "SSUs_v1_p076_txt_00_59ec51", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 76, "page_end": 76, "section_path": ["TURP", "TURP"], "specialty_tags": ["TURP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "TURP", "keywords": [], "text": "TURP\nInnervation: bladder T11 – L2, prostate S2 – S4\nPre-op:\n•\nExclude UTI\nIntra-op:\n•\nSpinal:\no\nobturator spasm\no\n2.3 – 3mL bupivacaine 0.5% heavy\no\nT10 dermatome required for bladder\no\nTreat hypotension with vasopressor\n•\nGent 2mg/kg\n•\nMonitor for bleeding\nPost-op:\n•\n3-way tap\n•\nComplications:\no\nTURP syndrome\no\nBladder spasm\n▪\nKetorolac, MgSO4, benzos, buscopan\no\nHaemorrhage\no\nClot retention", "citations": [{"type": "pdf_page", "page": 76, "label": "p76"}]}
{"chunk_id": "SSUs_v1_p077_txt_00_9f5eef", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 77, "page_end": 77, "section_path": ["TURP", "Post-TURP / Hysteroscopy Syndrome", "Post-TURP / Hysteroscopy Syndrome"], "specialty_tags": ["TURP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Post-TURP / Hysteroscopy Syndrome", "keywords": [], "text": "Post-TURP / Hysteroscopy Syndrome\nIssues:\n•\nFluid overload (even with crystalloid irrigation)\n•\nHyponatraemia (with hyponatraemic solutions)\nSolutions used:\n•\nBipolar: normal saline / ringer’s lactate\n•\nWith monopolar:\no\n1.5% glycine (200mOsm/kg)\no\n3% sorbitol (165 mOsm/kg)\no\n5% mannitol (275 mOsm/kg i.e. isotonic)\nIncidence:\n•\nTURP 1%\n•\nHysteroscopy 1%\nRFs:\n•\nVolume used: 1000mL glycine → serum Na by 10mM\n•\nFemale (i.e. hysteroscopy > TURP)\n•\nIrrigation pressure\n•\nPerforation\n•\nOperative time >1hr\n•\nLow venous pressure\n•\nBlood loss\nPrevention:\n•\nAvoid non-conducting fluids\n•\nLow infusion pressures\n•\nLimit duration of surgery to <1 hr\n•\nMonitor fluid absorbed and stop at pre-determined threshold:\no\nHysteroscopy 100-1500mL\no\nTURP 2000mL\no\nNon-conducting fluid 2500mL\nPresentation:\n•\nSSx: confusion, nausea, seizures, visual, headache\n•\nIx:\no\nNa, serum osmols\no\nECG: prolonged QRS\nManagement:\n•\nAsymptomatic: monitor\n•\nSymptomatic:\no\nHypertonic saline 3% 100mL\n▪\nRepeat q10 mins until symptoms improve\no\nDiuretics\no\nStop surgery if intra-op\no\nTreat complications:\n▪\nSeizures: mgso4\n▪\nBradycardia\n▪\nFluid overload\no\nHDU", "citations": [{"type": "pdf_page", "page": 77, "label": "p77"}]}
{"chunk_id": "SSUs_v1_p078_txt_00_da7e36", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 78, "page_end": 78, "section_path": ["TURP", "Bariatric Surgery", "Bariatric Surgery"], "specialty_tags": ["TURP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Bariatric Surgery", "keywords": [], "text": "Bariatric Surgery\nIndications:\n•\nBMI ≥40 without comorbidities\n•\nBMI ≥35 with ≥1 comorbidity\no\nComorbidities: T2DM, OSA / OHS, HTN, hyperlipidaemia, NAFLD, NASH, idiopathic intracranial hypertension,\nGORD, asthma, venous stasis, severe urinary incontinence, arthritis, impaired QoL, disqualifications from other\nsurgery due to obesity\n•\nBMI ≥30 with major comorbidity\no\nUncontrollable diabetes\no\nMetabolic syndrome\nAll appropriate non-surgical measures have failed for ≥6mo\nPatient otherwise fit for anaesthesia\nCI:\n•\nUntreated eating disorders, major depression / psychosis\n•\nCurrent D&A use\n•\nSevere cardiac disease\n•\nSevere coagulopathy\n•\nInability to comply with diet / nutrient replacement post-op\n•\nInflammatory GIT disorders\n•\nLiver disease: cirrhosis, portal HTN\nOutcomes:\n•\nlong term weight loss than non-surgical\n•\nmetabolic effects: T2DM, HTN, lipids, CVS risk\n•\nCancer: hormone related ca, colorectal ca, skin cancer\n•\nMortality: all cause mortality, CVS mortalit\n•\nMorbidity: OSA / AHI, GORD, function, QoL, PCOS,\nGFR, urinary incontinence, sexual health, NAFLD\nMOA:\n•\nMalabsorption\n•\nRestriction\n•\nNeurohormonal modification: ghrelin\nComplications:\n•\nIntra-op: injury to organs\n•\nPost-op: routine +\no\nAnastomotic leak (persistent tachycardia)\n•\nLate complications:\no\nGastric remnant distension\no\nStenosis\no\nUlcers\no\nHernia\no\nShort bowel syndrome: nutrient deficiency\no\nFistula\no\nDumping syndrome: rapid transit into small bowel\no\nGORD", "citations": [{"type": "pdf_page", "page": 78, "label": "p78"}]}
{"chunk_id": "SSUs_v1_p079_txt_00_6472c6", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 79, "page_end": 79, "section_path": ["TURP", "Bariatric Surgery"], "specialty_tags": ["TURP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Bariatric Surgery", "keywords": [], "text": "Pre-op:\n•\nObesity severity:\no\nCentral v peripheral\no\nBMI\no\nAirway\n•\nComorbidities: STOP BANG – OSA / OHS, GORD, resp, diabetes, HTN\n•\nIndicated Ix\n•\nObesity Surgery – Mortality Risk Score (OS-MRS)\n•\nOptimise:\no\nOSA: 6/52 CPAP\no\nDiet: 2 - 4 weeks of calorie restriction (liver shrinking diet)\no\nDiabetes control\nIntra-op:\n•\nAllow to walk to table\n•\nOT – weight appropriate\n•\nEquipment: straps, hover mat, table extensions\n•\nPre-oxygenation:\n•\nIntubation:\no\nPre-oxygenation with CPAP, ETO2 >90%\no\nRSI: aspiration risk, time to intubation\no\nHFNP, VL, adjuncts, difficult airway trolley\n•\nVentilation: LPV, recruitment\n•\nDrugs:\no\nLBW: propofol induction, opioids, NMBA, paracetamol, LA\no\nABW: propofol infusion, neostigmine, sugammadex, antibiotics\no\nTBW: sux, LMWH, dantrolene\n•\nPositioning + pressure sores\nPost-op:\n•\nICU if OS-MRS 4 - 5", "citations": [{"type": "pdf_page", "page": 79, "label": "p79"}]}
{"chunk_id": "SSUs_v1_p080_txt_00_8683ae", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 80, "page_end": 80, "section_path": ["TURP", "Breast Surgery", "Breast Surgery"], "specialty_tags": ["TURP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Breast Surgery", "keywords": [], "text": "Breast Surgery\nTypes:\n•\nWide local excision\n•\nMastectomy: radical, simple, nipple or skin sparing\n•\nSentinel LN biopsy: patent blue dye, methylene blue (largely replaced axillary LN dissection)\no\nRisk of anaphylaxis\n•\nAxillary dissection\n•\nReconstruction: long procedures + pain ++\no\nTRAM: pedicle flap\no\nLat dorsi: pedicle flap\no\nDIEP: free flap\nPre-op:\n•\nCancer 4Ms:\no\nCyclophosphamide, doxorubicin: cardiotoxicity, myelosuppression → wait 6/52\no\nOther treatment: radioTx, hormonal therapy (cardiotoxic, risk VTE)\n•\nPre-med\nIntra-op:\n•\nAccess contralateral side\n•\nMonitoring: standard ANZCA\n•\nAirway: LMA or ETT\n•\nPositioning: supine, arm out (avoid brachial plexus injury), sit test at end\n•\nHigh risk PONV\n•\nFlap perfusion (see flap notes)\nRegional:\n•\nPVB: T1-T5 → spreads 3 dermatomes\no\npain in first 72 hours\no\nCPSP at 6mo\n•\nTEA\n•\nPECS:\no\nI: medial + lateral pectoral nerves\no\nII: lateral branch of intercostal nerve + intercostobrachial + long thoracic (covers wider area + axillae)\n▪\nMay deliver longer analgesia than PVB – consider adding, includes long thoracic not covered by PVB\n•\nSA\nESP not recommended – lack of data\nRecurrence:\n•\nSevo + opioid versus TIVA + PVB: no difference in recurrence, chronic pain, incisional pain\nAPSME:\nChronic post-surgical pain:\n•\nPVB\n•\nIV lignocaine + LA infiltration\nPVB:\n•\npain for 48 hours\n•\nPONV\n•\nCPSP at 3, 6, and 12 mo\nPECS block:\n•\nPECS I v placebo: no benefit\n•\nPECS II: pain, opioid requirement, mobilisation, satisfaction\nIV lignocaine intra-op + up to 2hr post-op:\n•\nNo improvement in pain scores up to 72 hours\n•\nacute opioid requirement\n•\nCPSP at 3 – 6 mo", "citations": [{"type": "pdf_page", "page": 80, "label": "p80"}]}
{"chunk_id": "SSUs_v1_p081_txt_00_14e23b", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 81, "page_end": 81, "section_path": ["TURP", "Post-Mastectomy Pain Syndrome", "Post-Mastectomy Pain Syndrome"], "specialty_tags": ["TURP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Post-Mastectomy Pain Syndrome", "keywords": [], "text": "Post-Mastectomy Pain Syndrome\n30%.\nRFs: young, high post-op pain score, major reconstruction, psychological\nPrevention:\n•\nPVB\n•\nIV lignocaine\n•\nVenlafaxine 10 days pre-op\n•\nMemantine 2 weeks pre- + post-\n•\nGabapentin\nTreatment:\n•\nAmitriptyline\n•\nVenlafaxine\n•\nTopical capsaicin\n•\nFat grafting", "citations": [{"type": "pdf_page", "page": 81, "label": "p81"}]}
{"chunk_id": "SSUs_v1_p082_txt_00_61da74", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 82, "page_end": 82, "section_path": ["OBSTETRIC ANAESTHESIA", "Obstetric Anaesthesia"], "specialty_tags": ["OBSTETRIC ANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Obstetric Anaesthesia", "keywords": [], "text": "Obstetric Anaesthesia\nHigh Risk Referral\nIndications:\n•\nAnaesthetic\n•\nObstetric\n•\nMajor systems disease\nRANZCOG 6 tier system: simple\n•\nLevel 6: all care regardless of risk\n•\nLevel 5: care beyond 32/40 weeks\no\nWould not look after major placental disease,\ntriplets or more, complex MDT\n•\nLevel 4: 34/40+ with no other risk factors (obs +\npaeds + anaesthetics 24 hours, usually supported by level 3\nneonatal service)\no\nWould not look after major placental disease or\nmultiple gestations\n•\nLevel 3: midwives, GP or specialist obs, no 24\nhour access to OT and pathology services\no\nWould not look after: planned preterm birth, C-\nsection for placenta praevia, vaginal birth for\nmultiple pregnancy, other complex births\n•\nLevel 2: midwives, GP obstetrician\no\nWould not look after: pre- or post- labour,\ninduction or augmentation of labour, planned C-\nsection, instrumental birth, care requiring CTG\n•\nLevel 1: antenatal / postnatal care only", "citations": [{"type": "pdf_page", "page": 82, "label": "p82"}]}
{"chunk_id": "SSUs_v1_p083_txt_00_6304b0", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 83, "page_end": 83, "section_path": ["OBSTETRIC ANAESTHESIA", "Miscarriage", "Molar Pregnancy"], "specialty_tags": ["OBSTETRIC ANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Molar Pregnancy", "keywords": [], "text": "Molar Pregnancy\n1/200-1000 pregnancies.\nGestational trophoblastic disease. No foetus. Pre-malignant.\nTypes:\n•\nComplete: absent foetal / embryonic tissue\n•\nPartial: some foetal / embryonic tissue\nPresentation:\n•\nbHCG\n•\nOvarian enlargement\n•\nHyperemesis\n•\nEarly PET\n•\nHyperthyroidism (induced by molar pregnancy)\n•\nVaginal bleeding\nIx: bHCG, US, group + antibody screen\nRx: surgical evacuation (promptly, in case malignant) +/- hysterectomy\nAnaesthetic management:\n•\nPre-op:\no\nOptimise:\n▪\nThyroid dz (ECG +/- beta blockade)\n▪\nG&H\n▪\nManage pre-eclampsia\n•\nIntra-op:\no\nD+C + prepare for bleeding\no\nOxytocin after evacuation to risk trophoblastic pulmonary embolization (supportive care)\n•\nPost-op:\no\nCounselling (risk in future pregnancies 1/70)\no\nMonitor for bleeding\no\nManage PET\no\nMonitor resolution of bHCG", "citations": [{"type": "pdf_page", "page": 83, "label": "p83"}]}
{"chunk_id": "SSUs_v1_p083_txt_01_31fac9", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 83, "page_end": 83, "section_path": ["OBSTETRIC ANAESTHESIA", "Miscarriage", "Miscarriage"], "specialty_tags": ["OBSTETRIC ANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Miscarriage", "keywords": [], "text": "Miscarriage\nPregnancy loss <20/40 weeks gestation.\nAssessment: gestation, presence of bleeding, GORD, hyperemesis\nComplications: bleeding, infection / sepsis, DIC\nAnaesthetic management:\n•\nPre-op:\no\nResus\no\nAnti-D if indicated\no\nMisoprostal 1hr prior (at discretion of obs)\no\n+/- Antibiotic prophylaxis (doxycycline 400mg PO) -\n•\nIntra-op:\no\nAirway: RSI after 12 weeks, ramped, aspiration prophylaxis\no\nMaintenance: TIVA (volatile bleeding)\no\nBleeding management bundle\no\nUterotonics: minimal oxytocin-R prior to 17/40 → ergot + carboprost\no\nPONV: high risk – give ≥2 agents\no\nAnalgesia: paracetamol, NSAIDs\nComplications: retained POC, uterine atony, cervical trauma, uterine perforation, infection, intra-uterine adhesions,\nalloimmunisation", "citations": [{"type": "pdf_page", "page": 83, "label": "p83"}]}
{"chunk_id": "SSUs_v1_p084_txt_00_e0c229", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 84, "page_end": 84, "section_path": ["OBSTETRIC ANAESTHESIA", "Ectopic Pregnancy", "Termination of Pregnancy"], "specialty_tags": ["OBSTETRIC ANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Termination of Pregnancy", "keywords": [], "text": "Termination of Pregnancy\n•\nPre-op:\no\nAnti-D if indicated\no\nMisoprostal 1 hour prior (at discretion of obs)\no\nAntibiotic prophylaxis (doxycycline 400mg PO 1 hour prior, azithro 1g PO 1 hour prior)\n•\nIntra-op:\no\nAirway: ETT if ≥12 weeks gestation\no\nUterotonics: minimal oxytocin-R prior to 17/40 → ergot + carboprost\no\nComplications:\n▪\nHaemorrhage: tone, trauma (including laceration/perforation), tissue (retained), thrombus (DIC?)\n•\nPost-op:\no\nDay surgery if stable", "citations": [{"type": "pdf_page", "page": 84, "label": "p84"}]}
{"chunk_id": "SSUs_v1_p084_txt_01_16e6ed", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 84, "page_end": 84, "section_path": ["OBSTETRIC ANAESTHESIA", "Ectopic Pregnancy", "Septic Abortion"], "specialty_tags": ["OBSTETRIC ANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Septic Abortion", "keywords": [], "text": "Septic Abortion\nUterine infection during or shortly after a spontaneous or induced abortion – gynaecological emergency\nConsider if:\n•\nFebrile on two occasions >24 hours after abortion or\n•\nAny woman of reproductive age who presents with fever, abdo pain and bleeding\nManagement:\n•\nD&C if any retained products\n•\nIV abx\n•\nSupportive management of shock", "citations": [{"type": "pdf_page", "page": 84, "label": "p84"}]}
{"chunk_id": "SSUs_v1_p084_txt_02_be9743", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 84, "page_end": 84, "section_path": ["OBSTETRIC ANAESTHESIA", "Ectopic Pregnancy", "Ectopic Pregnancy"], "specialty_tags": ["OBSTETRIC ANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Ectopic Pregnancy", "keywords": [], "text": "Ectopic Pregnancy\nExtrauterine pregnancy. 2-10/100,000 births.\nRFs: previous ectopic, tubal surgery/pathology, IUD, IVF, OCP, previous STI/PID, smoking, age ≥40\nLocation: 96% fallopian tube, 3% ovarian, uterine scar, abdominal\nClinical presentation:\n•\n1st trimester bleeding\n•\nAbdominal pain\n•\nCV collapse\nDiagnosis:\n•\nExtrauterine gestational sac\n•\nPositive bHCG with no intra-uterine pregnancy\n•\nVisualisation at surgery\nIx: bHCG, TVUS, diagnostic lap\nManagement: expectant, medical (methotrexate), surgical\nAnaesthetic management:\n•\nPre-op:\no\nResus + bleeding management bundle\n•\nIntra-op:\no\nMonitoring: routine ANZCA + art line + temp\no\nInduction: consider haemodynamics\n▪\nNMB can release tamponade – surgeons scrubbed + ready", "citations": [{"type": "pdf_page", "page": 84, "label": "p84"}]}
{"chunk_id": "SSUs_v1_p085_txt_00_76b0e4", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 85, "page_end": 85, "section_path": ["GORD", "Rhesus Iso-Immunisation", "GORD & Aspiration Prophylaxis"], "specialty_tags": ["GORD"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "GORD & Aspiration Prophylaxis", "keywords": [], "text": "GORD & Aspiration Prophylaxis\nIncreased risk 2’:\n•\nLOS tone\n•\ngastric emptying (labour, opioids)\n•\nIAP\n•\nDifficult airway + apnoea time\nManagement:\n•\nNon-particulate antacid: sodium citrate 30mL within 30 mins\n•\nRanitidine PO 150mg 1-8 hour prior\n•\nMetoclopramide 10mg IV\nAll women in labour considered to have a full stomach", "citations": [{"type": "pdf_page", "page": 85, "label": "p85"}]}
{"chunk_id": "SSUs_v1_p085_txt_01_82c4f8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 85, "page_end": 85, "section_path": ["GORD", "Rhesus Iso-Immunisation", "Rhesus Iso-Immunisation"], "specialty_tags": ["GORD"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Rhesus Iso-Immunisation", "keywords": [], "text": "Rhesus Iso-Immunisation\nCan occur following: delivery, TOP, spontaneous abortion, ectopic, martial molar, chorionic villus sampling, amniocentesis, ECV,\nantepartum haemorrhage, abdominal trauma, MROP, FDIU\nConsequences:\n•\nHaemolytic disease of newborn\n•\nHydrops foetalis\n•\nThrombocytopaenia / neutropaenia\n•\nFDIU\nScreening:\n•\nMaternal D-typing + antibody screen @ 1st visit, 28/40, delivery **this will be positive if recently administered anti-D\n→ indirect Coombs if +ve ab screen\nPrevention:\n•\nAnti-D immunoglobulin 625iu @ 28/40, 34/40, delivery\n*in the setting of a sensitising event do a Kleihauer-Betke test to determine the dose\nManagement:\n•\nCheck paternal Rh-D status\n•\nCheck foetal Rh-D status\n•\nMonitor maternal anti-D titre by indirect antiglobulin\n•\nMonitor foetal MCA peak systolic velocity (non-invasive test of foetal anaemia)\n•\nCheck foetal Hb → intra-uterine transfusion if Hb <2 SD below mean, gestation <35/40 – otherwise deliver\nSubsequent pregnancies:\n•\nConsider plasmaphoresis\n•\nIVIg\n•\nIntrauterine blood transfusion", "citations": [{"type": "pdf_page", "page": 85, "label": "p85"}]}
{"chunk_id": "SSUs_v1_p086_txt_00_071bf5", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 86, "page_end": 86, "section_path": ["GORD", "Thrombocytopaenia in Pre-Eclampsia", "Platelet Disorders"], "specialty_tags": ["GORD"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Platelet Disorders", "keywords": [], "text": "Platelet Disorders\nAffects 7-11% of pregnancies. Thrombocytopaenia: plt <150 x 109/L. Most common haematological disorder of pregnancy.\nCauses:\n•\nPregnancy specific: gestational, hypertensive disorder, pre-eclampsia, HELLP, fatty liver of pregnancy\n•\nPregnancy related: TTP, DIC, type 2 vWD\n•\nNon-pregnancy related: ITP, hereditary, marrow infiltration, viral infection, hypersplenism, drugs\nManagement:\n•\nDelivery: plt >50\n•\nNeuraxial: plt >70\n•\nCan do a blood film / manual plt count to confirm count and exclude clumping (generally adds ~20%)\n•\nCheck trend\n•\nCheck prior to catheter removal if concerns (repeat count in a citrate or heparin tube)\nIf low risk pregnancy do not need to wait for FBC to place epidural.\nSOAP 2021 guideline:\n•\nPlt count >70 okay for epidural in gestational thrombocytopaenia, ITP, HDP if no other risk factors\n•\nRisk assessment must also include risk of GA (airway, comorbidities, available staff/equipment) + patient preference\n•\nPlt count 50 – 70: risk versus benefit, risk discussion with patient and document\no\nPossible spinal, not epidural\nGestational Thrombocytopaenia\n75% of thrombocytopaenia. Benign, self-limiting. 2nd half of pregnancy. Usually plt >100. Underlying pathology is unlikely to be\nsolely gestational thrombocytopaenia if plt count <100. It is a diagnosis of exclusion. Recurs in subsequent pregnancies.\nITP\n1/1000 pregnancies. Large platelets on blood film. Autoimmune 2’ IgG against plt glycoprotein → splenic sequestration.\nCrosses placenta → neonatal thrombocytopaenia  avoid vacuum / caution with forceps delivery (risk to neonate)\nTreat if platelets <30:\n•\nSteroids: improves within 5-7 days (pred 1mg/kg, dex 40mg, betamethasone)\n•\nIVIg: 0.5g/kg (usually transient improvement)\n•\nPlatelet transfusion will likely be rapidly consumed\n•\nTarget plt >50 for delivery, neuraxial aim >70 (but risks need to be weighed against benefit)\n•\nIf bleeding: platelet transfusion + IVIg + steroids\n•\nRecalcitrant disease: splenectomy, rituximab, TPO-R antagonists\nThrombocytopaenia in DIC\nCauses: placental abruption, sepsis, FDIU, AFE\nThrombocytopaenia in Acute Fatty Liver\nMust check coags.\nTTP\nPlasma exchange.\nThrombocytopaenia in Pre-Eclampsia\n•\nPlts >100: do not need coags – do not tend to see coagulation abnormalities if plt >100. FBC within last 12 hours okay.\n•\nPlts <100: needs coags with plts. Results within 6 hours of neuraxial. Proceed if plt >70 + no abnormalities on coags.\n•\nPlt 50-70: if no coag abnormalities can consider spinal but not epidural\n•\nSevere HELLP: platelets drop ~60/day or ~10-12/6 hours", "citations": [{"type": "pdf_page", "page": 86, "label": "p86"}]}
{"chunk_id": "SSUs_v1_p087_txt_00_79aee5", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 87, "page_end": 87, "section_path": ["GORD", "Hypertensive Disorders", "Hypertensive Disorders"], "specialty_tags": ["GORD"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Hypertensive Disorders", "keywords": [], "text": "Hypertensive Disorders\n5-10% pregnancies world-wide. Second most common cause of maternal death.\nComplications: cerebral haemorrhage, pulmonary oedema, coagulopathy\nHypertension in pregnancy:\n•\nsBP >140mmHg or dBP >90mmHg on two occasions >4 hours apart\nHypertensive disorders in pregnancy:\n•\nChronic hypertension (essential, secondary, white coat)\n•\nGestational hypertension: after 20 weeks gestation, previously normotensive (nil proteinuria)\n•\nPre-eclampsia\no\n+/- pre-eclampsia superimposed on chronic hypertension\n•\nEclampsia\nTreatment of BP:\n•\nMust treat sBP >160 and dBP >110 – risk of cerebral haemorrhage and eclampsia\n•\nTreating blood pressures below this is controversial (prevents severe hypertension, but not shown to risk of pre-\neclampsia or adverse perinatal outcomes)\nRx: target ≤135/85\n•\nLabetalol BD / TDS: 200 – 2400mg daily\n•\nNifedipine SR: 30 – 120mg daily\n•\nMethyldopa BD / TDS: 500-3000mg daily\n•\nHydralazine QID 40 – 200mg daily\n•\nPrazosin\n*ACEis and ARBs contraindicated\nPost-partum hypertension can persist for 8/52 post-partum + lifelong risk of CVS dz – should be followed up", "citations": [{"type": "pdf_page", "page": 87, "label": "p87"}]}
{"chunk_id": "SSUs_v1_p088_txt_00_850d4d", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 88, "page_end": 88, "section_path": ["GORD", "Preeclampsia"], "specialty_tags": ["GORD"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Preeclampsia", "keywords": [], "text": "Preeclampsia\n3% of all pregnancies.\nDefinition: hypertension plus involvement of one or more other organ systems and/or the foetus\nRFs:\n•\nStrong: hx of PET, chronic HTN, BMI >30, pre-gestational diabetes, APLS/SLE, assisted reproduction, autoimmune dz\n•\nModerate: primip, primi-paternity, pregnancy interval >5y, age >40, FHx, multiple gestation, CKD\nRisk prediction models:\n•\nsFLT1/PIGF ratio ≥38\n•\nPREP-S: risk of complications in early-onset PET\no\nVariables: maternal age, gest age, reflexes, PMHx, Pr:Cr, urea, plt, sBP, HTN, MgSO4, sats, ALT, Cr\n•\nfullPIERS: predicts adverse outcomes within 48 hours\no\nVariables: gest age, chest pain/SOB, Cr, ALT, AST, Cr, plt, sats\nPrevention:\n•\nDiet + exercise (+/- bariatric surgery)\n•\nAspirin 75 - 150mg PO daily from 12 – 36 weeks\no\nASPRE trial: 1.6% versus 4.3%\n▪\n1 MAJOR RF: hx PET, diabetic, chronic HTN, multiple gestation, renal dz, autoimmune dz (APLS/SLE)\n▪\n2 MOD RF: nulliparity, BMI >30, age ≥35, socioeconomic, IVF\n•\nCalcium supplementation\nHigh dose folic acid supplementation beyond 1st trimester not shown to prevent PET (FACT trial)\nDiagnosis: hypertension after 20/40 with evidence of one or more organ system involvement\nTwo categories:\n•\nPre-eclampsia: hypertension + proteinuria >300mg or protein:Cr >0.3\n•\nPre-clampsia with severe features:\no\nsBP >160mmHg, dBP >110mmHg (on two separate occasions at least 4 hours apart on bed rest)\no\nPlatelets <100\no\nLiver enzymes >2x normal\no\nRUQ pain\no\nProgressive renal impairment with serum Cr >100 (or doubling of serum Cr without renal dz)\no\nPulmonary oedema\no\nNew onset cerebral or visual abnormalities, clonus ≥3 beats\n*In absence of proteinuria pre-eclampsia can be diagnosed in setting of hypertension + severe feature\nMassive proteinuria (>5g/24hr) and foetal growth restriction have been removed as severe features\nPathophysiology unknown – presumed impaired trophoblastic cell invasion → impaired spiral artery dilatation → cascade of\nantiangiogenic factors → generalised maternal endothelial dysfunction\nBiomarkers: uterine a. doppler, placental growth factor, soluble fms-like tyrosine kinase 1, sFLT-1/PIGF ratio\nManagement of hypertensive emergency: MUST GIVE DOSES\n•\nTreat if ≥160/110 for ≥15 mins or end-organ dysfunction (aim sBP <150, dBP 80-100mmHg)\no\nRapid reduction may be harmful, aim 1-2mmHg / minute\n•\nIx: FBC / EUC / LDH / fibrinogen / haptoglobin / urine PCR + ACR + micro\n•\nECG +/- TTE\n•\nFundoscopy of eye\n•\nCTG / continuous monitoring until BP is stable\n•\nRx:\no\nLabetalol 20mg (up to 80mg) IV\no\nHydralazine 5-10mg (up to 20mg) IV\no\nNifedipine 10mg PO (20mg after 20 mins) – use cautiously with magnesium\no\nGTN 5-100mcg/min\no\nFrusemide if APO +/- IDC\nManagement:\n•\nImmediate: delivery with 48 hours\n•\nExpectant: delivery >48 hours with monitoring", "citations": [{"type": "pdf_page", "page": 88, "label": "p88"}]}
{"chunk_id": "SSUs_v1_p089_txt_00_c473d0", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 89, "page_end": 89, "section_path": ["HELLP"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "HELLP", "keywords": [], "text": "Delivery <37 weeks if:\n•\n3 or more anti-hypertensives\n•\nDeteriorating renal / liver fx, haemolysis\n•\nSevere thrombocytopaenia\n•\nSpO2 <90% on RA\n•\nOngoing neurology\n•\nPlacental abruption\n•\nReversed end-diastolic flow in umbilical a.\n•\nNon-reassuring CTG\n•\nFDIU\nHELLP\nAffects 4-20% of pts with PET. Maternal mortality <1%.\nHELLP: haemolysis, liver enzymes (transaminases), platelets\nIf pre-eclampsia + HELLP is considered ‘pre-eclampsia + HELLP syndrome’.\nDiagnosis: ACOG criteria\n•\nLDH ≥600\n•\nAST / ALT ≥2x ULN\n•\nPlatelets <100\nBili >20.\nIf “hepatic angina” i.e. RUQ pain – may be delay in deranged bloods – must repeat\nTreatment: same as PET (stabilise + deliver foetus)\nDIC in up to 20%\nHepatic haematoma/rupture - 50% mortality\nMust image if triad:\n•\nRUQ pain\n•\nPET/HELLP\n•\nUnexplained hypotension", "citations": [{"type": "pdf_page", "page": 89, "label": "p89"}]}
{"chunk_id": "SSUs_v1_p090_txt_00_73d33a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 90, "page_end": 90, "section_path": ["HELLP", "Eclampsia"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Eclampsia", "keywords": [], "text": "Eclampsia\nDefinition: pre-eclampsia with seizure activity. 0.1% of all births.\nClassic warning signs: headache, visual disturbance, epigastric pain\nPrevention of eclampsia:\n•\nMgSO4:\no\n4g IV loading over 20 mins → infusion 1g/hour\no\nRepeat bolus of 2g for recurrent seizures (max 6g / hour)\no\nMonitor for hypo-reflexia / Mg toxicity (resp failure, muscle paralysis)\no\nTarget serum concentration 2-4mmol/L\no\nRx toxicity: 10mL 10% calcium gluconate over 10 minutes\nMAGPIE trial: MgSO4 v placebo – during labour + 24hr post-partum will risk of seizures in severe PET or imminent eclampsia\nReceiving MgSO4 is institution dependent\nSeizures may occur pre-, intra-, and post-partum\nTreatment:\n•\nResuscitation:\no\nABC\no\nBenzodiazepine to terminate prolonged seizures\n•\nPrevention of further seizures w/ magnesium\no\nMagnesium >> phenytoin & diazepam at preventing 2nd seizure (though high NNT)\n•\nControl of hypertension: treat any BP >160mmHg\n•\nDelivery – main treatment\nHypertension may persist post-delivery\nAnaesthetic technique for pre-eclampsia/eclampsia: neuraxial is preferred if no contra-indications\n•\nEpidural: provides excellent sympathetic blockade\no\nCI: thrombocytopaenia, rapidly dropping platelet levels, DIC – all pts should have FBC within 6hr of procedure,\nor within 2hr if plt trajectory requires – safe plt level 80 (consider manual platelet count) though remember\nmay also have plt dysfunction. Must recheck prior to removal of catheter in severe pre-eclampsia.\n•\nGA: must blunt hypertensive response to laryngoscopy – cases of maternal death from cerebral bleed\no\nIDC awake → reduced time from anaesthesia to foetal delivery\no\nMonitoring: ANZCA routine + 5-lead ECG + art line + BIS\no\nInduction: good pre-oxygenation\n▪\nCo-induction: propofol: 1-2mg/kg + sevo rapid wash in + roc 1.2mg/kg\n▪\nAlfentanil 20-30mcg/kg – ensure effect prior to laryngoscopy – paeds support\n▪\nOther Rx:\n•\nRemifentanil 1mcg/kg, labetolol 0.25mg/kg, esmolol 0.5mg/kg, ligonocaine 1.5mg/kg\n▪\nCaution: sensitivity to exogenous catecholamines\no\nIntubation:\n▪\nAdjuncts - high risk airway oedema - ETT size\n▪\nVL + X-blade / stylet + ramped\n▪\nO&G start at the first sign of CO2\no\nMaintenance:\n▪\nSwitch to TIVA to uterine atony\n▪\nMinimise IVF - risk of APO (frusemide if concerns)\n▪\nContinue magnesium (risk of atony)\n▪\nAvoid NSAIDs\no\nBlood management bundle +\n▪\nTargets in haemorrhage: Hb >80, fibrinogen >2, plt >75, INR/aPPT 1.5x normal\n▪\nCell-salvage + leukocyte reduction filter\no\nUterotonics:\n▪\nOxytocin 40ui in 100mL normal saline @ 25mL/hour\n▪\nErgot CI unless life-threatening haemorrhage\no\nExtubation:\n▪\nTOF ratio >0.9 (risk with MgSO4)\n▪\nCheck cuff leak", "citations": [{"type": "pdf_page", "page": 90, "label": "p90"}]}
{"chunk_id": "SSUs_v1_p091_txt_00_c87c7c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 91, "page_end": 91, "section_path": ["HELLP", "Chronic Liver Disease", "Liver Derangement in Pregnancy"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Liver Derangement in Pregnancy", "keywords": [], "text": "Liver Derangement in Pregnancy\nCauses:\n•\nPregnancy related: intrahepatic cholestasis, acute fatty liver of pregnancy, HELLP syndrome, pre-eclampsia, PONV\n•\nExacerbated by pregnancy: gallstones, vascular (Budd Chiari)\n•\nUnrelated: acute viral hepatitis, drugs\nHx: pruritis, toxins, headache, visual disturbance, abdo pain\nExam: jaundice, hepatic flap, encephalopathy, hepatomegaly, ascites, oedema\nNote: spider naevi, palmar erythema can be normal with oestrogen\nInv: routine + blood gas + liver US, MRI\n→ Lactate >2.8 + presence of encephalopathy are poor prognostic indicators of severe liver dz in pregnancy\nDifferentiating cause:\n•\nIntrahepatic cholestasis of pregnancy: bile acids (bili normal)\n•\nPre-eclampsia with hepatic impairment: >2 x ALT (bili and bile acids normal)\n•\nHELLP: up to 30x ALT, bili (bile acids normal)\n•\nAcute fatty liver of pregnancy: 4 – 15x bilirubin, ALT\nManagement:\n•\nMDT input in a specialist liver centre – early liver centre referral in case transplantation required\n•\nAssess: encephalopathy, synthetic function\nAnaesthetic considerations:\n•\nAvoid NSAIDs\n•\nConsider alternative to rocuronium\n•\nCheck plt + coags prior to neuraxial (role of TEG in this setting is not validated)\nIntrahepatic Cholestasis of Pregnancy\nIncidence 27% (most common liver disease of pregnancy)\nDescription: pruritis + elevated bile acids in 2-3rd trimester that resolves after delivery\nSSx: pruritus (hands / feet → generalised), RUQ pain, nausea, anorexia, steatorrhoea\nIs unlikely to cause liver failure / encephalopathy\nIx: bile acids, transaminases 2x ULN, bili, ALP, vit K deficiency → INR (check coags)\nImaging: normal liver US\nRelevance:\n•\nfoetal mortality 2’ FDIU/stillbirth, meconium, preterm labour, neonatal respiratory distress\n•\nVitamin K deficiency → coagulopathy\nTreatment:\n•\nUrsodeoxycholic acid for pruritis\n•\nEarly foetal delivery depending on bile acid level\n•\nCheck coags prior to neuraxial\n•\nAvoid IT morphine → itch\nBudd-Chiari Syndrome\nHepatic venous outflow obstruction. 75% of cases are due to thrombosis (pregnancy is a RF). Same prothrombotic conditions\npre-dispose to early foetal loss.\nIncidental Hepatic Disorders\n•\nViral hepatitis: includes hep A – E, HSV, CMV, EBV (Hep E and HSV → worse outcomes in pregnancy)\n•\nAutoimmune hepatitis: usually improves in pregnancy\n•\nDrug-induced\nChronic Liver Disease\nPregnancy + cirrhosis →\n•\nWorsening of portal hypertension\n•\nrisk of variceal bleeding (C-section > labour to avoid Valsalva)", "citations": [{"type": "pdf_page", "page": 91, "label": "p91"}]}
{"chunk_id": "SSUs_v1_p092_txt_00_1c39c3", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 92, "page_end": 92, "section_path": ["HELLP", "Acute Fatty Liver of Pregnancy"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Acute Fatty Liver of Pregnancy", "keywords": [], "text": "Acute Fatty Liver of Pregnancy\n1/7000 – 20000. Perinatal mortality 20 – 50%. Maternal mortality 2%.\nRFs: foetal B-fatty acid oxidation disorder, previous AFLP, multiple gestation, pre-eclampsia, HELLP, male foetus, low BMI,\nnulliparity\nPresentation:\n•\nUsually 3rd trimester\n•\nNon-specific SSx i.e. nausea, abdo pain, headache, anorexia, HTN +/- proteinuria, HELLP in 20%, PET 40%\n•\nAcute liver failure\n•\nAKI, central DI, pancreatitis\nDiagnosis: Swansea criteria for AFLP (≥ 6)\n•\nSSx:\no\nVomiting\no\nAbdo pain\no\nPolydipsia / polyuria\no\nEncephalopathy\n•\nIx:\no\nBili\no\nHypoglycaemia\no\nWBC\no\nAST / ALT\no\nammonia\no\nurate\no\nAKI\no\nCoagulopathy\n•\nImaging: ascites or bright liver on US\n•\nHisto: microvascular steatosis on biopsy\nAlso fragmented RBC / Burr cells\nManagement: MDT obstetrics, neonatology, ICU, anaesthesia, hepatology, haematology\n•\nPrompt delivery of foetus\n•\nSupport as for ALF\no\nLiver transplant if indicated", "citations": [{"type": "pdf_page", "page": 92, "label": "p92"}]}
{"chunk_id": "SSUs_v1_p093_txt_00_2b6574", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 93, "page_end": 93, "section_path": ["HELLP", "Peripartum Cardiomyopathy", "Peripartum Cardiomyopathy"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Peripartum Cardiomyopathy", "keywords": [], "text": "Peripartum Cardiomyopathy\nDefinition: diagnosis of exclusion\n•\nNew onset cardiomyopathy with LVEF <45%\n•\nNo reversible cause\n•\nPresenting last month of pregnancy or within 5/12 post-partum\n•\nNo known heart disease\nRFs: previous peripartum CM, PET, tocolytic Rx >4/52, obesity, age >30, viral infection, multiple pregnancy, cocaine, genetic\nSymptoms: dyspnoea, cough, orthopnoea, ET, paroxysmal nocturnal dyspnoea, pedal oedema, haemoptysis, fatigue\nSigns: JVP, pedal oedema, displaced apex beat, 3rd heart sound, MR murmur\nIx: ECG (non-specific findings), CXR, pro-BNP, CMRI, TTE (global LV, LVEF <45% +/- other features, may have thrombus)\nRx: heart failure management\n•\nBeta blockers\n•\nFrusemide\n•\nAnticoagulation\nCI during pregnancy: ACEi, ARB, neprilysin inhibitors, spironolactone\nAcute Rx: oxygen, IPPV, inotropic / mechanical support, diuresis\n+/- arrhythmia management, mechanical support, cardiac transplant, bromocriptine (prolactin antagonist)\nDelivery: stabilise mother first\n•\nIdeal method of delivery: vaginal with epidural and haemodynamic monitoring\n•\nEarly delivery not required if stable\nSuppress breastfeeding (if going to breastfeed avoid AT-2 blockers) + contraception\nPrognosis: mortality 10% at 2y, 30-80% with persistent heart failure, recurrence in future pregnancies\nDiabetes in Pregnancy\nComplications (HAPO study): macrosomia, birth injury, perinatal mortality (5x), premature foetus, hyperbilirubinaemia,\ncongenital abnormality, C-section, PET, sepsis, neonatal hypoglycaemia +/- micro/macrovascular\nMaternal hyperglycaemia → hyperplasia of foetal B cells → foetal insulin → risk of neonatal hypoglycaemia +/- neurological\nconsequences\nRisk of hyponatraemia in intrapartum period with glucose administration + oxytocin  recommended to use glucose in saline/\nAvoid fluid overload in pts with hypertensive disorders +/- PET\nPost-partum:\n•\nType 1 or insulin dependent T2DM: VRII should 50% post-delivery and stopped 30-60mins post-first meal\n•\nPre-existing diabetes on OHGs: insulin should be ceased after delivery – discuss restarting OHGs with endocrine", "citations": [{"type": "pdf_page", "page": 93, "label": "p93"}]}
{"chunk_id": "SSUs_v1_p094_txt_00_d3587a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 94, "page_end": 94, "section_path": ["HELLP", "Gestational Diabetes", "Gestational Diabetes"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Gestational Diabetes", "keywords": [], "text": "Gestational Diabetes\nHuman placental lactogen promotes insulin resistance in pregnancy\nRFs:\n•\nHigh: previous GDM, previous hyperglycaemia, age ≥40, FHx, BMI >35, Hx macrosomia, PCOS, steroids, antipsychotics\n•\nModerate: Asian / Indian, ATSI, pacific islander, Maori, middle eastern, non-white African, BMI 25 – 35\nDiagnosis:\n•\n75g OGTT at 24 – 28 weeks (earlier if high risk) – present if\no\nFasting ≥ 5.1mM\no\n1 hour ≥10.0mM\no\n2 hour ≥ 8.5mM\nManagement:\n•\nLabour:\no\nQ1 hourly BSL – target 4 – 7 mM\no\nVRII if unable to maintain above\no\nInsulin pump is safe in labour - if BSL >7 on two consecutive readings or ketones >1.5 → VRII\n•\nC-section: aim first on list\no\nQ1 hourly BSL - target 5 – 8 mM (q30min if GA)\no\nConsider aspiration risk\no\nPost-op insulin rarely required (start with 50% dose reduction) – target 6 – 10mM\nRepeat OGTT at 6 – 12 weeks post-partum; ~5% go on to have NIDDM", "citations": [{"type": "pdf_page", "page": 94, "label": "p94"}]}
{"chunk_id": "SSUs_v1_p095_txt_00_da37f2", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 95, "page_end": 95, "section_path": ["HELLP", "Obesity", "Anaesthetic Management of Co-Existing Maternal Conditions"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Anaesthetic Management of Co-Existing Maternal Conditions", "keywords": [], "text": "Anaesthetic Management of Co-Existing Maternal Conditions\nMaternal mortality causes: cardiovascular conditions > infection > non-cardiovascular medical condition > cardiomyopathy >\nhaemorrhage > VTE > hypertensive disorders of pregnancy", "citations": [{"type": "pdf_page", "page": 95, "label": "p95"}]}
{"chunk_id": "SSUs_v1_p095_txt_01_b619d5", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 95, "page_end": 95, "section_path": ["HELLP", "Obesity", "Obesity"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Obesity", "keywords": [], "text": "Obesity\nNormal obesity classification system. 23% of pregnant patients.\nComplications:\n•\nMaternal: mortality, GDM, hypertensive disorders +/- PET, OSA, CVD, infection / sepsis, instrumental delivery,\ncaesarean section (50%), PPH, prolonged admission, accidental dural puncture, wound infection, uterine atony\n•\nNeonatal: preterm, miscarriage, SGA, LGA, macrosomia, stillbirth, shoulder dystocia, neural tube defects, neonatal\ndeath, NICU admission\nHigh risk anaesthetic referral if:\n•\nBMI ≥40\n•\nComorbid\n*Most small hospitals have a BMI cut off\nAssessment:\n•\nAs for obesity: airway, resp (OSA +/- cor pulmonale), sleep study, ET, ECG, aspiration risk, diabetes\n•\nNeuraxial: dural puncture 4% cf 1%\nRecommended:\n•\nLocal guidelines for appropriate facility\n•\nEarly epidural (challenging + risk of GA)\no\nLeave in longer length\no\nObesity protective for PDPH\no\nCSE - lower failure rates\n•\nEquipment likely needed: US, long spinal / epidural needles, large BP cuffs / invasive BP (consider forearm BP cuff),\nappropriate operating table / pt bed\n•\nCaution use of opioids\nC-section considerations:\n•\nPosition: ramped, left lateral tilt, pannus retraction\n•\nAbx 3g cephazolin if >120kg\n•\nRegional technique: CSE recommended + spinal dose if BMI >50\nGA C-section:\n•\nRamp + position\n•\nAntacid prophylaxis\n•\nPre-oxygenate >0.9\n•\nTHRIVE\n•\nVL for first attempt\n•\nDosing:\no\nSux – TBW\no\nProp – lean BW\no\nNon-depolarising NMB – ideal BW\n•\nDecompress stomach with OG tube (nasal passage friable)\n•\nExtubate awake ++\n•\nOSA: commence CPAP immediately\nPost-op:\n•\nSats monitoring\n•\nVTE prophylaxis\n•\nEarly mobilisation\n•\nMonitor for infection (risk)", "citations": [{"type": "pdf_page", "page": 95, "label": "p95"}]}
{"chunk_id": "SSUs_v1_p096_txt_00_80f489", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 96, "page_end": 96, "section_path": ["HELLP", "Cardiac Disease", "Cardiac Disease"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Cardiac Disease", "keywords": [], "text": "Cardiac Disease\nLeading cause of maternal mortality.\nRisk – WHO classification:\n•\nClass I (very low risk):\no\nUncomplicated disease (small or mild pulmonary stenosis, PDA, MV prolapse)\no\nSuccessfully repaired simple lesions (ASD/VSD, PSA, anomalous pulmonary venous drainage)\no\nAtrial or ventricular ectopic beats\n•\nClass 2 (low to mod risk): if otherwise well and uncomplicated\no\nUnoperated ASD/VSD\no\nRepaired ToF\no\nMost arrhythmias\n•\nClass 2 - 3 (between – depending on individual)\no\nMild LV impairment\no\nHOCM\no\nNative or tissue valvular disease not classed type 1 or 4\no\nMarfan’s without aortic dilatation\no\nAorta <45mm in aortopathy with bicuspid valve\no\nRepaired coarctation\n•\nClass 3 (high risk)\no\nMechanical valve\no\nSystemic RV\no\nFontan circulation\no\nUnrepaired cyanotic heart disease\no\nOther complex congenital disease\no\nAortic dilatation <45mm in Marfan’s\no\nAortic dilatation 45-50mm in aortic disease with bicuspid valve\n•\nClass 4 (extremely high risk): pregnancy contraindicated – there are 7\n•\nAortic:\no\nMarfan syndrome with aorta >45mm\no\nAortic dilatation >50mm of any cause\no\nNative severe coarctation\n•\nPulmonary arterial hypertension\n•\n(Left) heart:\no\nSevere mitral stenosis\no\nPrevious peripartum cardiomyopathy\no\nSevere systemic ventricular dysfunction (EF <40%)\n•\nAdmission for bed rest indicated to cardiac demand and to viability if borderline\nCARPREG II Score – risk of maternal cardiac complications\nPro-BNP @ 20/40 → value >120pg/mL is predictive of adverse event, high NPV\nMust determine:\n•\nAppropriate hospital / ward\n•\nSafe drugs\n•\nAnticoagulation regimen\n•\nRisk of labour Valsalva\n•\nNeed for CTSx / ECMO\nIndication for anticoagulation:\n•\nLow flow state\n•\nFontans circulation\n•\nPulmonary hypertension\n•\nMechanical valve\n•\nAF\nOptimise:\n•\nAnaemia / Fe deficiency\n•\nthyroid\n•\nModifiable RFs: obesity, smoking\n•\nGDM\n•\nHTN", "citations": [{"type": "pdf_page", "page": 96, "label": "p96"}]}
{"chunk_id": "SSUs_v1_p097_txt_00_41cc48", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 97, "page_end": 97, "section_path": ["HELLP", "Cardiac Disease"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Cardiac Disease", "keywords": [], "text": "Important to appreciate major CVS changes and how that affects specific cardiac disease – preload +++ at time of delivery 2’:\n1. Increased CO during pregnancy (including blood volume)\n2. Uterine contractions\n3. Decompression of the IVC at delivery\n4. Post-delivery uterine involution\nThere are also major changes to afterload:\n1. Overall decrease in SVR 2’ vasodilation by progesterone, oestrogen, PGs, relaxin, nitric oxide\n2. Placenta creates a high-flow, low resistance shunt\n→ high risk for afterload dependent lesions e.g. LVOT obstruction\nVaginal Delivery\nBenefits: blood loss, infection, VTE, pain post-delivery cf C-section\nExceptions to vaginal delivery: aortic dissection and Marfans with dilated aortic root\nAvoid sudden changes in preload and afterload, slow rising epidural usually best – beware autotransfusion and synto\nRegurgitant valvular lesions generally tolerated better than stenotic lesions\nManagement:\n•\nTiming of delivery an MDT decision – usually IOL at 40 weeks, all methods of IOL are safe\n•\nEarly epidural to catecholamine release and CO/tachycardia – replace if issues – avoid fluid bolus if risk of APO\no\nAvoid adrenaline, go slow\no\nManage hypotension\no\nIntrathecal morphine only can also decrease sympathetic response.\no\nLOR to saline reduces risk of air embolism\n•\nIE prophylaxis: not required\n•\nSecond stage: allow passive head descent to active phase, assisted 2nd stage, CI to Valsalva, ensure epidural with good\nsacral coverage\nMonitoring:\n•\nContinuous pulse ox\n•\n5-lead ECG\n•\nArt line (L heart obstruction, LVEF, RH dysfunction, pulmonary hypertension)\n•\nCTG\nCaesarean Section\nIndications: obstetric, unstable aortic disease, maternal anticoagulation with warfarin (note: warfarin reversal does not cross\nplacenta) → risk of neonatal haemorrhage, critical valve stenosis / severe LVOT obstruction, severe decompensated pulmonary\nhypertension, acute HF requiring intubation, Eisenmenger syndrome\nManagement:\n•\nNeuraxial preferred: class I – II normal spinal, class III – IV slow epidural top up\n•\nMonitoring: invasive arterial +/- CVC +/- PAC\n•\nUterotonics: caution, slow infusion (no boluses)\n•\nMonitor for PPH, treat early with goal-directed therapy\n•\nAim to maintain sinus rhythm (treat as for non-pregnant, avoid amio / warfarin / noacs)\n•\nAvoid exteriorisation of uterus (risk of air embolism)\nIndications for GA (3):\n1. Maternal refusal neuraxial\n2. Anticoagulation / thrombocytopaenia / coagulopathic\n3. inability to lie flat\nInterventions During Pregnancy\n•\nPercutaneous cath: best after 4 mo, radiation exposure\n•\nCardiopulmonary bypass:\no\nOutcomes for pregnant women similar to non-pregnant women\no\nFoetal outcomes are poor; mortality ~20% - best time 13 – 28 weeks (2nd trimester)\no\nBypass: risk to foetus by using pulsatile flow (high flows >2.5L/min/m2), high perfusion pressures (MAP\n>70mmHg), strict potassium balance, normothermic bypass, normocapnia\no\nConsider caesarean delivery after 28 weeks with steroid cover", "citations": [{"type": "pdf_page", "page": 97, "label": "p97"}]}
{"chunk_id": "SSUs_v1_p098_txt_00_1c405c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 98, "page_end": 98, "section_path": ["HELLP", "Aortic Disease"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Aortic Disease", "keywords": [], "text": "Aortic Disease\nInherited aortic disease:\n•\nMarfan syndrome (3% dissection in pregnancy)\n•\nLoeyz-dietz syndrome\n•\nOsteoaneurysm syndrome\n•\nVascular ehlers danlos syndrome (type IV)\n•\nTurner syndrome\nSecondary causes:\n•\nToF\n•\nAortic coarctation (repaired)\n•\nBicuspid aortic valve\n•\nHypertension\nRisk:\n•\nDissection: 50% third trimester, 33% post-partum\n•\nCardiac tamponade\nManagement:\n•\nPre-pregnancy: aortic imaging (CT / MRI) + counselling\n•\nAntenatal: monthly TTE if high risk\n•\nThroughout:\no\nStrict BP control: beta-blockade\no\nIntervention if progressive dilatation\no\nRupture:\n▪\nStanford type A: simultaneous C-section + vascular repair (foetal mortality 30%)\n▪\nStanford type B: medical management +/- TEVAR\n•\nLabour:\no\nRecommended if aorta is <40mm, CI if aorta >45mm\no\nContinue beta blocker (celiprolol for ehlers danlos)\no\nEarly and effective epidural\no\nAvoid Valsalva → assisted and passive second stage\n•\nCaesarean:\no\nArt line + slowly titrated epidural – treat hypo + hypertension aggressively\no\nNo oxytocin bolus; ergot CI\no\nTreat haemorrhage early\nGoals:\n•\nMinimise aortic wall tension\n•\nMinimise haemodynamic fluctuations", "citations": [{"type": "pdf_page", "page": 98, "label": "p98"}]}
{"chunk_id": "SSUs_v1_p099_txt_00_42c554", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 99, "page_end": 99, "section_path": ["HELLP", "Mitral and Aortic Regurgitation"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Mitral and Aortic Regurgitation", "keywords": [], "text": "Valvular Disease\nAortic Stenosis\nPhysiology:\n•\nSVR → coronary driving pressure\n•\nHigh risk of pulmonary oedema\nWell tolerated in asymptomatic severe AS\nRed flags: exercise tolerance, LV impairment, progressive disease\nTreatment:\n•\nBAV +/- TAVI\n•\nMedical management\n•\nMode of delivery:\no\nSymptomatic AS → C-section\no\nAsymptomatic AS → labour\nGoals:\n•\nMaintain afterload (art line, pressor)\n•\nAvoid tachycardia (early + effective epidural, 5 lead ECG, treat hypertension)\n•\nMaintain normovolaemia\n Avoid: terbutaline (SVR + HR)\nMitral Stenosis\nSee Blue Book Article. Mortality 0-3%. Physiology: CO →\n•\ntransvalvular gradient\n•\nLA pressure\n•\npulmonary oedema / pulmonary pressures +/- RHF\nFixed preload → inability to CO\nCan also precipitate AF which is poorly tolerated → cardiac failure.\nMV area is best predictor for APO i.e. severe dz (valve area <1cm2) 1 in 2 – heart failure usually in 2nd trimester\nOther RFs: NYHA >2, sPAP >30, older age, mean gradient, co-existing MR\nFoetal complications: prematurity 20-30%, IUGR, foetal death 1-5%\nGoals:\n•\nMaintain SR: cardioversion if unstable\n•\nAvoid tachycardia: beta blockade, neuraxial, avoid terbutaline + synto boluses, 5 lead ECG\n•\nErgot CI\n•\nPreload: avoid AC compression / hypovolaemia – strict fluid balance\n•\nAfterload: treat hypertension but maintain SVR, art line\n•\nLabour in upright position\n•\nPrevent pulmonary vascular resistance\nTreatment:\n•\nPerc mitral commissurotomy (>20/40 is better) if NYHA class 3 or 4, sPAP >50\n•\nMedical: b-blockade, restrict anything that induces tachycardia, diuresis, anticoagulation\nManagement:\n•\nMild MS / NYHA 1-2 / no pulmonary hypertension → labour with early, slow epidural, assisted / passive 2nd stage\n•\nMod MS / NYHA 3-4 / CI to perc valve → C-section, give oxytocin slowly, ergot CI\nMonitor post-delivery – autotransfusion → risk of APO\nMitral and Aortic Regurgitation\nPhysiology: SVR is beneficial → regurgitant volume; blood volume → ventricular dilatation → worsens AR / MR\nGoals:\n•\nAvoid SVR: epidural analgesia, consider afterload reduction, treat hypertensive disorders of pregnancy\n•\nAvoid contractility and bradycardia: avoid beta-blockers, consider ephedrine > phenylephrine", "citations": [{"type": "pdf_page", "page": 99, "label": "p99"}]}
{"chunk_id": "SSUs_v1_p100_txt_00_33e924", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 100, "page_end": 100, "section_path": ["HELLP", "Pulmonary Hypertension"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pulmonary Hypertension", "keywords": [], "text": "Pulmonary Hypertension\nMaternal mortality 30-50%, mWHO class IV carries 40-100% risk. Pregnancy CI. Greatest period week post-delivery.\nPotential complications:\n•\nmortality (30%) – highest during labour / post-partum\no\nFoetal mortality also 30%\n•\npulmonary emboli risk (hypercoaguable)\n•\npulmonary vascular reactivity\n•\nmyocardial contractility (in presence of decreased filling state)\nPhysiology:\n•\nCO overwhelms RV with fixed afterload\n•\nSVR → impaired RV perfusion\nManagement @ specialist centre with MDT care. 3rd trimester requires weekly r/v +/- inpatient management.\nMedication:\n•\nSafe:\no\nSildenafil (1st line)\no\nProstacyclin analogues\n▪\nEproprostenol (IV prostaglandins) may inhibit platelet aggregation\n•\nContraindicated:\no\nBosentan /endothelin-R antagonists (due to embryopathy → category X)\no\nRiociguat (nitric oxide pathway)\nMay be indication for caesarean – recommended at 34/40 (balance of risk benefit)\nMost will be anticoagulated – must consider for epidural\nGA has 4x greater mortality than regional\nGoals:\n•\nPVR: normal measures + consider PAC\n•\nMaintain preload: fluids + early treatment of haemorrhage (avoid fluid overload)\n•\nAvoid myocardial depression: avoid beta blockers, consider dobutamine +/- low dose norad\n•\nAvoid arrhythmia/ischaemia: 5 lead ECG\n•\nMaintain SVR: art line + slow titration of epidural\n•\nUterotonics:\no\nAvoid: oxytocin bolus (low dose infusion okay or 0.1iu boluses), ergot, carboprost\no\nMisoprostal safe\n•\nPostpartum: high risk → monitor in ICU, may need mechanical support", "citations": [{"type": "pdf_page", "page": 100, "label": "p100"}]}
{"chunk_id": "SSUs_v1_p101_txt_00_92eec4", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 101, "page_end": 101, "section_path": ["HELLP", "Anticoagulation in Pregnancy"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Anticoagulation in Pregnancy", "keywords": [], "text": "Anticoagulation in Pregnancy\nParticular issue with mechanical valves - warfarin is best anticoagulant but causes:\n•\nTeratogenesis in 1st trimester\n•\nFoetal anticoagulation in 3rd trimester → risk of bleed (vaginal birth is CI)\nMDT + pre-pregnancy counselling\nManagement:\n•\nPre-pregnancy TTE to assess valve + ventricular function\n•\nAnticoagulation: risk benefit discussion with mother\no\n1st trimester:\n▪\nWarfarin <5mg / day: continue\n▪\nWarfarin >5mg / day: replace with therapeutic clexane for weeks 6 – 12\no\n2nd trimester: warfarin is better\no\nCease warfarin at 36/40 → clexane → IV heparin 36 hours prior to planned birth\n▪\nINR / anti-Xa monitoring at least weekly\n▪\nDelivery:\n•\nIf warfarin within 2/52 → C-section (risk of foetal ICH even with normal INR)\no\nAspirin added only if indicated i.e. PET\nHaemorrhage: major maternal haemorrhage complicates up to 11% of pregnancies with mechanical valves\nPros and cons of anticoagulants – specifically mechanical valves:\n•\nWarfarin:\no\nLowest maternal mortality & thrombosis\no\nLowest livebirth rate 2’ foetal ICH, embryopathy / foetopathy, lowest if <5mg / day\no\nCan reverse with prothrombinex\n•\nClexane:\no\nHigh maternal complication\no\nHighest livebirth rate + no adverse effects\no\nTarget anti-Xa 0.8 – 1.2 (though lack of established pregnancy-specific ranges)\no\nMust wait pre-specified time period, reversal with protamine not reliable\n•\nIV heparin: cease 4-6 hours prior + normal aPTT prior to neuraxial (4 hours + normal aPTT is okay)\no\nAble to reversed with protamine\no\nRestart 4 hours post neuraxial or removal of epidural catheter\nBreastfeeding is safe with therapeutic doses of LMWH and warfarin\nSpecial scenarios:\n•\nTOP: surgical > medical for bleeding (+ better control of anticoagulation)\n•\nThrombosed MHV: cardiac SSx +/- loss of mechanical “click” → urgent CTSx\n•\nStroke: thrombotic or haemorrhagic", "citations": [{"type": "pdf_page", "page": 101, "label": "p101"}]}
{"chunk_id": "SSUs_v1_p102_txt_00_cac3fa", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 102, "page_end": 102, "section_path": ["HELLP", "Spinal Dysraphisms", "Neurological Disorders"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Neurological Disorders", "keywords": [], "text": "Neurological Disorders\nEpilepsy\nTreat intrapartum seizures as eclampsia. Hx of epilepsy should not dictate mode of delivery.\nNeuraxial okay – may seizure risk by fatigue and stress.\nAvoid pethidine. All GA drugs okay except etomidate.\nKeppra safest AED (teratogenic potential 2%) and gabapentin.\nHepatic induction from AEDs may duration of action of neuromuscular blocking agents\nMultiple Sclerosis\nPregnancy associated with relapse, but relapse within 3mo post-delivery is common\nNot associated with epidurals, though possible association with high dose LA – use lowest effective [ ], avoid vasoconstrictors\nASA recommends epidural > neuraxial (but not CI)\nDMARDs usually ceased prior to conception.\nAnte-partum relapse: high dose steroids, IVIg or plasma exchange\nMyasthenia Gravis\nPyridostigmine + other immunosuppressants are safe.\nAssess for bulbar signs + resp weakness.\nNeuraxial recommended in labour to avoid crisis.\nWeakness → rate of instrumental or surgical delivery. Neuraxial is safe but must caution with level of motor blockade (resp) –\nCSE recommended with low dose spinal component.\nGA: non-depolarising NMBA at 10% dose + sugammadex\nCaution weakness with MgSO4\nSMA\nSSx: severe scoliosis, resp failure, cardiac abnormalities\nObstetric outcomes poor. Rarely able to deliver spontaneously. Challenging neuraxial (caution deformities + spinal hardware)\nOpioids – sparingly or avoid. Likely require NIV. Sux CI. Non-depolarising can cause prolonged blockade → sugammadex.\nSpinal Dysraphisms\nCongenital malformations of vertebral arches, spinal cord, meninges.\nTypes:\n•\nOpen (no overlying skin) → repaired:\no\nUnlikely to have patent epidural space or ligamentum flavum – epidural is CI\no\nSpinal above area if recent MRI shows low risk spinal cord injury\no\nChiari malformation common – may have shunt, consider shunt malfunction if PET symptoms\n•\nClosed (overlying skin):\no\nUnderlying spinal cord and structures are abnormal\no\nSkin abnormalities (lipoma, hair tuft, skin tag, naevi) – lipomas associated with dural defects +/- tethered to\nspinal cord/filum terminale\no\nAny suspicion:\n▪\nSpinal MRI: level of cord termination, CSF volume +/- presence of tethering +/- intact ligamentum\nflavum\n•\nEpidural may not give complete block if dural space altered\n•\nSpinal okay above level\nIf spina bifida occulta (least serious, most common) can consider neuraxial if proper consent + counselling\nComplex spina bifida:\n•\nOften associated conditions eg cutaneous manifestations +/- urinary / back / leg symptoms, LL pain, bowel symptoms\n•\nShould be considered a CI to neuraxial", "citations": [{"type": "pdf_page", "page": 102, "label": "p102"}]}
{"chunk_id": "SSUs_v1_p103_txt_00_6e6544", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 103, "page_end": 103, "section_path": ["HELLP", "Sickle Cell Disease", "Haematological Disease"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Haematological Disease", "keywords": [], "text": "Haematological Disease\nVon Willebrands Disease\nProphylactic Rx if vWF <50 units/dL\nType\nClinical Effect\nTreatment\nPartial reduction in vWF\nUsually rises in 3rd trimester to >50\nUsually not required\n•\nConsider desmopressin → release\n•\nDesmopressin CI in PET due to vasoconstriction\nDefect in quality of vWF\nBiostate\nDesmopressin only works in some subtypes (not 2b)\nNear complete absence of vWF\nBiostate\nvWF >50 + normal platelets → no concern for epidural. Ensure surveillance post-epidural removal\nUsually use TXA and Biostate (factor VIII + vWF) – DDAVP rarely used anymore\nIf foetus at risk of type 2 or 3 avoid ECV, ventouse, and forceps\nHaemophilia\nX-linked congenital bleeding disorder.\n•\nHaemophilia A: factor VIII usually in normal range by 3rd trimester. Desmopressin can factor VIII.\n•\nHaemophilia B: factor IX doesn’t change in pregnancy\nShould check baseline factor [ ] prior to conception.\nRx:\n•\nRecombinant factors (treatment of choice)\n•\nTXA\n•\nAvoid ventouse + forceps\nFactor concentrations should be maintained >0.5iu/mL for 3/7 after vaginal delivery and 5/7 after C-section\nSickle Cell Disease\nMost common inherited haemoglobinopathy.\nPregnancy →\n•\nSickle cell complications: pain crisis, acute chest syndrome, infections (i.e. sickling at low O2 tensions → micro infarcts)\n•\nPregnancy complications: PET, placental insufficiency, and C-section rates\no\nAspirin from 12/40 due to risk of PET\no\n+/- LMWH from 28/40\nPhysiological changes including prothrombosis, aortocaval compression, vascular stasis and physiological anaemia can\nexacerbate pre-existing organ dysfunction +/- acute decompensation.\nAnaesthetic considerations: r/v prior to 36/40\n•\nPulmonary hypertension 10%: TTE from past 1yr\n•\nIx: Hb, retics, HbS%\no\nTransfusion if: Hb <50, >20 drop from baseline, haemodynamic compromise\no\nRisk of antibodies → cross-match delay\no\nTransfusion painful crises in 3rd trimester, but does not change foetal outcomes and has risks of transfusion\no\nExchange transfusion (aiming HbS <30%) only if recommended by haematology\no\nHb >80 for delivery, >100 for C-section\n•\nMay be on life-long abx 2’ splenic infarct\nIf presenting with acute pain – assess:\n•\nInfection\n•\nAcute chest syndrome\n•\nDehydration\nGive analgesia. Ensure normothermia.\nSCD not an absolute CI to cell salvage.\nIf requires GA:\n•\nIncentive spiro\n•\nGood analgesia\n•\nVTE: prophylaxis 7/7 post vaginal delivery or 6/52 post C-section", "citations": [{"type": "pdf_page", "page": 103, "label": "p103"}]}
{"chunk_id": "SSUs_v1_p104_txt_00_097f26", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 104, "page_end": 104, "section_path": ["HELLP", "Thromboembolism", "Thromboembolism"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Thromboembolism", "keywords": [], "text": "Thromboembolism\nLeading cause of direct maternal death.\nRFs:\nMaternal: previous VTE, age >35, BMI >30, parity ≥3, smoking, varicose veins, cancer, heart failure, IBD, FHx\nObstetric: multiple pregnancy, PET, C-section, prolonged labour >24hr, mid-cavity / rotational operative delivery, stillbirth,\npreterm, PPH\nOther: post-surgery, post-partum sterilisation, hyperemesis, ovarian hyperstimulation, ART/IVF, immobility, fracture,\nsystemic illness, long distance travel >4 hr\nPrevention:\nRisk assessment\nConservative: avoid dehydration, mobilisation\nMechanical: TEDS, SCDS\nPharmaceutical: clexane, full anticoagulation\nPresentation: LL oedema / pain (L side more common), erythema, palpitations, anxiety, chest pain, cyanosis, sweating, cough,\nshock\nNo validated risk criteria for pregnancy (e.g. Wells) → challenging diagnosis\nIx: start therapy prior to firm diagnosis if high risk → ECG, CXR, venous doppler, V:Q scan, CTPA (do not to D dimer)\nAdvise that V:Q scanning may carry slightly higher risk of childhood cancer but is associated with less risk of maternal breast\ncancer than CTPA\nRx:\nClexane (based on pre-booking weight)\nCI to anticoagulation: active / high risk bleeding, allergy, coagulopathy, thrombocytopaenia, HITS, stroke <4 weeks,\nuncontrolled hypertension\nVena cava filter (mortality 0.3%, filter migration >20%, filter fracture or IVC perforation 5%) – only if anticoagulation CI or\nrecurrent events despite anticoagulation\nThrombolysis: risk of major bleed is same as baseline population\nCI to anticoagulation: high risk bleeding condition e.g. praevia, allergy, coagulopathy, thrombocytopaenia, acute stroke, severe\nliver dz, uncontrolled HTN\nAcute massive PE with haemodynamic instability → thrombolysis + IV heparin infusion\nLabour:\nCease anticoagulation at onset of labour\nPlan delivery time based on last dose", "citations": [{"type": "pdf_page", "page": 104, "label": "p104"}]}
{"chunk_id": "SSUs_v1_p105_txt_00_1abbd9", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 105, "page_end": 105, "section_path": ["HELLP", "Analgesia", "Labour"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Labour", "keywords": [], "text": "Labour\nMechanism and progress of normal labour:\n•\nFirst stage:\no\nOnset of labour until full cervical dilatation (latent <4cm, active 4-10cm)\no\nTiming: 0.5cm/hour primip, 1cm/hour multip\n•\nSecond stage:\no\nFull dilatation to delivery of foetus\no\nTiming: <3 hrs primip, <2 hrs multip\n•\nThird stage:\no\nFoetus until placenta ~ 30 mins\nAnalgesia: full text in pain notes\n•\nNon-pharmacological:\no\nMay pain: (L1)\n▪\nSmall birth ball\n▪\nAcupuncture\n▪\nHeat packs\n▪\nMassage (in first stage)\n▪\nNo effect:\n•\nTENS unless severe pain and on pressure points\no\nMay analgesia consumption:\n▪\nAcupuncture\n▪\nHypnosis\n▪\nContinuous 1:1 nursing (also rate of assisted birth)\n▪\nWater immersion\no\nNo effect: yoga, music, audio\n•\nPharmacological: (L1)\no\nNitrous:\n▪\nSome analgesia but maternal adverse effects (nausea, vomiting, dizziness)\n▪\nInferior to epidural\no\nRemifentanil: cont sats monitoring + O2 – consider capnography\n▪\nSuperior to other opioids but inferior to epidural\n▪\nSame APGARs as epidural – must have naloxone, sats monitoring, neonatal resus + paeds available\nNeuraxial:\n•\nImproved by US (L1)\n•\nEpidural and CSE → superior pain relief for labour and delivery\n•\nEpidural cf systemic opioid:\no\nN&V, need for O2 but slightly duration of the first and second stage of labour (L1)\no\nDoes not rate of Caesarean, long term back ache, headache, pruritus, PND (L1)\no\nrisk of foetal acidosis and need for naloxone administration with no in need for NICU (L1)\n•\nEpidurals:\no\nEpidural may risk of assisted vaginal delivery, but not with low-concentrations (L1)\no\nLow concentrations via epidural lead to shorter duration of second stage of labour, fewer assisted deliveries,\ngreater ambulation and less urinary retention cf higher concentrations (L1)\no\nNo difference between early v late epidural (L1)\no\nPCEA effective but optimal settings not known (L1)\no\nPIB > continuous infusion (L1)\no\nNo difference in LA for any outcome except ropivacaine may motor block (L1)\no\nSingle-injection intrathecal opioids provide comparable early labour analgesia to epidural local anaesthetics,\nwith increased pruritus but no difference in nausea (L1)\n▪\nAdding single injection IT morphine (250mcg) to LA + shorter acting opioids increases time to first\nanalgesic request, but is associated with increased adverse effects (L1)\n•\nCSE v epidural (L1), CSE →\no\ntime to effective analgesia\no\nNo maternal satisfaction\no\npruritus\no\nrisk of unilateral block\no\nnon-reassuring foetal HR", "citations": [{"type": "pdf_page", "page": 105, "label": "p105"}]}
{"chunk_id": "SSUs_v1_p106_txt_00_cda38d", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 106, "page_end": 106, "section_path": ["HELLP", "Total Spinal"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Total Spinal", "keywords": [], "text": "Epidural\nConsiderations:\n•\nAnticoagulants (APSME guidelines)\n•\nThrombocytopaenia\no\nEpidural haematoma risk:\n▪\nPlt 70 – 100: 0.2%\n▪\nPlt 50 – 69: 2.6%\n▪\nPlt <50: 9%\nMust follow same criteria for epidural catheter removal\n•\nPrevious surgery\n•\nChorioamnionitis\n•\nFDIU: if no evidence of DIC\n•\nRaised ICP: benign intracranial hypertension okay, otherwise d/w neurosurg re: risk of dural puncture\n•\nHypovolaemia – correct\nCOMET trial: comparative obstetric mobility epidural trial, low dose blocks i.e. bup 0.1% (or ropivacaine ≤0.2%) associated with:\n•\nLess instrumental delivery\n•\nRopivicaine – probably less motor block than bup\nEpidural related-hyperthermia: (mechanism unknown)\n•\n≥38C on one occasion\n•\n≥37.5C on 2x occasions two hours apart\nIncidence is 20% with epidural, 5% without\nConsequences:\n•\ncaesarean / assisted delivery (2x)\n•\nneonatal brain injury / resus requirements\nCSE\nCommonly needle-through-needle technique. No difference between CSE + epidural in rates of PDPH and C-section.\n•\nBenefits:\no\nConfirmed placement via CSF / incidence of failure cf epidural alone (despite “untested catheter”)\no\nBetter analgesia + more rapid onset\no\nurinary retention\no\nassisted delivery\no\nrescue analgesia\no\nunilateral block\n•\nDisadvantages:\no\nUnable to assess catheter until spinal anaesthesia subsided\no\nParasthesia from spinal needle\no\nPruritis\no\nCTG abnormality (manage with BP management +/- tocolytics)\nTotal Spinal\nNormal CTG prior – resus will\nimprove.\nABC approach.", "citations": [{"type": "pdf_page", "page": 106, "label": "p106"}]}
{"chunk_id": "SSUs_v1_p107_txt_00_31d2f0", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 107, "page_end": 107, "section_path": ["HELLP", "Urgent Delivery"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Urgent Delivery", "keywords": [], "text": "Urgent Delivery\nCategory:\n•\nCat 1\nUrgent threat to life or mother / foetus\n<30 minutes\n•\nCat 2\nCompromise but not immediately life threatening\n<1 hour\n•\nCat 3\nRequires earlier than planned delivery without current evidence of compromise\n<4 hours\n•\nCat 4\nAt a time acceptable to patient + staff - elective\nTocolytic\nMechanism\nAdverse Effects\nNSAIDs\n↓prostaglandins\n•\nBleeding\n•\nPeptic ulcer\n•\nRenal dysfunction\n•\nHypertension\nB2-agonists\n(inc adrenaline)\nSM relaxation (prevents pre-mature\nlabour ~48 hours)\n•\nTachycardia\n•\nTremor\nAtosiban\nOxytocin-R antagonist\n•\nVasodilation\n•\nN + V\nNifedipine\nL-type Ca2+ channel antagonist\n•\nHypotension\n•\nPeripheral oedema\nVolatiles\nSM relaxation\n•\nHypotension\n•\nSedation\nGTN\nNO release → SM relaxation\n•\nHypotension\nMonitoring assumes FHR proportional to foetal O2 status.\nFoetal / intrauterine resus:\n•\nCall for help\n•\nSupplemental O2\n•\nReposition (avoid aortocaval compression)\n•\nCorrect hypotension: fluid resus, vasopressor\n•\nTreat uterine tone (cease oxytocin, terbutaline s/c 250mcg, GTN s/l 400mcg i.e. 2 puffs, salbutamol 100mcg)\n•\nStimulate foetal head\n•\nCheck descent / dilation\n•\nExclude cord prolapse\nCTG\nCombines FHR + uterine contraction.\nEvidence:\n•\nintervention/C-section\n•\nneonatal seizures\n•\nNo decrease in perinatal death or cerebral palsy\n•\nNo RCTs\nIndications for continuous monitoring:\n•\nAugmentation of labour\n•\nRegional analgesia (role in low risk labour not established)\n•\nNon-reassuring FHR\n•\nHigh risk pregnancy\n•\nProlonged labour\n•\nSuspected foetal compromise\nAssesses 4 domains: baseline HR, variability, decelerations, accelerations\n•\nDecels: >15 bpm lasting >15 seconds (late = bad)\n•\nBaseline is assessed over 10 mins\n•\nVariability peak to trough over 1 minute", "citations": [{"type": "pdf_page", "page": 107, "label": "p107"}]}
{"chunk_id": "SSUs_v1_p108_txt_00_63f8eb", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 108, "page_end": 108, "section_path": ["HELLP", "Conversion of Labour Epidural"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Conversion of Labour Epidural", "keywords": [], "text": "Conversion of Labour Epidural\nMust stay with patient after top up dose given.\nLA options:\n•\nLignocaine 2% with adrenaline 1:200000\no\nFastest onset 1.5 – 4.5 minutes faster\no\nAdding fentanyl → 2 minutes faster\no\nAdding HCO3 → 4.5 minutes faster\n•\nRopivicaine 0.75%\no\nLowest need for intra-op supplementation\n•\nBupivicaine 0.5% - worst option\nLoss of sensation to T5 dermatome is required to prevent pain reliably during C-section\nEpidural morphine only if certain of location.\nFailed top up:\n•\nNo time → GA\n•\nSome time → CSE with 50% reduction in spinal dose + manipulate", "citations": [{"type": "pdf_page", "page": 108, "label": "p108"}]}
{"chunk_id": "SSUs_v1_p109_txt_00_67ea73", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 109, "page_end": 109, "section_path": ["HELLP", "Management of Suboptimal Block", "Neuraxial Anaesthesia for Caesarean"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Neuraxial Anaesthesia for Caesarean", "keywords": [], "text": "Neuraxial Anaesthesia for Caesarean\nSafer for mother. Probably best for baby also – APGARs with GA vs neuraxial → 5x chance of lower APGAR (however must\nacknowledge confounders such as indicators for Cat A delivery).\nSpinal\nED50 for heavy bup is 6-8mg = 1.2 – 1.6mL usual dose far exceeds (usually 10-12mg)\n*Neither weight nor height affect block extension except for extremes of height\nSSS doses associated with hypotension, nausea & vomiting\nSSS failure: <1%, reasonable to try 1mL repeat + CSE (otherwise GA)\nHigh spinal: ~0.2%\nIntrathecal morphine: 100mcg – good balance between analgesia + side effects. No effect shown on APGARs or foetal pH.\nNo other neuraxial adjuncts are recommended for routine CS.\nNote: evidence for association between intrathecal / epidural morphine and reactivation of herpes\nIncidence of extreme hypotension i.e. systolic pressure <75% of baseline is 38%. Significant maternal hypotension is greater with\nSSS cf epidural. Must be anticipated and prevented.\nManagement:\nLeft uterine displacement (15 degree tilt)\nFluids\nPressors: phenylephrine > ephedrine – less foetal acidosis (2’ less foetal transfer)\nMust know baseline BP (should be taken prior to OT) and aim to maintain BP at ≥90% baseline\nManagement of Suboptimal Block\nPre-op:\nAssess: pain versus sensation versus nausea versus other\nManipulate position i.e trendelenberg v lateral\nRepeat spinal if urgency permits\nGARNER: whole dose if NO block, reduced dose 1-1.5mL if <T12, consider CSE\nVersus predetermined upper dose\nAlways offer GA\nIntra-op:\nInadequate block at any stage – inform surgeon and stop if able\nReassure patient and support person\nPre-delivery:\nTop-up epidural with LA or opioid\nN2O + short acting opioid e.g. alfentanil – notify paediatrician\nOffer GA\nAfter-delivery:\nAs above\nCan consider ketamine IV 10mg aliquots\nTopical LA infiltration into wound if dose allows\nAfter procedure:\nAlways debrief patient and surgeon\nConsider causes", "citations": [{"type": "pdf_page", "page": 109, "label": "p109"}]}
{"chunk_id": "SSUs_v1_p110_txt_00_2da5b1", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 110, "page_end": 110, "section_path": ["HELLP", "General Anaesthesia for Caesarean", "General Anaesthesia for Caesarean"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "General Anaesthesia for Caesarean", "keywords": [], "text": "General Anaesthesia for Caesarean\nC-sections ~25% all births. Maternal mortality is 10x higher in Caesarean section versus vaginal delivery (many confounders).\nIndications: foetal malpresentation, foetal distress, labour dystocia, prior c-section, maternal request, failed neuraxial, skin\ninfection over neuraxial site, intra-op complication\nConsiderations:\nAirway:\n↑Mallampati w/ gestation 2’ airway oedema (RASS, worsened by hypertension + post-pushing) +/- pregnancy\nweight gain +/- breast tissue\nNasal capillary engorgement → vasculature becomes friable – nasal intubation should be avoided\nFailed intubation: 1/400 (used to be 1/250 pre-VL) – 10x failed intubation rate cf non-pregnant population\nRPA CICO - 1/40,000\nRamp + pre-oxygnate to ETO2 >0.9\nBreathing:\n↓FRC (↓20% erect, ↓30% supine) – closing col unchanged but ↓FRC → airway closure in 50% in supine position\n↑O2 consumption 60% + ↓FRC → rapid desats\nCirculation:\nResponse to laryngoscopy – must blunt in hypertensive disorders\nDrugs:\npseudocholinesterase by 30% from 10/40 until 6/52 post-partum\nplasma proteins / albumin → serum levels of highly protein-bound Rx\nKetamine can cause uterine tone + uterine arterial perfusion\nSuxamethonium not detected in umbi cord unless dose >2mg/kg (requires 10mg/kg for any neonatal blockade)\nMagnesium (esp high dose infusions) potentiate non-depolarising NMB\nOther:\nGI: ↓lower oesophageal sphincter tone regardless of labour or not → ↑risk of aspiration (up to 15% mortality)\nBIS: awareness 1/670\nPositioning:\nMeasures to minimise risk of injury\nL tilt 15: no change in foetal acid-base status cf supine, however tilt → CO and requirement for phenylephrine\nConsider risks: aspiration, difficult airway, hypertension to laryngoscopy, awareness, reduced t/f to foetus, passive pressure circ\nQuantify:\nSignificant aspiration in induction – incidence 1/5,000 – mortality rate ~15%\nFailed intubation: 1/400 (used to be 1/250 pre-VL) – 10x failed intubation rate cf non-pregnant population (RPA CICO -\n1/40,000)\nAwareness: 1/19,000 for all GAs versus 1/670 for C-sections (risk  in improper monitoring, inexperienced provider,\nemergent setting, patient obesity)\nOptimise:\nPre-op non-particulate antacid\nNotify paediatric/neonatal team if emergency GA (note: Cochrane review showed no difference between APGAR scores +\nneed for neonatal O2 between regional + GA for uncomplicated non-emergent Caesars)\nAnaesthetic plan:\nInduction:\nRamped + abducted arms, L tilt 15\nBIS monitoring\nHigh flow + RSI with cricoid, VL always first go +/- Xblade stylet, back-up auragain available, ETT 6.0-7.0 cuffed\nFailed intubation → auragain LMA + gastric tube down port + fundal pressure on delivery\nPropofol 2mg/kg + sevo/N2O + suxamethonium 1.5mg/kg\nMaintenance:\nVolatile → propofol infusion (improve atony) + MAC 0.3\nDo not re-paralyse until evidence of NMJ recovery post-sux\nHalogenated anaesthesia reduce to <0.5MAC post-delivery to reduce atony\nEmergence:\nMust use neuromuscular monitoring, sugammadex reasonable\nDisposition: specialised ward with PCA obs if IT morphine used", "citations": [{"type": "pdf_page", "page": 110, "label": "p110"}]}
{"chunk_id": "SSUs_v1_p111_txt_00_053bcd", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 111, "page_end": 111, "section_path": ["HELLP", "ERAS for Caesarean Section", "ERAS for Caesarean Section"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "ERAS for Caesarean Section", "keywords": [], "text": "ERAS for Caesarean Section\nPre-op:\n•\nAntenatal care: obesity, diabetes, hypertensive disorders, anaemia, smoking\n•\nLSCS without medical indication should not be suggested\n•\nAntacid prophylaxis\n•\nAvoid sedation\n•\nMinimise fasting (6 hours) + carbohydrate fluid supplementation until 2 hrs prior (unless diabetic)\n•\nPre-admission counselling\n•\nNo bowel prep\n•\nShower with antimicrobial soap (chlorhex-alc > pov iodine)\nIntra-op:\n•\nAntimicrobial prophylaxis (30 – 60 mins prior to skin incision)\n•\nSkin + vaginal prep (chlorhex skin, pov-iodine vagina)\n•\nRegional anaesthesia preferred method\n•\nAvoid hypothermia <36C (forced air, fluid warmer, increased OT temp >23C)\n•\nTarget euvolaemia\n•\nSurgical:\no\nBlunt hysterotomy (bleeding)\no\nHysterotomy closure in 2 layers\no\nNo peritoneal closure\no\nTissue reapproximation\no\nSkin closure with subcuticular sutures\no\nJoel Cohen > Pfannenstiel (surgical time, blood loss + need for analgesics)\n•\nNeonate: delayed cord clamping for at least 1 min at term delivery (30s for preterm)\nPost-op:\n•\nPONV: minimise intra-op hypotension + anti-emetic prophylaxis\n•\nAnalgesia: multimodal\n•\nDiet: regular within 2 hours, chewing gum may help time to first flatus / bowel motion if delayed\n•\nBSL: normoglycaemia\n•\nVTE: compression stockings (TEDS / SCDS), heparin not routine, early mobilisation\n•\nIDC: remove at end of surgery (no evidence yet of bladder damage from urinary retention)\n•\nDischarge counselling\nVasopressor comparison:\n•\nNoradrenaline versus phenylephrine\no\nLess bradycardia\no\nHigher CO\no\nNo difference: hypotension, foetal acidosis, APGARS, N&V\n•\nPhenylephrine versus ephedrine\no\nLess N&V\no\nLess foetal acidosis\no\nMore bradycardia", "citations": [{"type": "pdf_page", "page": 111, "label": "p111"}]}
{"chunk_id": "SSUs_v1_p112_txt_00_26c725", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 112, "page_end": 112, "section_path": ["HELLP", "Epidural Blood Patch", "Post-Partum Headache"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Post-Partum Headache", "keywords": [], "text": "Post-Partum Headache\nWithin 6 weeks.\nCondition\nAcute Ischaemic\nStroke\nIntracerebral\nHaemorrhage\nCentral Venous\nSinus Thrombosis\nReversible Cerebral\nVasoconstriction\nPRES\nOnset\nAnytime during +\npostpartum\nAnytime during +\npostpartum\n3rd trimester,\npostpartum\nPostpartum\n(abrupt)\nPostpartum\n(rapid – hours)\nSSx\nFocal neurology\nPain in 10%\nThunderclap\nheadache, LOC,\nfocal neurology\nHeadache, seizures,\nfocal neurology\nThunderclap\nheadache, transient\nfocal deficit,\nseizures\nSeizures, dull\nheadache, visual\ndisturbance\nImaging\nCT/MRI – sensitive\nCT\nCT venogram\nUsually normal CT\nVasogenic oedema\nin occipitoparietal\nregions\nRx\nThrombolysis,\nanticoagulation\nSupportive,\nintervention or\ncoiling/clipping\nAnticoagulation,\nseizure control\nCCB, triple H,\nseizure control\nSeizure control, BP\ncontrol\nDural Puncture Headache\nCSF leak → vascular hyperaemia, migraine physiology + traction on pain sensitive fibres\nAssess:\n•\nHistory: SOCRATES\n•\nCharacteristics:\no\nUsually bilateral, frontal, occipital\no\nWorse when upright, relieved lying down\no\nAssociated neck stiffness, photophobia, nausea, tinnitus\n•\nRisk factors: multiple punctures, needle size, patient\no\nHigh risk: risk with preventative morphine or aminophylline (L1)\n•\nExamination\n•\nRed flags: fevers, worsening back pain, neurology\no\nImaging i.e. CT/MRI\n•\nIncidence is by smaller gauge spinal or non-cutting bevel needles (or by orienting cutting bevel parallel to spinal\nsagittal plane (L1)\nManage:\n•\nConservative:\no\nEuvolaemia (no evidence for hypervolaemia)\no\nCaffeine\no\nLying flat\n•\nPharmacological:\no\nSimple analgesia\no\nCaffeine, gabapentin, hydrocort and theophylline are effective treatments for PDPH (L1)\n▪\nCaution caffeine in breastfeeding\n*Avoid dexamethasone → risk of PDPH (L1)\n•\nInterventional: epidural blood patch (> conservative or sham L1)\nEpidural Blood Patch\nIf evidence of CN involvement e.g. diplopia → perform immediately. Otherwise if symptoms limit activity.\nNote: c/o muffled hearing is common – not 2’ CN involvement but 2’ middle ear pressure (middle ear fluid connected to CSF)\nMust lie flat for 2hr post. Avoid heavy lifting for 24hr.\nTiming: effectiveness if >48 hours after dural puncture (<48 hours → rate of 2nd EBP)\nComplications: back pain (35%), recurrence of headache (30%), subdural haematoma, facial n. palsy, intrathecal injection,\narachnoiditis, infection / abscess, spastic paraparesis, cauda equina syndrome, transient bradycardia", "citations": [{"type": "pdf_page", "page": 112, "label": "p112"}]}
{"chunk_id": "SSUs_v1_p113_txt_00_7086c3", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 113, "page_end": 113, "section_path": ["HELLP", "Amniotic Fluid Embolism", "Sepsis"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Sepsis", "keywords": [], "text": "Sepsis\nTwo or more of:\n•\nT >38 or T <36\n•\nHR >100bpm (>90 if not pregnant)\n•\nRR >20\n•\nWCC >17 (12 if not pregnant) or <4\n= SIRS\nPuerperal sepsis: GUT from labour until 42 days post-partum\nPrinciple organisms: Strep pneumoniase, E coli, rarely Group A Strep (Strep pyogenes)\nRFs: C-section, obesity\nManagement: hydration + early abx (<1hr)\nRegional anaesthesia: generally CI in septic hypotensive pts, may have associated coagulopathy, small risk of epidural abscess /\nmeningitis – can consider if responding to abx\nGA: highly likely to be required\nCaution oxytocin boluses", "citations": [{"type": "pdf_page", "page": 113, "label": "p113"}]}
{"chunk_id": "SSUs_v1_p113_txt_01_a52e8f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 113, "page_end": 113, "section_path": ["HELLP", "Amniotic Fluid Embolism", "Amniotic Fluid Embolism"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Amniotic Fluid Embolism", "keywords": [], "text": "Amniotic Fluid Embolism\n1 – 7 / 100,000. Fatality 20%. Neonatal mortality 40%.\nMechanical + immune theory. No sig in serum mast cell tryptases. Diagnosis of exclusion.\nPhases:\n•\n1: initial entry – 30 min\no\nPAP + RHF\no\nMicrovascular damage\no\nHypotension\no\nDIC\n•\n2: progression\no\nLV failure (risk by meconium in amniotic fluid)\no\nEndothelial activation + leakage\no\nDIC\nDiagnosis: UKOSS\n•\nAbsence of other cause\n•\nPost-mortem finding of foetal squamous / hair in lungs (can also be present in healthy normal women)\n•\nAcute maternal collapse with ≥1 of:\no\nAcute foetal compromise\no\nCardiac arrest\no\nArrhythmia\no\nCoagulopathy\no\nHypotension\no\nHaemorrhage (exclude first)\no\nPremonitory symptoms\no\nSeizure\no\nSOB\n•\nTiming: 70% labour, 19% C-section, 11% post-vaginal delivery\n•\nSSx: hypotension (100%), foetal distress (100%), APO/ARDS (93%), cardiac arrest (87%), cyanosis (83%), coagulopathy\n(83%) + others\n•\nIx: are no aid in diagnosis but aid in severity – full bloods including viscoelastic, ECG, TTE\n•\nBiomarkers:\no\nLow C3/C4 complement\no\nZinc coproporphyrin & sialyl-Tn antigen (components of meconium and amniotic fluid)\no\nInsulin-like growth factor binding protein 1\n•\nHistology: foetal squamous / hair\nSupportive management", "citations": [{"type": "pdf_page", "page": 113, "label": "p113"}]}
{"chunk_id": "SSUs_v1_p114_txt_00_ad5a09", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 114, "page_end": 114, "section_path": ["HELLP", "Intrinsic Obstetric Palsies", "Post-Natal Neurology"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Post-Natal Neurology", "keywords": [], "text": "Post-Natal Neurology\nLabour causes majority of injuries, not neuraxial.\nMechanisms:\nMechanical – stretch, compression, transection\nIschaemic, infective\nNeedle\nIntraneural injection\nAdhesive arachnoiditis, aseptic meningitis\nNAP 3 findings:\nOverall:\nPermanent injury\n1/24,000 – 54,000\nParaplegia / death\n1/50,000 – 140,000\nObstetric:\nPermanent harm\n1/80,000 – 320,000\nSpinal\n1/67,000 – 100,000\nEpidural\n1/161,000\nCSE\n1/25,000\nDirect spinal cord damage is exceedingly rare as procedures are generally performed below conus medullaris. In a small\ngroup of patients with unintentionally high injections a spinal syrinx formed → all described pain on injection, if\npatients complain of pain on injection stop immediately.\nNeuropraxia following childbirth 1/2000\nIntrinsic Obstetric Palsies\nIncidence 1%.\nRFs: prolonged 2nd stage, forceps delivery, primiparity, lithotomy position, diabetes, lumbar lordosis, obesity, increased intra-\nabdominal pressure\nUsual duration 6 weeks – 2 months.\nSyndromes:\nLateral femoral cutaneous nerve: meralgia parasthetica (2’ extreme hip flexion)\nLumbosacral trunk: foot drop + sensation to lateral lower leg / dorsal foot\nFemoral nerve: inability to climb stairs, knee jerk, femoral sensory loss\nObturator nerve: inner thigh sensation, weak hip adduction / rotation\nPeroneal nerve: sensory loss\nInvestigation:\nHx: pre-existing neuro deficits, bowel / bladder / saddle parasthesia, back pain, fevers, symptom progression\nExamination: full lower limb motor + sensory, ?bilateral v unilateral, presence of fever + tachycardia, inspect puncture site\nIx: WCC, CRP, MRI spine, NCS / EMG\nReferral: neurology, neurosurgery\nRed flags: bilateral symptoms, progressive worsening, motor deficit, fever, back pain, bowel / bladder dysfunction, saddle\nparasthesia, coagulopathy", "citations": [{"type": "pdf_page", "page": 114, "label": "p114"}]}
{"chunk_id": "SSUs_v1_p115_txt_00_7253c5", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 115, "page_end": 115, "section_path": ["HELLP", "Multiple Gestation", "Premature Labour"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Premature Labour", "keywords": [], "text": "Premature Labour\nLabour between 20 – 37 weeks. 10%.\nRFs: previous, multiple gestation, infection, abnormal placentation, cervical incompetence, smoking, age <15 or >40, PPROM,\ninduction for obstetric reasons\nManagement:\nTocolysis: salbutamol, terbutaline, nifedipine, GTN, atosiban\nDelay delivery for foetal lung maturation if <34 weeks\n<34/40 betamethasone 2x doses q12 hr – aim to deliver >24 hr after 1st dose\n<3/40 magnesium sulfate infusion for neuroprotection (cerebral palsy) – 4g loading over 20 mins → 1g/hr until delivery\nNICU referral\nGBS antibiotics", "citations": [{"type": "pdf_page", "page": 115, "label": "p115"}]}
{"chunk_id": "SSUs_v1_p115_txt_01_755986", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 115, "page_end": 115, "section_path": ["HELLP", "Multiple Gestation", "Multiple Gestation"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Multiple Gestation", "keywords": [], "text": "Multiple Gestation\nIncidence: 4 in 1000 ( 2’ ART) - terminology:\nMonozygotic: single fertilised ovum\nMonochorionic monoamniotic (MCMA) – deliver at 32 – 34 weeks\nMonochorionic diamniotic (MCDA) – deliver at 34 – 36 weeks\nDichorionic diamniotic (DCDA) – deliver at 38 - 39 weeks\nRFs: IVF, AMA, race, parity, FHx, obesity\nMaternal physiology: → exaggerated resp + CVS changes\nResp: larger gravid uterus → TLC, FRC, IAP + regurgitation, breast size, MV\nCVS: plasma volume (by 400mL), dilutional anaemia, CO, aortocaval compression\nNeuro: LA sensitivity (but may not need dose)\nComplications: higher rates of every complication except post-term delivery and macrosomia\nFoetal: preterm delivery, congenital abnormality, polyhydramnios, cord entanglement, cord prolapse (2nd twin), IUGR\nMonochorionic complications only: (monochorionic is highest risk)\nTwin-twin transfusion syndrome\nTwin anaemia polycythaemia sequence\nTwin reversed antenatal perfusion sequence\nManagement:\nExpectant\nFoetoscopic laser ablation of anastomotic vessels\nAmnioreduction\nSelective foetal reduction\nEarly delivery\nMonoamniotic complications:\nCord entanglement → foetal death\nConjoined\nMaternal: all cause morbidity and mortality, PPROM, PROM, prolonged labour, HTN +/- PET, GDM ( severity and worse\naspiration), placental abruption, placenta praevia, DIC, operative delivery, atony / PPH, obstetric trauma\nECV is contraindicated due to risk of placental abruption and cord prolapse\nanaesthetic intervention rate\nManagement:\nEarly epidural (facilitates vaginal delivery e.g. external / internal cephalic version)\nCTG monitoring of both twins\n50% c-section rate\n2nd twin may require internal podalic version (tocolysis with GTN)\nTwin birth study: no difference in outcomes with C-section versus vaginal delivery if 1st is cephalic (2nd twin has 10% c-section\nrate mostly due to malpresentation) between 32 – 39 weeks\nMost obstetric providers prefer C-section for triplet delivery or higher, however no formal recommendations are in place –\nshould be based on discussion with patient and care team’s ability / experience", "citations": [{"type": "pdf_page", "page": 115, "label": "p115"}]}
{"chunk_id": "SSUs_v1_p116_txt_00_3e0134", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 116, "page_end": 116, "section_path": ["HELLP", "Assisted Vaginal Birth", "Breech"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Breech", "keywords": [], "text": "Breech\nFoetal buttocks or lower limbs are presenting part. Incidence is 25% at 28/40, reduced to 4% by term.\nTypes:\nFrank: flexed hip, extended knee\nComplete: flexed hip & knee\nFootling: incomplete\nRisks:\nMaternal: abruption, rupture of membranes, need for emergent delivery\nFoetal: foetal bradycardia, perinatal mortality (2/1000), stillbirth >39 weeks though no long term morbidity\nExternal Cephalic Version\nMay be rotated by ECV.\nCI:\nAbsolute: LSCS required for other reason, APH, abnormal CTG, uterine abnormality, ruptured membranes, multiple\npregnancy\nRelative: SGA, abnormal dopplers, PET, oligohydramnios, major foetal abnormality, scarred uterus, unstable lie\nAnalgesia for procedure:\nNeuraxial anaesthesia associated with higher success rate (60% v 40%) 2’ relaxation of abdominal wall\nOptimal dose unknown – should take into account hypotension + block level in event of urgent C-section\nCSE good option – lower dose spinal with catheter in situ if required\nRemifentanil infusion\nNO2 – not supported in literature\nNeed to give tocolysis terbutaline 250mcg s/c 15 – 30 mins prior +/- GTN → monitor FHR + consider anti-D\nSuccess rate overall ~60%, complication rate 6% (foetal bradycardia, PV bleed, ruptured membranes, abruption, maternal-foetal\ntransfusion, emergency CS, perinatal mortality).\nAnaesthesia provider must be immediately available. Higher order pregnancies usually delivered by caesarean due to risk of cord\nentanglement and possibility of head entrapment.", "citations": [{"type": "pdf_page", "page": 116, "label": "p116"}]}
{"chunk_id": "SSUs_v1_p116_txt_01_a33777", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 116, "page_end": 116, "section_path": ["HELLP", "Assisted Vaginal Birth", "Assisted Vaginal Birth"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Assisted Vaginal Birth", "keywords": [], "text": "Assisted Vaginal Birth\nForceps or vacuum.\nIndications:\nFailure to progress to 2nd stage\nMaternal exhaustion\nCardiac disease (to reduce maternal pushing)\nFoetal distress\nLocation: labour floor v OT\nLow-dose epidural analgesia may be inadequate.\nNeuraxial options:\nEpidural: lignocaine 1-2% 5-10mL\nCSE: good option in event of C-section\nSpinal: sufficient dose for C-section\nPudendal block S2-S4: can assist in second stage of labour, at discretion of obstetric team\nComplications: uterine atony, PPH, peroneal injury / repair", "citations": [{"type": "pdf_page", "page": 116, "label": "p116"}]}
{"chunk_id": "SSUs_v1_p117_txt_00_240ec4", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 117, "page_end": 117, "section_path": ["HELLP", "Placenta Accreta Spectrum", "Abnormal Placental Implantation"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Abnormal Placental Implantation", "keywords": [], "text": "Abnormal Placental Implantation\nPlacenta Praevia\nPlacenta praevia: placental tissue close to or over internal cervical os. Incidence 0.5%.\nRFs: advanced maternal age, assisted pregnancy, multiparity, prior placenta praevia, or uterine scarring from infection or prior\nsurgery.\nDiagnosis: US\nClassification:\nMinor:\nGrade 1: lower segment but not os\nGrade 2: reaches but not covers os\nMajor:\nGrade 3: eccentrically covers os\nGrade 4: centrally covers os\nNeed to know anterior or posterior.\nAccounts for 15-20% of all APH:\n30% prior to 30 weeks\n30% 30 – 36 weeks\n30% after 36 weeks\nOnly 10% have nil bleed\nRequires C-section unless resolves prior to delivery.\nComplications:\nMaternal: APH / PPH, blood transfusion, morbidity / mortality\nNeonatal: preterm birth, NICU, death\nManagement:\nMonitor position with US\nExclude accrete\nAvoid PV exam / speculum / sexual activity\nAvoid strenuous activity\nSteroids +/- MgSO4 +/- inpatient monitoring\nCaesarean planned delivery\nPlacenta Accreta Spectrum\nIncidence 0.04% of all pregnancies.\n3 subtypes:\nAccreta vera: 80% - abnormal adherence to myometrium with absent decidual line of separation\nIncreta: 15% - abnormal implantation and growth of placenta into myometrium\nPercreta: 5% - growth of placenta through uterine wall with placental implantation onto other tissues which may include\nbladder, bowel, ovaries or other organs\nRFs: previous CS, myomectomy, curette, hysteroscopy, endometrial ablation, placenta praevia, IVF, asherman’s, multip, AMA\nDiagnosis:\nUS:\nPlacental lacunae (lakes)\nUterine-bladder or uteroplacental interface abnormality\nMyometrium 1mm thick\nMRI:\nDark intraplacental bands (T2)\nDisruption between uterus and placenta\nAbnormal placental bulging\nAssessment:\nPre-op review (routine obstetric + tailored) + counselling with partner / support person\nDiscuss need for GA or regional\nKnow exact placental location", "citations": [{"type": "pdf_page", "page": 117, "label": "p117"}]}
{"chunk_id": "SSUs_v1_p118_txt_00_f47a6a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 118, "page_end": 118, "section_path": ["HELLP", "Cord Prolapse"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Cord Prolapse", "keywords": [], "text": "Management:\nCareful timing of delivery (35 – 36+6 weeks)\nElective CS in appropriate facility: blood bank, cell salvage, rapid transfusion capability, high volume centre, ICU, IR\nConsider hybrid OT/IR – no evidence for pre-op balloons, consider sheaths\nCorrect anaemia / iron deficiency\nSteroid cover if <36/40\nIntra-op:\nNeuraxial v GA based on surgical plan / predicted time, risk of bleeding, maternal preference, known difficult airway\nSurgical options:\nHysterotomy with attempted placental separation\nClassical hysterotomy\nPre-emptive vascular occlusion of IA with balloon catheters (→ blood loss + hysterectomy rate)\nOvarian a. is also important supply\nREBOA (resuscitative endovascular balloon occlusion of aorta)\nHysterectomy\nIR embolization\nManagement of PPH (usual + →)\nQuantitative blood loss methods e.g. calibrated under buttocks v drape\nNote: expert consensus supports avoidance of prophylactic uterotonic drugs unless placental removal/separation\nwith atonic bleeding – use of uterotonics is a collaborative decision\nCell salvage (safe)\nPost-op: may require ICU, VTE prophylaxis, monitor for anaemia / volume overload / PPH / organ dysfunction\nComplications: mortality (maternal), PPH (+ coagulopathy, anaemia), AKI, hysterectomy\nMay require pre-op iliac balloons or selective embolization +/- hysterectomy.", "citations": [{"type": "pdf_page", "page": 118, "label": "p118"}]}
{"chunk_id": "SSUs_v1_p118_txt_01_ecd1a9", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 118, "page_end": 118, "section_path": ["HELLP", "Cord Prolapse", "Vasa Praevia"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Vasa Praevia", "keywords": [], "text": "Vasa Praevia\nVessels are adherent to membranes over the cervical os and can be torn open with cervical dilatation. Incidence 0.04%.\nSignificant foetal morbidity and mortality if not diagnosed antenatally.If diagnosed antenatally usually planned for C-section at\n36 weeks with steroid cover. If bleeding → obstetric emergency requiring C-section under GA.", "citations": [{"type": "pdf_page", "page": 118, "label": "p118"}]}
{"chunk_id": "SSUs_v1_p118_txt_02_2739b3", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 118, "page_end": 118, "section_path": ["HELLP", "Cord Prolapse", "Cord Prolapse"], "specialty_tags": ["HELLP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Cord Prolapse", "keywords": [], "text": "Cord Prolapse\nIncidence 0.5%. Obstetric emergency. ~50% of cases caused by obstetric intervention.\nDescent of umbilical cord through cervix:\nOccult: alongside foetus\nOvert: visualisation or palpation of cord in vaginal canal below presenting foetal part\nMay occur at rupture of membranes if abnormal foetal position or polyhydramnios\nRisks: LBW, transverse/unstable lie, breech, multiple gestations (specifically 2nd twin), abnormally long umbilical cord, low lying\nplacenta, ARM with high presenting part, unengaged presenting part, ECV, transcervical balloon >180mL\n*Elective admission at 37 weeks for women with breech/unstable/transverse lie should be offered – must present to hospital\nimmediately if signs of labour\nSSx: abrupt prolonged foetal bradycardia\nManagement:\nReduce cord pressure / intrauterine ressucitation:\nManual pressure for cord inside uterus (avoid handling cord to avoid vasospasmF, pressure on presenting part)\nSteep head down\nTocolysis\nFill bladder\nKnee to chest or lateral position\nImmediate delivery: vaginal if possible / imminent → emergency C-section if not or CTG abnormal\nNeonatal resus: staff + equipment\nAnaesthetic: top up epidural if in and working, usually GA as fastest decision-to-delivery interval", "citations": [{"type": "pdf_page", "page": 118, "label": "p118"}]}
{"chunk_id": "SSUs_v1_p119_txt_00_e93b70", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 119, "page_end": 119, "section_path": ["VBAC", "Uterine Inversion", "Shoulder Dystocia"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Shoulder Dystocia", "keywords": [], "text": "Shoulder Dystocia\nAfter delivery of head anterior or posterior should impacts on maternal pelvis or sacral promontory – obstetric emergency\nRisk factors: prolonged gestation, labour induction, obesity, high foetal weight, prolonged dilatation from 8-10cm, and epidural\nanalgesia (this is just an association) – however epidural provides superior conditions for infant rescue\nManagement:\nMcRoberts manoeuvre: mother’s legs flexed and pushed tightly to abdomen + suprapubic pressure\nDeliver posterior arm → rest of baby\nInternal rotation\nGaskin manoeuvre: mother on hands and knees (may not be possible with epidural)\nCleidotomy\nSymphysiotomy\nIf above unsuccessful → foetus pushed back in (Zavanelli manoeuvre) + proceed to emergency C-section\nShoulder dystocia → ↑risk of PPH + fourth degree tears\nNeonatal risk: HIE, mortality, brachial plexus injury", "citations": [{"type": "pdf_page", "page": 119, "label": "p119"}]}
{"chunk_id": "SSUs_v1_p119_txt_01_563ee0", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 119, "page_end": 119, "section_path": ["VBAC", "Uterine Inversion", "Uterine Rupture"], "specialty_tags": ["VBAC", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Uterine Rupture", "keywords": [], "text": "Uterine Rupture\nEncompasses scar dehiscence to complete uterine wall rupture.\nRisk factors: VBAC (1% of all VBACs), foetal malposition, instrumental delivery, macrosomia, excessive oxytocin administration,\nrapid delivery, trauma + tumour, myometrial wall thickness <2.1mm\nTypical presentation: foetal bradycardia (most reliable sign), cessation of uterine contractions, abdominal pain, vaginal bleeding,\nloss of station (foetal head away from pelvis)\nManagement:\nEmergency laparotomy and delivery of foetus → repair +/- arterial ligation +/- hysterectomy\nMassive haemorrhage management\nRSI + ETT\nPost op ICU\nVBAC\nIdeal interpregnancy interval >18 months. Success rate 60-80%.\nBenefits: less post-partum pain, faster return to function, lower risk of future placental issues, LOS, patient satisfaction\nRisks: failure (25%), uterine rupture (0.5%) +/- transfusion +/- hysterectomy, foetal demise / morbidity, HIE, pelvic floor trauma\nCIs: previous uterine rupture, classical incision, full thickness myomectomy, >2 previous C-sections, CIs to vaginal delivery (i.e.\nabnormal placental implantation / location, untreated HIV / HSV)\nVariables:\nFavour success: previous VBAC, previous vaginal birth, 1 prior CS, spontaneous labour, low risk pregnancy\nDo not favour success: IOL, ≥2 CS, obesity, macrosomia, AMA, comorbidity, >41/40\nManagement:\nAppropriate facility with immediate help available\nContinuous CTG monitoring\nPreparation for haemorrhage management i.e. 2x large bore access + G&H\nFrequent assessment of progress of labour\nAnalgesia: epidural is beneficial (able to top up quickly), though no effect on success of VBAC, no effect on rupture\npresentation", "citations": [{"type": "pdf_page", "page": 119, "label": "p119"}]}
{"chunk_id": "SSUs_v1_p119_txt_02_505d09", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 119, "page_end": 119, "section_path": ["VBAC", "Uterine Inversion", "Uterine Inversion"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Uterine Inversion", "keywords": [], "text": "Uterine Inversion\nPassage of uterus through cervix. Incidence 0.04%. Associated with hypotension, pain, severe PPH.\nRisks: excessive cord traction prior to placental separation, uterine atony, placenta at fundus, presence of placenta accreta.\nRx:\nDiscontinue uterotonics (relaxation of uterus) +/- GTN or volatile anaesthesia\nMaternal resus\nReplacement of uterus\nUterine contraction after replacement to reduce haemorrhage\nIf GA required RSI with volatile → propofol TIVA post-replacement", "citations": [{"type": "pdf_page", "page": 119, "label": "p119"}]}
{"chunk_id": "SSUs_v1_p120_txt_00_60de42", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 120, "page_end": 120, "section_path": ["VBAC", "Sepsis", "Foetal Death in Utero"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Foetal Death in Utero", "keywords": [], "text": "Foetal Death in Utero\nNo specific cause in 50%.\nAssess for: sepsis, coagulopathy / DIC, anti-D requirement, PET, bleeding (e.g. abruption), psychosocial\nManagement:\nExpectant: most spont labour within 3 weeks\nInduction: recommended\nCaesarean\nUp to maternal preference\nGoals of care:\nSingle room way from labouring women\nAccommodate emotional and social needs including bed for partner, experienced midwife, social work\nInvestigate and manage complications: PET, sepsis, DIC, bleeding + all maternal complications\nAnalgesia: neuraxial if not CI (DIC/sepsis) or PCA\nAfterwards:\nCounselling\nSocial work\nCulturally sensitive care\nDebriefing (staff also)\nPost-mortem testing if indicated\nFollow up", "citations": [{"type": "pdf_page", "page": 120, "label": "p120"}]}
{"chunk_id": "SSUs_v1_p120_txt_01_e2d18a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 120, "page_end": 120, "section_path": ["VBAC", "Sepsis", "Sepsis"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Sepsis", "keywords": [], "text": "Sepsis\nTwo or more of: T >38 or T <36, HR >100bpm (>90 if not pregnant), RR >20, WCC >17 (12 if not pregnant) or <4 = SIRS\nSevere sepsis is associated with organ dysfunction.\nPuerperal sepsis: infection of genital tract occurring at any time from labour/ROM until 42 days post-partum associated with two\nof – pelvic pain, fever, abnormal discharge, abnormal smell of discharge, delay in reduction of uterine size\nPrinciple organisms: Strep pneumoniase, E coli, rarely Group A Strep (Strep pyogenes)\nRFs: C-section, obesity\nManagement: hydration + early abx (<1hr)\nRegional anaesthesia: generally CI in septic hypotensive pts, may have associated coagulopathy, small risk of epidural abscess /\nmeningitis – can consider if responding to abx\nGA: highly likely to be required\nCaution oxytocin boluses", "citations": [{"type": "pdf_page", "page": 120, "label": "p120"}]}
{"chunk_id": "SSUs_v1_p121_txt_00_ca628d", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 121, "page_end": 121, "section_path": ["VBAC", "Advanced Life Support in Pregnancy", "Diagnosis and Management of Maternal Collapse"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Diagnosis and Management of Maternal Collapse", "keywords": [], "text": "Diagnosis and Management of Maternal Collapse\nMaternal collapse: acute event involving cardiorespiratory systems and/or central nervous systems → or absent conscious\nlevel (and potentially cardiac arrest and death) at any stage in pregnancy up to 6 weeks post-partum.", "citations": [{"type": "pdf_page", "page": 121, "label": "p121"}]}
{"chunk_id": "SSUs_v1_p121_txt_01_bb2831", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 121, "page_end": 121, "section_path": ["VBAC", "Advanced Life Support in Pregnancy", "Advanced Life Support in Pregnancy"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Advanced Life Support in Pregnancy", "keywords": [], "text": "Advanced Life Support in Pregnancy\nSimilar to adult ALS +: (no alteration in drugs /doses or defib charge) – pads may need to be placed AP\nLeft manual displacement of uterus after 20/40\nCompressions higher on chest\nIV access ABOVE diaphragm\nEarly intubation – cricoid if enough people are present\nNo ROSC after 4 mins prepare for peri-mortem caesarean by 5 mins (only necessary equipment is scalpel + 2x cord clamps)\nMaternal survival: 61% versus 35% by 5 mins\nNeonatal survival: 96% versus 70% by 5 mins\nSurvival at site of collapse: 72% versus 36%\n4 Hs + 4 Ts; obstetric specific causes →\nHypovolaemia\nBleeding: obstetric + non-obstetric, always consider possibility of concealed bleeding i.e. abruption, splenic a.,\nhepatic a.\nSepsis\nHigh spinal\nSupine hypotension / aortocaval compression can precipitate maternal collapse\nHypoxia\nPET → pulmonary oedema\nPPCM\nMI\nAortic dissection\nHypo/hyperkalaemia\nHypothermia\nThromboembolism\nVTE/PE\nAFE\nAir embolism\nMI\nToxicity\nLAST (has been associated with TAP blocks – concentration should be no greater than 0.25% with adrenaline – no\nmore than 20mL each side. Should use US and aspirate frequently)\nMagnesium\nIllicit drug use\nAnaphylaxis\nTension pneumothorax\nTamponade\nAortic dissection\nObstetric specific:\nAnaesthesia: high / total spinal, anaphylaxis, airway complication, LAST\nObstetric: PET, ICH\nConsider TOE\nEarly ECMO referral\nClinical governance: accurate documentation, incident form, continued ALS training with obstetric specific scenarios", "citations": [{"type": "pdf_page", "page": 121, "label": "p121"}]}
{"chunk_id": "SSUs_v1_p122_txt_00_522498", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 122, "page_end": 122, "section_path": ["VBAC", "Major Obstetric Haemorrhage", "Major Obstetric Haemorrhage"], "specialty_tags": ["VBAC", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Major Obstetric Haemorrhage", "keywords": [], "text": "Major Obstetric Haemorrhage\nType\nGestation / Timing\nVolume\nCauses\nEarly\n1st and 2nd trimester\n<24/40 weeks\nAny\nEctopic, miscarriage, septic miscarriage\nAntepartum\n(Incidence 3-5%)\n≥24/40 - delivery\nMajor: 50-1000mL without signs of shock\nMassive: ≥1000mL and/or bleeding of any\nvolume with clinical signs of shock\nAbruption 33%\nPraevia 33%\nOther 33%\nPostpartum\nPrimary: within 24\nhours of delivery\nSecondary: 24hr – 12\nweeks post-\ndelivery\nNo agreed upon volumes for PPH - WHO\n≥500mL.\nRANZCOG: severe >1000mL or SSx HD\ninstability regardless of volume\n4Ts:\nTone 80%\nTrauma (CS, epis, assisted delivery, LGA,\nrupture)\nTissue\nThrombus (congenital / acquired)\nRFs: previous PPH, placental abnormality, multiple pregnancy, polyhydramnios, chorioamnionitis, Asian, obesity, prolonged\nlabour/short labour, primip >40\nPathophysiology: uteroplacental unit = high-flow, low resistance and receives 25% CO.\nManagement:\nFollow department PPH protocol\nPriorities: lateral if antepartum, 2x large bore access, bloods (FBC, EUC, LFTs, coags + fibrinogen, blood gas, group & cross\nmatch), keep patient warm, alert blood bank (O neg / uncrossmatched type specific / crossmatched), correct underlying\ncause simultaneously\nLow fibrinogen levels are an independent risk factor for development of severe PPH – one study showed fibrinogen <2g/L →\n100% PPV for development of severe PPH.\nGoals: correct volume, anaemia (to improve O2 delivery + acidosis/lactataemia), coagulopathy\nTherapy:\nTone\nSurgical:\nUterine massage\nIntra-uterine balloon tamponade (i.e. Bakri)\nUterine compression sutures (e.g. B-lynch)\nIR embolization / catheter balloon occlusion (radiation exposure)\nLigation of pelvic vessels: iliacs, uterine, hypogastric, ovarian\nUterine a. ligation - no major effects on fertility, only effective in 50% of cases\nHysterectomy\nMedical\nOxytocin (after 17/40)\nPPH: vaginal 5iu slowly, C-section 3iu over 30s\n(both followed by infusion)\nErgometrine 250mcg IM + IV\nCarboprost 250mcg IM q15 min x 8\nMisoprostal 400-1000mcg PR\nThrombin\nTxA 1g → another 1g at 30 min if still bleeding\nEarly cryoprecipitate (target fibrinogen >2.0)\niCa >1\nKeep warm T >36\nCorrect acidosis pH >7.2\nPlatelets >100 if bleeding ongoing\nBlood products 1:1:1 with early cryo (MTP versus goal-directed depends on stability of patient)\nViscoelastic testing:\nDetects well: low fibrinogen, decreased plt fx, fibrinolysis, factor deficiency\nDetects poorly: VWD, drug effects (e.g. aspirin, warfarin, NOAC)\nConsider cell salvage - leukocyte reduction filter → removal of tissue factor, a-foetoprotein, fetal squamous cells,\nbacteria and other contaminants → risk of AFE\nTargets during haemorrhage: fibrinogen >2, PT & aPTT 1.5x normal, plt >75\nTrauma / tissue → surgical management\nIf parturient is Rh -ve give anti-D as soon as able + Kleihauer-Betke testing to prevent alloimmunisation", "citations": [{"type": "pdf_page", "page": 122, "label": "p122"}]}
{"chunk_id": "SSUs_v1_p123_txt_00_bb16c2", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 123, "page_end": 123, "section_path": ["VBAC", "Uterotonics"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Uterotonics", "keywords": [], "text": "TxA: no risk VTE, but seizure threshold\nWOMAN trial:\n1g over 10 mins versus placebo\n2nd dose if still bleeding at 30 mins or re-bleed within 24hr\nSignificant: death due to bleeding if within 3 hrs, after 3 hrs\nNo difference:\nComposite of all-cause mortality or hysterectomy\nComplications e.g. VTE, CVA, MI\nSurgical intervention\nTRAAP2: routine TXA for LSCS, some issues with reported vs calculated blood loss, no difference in transfusion or pre- &\npost-Hb, ↑N&V with TXA\nCIs: active VTE, significant renal disease, subarachnoid haemorrhage\nUterine Tone\nRisks factors: chorioamnionitis, labour augmentation, high parity, macrosomia, multiple births, prolonged labour, retained\nproducts, volatile anaesthetics, magnesium, terbutaline\nNon-Pharmacological\nMechanism\nAdverse Effects\nUterine massage\nPressure and movement on uterus\nNil adverse though may not be effective\nTime-consuming\nBimanual compression\nClosed fist into vagina and hand on\nabdominal wall\nLow quality – only weak recommendations\nMinimal actual adverse effects though may not work and\nonly temporising\nUterotonics\nDrug\nMechanism\nAdverse Effects\nOxytocin\nElective: 1iu bolus → infusion\n(repeat 3iu slowly if required\nafter 2 mins)\nIntrapartum: 3iu slowly (some\ndesensitisation if augmented\nlabour) → infusion\nOxytocin-R (Gq GPCR) →\n↑IP3 / DAG → ↑[uterine SM\nintracellular Ca2+] →\ncontraction (synthetic\nanalogue of endogenous\nposterior pituitary hormone)\nHypotension, tachycardia, ST depression\nMild ADH effect\n↓uterine blood flow may cause foetal distress\nRecommend 1st line PPH though no RCTs\nAdverse outcomes increase with bolus doses >1iu\nIf oxytocin/carbetocin fail to produce uterine tone →\nconsider second uterotonic early\nCarbetocin\n100mcg (= 5iu of oxytocin)\n½ life of 40 mins\nSynthetic oxytocin analogue\nbut chemical structure makes\nit less susceptible to\nmetabolism\nSame as oxytocin\nCarbetocin > oxytocin in Cochrane review for avoiding\nsevere PPH + required less uterine massage\nOxytocin + carbetocin are CI in PET as they can cause\n↓CO (however studies have shown no major adverse\neffect)\nErgometrine\n250mcg IM +/- 250mcg IV (can\nrpt after 2 hr)\n½ life 30-120 mins\nErgoid alkaloid – agonist at\nα1, 5HT and dopamine\nreceptors → vasoconstriction\nand SM contraction\nN + V ++++ (D2-R in CTZ)\nVasoconstriction → ↑MAP + ↑pulmonary HTN\nCoronary vasospasm\nMay cause placental retention if not delivered\nCI: PET, pulmonary HTN, IHD, intracardiac shunt,\naortopathy / aneurysms\nCarboprost\n250mcg IM q15 min x 8\nSynthetic PGF2α → ↑uterine\ntone\nBronchospasm\n↑pulmonary hypertension (can ↑PVR by >100%)\nN&V\nCI: asthma, fontan’s, pulmonary HTN, intracardiac shunt,\nRHF\nMisoprostal\n400-600mcg rpt after 15 mins if\nrequired (max dose 800mcg)\nSynthetic PGE1 → ↑uterine\ntone\nNot as effective as others – co-uterotonic\nCauses fever (can be difficult to discern if infection)\nSafe in all patients\nVasopressin also a uterotonic.", "citations": [{"type": "pdf_page", "page": 123, "label": "p123"}]}
{"chunk_id": "SSUs_v1_p124_txt_00_957f95", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 124, "page_end": 124, "section_path": ["VBAC", "Aortocaval Compression", "Management of Obstetric Trauma Patient"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Management of Obstetric Trauma Patient", "keywords": [], "text": "Management of Obstetric Trauma Patient\nMust consider:\nAltered maternal physiology\nMaternal resus is always first priority\nEarly PC to obs + neonatology (+ clarify gestation)\nRh therapy to Rh negative mothers\nAssign roles:\nLeft uterine displacement\nFHR assessment\nResuscitative hysterotomy team\nNeonatal resus team\nPrimary survey:\nC-spine immobilisation / MILS\nA:\nHigh risk of aspiration\ndifficult airway\n30 degrees head up (lower FRC, higher VO2) – use apnoeic oxygenation (must use <15L/min if possible BOS #)\nAvoid nasal / blind intubation (friable, oedematous tissue)\nFONA → longitudinal incision\nB:\nTarget SpO2 >94%, PaCO2 30-35\nPlace chest tubes 1-2 spaces higher due to cephalad displacement of diaphragm\nC:\nLeft uterine displacement >20/40\nSecure IV access above diaphragm (caval compression may reduce circulation)\nBloods (check for foetal maternal haemorrhage)\nKleihauer-Betke test to calculate anti-D dose\nResuscitative hysterotomy started at 4 mins of arrest, completed by 5 minutes\nD: damage control surgery → indications to empty the uterus:\nPenetrating uterine injury\nPlacental abruption\nUterine rupture\nSurgical access to pelvis for haemorrhage control\nMaternal cardiac arrest\nFDIU\nE:\nEverything else including massive haemorrhage management\nRatio 1:1:1: request CMV -ve RBCs and platelets irrespective of patient’s CMV status\nEarly cryo/fibrinogen\nPV examination for blood loss\nTrauma CT series is not contraindicated in pregnancy – risk to foetus from single CT scan is low\neFAST increasingly limited with increasing gestation\nF: foetal monitoring (CTG) for 4 hours, longer if:\nContractions >1 in 10\nUterine tenderness\nAbdominal pain\nRuptured membranes\nPV bleeding\nPositive KB test\nNon-reassuring FHR", "citations": [{"type": "pdf_page", "page": 124, "label": "p124"}]}
{"chunk_id": "SSUs_v1_p124_txt_01_557107", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 124, "page_end": 124, "section_path": ["VBAC", "Aortocaval Compression", "Aortocaval Compression"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Aortocaval Compression", "keywords": [], "text": "Aortocaval Compression\nOccurs in nearly all term parturients. Only 10% of women suffer supine hypotension syndrome: MAP by 15mmHg + HR by\n20bpm (+/- diaphoresis, nausea, changes in mentation). Return of blood from lower extremities via epidural veins, azygos, and\nvertebral veins. Left uterine displacement recently challenged – MRI shown no change in IVC volume with 15 L tilt (however\nthere is an increase with 30).", "citations": [{"type": "pdf_page", "page": 124, "label": "p124"}]}
{"chunk_id": "SSUs_v1_p125_txt_00_277641", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 125, "page_end": 125, "section_path": ["VBAC", "Perimortem Caesarean", "Placental Abruption"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Placental Abruption", "keywords": [], "text": "Placental Abruption\nPlacental abruption: partial or complete separation of the placenta from the uterine wall after 20/40.\n~1% all pregnancies. Accounts for 25% of APH.\nRisk factors: advanced maternal age, chorioamnionitis, cocaine use, excessive alcohol, hypertension, premature rupture of\nmembranes, history of abruption, smoking and trauma.\nSSx: vaginal bleeding + uterine tenderness on examination.\nRemember bleeding can be concealed. Foetal distress if >30%. Beware coagulopathy.\nUterine monitoring.", "citations": [{"type": "pdf_page", "page": 125, "label": "p125"}]}
{"chunk_id": "SSUs_v1_p125_txt_01_184908", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 125, "page_end": 125, "section_path": ["VBAC", "Perimortem Caesarean", "Perimortem Caesarean"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Perimortem Caesarean", "keywords": [], "text": "Perimortem Caesarean\nchance of maternal ROSC as it CO via two mechanisms:\nuterine blood flow\nRelieves diaphragmatic pressure + aortocaval compression\nAlso may save a viable foetus\nIndication: maternal arrest within 4 minutes (do not wait for seniors or US or sterile prep AND >24/40 gestation\nNo CI – heroic attempt in an arrested patient\nProcedure:\nMost experienced person\nVertical incision from pubic symphysis to umbilicus or higher along linea nigra into peritoneal cavity\nRetract abdominal wall laterally\nReflect bladder and empty (by aspiration)\n5cm incision verticaly into the inferior presenting part of the uterus until amniotic fluid comes through\nInsert 2 fingers and lift up uterus from foetus\nExtend uterine incision up to fundus with safety scissors curved away from foetus\nDeliver foetus – may need to disengage presenting part\nClamp cord twice and cut between → neonatology\nDeliver placenta + swab cavity\nPack uterus and abdomen +/- clamp bleeding vessels and suture uterine incision\nOxytocin bolus + infusion\nContinue maternal resuscitation", "citations": [{"type": "pdf_page", "page": 125, "label": "p125"}]}
{"chunk_id": "SSUs_v1_p126_txt_00_ed4fb0", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 126, "page_end": 126, "section_path": ["VBAC", "Anaesthesia for Obstetric Patient for Non-Obstetric Surgery", "Anaesthesia for Obstetric Patient for Non-Obstetric Surgery"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Anaesthesia for Obstetric Patient for Non-Obstetric Surgery", "keywords": [], "text": "Anaesthesia for Obstetric Patient for Non-Obstetric Surgery\n~1% require during pregnancy. Most commonly acute appendicitis, cholecystitis, maternal trauma, and cancer.\nIn standard dosing, no current anaesthetic drugs have been shown to be teratogenic in humans (nitrous oxide may not be okay -\nlittle evidence in humans, but better to avoid). Greatest risk to foetus is hypoxia / hypotension.\nFoetal Considerations\nMaternal Considerations\nFirst\ntrimester\nTeratogenesis: occurs during organogenesis (days\n15 – 56) - major organogenesis complete by\nweek 8\nMiscarriage rate: 10%\nAvoid: hypo/hyperthermia, hypoxia, hypercarbia,\nhypotension, N2O, atropine (use glyco), sugammadex\nAvoid NSAIDS: risk of miscarriage and foetal\nmalformation in early pregnancy\nSecond\ntrimester\nLowest risk trimester\nConsider steroids for foetal lung maturation 24-\n34 weeks\nRoutine tocolysis not indicated\nMiscarriage rate: 1%\nAvoid: NSAIDs\nLeft tilt after 20/40\nThird\ntrimester\nPreterm labour risk: 10%\nAvoid NSAIDs: after 32/40 can cause premature closure of\nPDA (esp if >48 hours use) + oligohydramnios\nAt any\nstage\n•\nPostpone elective surgery until 6 weeks post-partum if possible (emergent surgery should not be\ndelayed)\n•\nOverall miscarriage rate 6% (3x risk with abdominal surgery)\n•\nFHR before and after surgery at any gestation (intra-op after 24/40) – note that variability and\nbaseline is normal – but not bradycardia\n•\nAirway considerations, L tilt if able, PaCO2 30-35, ETO2 >80%, DVT prophylaxis + aspiration prophylaxis\n(note: multiple studies have failed to show aspiration risk with pregnancy)\n•\nMAC + sedation doses (however always use BIS)\n•\nRegional always better than GA if possible (must LA requirements - a1 acid glycoprotein, drug\nuptake due to venous engorgement + cardiac irritability from altered oestrogen and progesterone)\n•\nVolatile > TIVA due to tocolysis\n•\nShould always be done in hospital with obstetric / C-section services\n•\nAvoid: beta blockers (slow foetal HR), ketamine (uterine contraction +++, 2mg/kg uterine contraction\nas much as ergot)\n•\nNon-fatal bradycardia reported with neostigmine – atropine > glycol – crosses placenta quicker\n•\nAnalgesia: important, may risk of preterm labour - multimodal analgesia recommended\nSpecific surgeries:\nLaparoscopy: smallest intraabdominal pressure should be used, no definitive evidence for open versus laparoscopic on\nfoetal outcomes\nPneumoperitoneum: pressure <15mmHg, tight PaCO2 target, avoid hypotension\nRisk of pre-term labour after abdominal surgery ~5% (increased if uterus manipulated or infection present)\nTrauma: 1st trimester foetus is protected by bony pelvis, later gestations risk of exposure + aortocaval compression\nNeurosurgery: MAP <70mmHg may significantly reduce foetal blood flow – use foetal monitoring. Extreme hyperventilation\ncan cause constriction to blood flow + shifts oxyHb curve to left (less offloading to foetus). Osmotic diuresis can reduce\namniotic fluid.\nNo sufficient evidence to suggest any long term effects on foetal neurodevelopment from GA in utero.", "citations": [{"type": "pdf_page", "page": 126, "label": "p126"}]}
{"chunk_id": "SSUs_v1_p127_txt_00_077cfe", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 127, "page_end": 127, "section_path": ["VBAC", "TGA Medication Classification in Pregnancy", "TGA Medication Classification in Pregnancy"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "TGA Medication Classification in Pregnancy", "keywords": [], "text": "TGA Medication Classification in Pregnancy\nCategory\nDefinition\nExamples\nA\nMedications which have been taken by a large number of\npregnant women and women of childbearing age without any\nproven increase in the frequency of malformations or other\ndirect harmful effects on the foetus\nParacetamol, codeine, LA (bup +\nlignocaine), metocloperamide,\nthiopentone, suxamethonium, terbutaline,\nmethyldopa, halothane, N2O, clindamycin\nB1\nLimited # of pregnant women\nNo increase observed\nAnimal studies show no increase in foetal damage\nLA (prilocaine), gabapentin, ondansetron,\ngranisetron, cephazolin\nB2\nAnimal studies are inadequate or lacking\nAvailable data shows no increased risk\nLA (ropivacaine), duloxetine, venlafaxine,\ndesvenlafaxine, hyoscine, domperidone,\nsugammadex / rocuronium, sevoflurane\nB3\nAnimal studies have shown foetal damage – significance of\nwhich is uncertain in humans\nCelecoxib, LA (procaine, levobupivacaine),\nmirtazapine, moclobemide, pregabalin,\nKeppra, desflurane, ketamine\nC\nOwing to pharmacological effect can be suspected of causing\nharm, which may be reversible\nOpioids, aspirin, NSAIDs, parecoxib, SSRI,\nTCAs, clonazepam, prochlorperazine,\ndroperidol, hydralazine, methoxyflurane\nD\nWhich have, or are expected to cause, damage that may be\nirreversible\nAdverse pharmacological effects\nParoxetine, carbamazepine, phenytoin,\nsodium valproate, lamotrigine\nX\nHigh risk of permanent foetal damage\nShould not be used if pregnant or possibly pregnant", "citations": [{"type": "pdf_page", "page": 127, "label": "p127"}]}
{"chunk_id": "SSUs_v1_p128_txt_00_6173ff", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 128, "page_end": 128, "section_path": ["VBAC", "Maternal Mortality in Australia", "Maternal Mortality in Australia"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Maternal Mortality in Australia", "keywords": [], "text": "Maternal Mortality in Australia\nDefinition: death whilst pregnant or within 6 weeks of delivery\nIncidence: 5/100,000 (global 211/100,000)\nTiming:\nDuring pregnancy 30% (43% in first trimester)\nDuring or within 24 hours of birth 20%\nAfter birth within 6 weeks 50% (60% of those within 2 weeks)\nCauses:\nDirect: obstetric complication or related to management e.g. VTE, AFE, sepsis, HDP, ectopic, anaesthesia-related\nIndirect: 2’ aggravated by physiology of pregnancy e.g. CVD, non-obstetric haemorrhage (ICH, splenic aneurysm), suicide,\nsubstance abuse\nCoincidental: entirely unrelated to pregnancy e.g. trauma, cancer\nCardiovascular causes are single, highest cause\nAnaesthesia causes: airway-related, aspiration, neuraxial (subdural haematoma, cerebral vein thrombosis, total/high spinal),\nanaphylaxis\nRFs: age <20yo or >40yo, indigenous, higher parity, smoker, remote location", "citations": [{"type": "pdf_page", "page": 128, "label": "p128"}]}
{"chunk_id": "SSUs_v1_p129_txt_00_226ed1", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 129, "page_end": 129, "section_path": ["VBAC", "Lactation and Anaesthesia", "Lactation and Anaesthesia"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Lactation and Anaesthesia", "keywords": [], "text": "Lactation and Anaesthesia\nWHO suggests:\nExclusive breastfeeding for 6mo\nBreastfeeding + supplemental solids until 2yo (and ongoing)\nIn Australia:\n96% initiate breastfeeding\n69% at 3mo (39% exclusively)\n60% at 6mo (15% exclusively)\n28% at 12mo\n9% at 18mo\n5% at 24mo\nNo longer advised to “pump & dump” – only applies to a select list of medications (amiodarone, iodides, lithium, oral retinoids,\ngold salts and chemo)\nRisk of being given this incorrect advice:\nPremature weaning\nFeeding issues\nMastitis in mother\nPumping is difficult\nNote: majority of breast milk is made at the time of the feed\nCharacteristics of drugs secreted in breast milk:\nMW <800\nLow maternal protein binding\nHighly lipid soluble\nImportant factors at time of feed: [plasma], active metabolites\nFeatures important to infant:\nPO bioavailability + first pass metabolism\nHalf life\nTherapeutic range in infants\nGenerally most drugs diffuse across lipid bilayer of the lactocyte\nHowever colostrum and transitional milk immediately post-partum allows passage of large Ig, lymphocytes and proteins due to\ngaps between alveolar cells → more maternal drugs pass than mature milk (however smaller volume i.e. 30-100mL/day = lower\ntotal dose)\nPharmacology:\nDrugs generally travel down [ ] gradient\nMilk is acidic ∴ weakly basic drugs are sequestered (e.g. oxycodone)\nActive transport systems for iodine/amiodarone (avoid iodine skin preps on broken/mucosal skin)\nAll anaesthetic drugs advice is “if mum is awake enough to hold baby it’s safe enough to breastfeed”\nSome NSAIDs more data than others, but probably all okay\nAspirin: <300mg for antiplt effect probably okay, but analgesic doses avoid – possible risk of Reye’s syndrome\nRisk of oxycodone trapping in breast milk – cyp2d6 metabolism → oxymorphone. Drug level in milk >3x maternal serum 2’\nion trapping. Advised to limit maternal dose to <30mg/day for 2-3 days and where possible choose another drug (i.e.\ntramadol) though advised safe to use if mum is awake enough to breastfeed, monitor baby for sedation\nRemi/fentanyl/alfentanil – limited t/f to breastmilk\nTramadol excretion to breastmilk is low, and even lower for M1 (O-desmethyltramadol) – cyp2D6 ∴ some population\nvariability → in poor metaboliser 1.5% usual dose, in extensive metaboliser 3% usual dose. Considered safe in UK/AUS.\nIf awake enough considered safe to breastfeed\nWarnings related to codeine should not apply to tramadol\nNo data on tapentadol, probably safe but probably choose something else\nCodeine CYP2D6, highly lipophilic, weakly protein bound → rapid metabolisers having high [ ] in breast milk → exposure\n>10% recommended infant dose can occur\nPregabalin – caution advised\nClonidine can reduce breast milk\nLocal anaesthetics:", "citations": [{"type": "pdf_page", "page": 129, "label": "p129"}]}
{"chunk_id": "SSUs_v1_p130_txt_00_0f53ae", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 130, "page_end": 130, "section_path": ["VBAC", "Lactation and Anaesthesia"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Lactation and Anaesthesia", "keywords": [], "text": "Amino amides: poor PO bioavailability, great option for parturients\nCocaine: limited data for non-medicinal uses, infants unable to metabolise, probably avoid feeding for 24 hours\nReversal:\nNeo: limited data, short half life, unlikely to be harmful\nSugammadex: large and polar unlikely to enter breastmilk\nAntimuscarinics: glyco better than atropine - large Vd, low oral BA, both can reduce prolactin\nAnti-emetics:\nLimited probably all safe inc ondans, cyclizine\nMetoclopramide + domperidone milk production (D2 antagonist, check QTc)\nDexamethasone prolactin\nProchlorperazine – caution use with very young infants\nAntibiotics:\nprobably all safe though risk of GI upset\ntetracyclines can stain infants developing teeth\nMedical imaging:\nIV contrast – safe, consider if high dose / preterm infant\nPET scan: limit contact for 12 hours due to radiation\nIodine skin prep:\nMuscosa/broken skin → breast milk [ ] up to 20x plasma levels due to active transport\nTransient neonatal hypothyroidism\nRe: EtOH – greatest risk to infant is carer drunkiness, not EtOH via breastmilk. Some foods have surprisingly high EtOH %\nincluding ripe fruits. Death BAC ~0.45% which is less than the EtOH in orange juice ~0.5%.\nFenugreek can cause serotonin syndrome\nPeri-op care:\nAlways ask if breastfeeding, educate on safety of anaesthesia, address anxiety about separation, refer to lactation service\nMinimise separation with child, consider first on list, provide space for breastfeeding, if significant delays consider IV fluids\nor allow ongoing oral fluids\nFacilitate expressing + storing milk if child is unable to stay with mother or in the event of prolonged surgery\nIntra-op:\nUndrained breasts are at risk of blocked ducts and mastitis – Rx frequent emptying +/- abx (fluclox)\nConsider straps, arm position, prone/lateral positioning, using pt as table\nMultimodal analgesia, regional where able, PONV prevention, neutral/positive fluid balance\nPost-op:\nEarly reunion +/- discharge DOS if appropriate\nDischarge advice for anyone with babies:\nShouldn’t co-sleep for 24 hours – longer if taking ongoing opiates, sleep related infant death 10x higher if bed sharing with\ndrug affected parent\nAlternative adult for primary baby care/supervision during breast feeds (risk to baby is mum falling asleep, not drugs in\nbreast milk), sleep related infant death 67% higher if falling asleep on couch/chair\nProvide analgesia weaning plan", "citations": [{"type": "pdf_page", "page": 130, "label": "p130"}]}
{"chunk_id": "SSUs_v1_p131_txt_00_700b2f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 131, "page_end": 131, "section_path": ["VBAC", "Physiological Changes in Pregnancy (Primary Notes)", "Physiological Changes in Pregnancy (Primary Notes)"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Physiological Changes in Pregnancy (Primary Notes)", "keywords": [], "text": "Physiological Changes in Pregnancy (Primary Notes)\nSystem\nΔ\nCVS\n↑CO 40% (attained by 24/40) (both ↑HR 15 bts/min and ↑SV)\nFirst stage labour: CO ↑25% (from prelabour values)\nSecond stage labour: CO ↑40% (from prelabour values)\nImmediately after delivery up to 100% ↑CO from prelabour values 2’ autotransfusion, ↓LL venous pressure due to\naortocaval pressure release\n↑femoral + IVC venous pressures → collateral maintenance of atrial filling however this leads to engorgement of epidural\n(Baston’s) venous plexus (↑risk of venous epidural placement)\nFilling pressures (CVP, cap wedge pressure, LV EDP) do not change due to cardiac remodelling\n↓SVR 20%, ↓BP (↓sBP 8%, ↓dBP 20%)\nECG: possible benign dysrhythmias/tachy, ST dep or flattened T waves, R dev (1st TM) → L dev (3rd TM)\nTTE: RH chambers ↑20%, LH chambers ↑10%, LV eccentric hypertrophy, every valve except aortic annuli increase, MR 25%,\nsmall insignificant pericardial effusions\nAuscultation: systolic murmur, MR/TR, 3rd or 4th heart sound\nResp\n↑MV 50% (mainly 2’ ↑TV by 40%, lesser extent ↑RR 15% due to progesterone)\n↑Alveolar ventilation due to ↑MV without ↑in dead space\n↓pCO2 32-35mmHg (pH normal due to renal excretion of bicarb)\n↑O2 consumption 35% at term; 1st stage labour O2 consumption ↑40% (prelabour), 2nd stage ↑75% (prelabour)\nProduction of CO2 can ↑by 60%, labour pain can cause hyperventilation of paCO2 down to 20mmHg\n↓FRC, ERV, RV 2’ cephalad displacement of diaphragm\n↓IC due to ↑baseline TV\n↓TLC only slightly as ↑chest circumference / diaphragm excursion\nCC (RV + CV) unchanged but ↓FRC → tendency for earlier desats\nMucous membranes become oedematous + friable 2’ RASS → ↑Mallampati w/ gestation (use smaller ETT)\n→ ↑O2 consumption + ↓FRC → rapid desats\nAlso ↓FRC → ↓time for de-nitrogenation → ↑speed of uptake of volatiles i.e. ↑rate of rise FA/FI of inhalational agent\nMetabolic alkalosis → foetal acidosis due to 1) ↓uteroplacental perfusion 2’ vasoconstriction and 2) L shift of maternal ODC\nUpper airway oedema + vocal chord swelling\nCNS\nMAC ↓by 20-40% 2’ progesterone\n↑sensitivity to general and Las (mechanism unknown) - ↓neuraxial anaesthetic req by 40% at term\nRenal\n↑GFR 2’ ↑renal flow → ↓urea and Cr 50%\nGlucose + AAs not reabsorbed as efficiently → glycosuria and aminoaciduria\nGIT\nUterus displaces lower oesophageal sphincter + progesterone relaxes → heartburn incidence 80% at term\nGastric emptying normal, but ↑intestinal transit time → constipation\nNil ↑risk of aspiration based on pH and volume of gastric contents prior to labour however during labour ↑risk aspiration\ndue to pain, augmented by opiates – should always assume full stomach – give non-particulate antacid\n↑transaminases, bili, LDH, ↑↑ALP due to placental production\nSerum cholinesterase production ↓by 25% (recommended to still use normal dose of sux)\nHaem\n↑Blood volume (plasma + red cells)\n↑Plasma vol 50% (2’ RAAS)\n↑Red cells 20%\n→ physiological haemodilutional anaemia of pregnancy (w/ associated ↓blood viscosity by 30%)\nMech unknown – presumed 2’ initial ‘underfill’ state from vasodilation → RAAS stimulation\n↑further during labour as blood squeezed from intervillious space, delivery → autotransfusion of 500mL\nClotting factors:\n↑factors I, VII, VIII, IX, X, XII and fibrinogen → hypercoagulable state pre- & post-partum (↓factors 11 & 13)\nFactors II and V unchanged\n↓Antithrombin III and protein S (protein C unchanged)\n↑TPO and platelets however platelet destruction also increased → fall in platelet count as pregnancy progresses\n→ ↓PT and aPTT by 20%\nEndocrine\n↑TBG but free T3 and T4 normal\nAdrenal cortical hyperplasia → ↑free and total cortisol\n↓Fasting BSL but tolerance to glucose may be impaired due to placental lactogen → transient mild diabetic state\nHPL → “insulin resistance”, mobilises FFAs for use\nMSK\nHormone relaxin responsible for ligamentous relaxation + softening of collagenous tissues\nExaggerated lumbar lordosis (implications for regional anaesthesia)\nStretching of lateral cutaneous nerve of thigh → meralgia paresthetica\nDerm\nMelanocyte-stimulating hormone → hyperpigmentation\nMammary\nEnlargement of breast tissue may complicate intubation – use short handled laryngoscope\nOcular\n↓intraocular pressure 2’ 1) ↑progesterone 2) ↑relaxin 3) ↓production of aqueous humour due to ↑production of human\nchorionic gonadotropin", "citations": [{"type": "pdf_page", "page": 131, "label": "p131"}]}
{"chunk_id": "SSUs_v1_p132_txt_00_b73089", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 132, "page_end": 132, "section_path": ["VBAC", "Pregnancy Effects on Respiratory System", "Maternal Cardiovascular Changes in Pregnancy"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Maternal Cardiovascular Changes in Pregnancy", "keywords": [], "text": "Maternal Cardiovascular Changes in Pregnancy\nCVS\n↑CO 40% (attained by 24/40) (both ↑HR 15 bts/min and ↑SV)\nFirst stage labour: CO ↑25% (from prelabour values)\nSecond stage labour: CO ↑40% (from prelabour values)\nImmediately after delivery up to 100% ↑CO from prelabour values 2’ autotransfusion, ↓LL venous\npressure due to aortocaval pressure release\n↑femoral + IVC venous pressures → collateral maintenance of atrial filling however this leads to engorgement\nof epidural (Baston’s) venous plexus\nFilling pressures (CVP, cap wedge pressure, LV EDP) do not change due to cardiac remodelling\n↓SVR 20%, ↓BP (↓sBP 8%, ↓dBP 20%)\nECG: possible benign dysrhythmias/tachy, ST dep or flattened T waves, R dev (1st TM) → L dev (3rd TM)\nTTE: RH chambers ↑20%, LH chambers ↑10%, LV eccentric hypertrophy, every valve except aortic annuli\nincrease, MR 25%, small insignificant pericardial effusions\nAuscultation: systolic murmur, MR/TR, 3rd or 4th heart sound\nHaem\n↑Blood volume (plasma + red cells)\n↑Plasma vol 50%\n↑Red cells 20%\n→ physiological haemodilutional anaemia of pregnancy (w/ associated ↓blood viscosity by 30%)\nMech unknown – presumed 2’ initial ‘underfill’ state from vasodilation → RAAS stimulation\n↑further during labour as blood squeezed from intervillious space, delivery → autotransfusion of 500mL", "citations": [{"type": "pdf_page", "page": 132, "label": "p132"}]}
{"chunk_id": "SSUs_v1_p132_txt_01_247b9e", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 132, "page_end": 132, "section_path": ["VBAC", "Pregnancy Effects on Respiratory System", "Pregnancy Effects on Respiratory System"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pregnancy Effects on Respiratory System", "keywords": [], "text": "Pregnancy Effects on Respiratory System\nResp\n↑MV 50% (mainly 2’ ↑TV by 40%, lesser extent ↑RR 15% due to progesterone)\n↑Alveolar ventilation due to ↑MV without ↑in dead space\n↓pCO2 32-35mmHg (pH normal due to renal excretion of bicarb)\n↑O2 consumption 35% at term; 1st stage labour O2 consumption ↑40% (prelabour), 2nd stage ↑75%\n(prelabour)\nProduction of CO2 can ↑by 60%, labour pain can cause hyperventilation of paCO2 down to 20mmHg\n↓FRC, ERV, RV 2’ cephalad displacement of diaphragm (FRC ↓20% erect, 30% supine, further w/ anaes)\n↓IC due to ↑baseline TV\n↓TLC only slightly as ↑chest circumference / diaphragm excursion\nCC (RV + CV) unchanged but ↓FRC → tendency for earlier desats\nMucous membranes become oedematous + friable 2’ RASS → ↑Mallampati w/ gestation (use smaller ETT)\n→ ↑O2 consumption + ↓FRC → rapid desats\nAlso ↓FRC → ↓time for de-nitrogenation → ↑speed of uptake of volatiles i.e. ↑rate of rise FA/FI of\ninhalational agent\nMetabolic alkalosis → foetal acidosis due to 1) ↓uteroplacental perfusion 2’ vasoconstriction and 2) L shift of\nmaternal ODC", "citations": [{"type": "pdf_page", "page": 132, "label": "p132"}]}
{"chunk_id": "SSUs_v1_p133_txt_00_d2ce66", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 133, "page_end": 133, "section_path": ["VBAC", "Reference Ranges for Physiological and Biochemical Changes in Pregnancy", "Pregnancy Effects of Wash-In of Volatiles"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pregnancy Effects of Wash-In of Volatiles", "keywords": [], "text": "Pregnancy Effects of Wash-In of Volatiles\nRate of volatile wash-in governed by balance of\nuptake by alveolus from breathing system - governed by minute ventilation and FRC\nuptake by blood from alveolus - governed by cardiac output and V/Q matching\nAlveolar wash-in may be approximated by first order kinetics with time constant given by\n = FRC/MV (if blood uptake is disregarded)\n∴ ↓FRC and ↑MV → smaller time constant () → faster alveolar uptake\nΔ at\nTerm\nMechanism\nVolatile Uptake\nOverall Wash\nIn Effect\nResp\n↑MV 50%\n↑TV by 40%\n↑RR 15%\nProgesterone stimulates resp\ncentre\n↑MV → ↑alveolar uptake of volatile from\nbreathing system → faster rise in FA/FI\n↑wash-in\n↓FRC\n↓20% erect\n↓30% supine\nCephalad displacement of\ndiaphragm (counteracted by\nrib flaring)\n↓FRC → ↓wash-in time constant → faster\nrise in FA/FI\n↑wash-in\nCVS\n↑CO 40%\n↑SV\n↑HR 15 bts/min\nUpregulation of RAAS, low\nresistance of placental bed,\n↑SNS\n↑CO → ↑uptake of volatile by pulm\ncirculation from alveolus → slows rise in FA/FI\n↓wash-in\nHaematocrit\n↑Plasma vol 50%\n↑Red cells 20%\nMechanism unknown but →\nhaemodilutional anaemia\nVolatiles dissolve in RBC membrane\n∴↓haematocrit → ↓blood:gas partion\ncoefficient of most volatiles → ↓blood uptake\n↑wash-in\nOther\n2nd gas effect\nVolatiles ↓uterine tone\n∴N2O used to ↓volatile use\nN2O ↑volatile uptake via 2nd gas effect\n↑wash-in\nOVERALL → volatile wash in is increased at term", "citations": [{"type": "pdf_page", "page": 133, "label": "p133"}]}
{"chunk_id": "SSUs_v1_p133_txt_01_c2979d", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 133, "page_end": 133, "section_path": ["VBAC", "Reference Ranges for Physiological and Biochemical Changes in Pregnancy", "Reference Ranges for Physiological and Biochemical Changes in Pregnancy"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Reference Ranges for Physiological and Biochemical Changes in Pregnancy", "keywords": [], "text": "Reference Ranges for Physiological and Biochemical Changes in Pregnancy\nBiochemical changes:\nFBC:\n↑Plasma vol 50% but ↑red cells only 20% → dilutional anaemia\n↑TPO and platelets production however ↑platelet destruction → ↓platelet count as pregnancy progresses\nRenal:\n↑GFR 2’ ↑renal flow → ↓urea and Cr 50%\n↓Na 3-5 mmol/L 2’ ↑plasma vol\n↓Ca2+, PO4, Mg2+ 2’ ↑plasma vol\nLiver:\n↑transaminases, bili, LDH\n↑↑ALP due to placental production\nSerum cholinesterase production ↓by 25% (recommended to still use normal dose of sux)\nEndo:\n↑TBG but free T3 and T4 normal\nAdrenal cortical hyperplasia → ↑free and total cortisol\n↓Fasting BSL but tolerance to glucose may be impaired due to placental lactogen → transient diabetic state\nClotting factors:\n↑factors I, VII, VIII, IX, X, XII and fibrinogen → hypercoagulable state", "citations": [{"type": "pdf_page", "page": 133, "label": "p133"}]}
{"chunk_id": "SSUs_v1_p134_txt_00_10140a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 134, "page_end": 134, "section_path": ["VBAC", "Anatomy and Physiology of Pain in Labour + Childbirth", "Pregnancy Effects on Neuraxial Anaesthesia"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pregnancy Effects on Neuraxial Anaesthesia", "keywords": [], "text": "Pregnancy Effects on Neuraxial Anaesthesia\nAnatomical changes:\nUterine enlargement → ↑femoral + IVC venous pressures → collateral maintenance of atrial\nfilling however this leads to engorgement of epidural (Baston’s) venous plexus (↑risk of\nvenous epidural placement)\n↑Epidural veins + ↑intraabdominal pressure → displacement of CSF from thoracolumbar\nregion of subarach space → ↓dose requirement for spinal anaesthesia\nCSF has lower specific gravity in pregnancy → ↓dose requirement for spinal anaesthesia\nPregnancy ↑lumbar lordosis →\nSmaller spaces for epidural / spinal insertion (i.e. “narrow interspace”\nCephalad movement of Tuffier’s line to ~L3/L4 cf L4/L5\nApex of lumbar lordosis is shifted caudad + thoracic kyphosis shifts cephalad → change in\nsubarach spread of spinal anaesthesia\nHormonal changes:\nHormones soften ligaments including ligamentum flavum\nPregnancy ↓amount of LA needed for both spinal and epidural anaesthesia (cf age-matched\nnon-pregnant women) likely 2’ to progesterone ↑sensitivity of nerve fibres", "citations": [{"type": "pdf_page", "page": 134, "label": "p134"}]}
{"chunk_id": "SSUs_v1_p134_txt_01_b1840e", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 134, "page_end": 134, "section_path": ["VBAC", "Anatomy and Physiology of Pain in Labour + Childbirth", "Anatomy and Physiology of Pain in Labour + Childbirth"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Anatomy and Physiology of Pain in Labour + Childbirth", "keywords": [], "text": "Anatomy and Physiology of Pain in Labour + Childbirth\nTypes of pain:\nSomatic: Aδ fibres, fast / sharp / well-localised, trigger withdrawal\nVisceral: C fibres, slow / dull / poorly-localised, elicits guarding\nReferred: perceived at location distal to insult due to convergence of somatic and visceral\n1° afferents on same WDR projection neurons\nStage of Labour\nMechanism\nPain Pathway\nFirst\nOnset of uterine\ncontraction → full\ncervical dilatation\nSomatic – minimal\nVisceral - pain caused by visceral\nstretch (uterus and cervix)\nNociceptors in LUS and cervix → visceral afferent (A and C fibres) travels\nvia sympathetic efferent fibres → uterine plexus → inferior\nhypogastric plexus → sympathetic chain → T10 – L1 dorsal horn\nEarly moderate labour pain = T11 and T12\nLate intense labour pain = T10 to L1\nSecond\n→ delivery of foetus\nSomatic – foetal descent →\nstretching and tearing of perineum\n(skin, subcutaneous tissue\nand fascia)\nVisceral – foetal descent → pressure\non other pelvic structures (bladder,\nurethra, rectum,\nlumbosacral plexus, etc)\nSomatic: nociceptors in cervix and perineum → somatic afferent (A) via\npudendal nerve → S2, S3, S4 dorsal horn, also via ilioinguinal and\ngenitofemoral nerves → L1, L2\nVisceral as above\nThird\n→ delivery of placenta\nSomatic – passage of placenta\nVisceral – contraction of uterus to\npost-partum size (cramps can persist\nfor days)\nSame as second stage but less intense\nFinal common pathway after synapsing in dorsal horn, pain signals ascend via:\nAnterior spinothalamic tract → thalamus (esp. ventral posterolateral nucleus) → sensory cortex → mediates discriminative aspect of pain\n(i.e. location, intensity, duration)\nLateral spinothalamic tract → thalamus (esp. posterior part of ventral medial nucleus Vmpo) → insular cortex → mediates autonomic and\nemotional aspects of pain\nSpinoparabrachial tract → parabrachial nucleus → emotional aspects of pain\n*Both spinothalamic and spinoparabrachial tracts also have projections to periaqueductal gray matter → links to descending modulatory\npathway and mediates arousal", "citations": [{"type": "pdf_page", "page": 134, "label": "p134"}]}
{"chunk_id": "SSUs_v1_p135_txt_00_3a6449", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 135, "page_end": 135, "section_path": ["VBAC", "Effect of Pregnancy on Pharmacokinetics and Pharmacodynamics of Anaesthesia / Analgesia Rx", "Analgesia Rx"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Analgesia Rx", "keywords": [], "text": "Analgesia Rx\nPharmacokinetic Δ:\nAbsorption and uptake:\nOral absorption and bioavailablity not effected, though may be affected by N+V\n↓intestinal motility but gastric emptying only delayed during labour or after opioids\n↑CO by 50% → ↑blood flow to skin and mucous membranes → enhanced absorption\n↓FRC → ↑wash in of volatile anaesthetics\nDistribution:\n↑CO by 50% → ↑distribution to all tissues\n↑TBW 8L, plasma vol ↑50% → ↑vol of distribution of hydrophilic drugs (eg neuromuscular Rx)\nBody fat ↑~4kg but unimportant given large VOD of lipophilic drugs\n↓plasma albumin by 70% which affects protein binding → ↑free drug\nMetabolism:\n↑CO ≠ ↑liver flow during pregnancy\n↑activity of p450 + UGT enzymes → ↑metabolism of phenytoin, midazolam, morphine\nElimination:\n↑GFR 2’ ↑renal flow → ↑renal excretion\n↑MV → ↑elimination of volatiles\nPlacental transfer and metabolism:\nPreviously thought that transport across placenta was mainly via diffusion however placenta contains many\ntransporters\nFoetal pH is lower than maternal pH – weak bases become ionised and prevents transfer back\nE.g. opioids and LAs\nPlacenta contains many enzymes responsible for phase I and II biotransformation\nFoetal and neonatal elimination:\nFoetal elimination is mainly dependent on placental transfer\n↓metabolism cf adults\nFoetal drugs → first pass hepatic metabolism (but some drug will bypass liver)\nRenal blood flow is minimal until term\nExcreted products pass into amniotic fluid → swallowed\nHigh MV promotes rapid neonatal elimination of volatiles\nPhamacodynamic Δ:\nGA:\nMAC ↓by 20-40% 2’ progesterone\nRegional anaesthesia:\n↑spread of neuraxial block\n↑sensitivity to general and local anaesthetics ?progesterone on nerves\nAnalgesia:\n↑endorphins proposed to ↑nociceptive threshold\n↑heat/pain threshold persists until 48hr post-delivery\nPsychosomatic component can produce widespread variability", "citations": [{"type": "pdf_page", "page": 135, "label": "p135"}]}
{"chunk_id": "SSUs_v1_p136_txt_00_fb4bf8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 136, "page_end": 136, "section_path": ["VBAC", "Utero-Placental Circulation", "Utero-Placental Circulation"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Utero-Placental Circulation", "keywords": [], "text": "Utero-Placental Circulation\n700-900mL/min at term (i.e. 10-15% CO)\nBlood supply to uterus: uterine artery +/- small variable contribution from ovarian arteries\nUterine artery arises from internal iliacs\nVariability in origin of arterial vessels + presence of anastomoses can thwart attempts to cease haemorrhage.\nUterine artery → spiral arteries → intervillious space in fountain-like jets → chorionic plate\nMaternal blood then returns to basal plate → collecting veins → uterine veins → iliac veins +/- ovarian veins\n→ IVC on right and renal vein on the left\nUterine flow follows Ohm’s law: uterine artery pressure – uterine venous pressure / uterine vascular resistance\nUteroplacental circulation usually vasodilated, minimal autoregulation ∴:\nMost important determinant is maternal MAP\nNormal pregnancy entails ↓MAP ∴ also dependent on low uterine vascular resistance\nMechanisms of decreased uterine flow:\nAortocaval compression (main mechanism)\nSympathectomy from regional anaesthesia\nHypovolaemia from haemorrhage\nUterine contraction → ↓uterine diastolic flow\nLabour pain → ↑MV → ↑resp alkalosis → ↓uterine artery flow\nEndogenous vasoconstrictors: catecholamines, vasopressin (if hypovolaemic)\nExogenous vasoconstrictors: epinephrine, local anaesthetics (in high concentration) – relative refractoriness cf non-\npregnancy\nPlasma protein binding important – it’s free drug that is in equilibrium across placenta therefore highly protein bound drugs are\nin higher concentration in mother than the foetus. Drugs in non-ionised form cross placenta therefore pKa matters.", "citations": [{"type": "pdf_page", "page": 136, "label": "p136"}]}
{"chunk_id": "SSUs_v1_p137_txt_00_57ff40", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 137, "page_end": 137, "section_path": ["VBAC", "Bohr and Haldane Effects in Trans-Placental O2/CO2 Gas Exchange", "Bohr and Haldane Effects in Trans-Placental O2/CO2 Gas Exchange"], "specialty_tags": ["VBAC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Bohr and Haldane Effects in Trans-Placental O2/CO2 Gas Exchange", "keywords": [], "text": "Bohr and Haldane Effects in Trans-Placental O2/CO2 Gas Exchange\nPlacenta: connects uterine wall to foetus\nFunction - facilitates nutrient and waste exchange between mother and foetus\nAt placenta, O2 and CO2 passively diffuse down their respective concentration gradients:\nCO2 from foetus → mother\nO2 from mother → foetus\nRate of diffusion is governed by Fick’s law of diffusion, which states that\nWhere –\nD = rate of diffusion\nA = diffusional surface area\nt = membrane thickness\nsol = solubility of diffusate\nMW = molecular weight of diffusate\nΔconc = concentration gradient\nPlacenta is much less efficient than the lung in terms of gas exchange because:\nSmaller surface area for diffusion (15 m2 placenta vs 80 m2 lung)\nGreater diffusion distance (3.5μm placenta vs 0.5μm lung)\nUterine Artery\nUterine Vein\nUmbilical Artery\nUmbilical Vein\nFlow (mL/min)\npO2 (mmHg)\npCO2 (mmHg)\nPlacental O2 consumption = 6 mL/min\nFoetal O2 consumption ≈ 17 mL/min\n*Foetal O2 saturation does not exceed 60% even with maternal FiO2 100%\nFoetal adaptations:\nLeft shift OHDC (p50 at 19mmHg cf 26mmHg) 2’ serine substitution → ↓affinity for 2,3-DPG\nHb 180g/L (cf 140g/L) 2’ hypoxia → erythropoeisis\nDouble Bohr and Haldane Effects\nBohr Effect\nHaldane Effect\nPrinciple\nChanges to pCO2 or pH influences Hb affinity for O2\ni.e. ↑pCO2 or ↓pH → ↓Hb affinity for O2 (right shift)\nChanges to Hb-O2 binding influences Hb affinity for CO2\ni.e. oxyHb →↓Hb affinity for CO2\nMechanism\nO2 binding to Hb releases H+ (and vice versa) ∴ H+ binding\nto Hb promotes O2 release\nDeoxyHb is a better buffer for H+ than oxyHb ∴ deoxyHb\nshifts the CO2 dissociation equation to the right (CO2 + H2O\n→ HCO3– + H+) → carries more CO2\nPlacenta\nFoetus unloads CO2 in placenta → ↑placental CO2 → ↓Hb\naffinity for O2 → ↑O2 unloading →↑O2 available for\nfoetus\nPlacenta unloads O2 to fetus → ↓placental O2\n→ ↑Hb affinity for CO2 → ↑placental CO2 uptake from\nfoetus\nFoetus\nFoetus unloads CO2 → ↓foetal CO2 → ↑Hb affinity for O2\n→ ↑foetal O2 binding\nFoetus takes up O2 from placenta →↑foetal O2 →↓Hb\naffinity for CO2 → ↑foetal CO2 release to placenta\n*gradient increased by maternal hyperventilation / resp alk", "citations": [{"type": "pdf_page", "page": 137, "label": "p137"}]}
{"chunk_id": "SSUs_v1_p138_img_5b1cde9c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 138, "page_end": 138, "section_path": ["NEUROANAESTHESIA", "Neuroanaesthesia"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "algorithm_image", "modality": "image", "title": "Neuroanaesthesia", "keywords": [], "text": "Bones of the Skull Supraorbital Coronal suture Tora sete Cranial Bones Bony orbit Facial Bones Nasal Lacrimal Vomer Inferior nasal concha Maxilla Infraorbital Mandible Nasal foramen Mental foramen aperture Anterior (Frontal) View Lateral (Side) View TheSkeletalsyster", "image": {"paths": ["p138_img1121.png", "p138_img1122.png", "p138_img1123.png", "p138_img1124.png"], "ocr_text": "Bones of the Skull\n\nSupraorbital Coronal suture\nTora sete Cranial Bones\n\nBony\norbit\n\nFacial Bones\n\nNasal\n\nLacrimal\n\nVomer\n\nInferior\nnasal\nconcha\nMaxilla\nInfraorbital\nMandible Nasal foramen Mental foramen\naperture\nAnterior (Frontal) View Lateral (Side) View\n\nTheSkeletalsyster"}, "citations": [{"type": "pdf_page", "page": 138, "label": "p138"}]}
{"chunk_id": "SSUs_v1_p139_img_fa755791", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 139, "page_end": 139, "section_path": ["NEUROANAESTHESIA"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "algorithm_image", "modality": "image", "title": "NEUROANAESTHESIA", "keywords": [], "text": "Anterior cerebral artery Middle cerebral artery Posterior cerebral artery Superior cerebellar artery Anterior inferior cerebellar artery Posterior inferior cerebellar artery", "image": {"paths": ["p139_img1128.png"], "ocr_text": "Anterior\ncerebral\nartery\n\nMiddle\ncerebral\nartery\n\nPosterior\ncerebral\nartery\n\nSuperior\ncerebellar\nartery\n\nAnterior\ninferior\ncerebellar\nartery\n\nPosterior\ninferior\ncerebellar\nartery"}, "citations": [{"type": "pdf_page", "page": 139, "label": "p139"}]}
{"chunk_id": "SSUs_v1_p140_txt_00_558f6d", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 140, "page_end": 140, "section_path": ["NEUROANAESTHESIA", "Brain Imaging", "Brain Imaging"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Brain Imaging", "keywords": [], "text": "Brain Imaging\nAbnormalities:\nImportant to assess effects on surrounding structures:\nVolume loss: structures move towards\nMass effect: push structures away\nCommon abnormalities:\nSwelling/mass effect → loss of 3rd ventricle + sulci (note: raised ICP cannot be ruled out by imaging)\nScalp haematoma: alter contour of skin\nFractures: straight lucent lines through skull (cf sutures – wavy) +/- haemorrhage, fluid levels, pneumocephalus\nCoup: injuries at site of impact\nContrecoup: injuries at opposite site of impact\nInfarction: loss of grey/white differentiation + swelling\nMalignant infarction: large infarct w/ mass effect + herniation – young\npts/pts without atrophy at greatest risk\nAcute thrombosis: hyperdensity (white) on non-con, hypodense on contrast\nHydrocephalus: enlargement of ventricles\nTumours:\nPrimary: irregular mass with solid rim + low density centre\nMets: multiple, solid, cystic, less irregular\nRisks:\nCataracts\nRadiation", "citations": [{"type": "pdf_page", "page": 140, "label": "p140"}]}
{"chunk_id": "SSUs_v1_p141_txt_00_1f13bc", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 141, "page_end": 141, "section_path": ["NEUROANAESTHESIA", "Spinal Cord Syndromes", "Vertebral Column"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Vertebral Column", "keywords": [], "text": "Vertebral Column\n2 columns:\nAnterior:\nAnterior longitudinal ligament\nVertebral bodies to discs\nPosterior longitudinal ligament\nPosterior (most strength):\nLigamentum flavum\nInterspinous / supraspinous ligament\nSpinous and transverse process", "citations": [{"type": "pdf_page", "page": 141, "label": "p141"}]}
{"chunk_id": "SSUs_v1_p141_txt_01_417e86", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 141, "page_end": 141, "section_path": ["NEUROANAESTHESIA", "Spinal Cord Syndromes", "Spinal Cord"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Spinal Cord", "keywords": [], "text": "Spinal Cord\nTracts:\nSensory\nPosterior columns (ipsilateral – cross in medulla)\nIpsilateral vibration, light touch, proprioception\nSpinothalamic (contralateral 1-2 segments)\nPain, temperature, course touch\nMotor\nCorticospinal (contralateral)\nBlood supply:\nAnterior spinal artery (anterior 2/3rd)\n2x posterior spinal arteries (posterior 1/3rd)\nReinforced by: vertebral arteries, PICAs, radicular, artery of Adamkiewicz (T9-T12)\nSpinal Cord Syndromes\nSCI is the lowest level with normal sensory / motor function on both sides\nSyndromes:\nTetraplegia / Quadriplegia: cervical level → arms / torso / pelvis / legs\nParaplegia: thoracic, lumbar or sacral w/ preserved arm function\nAnterior Spinal Artery Syndrome:\nLoss of motor (corticospinal)\nLoss of pain, temp, course touch (spinothalamic)\nPreserved vibration, light touch, proprioception (dorsal column)\nBladder dysfunction\nPosterior cord syndrome\nLoss of vibration, light touch, proprioception (dorsal column)\nPreserved pain, temp, course touch (spinothalamic)\nPreserved motor (corticospinal)\nVariable bowel and bladder dysfunction\nBrown-Sequard Syndrome: lateral cord damage\nLoss of ipsilateral motor, vibration, light touch, proprioception\nLoss of contralateral pain, temp\nCauda Equina Syndrome: lumbosacral nerve roots\nBowel / bladder dysfunction\nUMN symptoms in legs\nCentral Cord Syndrome (2’ bleeding, infarction, oedema) – most commonly cervical\nUMN legs\nMixed UMN/LMN arms\nLoss of pain + temp in arms\nSacral sparing\nSegmental Syndrome\nAll ascending and descending pathways in that segment + spinal shock\nIpsilateral dorsal columns\nContralateral motor + spinothalamic\nFlaccid paralysis, urine retention, decreased reflexes", "citations": [{"type": "pdf_page", "page": 141, "label": "p141"}]}
{"chunk_id": "SSUs_v1_p142_txt_00_08cbaf", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 142, "page_end": 142, "section_path": ["NEUROANAESTHESIA", "Spinal Cord Syndromes"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Spinal Cord Syndromes", "keywords": [], "text": "American Spinal Injury Association (ASIA) Impairment Scale\nComplete\nNo sensory / motor in S4 / S5\nSensory incomplete\nNo motor function below injury\nSensory function preserved including S4 / S5\nMotor incomplete\n50% of muscles less than grade 3 (i.e. can’t raise arms and legs off bed)\nSensory incomplete\nMotor incomplete\n50% of muscles greater than grade 3 (i.e. can raise arms and legs off bed)\nSensory incomplete\nNormal\nIn a patient who had a prior deficit\nPathophysiology of vertebral column injuries:\nFracture\nDislocation\nLigamental injury\nDisc herniation\nMechanism\nStable Injuries\nUnstable Injuries\nFlexion\nAnterior wedge #\nClay shoveler’s # (spinous\nprocess)\nTransverse process #\nFlexion tear drop\nSubluxation\nBilateral facet dislocation\nAtlanto-occipital dislocation\nAtlanto-axial dislocation\nOdontoid #\nFlexion –\nrotation\nUnilateral facet dislocation\nAtlanto-axial dislocation\nExtension\n-\nPosterior neural arch # C1\nHangman pedicle # C2\nExtension teardrop #\nAtlanto-axial dislocation\nVertical\ncompression\nBurst # vertebrae\nArticular pillar #\nJefferson burst # C1\nUMN\nLMN\nReflexes\nHyperreflexia\nUpgoing Babinski\nHyporeflexia\nTone\n\n\nPower\n\n\nFasciculations\nAbsent\nPresent\nAtrophy\nAbsent\nPresent\nAetiology\nBlunt trauma 97%\n40% MVA\n40% falls\n10% sports\nPenetrating 3%\nNon-traumatic", "citations": [{"type": "pdf_page", "page": 142, "label": "p142"}]}
{"chunk_id": "SSUs_v1_p143_txt_00_821b1d", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 143, "page_end": 143, "section_path": ["NEUROANAESTHESIA", "Autonomic Dysreflexia"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Autonomic Dysreflexia", "keywords": [], "text": "Consequences of Spinal Cord Injury\nNeurogenic Shock\nDisruption of sympathetic activity with preserved parasympathetic activity, particularly if high thoracic or cervical injury\nSSx: SVR (→ venous pooling), inotropy, bradycardia (may also have haemorrhagic shock)\nDiagnosis: sBP <100, HR <80 w/ autonomic dysregulation → can be life threatening\nDifferentiated from other forms of shock by lack of SNS compensation\nRx: pressors, inotropes\nSpinal Shock\nGenerally not life-threatening cf neurogenic shock\nLoss of spinal reflexes below SCI level\nDay 0-1: flaccid, areflexia\nDay 1-3: return of reflexes\nDay 4-28: hyperreflexia\nMonth 2-12: hyperreflexia, spasticity\nRespiratory Dysfunction\nLevel\nNerve\nVital Capacity\nCough\nManagement\nC3\nPhrenic\n<10%\nAbsent\nImmediate ventilation\nC3-C5\nPartial phrenic\n10 – 30%\nWeak\n80% require ventilation\nAbove T8\nIntercostals\nAbdominal\n30 – 80%\nWeak / normal\nImpaired sputum clearance\nMay require ventilation\nBelow T8\nLow intercostals\nAbdominal\n80 – 100%\nWeak / normal\nImpaired sputum clearance\nMay require ventilation\nSympathectomy above T6 → bronchospasm, secretions → mucous plugging, atelectasis\nAutonomic Dysreflexia\n50-70% of patients with damage >T6.\nDiagnosis: BP >20mmHg from baseline (but can be hypertensive crisis)\nPathophysiology:\nNoxious stimuli below lesion\nSympathetic activation\nIntact baroreceptors sense HTN → vagal response\nDisruption to descending inhibitory pathways to SNS of splanchnic\nvasculature (right →)\nCauses: bladder distension, pressure sores, uterine contractions, UTI, surgical\nstimulus\nSSx: uncontrolled hypertension, cardiac arrhythmias, flushing, headache,\nreflex bradycardia, sweating, blurred vision, nasal congestion, piloerection\nPrevention during anaesthesia: spinal anaesthetic, always deep during\nanaesthesia if GA (i.e. >1 MAC)\nManagement:\nSit upright, remove tight clothing / stockings\nCheck bladder\nEmpty catheter + check for blockages\nIf not catheterised – catheterise\nCease cystoscopy if currently in procedure\nExclude constipation: PR and remove any faecal mass\nVasodilators:\nGTN 1-2 tab q20mins or nifedipine s/l 10mg\nHydralazine 20mg IV slowly or diazoxide 20mg bolus\nResistant: IV GTN, phentolamine or magnesium\nContinue to search for cause throughout treatment", "citations": [{"type": "pdf_page", "page": 143, "label": "p143"}]}
{"chunk_id": "SSUs_v1_p144_txt_00_289d76", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 144, "page_end": 144, "section_path": ["NEUROANAESTHESIA", "Chronic Spinal Cord Injury"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Chronic Spinal Cord Injury", "keywords": [], "text": "Chronic Spinal Cord Injury\nMedical issues:\nVTE: 50 – 100%\nAnalgesia\nPressure area care\nStress ulcer prophylaxis\nUrinary catheterisation\nParalytic ileus\nHypothermia\nNutrition\nPatients with SCI are at risk of abnormal emergency presentations → morbidity and mortality\nPre-op:\nAssess:\nAirway including C spine movement + fixation\nCVS: bradyarrhythmia (high cervical lesions) +/- pacemaker, CAD\nResp: ventilatory function (see resp function), T-spine injuries may have inefficient cough\nFlow vol loops (likely restrictive dz from intercostal muscle spasticity + FEV1)\nPrior need for ventilation\nrisk OSA\n?Recent infections\nGI: delayed gastric emptying\nRenal: SPC +/- infection\nHaem: VTE (+/- prophylaxis)\nMetabolic:\nImpaired thermoregulation\nMSK: osteoporosis\nNeuro: spinal fusion may inhibit neuraxial, chronic pain\nPsychological\nPresence of ADR + triggers\n?Previous post-op course\nAnaesthetic plan →\nSpinal anaesthesia very effective and ablates ADR\n(height of block difficult to assess, loss of babinski\n+ change from spasticity to flaccid paralysis\nindicates block)\nIntra-op:\nCan be difficult IV access 2’ atrophy and contractures\nConsider art line to monitor for ADR\nAvoid depolarising NMBAs – ensure fully reversed at end\nReduced induction doses (smaller blood volume + muscle mass)\nVery careful positioning and padding\nWarm from anaesthetic bay to recovery\nObstetrics: higher rates of ADR, urological pathology, VTE, pressure\nsores, resp compromise from gravid uterus, pre-term delivery, need for c-section\nNote contractions may precipitate ADR (may be first sign of contractions) – consider early epidural", "citations": [{"type": "pdf_page", "page": 144, "label": "p144"}]}
{"chunk_id": "SSUs_v1_p145_txt_00_d3b554", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 145, "page_end": 145, "section_path": ["NEUROANAESTHESIA", "Pharmacological Manipulation of ICP", "Intracranial Pressure"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Intracranial Pressure", "keywords": [], "text": "Intracranial Pressure\nGoals:\nClosed cranium: to maintain adequate CPP (MAP – ICP) and prevent herniation of brain\nOpen cranium: may be to provide relaxation for surgical access, or reverse herniation\nSSx of ICP: headache, N&V, blurred vision, somnolence, papilloedema\nNormal values: 10-15mmHg adult, 3-4mmHg (<1yo) – treat ICP >22mmHg\nFor accurate CPP transducers for MAP and ICP should be at tragus (i.e. foramen of Munro)\nRadiological features of ICP:\nMidline shift\nObliteration of basal cisterns\nLoss of sulci / oedema\nVentricular effacement / ventriculomegaly\nHerniation\nICP monitoring: recommended in severe TBI *when ICP > venous pressure → bridging\nveins collapse → obstruction of venous drainage → cerebral perfusion (global cerebral\ncirc arrest when ICP approaches MAP)\nTwo main modalities for monitoring:\nIntraparenchymal bolts\nEVD (allows monitoring + treatment i.e. drainage)", "citations": [{"type": "pdf_page", "page": 145, "label": "p145"}]}
{"chunk_id": "SSUs_v1_p145_txt_01_a549a3", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 145, "page_end": 145, "section_path": ["NEUROANAESTHESIA", "Pharmacological Manipulation of ICP", "Non-Pharmacological Manipulation of ICP"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Non-Pharmacological Manipulation of ICP", "keywords": [], "text": "Non-Pharmacological Manipulation of ICP\nMechanisms:\nCSF drainage\nBlood:\nCBF (i.e. arterial):\nPaCO2 (but >25mmHg unless ++ emergency)\nPaO2\npain/arousal/seizures\nNormothermia\nvenous drainage:\nHead elevation 30 degrees\nintrathoracic pressure\nNil jugular compression / neck ties\nNeutral neck position", "citations": [{"type": "pdf_page", "page": 145, "label": "p145"}]}
{"chunk_id": "SSUs_v1_p145_txt_02_063cff", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 145, "page_end": 145, "section_path": ["NEUROANAESTHESIA", "Pharmacological Manipulation of ICP", "Pharmacological Manipulation of ICP"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pharmacological Manipulation of ICP", "keywords": [], "text": "Pharmacological Manipulation of ICP\nMechanisms:\nSteroids (nil effect acutely, usually given 48hr pre-op) – no role in trauma\nDiuretics: frusemide\nOsmotic agents: no evidence for superiority of either – pt individualised\nMannitol: 0.25 – 1g/kg over 15 minutes\nHypertonic saline 3% 2-5mL/kg (keep serum Na <160mM)\nBlood:\nCBF (i.e. arterial):\nTIVA (except ketamine)\nAvoid vasodilators / NO2\nRapid reduction in ICP:\nHyperventilate to ETCO2 ≥25mmHg\nCSF drainage (ventriculostomy, brain needle) – never adjust bed height or head without clamping\nDiuresis\nCMR / burst suppression:\nThiopentone 3 – 5mg/kg then 3 – 5 mg/kg/hr or prop 50 – 100mg then >0.125mg/kg/hr\nMAP reduction\nSeizure control: saline irrigation, anticonvulsants\nClamped to\nFree drainage", "citations": [{"type": "pdf_page", "page": 145, "label": "p145"}]}
{"chunk_id": "SSUs_v1_p146_txt_00_132d49", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 146, "page_end": 146, "section_path": ["NEUROANAESTHESIA", "Intra-Operative Positioning", "Basic Elements and Principles of Neuroanaesthesia"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Basic Elements and Principles of Neuroanaesthesia", "keywords": [], "text": "Basic Elements and Principles of Neuroanaesthesia\nRecurrent issues:\nControl of ICP\nManagement of PaCO2\nManagement of arterial blood pressure\nUse of steroids\nOsmotherapy\nDiuretics\nAnticonvulsants\nPatient positioning\nPneumocephalus\nVAE\nMonitoring\nIV fluid management: balanced crystalloid or normal saline\nAlbumin avoided based on SAFE trial: however pt cohorts not equal, albumin solution was hypoosmolar\nHypothermia\nNote bladder temp doesn’t correlate with deep brain structures\nGlucose management\nEmergence from anaesthesia: smooth to avoid straining → hypertension and oedema\nOpioids - antitussive\nNeuroprotective strategies:\nCMRO2\nPaCO2 35-40\nNormoxia\nNa 140\nBSL 6-10mM\nNormothermia", "citations": [{"type": "pdf_page", "page": 146, "label": "p146"}]}
{"chunk_id": "SSUs_v1_p146_txt_01_2334df", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 146, "page_end": 146, "section_path": ["NEUROANAESTHESIA", "Intra-Operative Positioning", "Intra-Operative Positioning"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Intra-Operative Positioning", "keywords": [], "text": "Intra-Operative Positioning\nRisks + risk minimisation\nImplications for anaesthesia\nPositions:\nSupine: shoulder roll obstruction to venous drainage\nLateral (park bench)\nSemi-lateral (Janetta)\nProne (see peri-op medicine)\nSitting: transducer at tragus, minimum CPP 60mmHg (higher for elderly)\nPositioning Aids / Supports:\nPin (“Mayfield”) head holder\nRadiolucent head holder\nHorseshoe\nFoam head support\nBean bag\nWilson-type frame\nAndrews (“hinder binder”) type frame\nRelton-Hall (four poster) frame\nAll pressure points - identify and pad.", "citations": [{"type": "pdf_page", "page": 146, "label": "p146"}]}
{"chunk_id": "SSUs_v1_p147_txt_00_44e854", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 147, "page_end": 147, "section_path": ["NEUROANAESTHESIA", "NIRS / Cerebral Oximetry", "Cerebral Blood Flow Monitoring"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Cerebral Blood Flow Monitoring", "keywords": [], "text": "Cerebral Blood Flow Monitoring\nAll types are indirect measures – use other measures to infer changes to CBF.\nIndications:\nAcute encephalopathy: severe TBI, space occupying lesions – gold standard is invasive ICP\nSelective vascular clamping / high risk thromboembolic event: consider TCD, NIRS, EEG\nExpected arterial hypotension / CO e.g. cardiac surgery: consider TCD, NIRS, EEG", "citations": [{"type": "pdf_page", "page": 147, "label": "p147"}]}
{"chunk_id": "SSUs_v1_p147_txt_01_02780c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 147, "page_end": 147, "section_path": ["NEUROANAESTHESIA", "NIRS / Cerebral Oximetry", "Transcranial Doppler"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Transcranial Doppler", "keywords": [], "text": "Transcranial Doppler\nInfers cerebral blood flow from blood flow velocity. Assumes cortical flow ∝ basal flow.\nChange in velocity ∝ flow assuming:\nConstant angle of insonation i.e. probe must remain fixed\nConstant vessel diameter\nMethod: 2MHz probe → pulses of sound waves through bone → reflected off RBCs back to probe, altered by velocity + direction\nChanges from baseline + asymmetry more useful than absolute values\nExamples of clinical applications:\nDetection of emboli (highly echogenic)\nDetection of vasospasm (e.g. after SAH) – velocity >120cm/s\nIntracranial circulatory arrest\nCAE: decision to shunt (>60% decrease in flow)\nICP via pulsatility index – change infers risk of flow", "citations": [{"type": "pdf_page", "page": 147, "label": "p147"}]}
{"chunk_id": "SSUs_v1_p147_txt_02_f45873", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 147, "page_end": 147, "section_path": ["NEUROANAESTHESIA", "NIRS / Cerebral Oximetry", "Jugular Bulb Venous Oxygen Saturation"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Jugular Bulb Venous Oxygen Saturation", "keywords": [], "text": "Jugular Bulb Venous Oxygen Saturation\nSjvO2 measures oxygen delivery / extraction of the brain\nSJVO2 = SaO2 – (CMRO2 / CBF) x (1 / (Hb x 1.34))\nMethod: fibreoptic catheter placed in retrograde fashion into jugular bulb through IJ vein under fluoroscopic guidance\nComplications: incorrect placement – may give false reading, thrombosis, cannulation complications\nValues: normal SJVO2 55 – 75%\n<55%\nO2 delivery versus demand\ndelivery: ICP, CBF, hypoxia, hypocapnia\ndemand: seizure, hyperthermia\n>55%\ncannot assume O2 adequate for demand\n>75%\nhyperaemia or metabolic demand\ndelivery: hypercapnia, vasodilation\ndemand: coma, hypothermia, infarcton\nLimitations:\nPossible differences between R & L sides – place on side of worst pathology\nNo indication of focal ischaemia\nProne to inaccuracy", "citations": [{"type": "pdf_page", "page": 147, "label": "p147"}]}
{"chunk_id": "SSUs_v1_p147_txt_03_1a23ba", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 147, "page_end": 147, "section_path": ["NEUROANAESTHESIA", "NIRS / Cerebral Oximetry", "NIRS / Cerebral Oximetry"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "NIRS / Cerebral Oximetry", "keywords": [], "text": "NIRS / Cerebral Oximetry\nUses reflectance oximetry to measure O2 sats (infrared @ 700 – 1000nm) via two sensors to both sides of forehead\n~70% of cerebral blood volume is venous  predominantly reads local venous O2 sats (i.e. delivery versus demand)\nNormal range: 65 – 70% w/ high variability - baseline value prior to induction is important\nSources of error: extracranial blood, ambient light, electrical interference e.g. diathermy\nLimitations:\nGlobal perfusion inferred from focal / frontal measurements\nData on normal values is absent – place prior to starting procedure and monitor trend; lowest acceptable value unknown –\ngenerally desaturation >20% baseline\nCauses of values: CBF, O2 content, O2 consumption\nUses: cardiac surgery, deep hypothermic circ arrest, CAE (>12% → shunt), IVH, beach chair\nOther uses: splanchnic NIRS for NEC, calves during long trendelenberg / Lloyd-Davis position\nWindows:\nTranstemporal: MCA (flow 35-90cm/s, PCA,\nACA) – temporal bone too thick in 20% of\npopulation\nTransorbital: ophthalmic, carotid\nTransforaminal: basilar, vertebral\nPrinciple: pathway at risk must be\namenable to monitoring → must\nproduce reliable + reproducible\ndata able to be acted upon\n% oxyHb / (% oxyHb + deoxyHb)", "citations": [{"type": "pdf_page", "page": 147, "label": "p147"}]}
{"chunk_id": "SSUs_v1_p148_txt_00_9bc1be", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 148, "page_end": 148, "section_path": ["NEUROANAESTHESIA", "Evoked Potentials", "Evoked Potentials"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Evoked Potentials", "keywords": [], "text": "Evoked Potentials\nAll types described in terms of:\nLatency: time between application of stimulus to response\nAmplitude: voltage of response\nRequire reproducible, reliable tracings must be obtained at baseline prior to intervention – if not possible then should not be\nused for clinical decision making. Should obtain baseline prior to surgery.\nClinically significant pathological change:\nProne to electrical interference – needs to be averaged\nType\nStimulus\nPathway\nUses\nConsiderations\nSig Change\nSSEPS\nLow amplitude\npotentials\nmeasured over\nsomatosensory\ncortex\nTranscutaneous\nelectrical stimulus\nPeripheral nerve →\ndorsal column → brain\nstem → thalamus →\nsensory cortex on\ncontralateral side\nSpine surgery where\ntwo posterior\nspinal arteries are\nat risk\nCerebral vascular\nsurgery\nAortic surgery\nCarotid surgery\namplitude by 50%\n(peak to trough)\nlatency by 10%\n(stimulus to\npeak)\nMEPs\nHigh\namplitude\npotentials\nmeasured in\nskeletal\nmuscles in\nresponse to\nstimulation of\nthe motor\ncortex\nTranscranial train\nof electric stimuli\n(high voltage short\nduration i.e. 500V,\n1.2A, 5 serial\nstimuli)\nMotor cortex →\ncorticospinal tract\n(anterior spinal a.\nsupply) → nerve root\n→ peripheral nerve →\nNMJ (muscle AP)\nSpinal surgery where\nanterior spinal artery\nat risk\nMore sensitive than\nSSEPs (changes\nseen earlier)\nRequires bite block\ndue to tongue\nbiting\nNMBDs will weaken or\nabolish MEPs so\nshould be avoided\namplitude by 50 –\n80% (peak to\ntrough)\nBrainstem\nAuditory EPs\nClicking noise in\near canal –\nelectrode placed\nover mastoid\nprocess – 5 short\nlatency (<10ms)\npeaks\nCN VIII → brainstem\n(lower pons) → inferior\ncolliculus (most\nimportant) → cortex\nPosterior fossa surgery\nEffect of anaesthesia\nDrug\nSSEP\nMEP\nBrainstem\nVolatiles / NO2\n if >1 MAC\nif >0.5 MAC\nMinimal effect\nPropofol\n but still useful\n but still useful\nBarbiturates\nMinimal effect\n\nBenzodiazepines\nMinimal effect\nMinimal effect\nOpioids\nMinimal \nMinimal \nKetamine\n\n\nPrecedex\nMinimal effect\n\nNMBA\nNil effect\n / abolished\nCauses of change in potential: surgical, pharmacological, physiological (hypoxia, hypotension, hypothermia, anaemia, hypoCO2),\npositional, technical\nManagement:\nNotify surgeon\nRepeat check to validate + check all leads / connections / settings\nAnaesthetist: check / adjust anaesthetic, assess depth + NMB, MAP to 90-100mmHg, optimise physiological causes then if\ntrue and ongoing → neuroprotection including burst suppression\nSurgeon: stop manipulation, assess for structural injury / compression, reverse, shunt, remove if temp clip, drain CSF", "citations": [{"type": "pdf_page", "page": 148, "label": "p148"}]}
{"chunk_id": "SSUs_v1_p149_txt_00_1b63c5", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 149, "page_end": 149, "section_path": ["NEUROANAESTHESIA", "EEG", "EMG Monitoring"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "EMG Monitoring", "keywords": [], "text": "EMG Monitoring\nPotentials measured in skeletal muscles in response to surgical stimulation of innervating peripheral or cranial nerve\nTypes:\nActive: stimulation → action potential response from muscle is recorded\nPassive\nNerve irritation → audible feedback to warn of impending nerve damage\nLimitation: sharp section may produce no EMG discharge at all", "citations": [{"type": "pdf_page", "page": 149, "label": "p149"}]}
{"chunk_id": "SSUs_v1_p149_txt_01_6a7e10", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 149, "page_end": 149, "section_path": ["NEUROANAESTHESIA", "EEG", "EEG"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "EEG", "keywords": [], "text": "EEG\nPathophysiological effects on EEG:\nHypoxia: initially CBF then same appearance as ischaemia\nHypotension: EEG changes not very pronounced (mild hypotension may result in significant ischaemia)\nHypothermia: complete EEG suppression at 15°C to 18°C\nHypocapnia: may show ischaemia\nHypercapnia: only effects secondary to CBF\nAnaesthetic drugs:\nCan induce burst suppression: propofol, thiopentone\nCan’t induce burst suppression: ketamine, benzos, precede, opioids", "citations": [{"type": "pdf_page", "page": 149, "label": "p149"}]}
{"chunk_id": "SSUs_v1_p150_txt_00_569a50", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 150, "page_end": 150, "section_path": ["NEUROANAESTHESIA", "Spinal Surgery", "Spinal Surgery"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Spinal Surgery", "keywords": [], "text": "Spinal Surgery\nIssues:\nProne positioning\nRisk of airway loss + airway oedema\nMajor haemorrhage\nRisk of post-op visual loss\nAnalgesia\nSpinal cord damage\nPre-op:\nConsent:\nTransfusion: risk if age >50, obesity, tumour, intra-abdominal pressure, transpeduncular osteotomy\nPost-op vision loss\nNerve injury\nScoliosis: restrictive lung pathology +/- pulmonary HTN → PFTs + ABG\nIntra-op:\nAirway: risk of difficulty with C-spine MILS – consider awake\nJackson table: normal ETT\nProne in Mayfield pins: nasal tube\nNMBD: safe for condition\nNeuromonitoring: routine + SSEPs, MEPs, BIS\nFrequent check of eyes (Wilson frame associated with ischaemic optic neuropathy)\nPressure care\nIDC\nGlycopyrulate for secretions\nPost-op:\nNeuro ICU\nAnalgesia: multimodal\nPOVL:\nCentral retinal artery occlusion\nDirect globe pressure → IOP → ischaemic\nSSx: unilateral vision loss, ophthalmoplegia, ptosis, supra-orbital n. sensory loss\nIschaemic optic neuropathy – risk factors: male, obesity, length >6 hrs, blood loss\nSpecial considerations:\nAnterior thoracic spine surgery: thoracotomy – DLT + regional analgesia\nAnterior cervical spine surgery:\nAirway compromise 2% at 6 – 36 hours\nRisk factors:\nMultiple level surgery ≥3 levels including one above / including C4 (C1, C2 in particular)\nBlood loss >300mL\nDuration >5 hr\nCombined anterior + posterior approach\nPrevious cervical surgery\nRespiratory disease\nCauses: prevertebral oedema (most common), haematoma, CSF leak, infection / abscess\nSigns: neck swelling, stridor, respiratory effort, tracheal tug / deviation\nConsider prior to extubating: intubation difficulty, facility i.e. 24 hr airway support, halo-thoracic brace,\nOSA, resp dz, facial oedema end of case, type of surgery\nManagement:\nCheck cuff leak, if concerns or risks above consider intubation until D1 or 2\nAirway emergency → remove clips / sutures, AFOI +/- surgical airway", "citations": [{"type": "pdf_page", "page": 150, "label": "p150"}]}
{"chunk_id": "SSUs_v1_p151_txt_00_dec848", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 151, "page_end": 151, "section_path": ["NEUROANAESTHESIA", "Craniotomy", "Craniotomy"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Craniotomy", "keywords": [], "text": "Craniotomy\nCraniotomy: removal of part of the skill to expose the brain\nPre-op: routine +\nNeuro: deficits, ICP, seizures, GCS\nMedications: AEDs, steroids, anticoagulation (?ceased / reversed)\nInvestigations: routine + TTE / TOE if high risk VAE\nElectrolyte – specifically sodium - abnormalities\nConsiderations:\nICP / CPP\nPositioning: pressure care, transducer height\nBP targets\nRisk of VAE → need for CVC\nExpected blood loss\nNeuro-monitoring: SSEPs, EEG, transcranial MEPs\nIntra-op:\nPre-med generally avoided\nMonitoring: routine + neuro + BIS + art line + VAE + ICP\nCVS: 2x large bore +/- CVC for VAE and pressor support, fluid warmer\nInduction goals: avoid ICP, maintain CPP (65-80mmHg), prevent hypertension if high risk of bleed\nNeuroanaesthesia unless specific reason to vary\nRapid ICP management (per ICP notes)\nTIVA versus volatile:\nTIVA:\nPONV (useful in neurosurgery as can be concern for new pathology)\nAssociated with ICP and better CPP\nProp/remi less hypotension than sevo/remi (but not significant)\nNo difference between TIVA & inhalation:\nEye opening / extubation time\nSurgical time & reported operating conditions\nPost-op agitation\nProgression-free survival or overall survival\nInhalational:\nMAC <1.0 does not ablate effects of CO2 on cerebral blood vessels / effect cerebral autoregulation\nLimited studies on NO2 - appears safe for use except sitting position, pneumocephalus\nOpioids:\nRemifentanil:\nBetter haemodynamic response to intubation\nRebound hypertension on emergence\nEarlier time to first analgesia compared to fentanyl\nKetamine: most data from TBI\nIn ventilated normocapnic patients shown to have no ICP\nMaintains CPP without affecting systemic BP\nNeuroprotective by inhibiting cortical spreading depolarisation\nNo difference in ICU stay / outcomes / mortality\nPrecedex:\nHaemodynamic stability compared to placebo + prop/remi\nMAC sparing\npost-op opioid requirement\nICP\ninflammation → neuroprotection\nCompared with prop/remi – comparable haemodynamics + post-op events\nLonger recovery time + PACU discharge + first analgesia cf remi\nAnalgesia:\nParacetamol alone is ineffective, NSAIDs useful if not CI, short acting opioids\nUntreated pain → agitation; scalp blocks improve pain scores up to 12 hours + opioids for 24 hr", "citations": [{"type": "pdf_page", "page": 151, "label": "p151"}]}
{"chunk_id": "SSUs_v1_p152_txt_00_2a350a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 152, "page_end": 152, "section_path": ["NEUROANAESTHESIA", "Craniotomy for Head Injury", "Craniotomy for Tumour Debulking"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Craniotomy for Tumour Debulking", "keywords": [], "text": "Craniotomy for Tumour Debulking\nCraniotomy +\nImportant features of tumour:\nType of tumour + location\nMass effects: ICP, N&V → give steroids 48 hours pre-op\n+/- need for pre-op lumbar drain\nImportance of pre-op imaging:\nSize and location of lesion\nChoice of anaesthesia: awake versus asleep, neuro-monitoring\nDuration of surgery\nDegree of oedema + midline shift\nLikely patient positioning\nBleeding risk\nVenous air embolism (if close to larger vessels)\nAnaesthetic considerations:\nNo difference shown between TIVA & volatile for disease-free survival\nVomiting: an anti-emetic anaesthetic to reduce vomiting (as vomiting can be alarming for new neuro pathology)\nManagement of “tight” brain: do quick sweep i.e. ABCDEquipment\nAirway: tube secured + not kinked, positioning\nBreathing: CO2, oxygenation, airway pressures/PEEP\nCirculation: blood pressure, venous drainage (ETT should be taped), consider further head up if not in pins\nDrugs:\nCMRO2: switch to prop if using volatile, pressors/downers, paralysis, anti-epileptics, steroids\nHypertonic / mannitol\nMannitol: satisfactory brain relaxation (at 1mg/kg), lower risk of moderate to severe post-op cerebral\noedema, greater urine output, higher lactate\n*risk of cerebral oedema if BBB not in tact\nEquipment: use lumbar drain if inserted pre-op\nPost-op agitation:\nDifficult to assess if new pathology versus emergence agitation", "citations": [{"type": "pdf_page", "page": 152, "label": "p152"}]}
{"chunk_id": "SSUs_v1_p152_txt_01_8106b5", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 152, "page_end": 152, "section_path": ["NEUROANAESTHESIA", "Craniotomy for Head Injury", "Craniotomy for Head Injury"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Craniotomy for Head Injury", "keywords": [], "text": "Craniotomy for Head Injury\nPriority is to open cranium as quickly as possible\nConflicting issues for intubation:\nRaised ICP\nNot-fasted → cricoid pressure, sux is okay (only small ICP)\nUncertain C-spine status (10% unstable with GCS <8):\nMILS, leave back half of collar as limits atlanto-occipital ext + x blade / stylet\nIf conscious, alert, not intoxicated + free of distracting injuries should have midline pain, limitation of movement +\nneurology in presence of cervical spine #\nUncertain airway status (potential for blood, possible laryngotracheal injury, possible BOS #)\nUncertain volume status\nPotentially uncooperative patient\nHypoxaemia\nAvoid nasal intubation in setting of facial #s.\nAim Hb >90", "citations": [{"type": "pdf_page", "page": 152, "label": "p152"}]}
{"chunk_id": "SSUs_v1_p153_txt_00_f92e06", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 153, "page_end": 153, "section_path": ["NEUROANAESTHESIA", "Craniotomy for AVM Malformation", "Craniotomy for Extracranial-Intracranial Bypass"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Craniotomy for Extracranial-Intracranial Bypass", "keywords": [], "text": "Craniotomy for Extracranial-Intracranial Bypass\nIndications: intracerebral atherosclerosis, moya-moya, aneurysm trapping\nIntra-op:\nMust balance O2 supply and demand – microcirculation often maximally dilated due to chronic ischaemia\nMaintain normal / greater than normal CPP\nNormocapnia to prevent ‘steal’\nMAP 10-20% for temporary arterial occlusion", "citations": [{"type": "pdf_page", "page": 153, "label": "p153"}]}
{"chunk_id": "SSUs_v1_p153_txt_01_341c7d", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 153, "page_end": 153, "section_path": ["NEUROANAESTHESIA", "Craniotomy for AVM Malformation", "Craniotomy for AVM Malformation"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Craniotomy for AVM Malformation", "keywords": [], "text": "Craniotomy for AVM Malformation\nMost commonly presents as ICH w/ 10-30% mortality (can present with an associated aneurysm)\nVascular mass: has a centre (nidus) with blood flow directly from dilated arteries to dilated draining veins creating high flow/low\nresistance shunts, may present as ‘steal’ syndrome\nSpecific issue to AVM: normal perfusion pressure breakthrough\nOccurrence of multifocal areas of haemorrhage after resection of high flow low resistance AVMs\nSudden engorgement and swelling of brain → cauliflower like protrusion from cranium – not entirely understood\nIntra-op:\nSimilar principles to aneurysm surgery\nUsually lower MAP\nPost-op: high risk of seizures + risk that dysautoregulated brain adjacent to resected AVM will develop hyperaemia/oedema +/-\nhaemorrhage", "citations": [{"type": "pdf_page", "page": 153, "label": "p153"}]}
{"chunk_id": "SSUs_v1_p154_txt_00_d37ba2", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 154, "page_end": 154, "section_path": ["NEUROANAESTHESIA", "Spontaneous Intracerebral Haemorrhage", "Spontaneous Intracerebral Haemorrhage"], "specialty_tags": ["NEUROANAESTHESIA", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Spontaneous Intracerebral Haemorrhage", "keywords": [], "text": "Spontaneous Intracerebral Haemorrhage\nBased on AHA/ASA guidelines.\nEarly deterioration is common in first few hours – must be diagnosed quickly.\nParamedics: history, airway management, CVS support, transport to closest acute stroke facility\nED management:\nRapid CT – ?ischaemia v ICH\nSevere coagulopathy – must reverse\nEarly lowering sBP to 140mmHg – associated with better functional outcome + no increase in death / adverse outcomes\nRisk factors for underlying vascular abnormalities: age <65yo, F, non-smoker, lobar ICH, intraventricular extension, no hx of HTN\nE.g moya-moya, AVM, tumour, cerebral vein thrombosis\nIVH occurs in 45% of ICH and is an independent factor associated with poor outcome\nAnticoagulation:\nOACs constitute 20% of ICH – lower risk than warfarin\nHaemodialysis is an option for dabigatran\nWarfarin: must rapidly correct; FFP / vit K / prothrombin concentrate – (prothrombin may thrombotic complications)\nAntiplatelets: multiplate can aid assessment, in high risk pts platelet transfusion within 12 hr → final haemorrhage size\nand independence @ 3mo\nICP: principles same as TBI\nICP monitor if GCS 3 – 8\nICP <20mmHg\nCPP 50 – 70mmHg\nImmediate management:\nNo evidence for steroids\nSurgery:\nSupratentorial haemorrhage: early haematoma evacuation not shown to be beneficial / benefit unknown\nPosterior fossa haemorrhage: cerebellar haemorrhage or brainstem compression – surgical decompression has\nbetter outcomes\nShould have early aggressive treatment and new DNR orders should be post-poned until D2\nOngoing management:\nNeuroprotective measures\nIntermittent pneumatic compression + elastic stockings for VTE prophylaxis\nInitial monitoring should take place in a dedicated stroke unit / ICU\nTreat seizures (no evidence for prophylaxis)\nFormal screening for dysphagia prior to PO intake\nMost common medical complications: pneumonia, aspiration, resp failure, PE, sepsis\nMDT rehab\nPrevention of recurrence: BP management, OSA, obesity, lifestyle modification\nOptimal timing of resumption of anticoagulation is unknown", "citations": [{"type": "pdf_page", "page": 154, "label": "p154"}]}
{"chunk_id": "SSUs_v1_p155_txt_00_619290", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 155, "page_end": 155, "section_path": ["NEUROANAESTHESIA", "Subarachnoid Haemorrhage", "Subarachnoid Haemorrhage"], "specialty_tags": ["NEUROANAESTHESIA", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Subarachnoid Haemorrhage", "keywords": [], "text": "Subarachnoid Haemorrhage\n5% of all strokes. Mortality 30 – 65%. Mostly ruptured saccular “berry” aneurysms at bifurcations (most haemodynamic stress)\nRFs: HTN, smoking, AD PCKD, Ehlers Danlos, NF1, Marfan’s, coarctation of aorta\nAetiology:\nNon-aneurysmal\nAneurysmal:\nLocation:\nAnterior 85% (ACOM, MCA)\nPosterior 15% (basilar, PICA,\ncerebellar)\nRisk of rupture:\nSize >7mm\nGrowth\nPosterior circ > anterior circ\nClassification:\nSmall: <12mm\nLarge: 12 – 24mm\nGiant: >24mm\nPresentation:\n18% die pre-hospital\nThunderclap headache: sentinel headache, meningism\nNeuro: LOC, N&V, photophobia, neck stiffness, focal neurology\nNeurogenic pulmonary oedema (22%, more common in posterior circ)\nStress CM\nEvaluation:\nStroke series: CTB non-con, CT perfusion, CT arch to COW (+/- MRA)\nLP: xanthochromia, RBC\nDSA: gold standard for aneurysm diagnosis\nECG: short PR, prolonged QTc +/- canyon T waves, ST depression\nNo relationship between ECG and cardiac dysfunction on TTE\nRisk of Takatsubo’s\nSeverity ∝ neurological injury\nRisk of Torsades with prolonged QTc\nBloods: routine + G&H + trops + TFTs\nSAH grading:\nWFNS (clinical)\nGrade I\nGCS 15, no motor deficit\nGrade II\nGCS 13-14, no motor deficit\nGrade III\nGCS 13-14, motor deficit\nGrade IV\nGCS 7-12\nGrade V\nGCS 3-6\nFisher (radiological) – validated for predicting risk of vasospasm\nGrade I\nBlood <1mm, no IVH\n24%\nGrade II\nBlood <1mm, bilateral IVH\n33%\nGrade III\nBlood >1mm, no bilateral IVH\n34%\nGrade IV\nBlood >1mm, bilateral IVH\n40%\nHunt & Hess: surgical risk based on initial neuro examination\nNo IVH\nIVH\nBlood <1mm\nGrade 1\nGrade 2\nBlood >1mm\nGrade 3\nGrade 4", "citations": [{"type": "pdf_page", "page": 155, "label": "p155"}]}
{"chunk_id": "SSUs_v1_p156_txt_00_7a06dc", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 156, "page_end": 156, "section_path": ["NEUROANAESTHESIA", "Subarachnoid Haemorrhage"], "specialty_tags": ["NEUROANAESTHESIA", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Subarachnoid Haemorrhage", "keywords": [], "text": "Management\nABCs\nIntubation if: GCS ≤8, ICP, hypoxia or hypercapnoea, haemodynamic instability, need for sedation / paralysis\nTransfer to neurocritical centre\nPrevent re-bleed:\nBed rest\nAnalgesia\nEuvolaemia\nStop + reverse anticoagulation\nBP control:\nTarget sBP <160mmHg, MAP <110mmHg\nRx: labetalol, clevidipine, hydralazine\nPrevent secondary injury:\nNeuroprotection: normothermia, normal O2, BSL 6-10mM\nTreat seizures\nStool softeners\nDVT prophylaxis: mechanical\nPrevent / treat vasospasm:\nNimodipine: 60mg PO q4 hourly for 21 days\nCommence with 96hr of SAH – note no evidence that it affects vasospasm or DCI – only proven for\naneurysmal SAH\nMgSO4 no effect (MASH-II)\nNormoglycaemia\nEuvolaemia + hypertensive augmentation\nDSA +/- angioplasty pr intra-arterial vasodilator\nEarly aneurysm securing: clipping or coiling\nComplications:\nMortality 40% at 7 days\nRebleeding:\nHighest in first 12 hours (5-10% in first 24 hours)\nMortality 70%\nULTRA trial:\nTxA: no clear benefit in clinical outcome at 6mo\nNo difference: rebleed prior to treatment, good\nclinical outcomes, all-cause mortality, delayed\ncerebral ischaemia, thromboembolic events\nMay delayed cerebral ischaemia\nVasospasm / delayed cerebral ischaemia:\nIncidence 30%\nRisk days 4 – 14, peak at 7-8 days\nRaised ICP:\nHydrocephalus: EVD, 22% develop shunt dependence\nHyponatraemia: 30%, SIADH versus cerebral salt wasting\nSeizures: 6 – 18%\nAnaemia: 18%, target Hb >80\nCardiac: 25 – 35%\nNeurogenic pulmonary oedema (2’ catecholamine surge), stress CM\nTrop elevation in 36%\nHyperglycaemia\nFever\nHPA dysfunction\nTerms:\nDelayed neurological deterioration (DND):\nclinically detected deterioration after\nstabilisation that is not due to a re-bleed\nDelayed cerebral ischaemia (DCI): any\nneurological deterioration >1 hour\npresumed due to ischaemia (and other\ncauses excluded) – occurs in 30-40% in\nthose who have Fisher grade 3/4", "citations": [{"type": "pdf_page", "page": 156, "label": "p156"}]}
{"chunk_id": "SSUs_v1_p157_txt_00_c716d8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 157, "page_end": 157, "section_path": ["NEUROANAESTHESIA", "Coiling"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Coiling", "keywords": [], "text": "Perioperative Management of Subarachnoid Haemorrhage\nManagement: coiling v clipping\nISAT trial:\nPrimary outcome death or dependence @ 1yr\nSignificantly better outcome in coiling\nDespite higher risk of rebleed amongst coiling group (survival benefits for 7y)\nIndications for clipping:\nWide-necked aneurysms\nDiseased or occluded proximal vessels\nOtherwise complex anatomy\nPre-op for both:\nASSESS:\nCardiac fx: ?Takatsubo’s, long QTc\nAssess for APO\nDiscuss BP targets with surgeons\nMANAGE:\nG&H + crossmatch\nREFER: ICU\nCoiling\nAnaesthesia considerations:\n•\nBlood management\no\nKnowledge of closest blood fridge\n•\nWarm: fluids, patient\n•\nRadiology precautions (distance, ALARA, PPE)\n•\nLines on left\nPrepare for acute bleed - recognition:\nBradycardia / hypertension\nContrast extravasation\nGCS if awake\nBIS / EEG / DSA\nManagement of bleed – initially they will aim to keep coiling:\nsBP <140mmHg\nReverse heparin with protamine 1mg / 100iu of heparin\nConsider antiplt reversal (pooled plt, desmopressin)\nManage ICP\nBlood management\nConsult neurosurgery early (may require EVD, crani)\nAlert theatres", "citations": [{"type": "pdf_page", "page": 157, "label": "p157"}]}
{"chunk_id": "SSUs_v1_p158_txt_00_491335", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 158, "page_end": 158, "section_path": ["NEUROANAESTHESIA", "Clipping"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Clipping", "keywords": [], "text": "Clipping\nCraniotomy considerations+\nPre-op:\nMust discuss BP targets\nMust have plan for rupture:\nCross-matched blood in fridge\nAdenosine\nDefib pads on\nUppers and downers – reasonable to site CVC if clipping following a bleed cf elective\nImportant considerations of aneurysm:\nNeuromonitoring: SSEPs, BIS, NIRS\nBP targets: discuss with surgeons but generally\nIf normal ICP: sBP <140mmHg, ≥60mmHg\nIHAST: normothermia > hypothermia → hypothermia → bacteraemia\nGA with controlled induction\nTransmural pressure = MAP – ICP\nAvoid rapid  or  of blood pressure → rapid change in transmural pressure gradient → risk rupture\nReasonable to reduce BP and hyperventilate just prior to dural opening\nManagement of rupture + acute bleed\nBEFORE aneurysm exposure:\nCPP ≥50-60mmHg\nMAP >90mmHg\nICP (CO2, osmo Rx, venous drainage)\nAFTER aneurysm exposure: must create bloodless field to facilitate clipping\nInduce hypotension → MAP 50-60mmHg\nCMRO2 w/ burst suppression\nFlow arrest:\nBP: labetalol, esmolol\nAdenosine: 0.3mg/kg + ALS drugs + defib pads\nCI: reactive airways dz, severe CAD, conduction abnormality, allergy\nMethod: place transcutaneous pacing pads → give dose\nRepeat dose only if SR and normotensive\nTemporary clipping:\nBP facilitates clipping\nBP then facilitates collateral circulation (MAP 10-20% titrated to monitoring)\nPost-clipping aim sBP <140mmHg\nIHAST post-hoc analysis:\nPharmacological burst suppression not fully substantiated\nPts with temp vessel occlusion >20mins have worse outcomes despite pharmacological intervention 2’\nischaemia distal to clip\nOnly barbiturates have been shown to protect against ischaemia though prolonged wake up, reserve for\nwhen prolonged vessel occlusion is unavoidable\nIndocyanide green: 25mg IV (prepare for NIRS, peripheral sats)\nRemi good for rapid extubation + lack of straining\nAdenosine adverse effects: flushing, dyspnoea, chest pain, GI, headache, AV block, AF, ST changes, arrhythmia, bronchospasm\nDefib pads on\nSpecific considerations:\neffect of adenosine: cardiac transplant, dipyridamole, carbamazepine\neffect of adenosine: methylxanthines, WPW, SVT, AV block, afterload dependent\nHigh degree of caution if severe CAD, AV node disease, PPM, WPW, afterload dependent, Rx (verapamil, digoxin,\ncarbamazepine)\nDose: 0.3mg/kg – higher doses may be needed if no central access\nRepeat doses only if HR & BP at baseline", "citations": [{"type": "pdf_page", "page": 158, "label": "p158"}]}
{"chunk_id": "SSUs_v1_p159_txt_00_f14db8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 159, "page_end": 159, "section_path": ["NEUROANAESTHESIA", "Posterior Fossa Surgery", "Posterior Fossa Surgery"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Posterior Fossa Surgery", "keywords": [], "text": "Posterior Fossa Surgery\nContains: cerebellum, ascending and descending sensorimotor pathways, cranial nerve nuclei, cardiorespiratory centres,\nreticular activating system, neural pathways for crucial protective reflexes\nIndications:\nTumour including cerebellarpontine\nVascular lesions e.g. aneuryms, AVM\nCranial nerve decompression\nCongenital e.g. Chiari malformation, Dandy-Walker\nHaemorrhage decompression\nPre-op: routine +\nCerebellar dysfunction / CN dysfunction / ICP or hydrocephalus / VAE\nSitting craniotomy:\nBenefits:\nGravity → CSF & venous drainage → ICP, “bloodless” field, less retraction\nDirect surgical access\nintrathoracic pressure\nintraoccular pressure\nErgonomics\nRisks:\ncardiac preload\nPost-op tension pneumocephalus\nExtreme neck flexion → upper airway obstruction → impaired venous/lymphatic drainage, risk of kinked ETT,\npressure injuries\nMacroglossia 2’ oedema – avoid unnecessary oral crowding\nMust maintain >2 finger breads between chin & sternum\nPotential for neuropraxia & pressure sores\nUnfavourable position if need for CPR\nVenous air embolism: incidence 75%\nVenous pooling\nUnexplained quadriplegia (presumed 2’ cervical spine stretching)\nCI:\nR→L cardiac shunt\nSevere spinal stenosis (reported cause of quadriplegias)\nSevere AS\nRelative CI: PFO, uncontrolled HTN, extremes of age, autonomic neuropathy\nAnaesthetic considerations:\nReinforced ETT, bite block\nCirculation: transducer at level of tragus\nRIJ CVC: for VAE aspiration\nNeuromonitoring: BIS + EEG, SSEPs, MEPs, EMG\nVAE monitoring: pre-cordial doppler, TOE\nRisk of haemodynamic swings and arrhythmias associated with irritation of brainstem – warn surgeon\nPosterior Fossa Syndrome: constellation of SSx\nSSx:\nDysarthria\nIrritability\nHypotonia\nCN deficit\nAtaxia\nDysphagia\nRare in adults cf 30% incidence in children", "citations": [{"type": "pdf_page", "page": 159, "label": "p159"}]}
{"chunk_id": "SSUs_v1_p160_txt_00_bbc692", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 160, "page_end": 160, "section_path": ["NEUROANAESTHESIA", "Vestibular Schwannoma", "Microvascular Decompression"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Microvascular Decompression", "keywords": [], "text": "Microvascular Decompression\nUsually for CN V (trigeminal neuralgia), VII (hemifacial spasm), and IX\nDissect down → place insulating Teflon pad between vessel and nerve\nAuditory SEPs can reduce risk of hearing loss from cerebellar retraction/stretch\nMonitoring:\nCN V decompression: brainstem auditory SEPs\nCN VII decompression: brainstem auditory SEPs, facial nerve EMG", "citations": [{"type": "pdf_page", "page": 160, "label": "p160"}]}
{"chunk_id": "SSUs_v1_p160_txt_01_da6dcc", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 160, "page_end": 160, "section_path": ["NEUROANAESTHESIA", "Vestibular Schwannoma", "Vestibular Schwannoma"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Vestibular Schwannoma", "keywords": [], "text": "Vestibular Schwannoma\nMost common lesion at cerebellopontine angle. Benign. Usually younger pts, mostly has vestibular/hearing changes\nCommon origin of cochlear component of CN VIII and facial nerve → risk of hearing loss and facial n. palsy\nMonitoring:\nFacial nerve: EMG\nCochlear nerve: brainstem auditory SEPs (for tumours up to 1.5cm)\nLong procedure: translabyrinthine vs retrosigmoid approach with ENT\nNo-paralysis – usually CN VII monitoring\nBeware: close to brain stem + sinuses", "citations": [{"type": "pdf_page", "page": 160, "label": "p160"}]}
{"chunk_id": "SSUs_v1_p161_txt_00_7a2fc3", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 161, "page_end": 161, "section_path": ["NEUROANAESTHESIA", "Pituitary Surgery", "Pituitary Surgery"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pituitary Surgery", "keywords": [], "text": "Pituitary Surgery\nPituitary (500-900mg) occupies sella turcica of the sphenoid bone at base of skull\nRelated to: 3rd ventricle, hypothalamus, visual pathways, CN III-VI, cavernous sinus, internal carotid arteries\nDamage to surrounds can lead to CN palsy, visual field defects, major haemorrhage, CSF leak\nAnterior lobe (adenohypophysis): ACTH, GH, LH / FSH, TSH, prolactin, MSH\nPosterior lobe (neurohypophysis): ADH, oxytocin\nBlood supply: ICA → superior hypophyseal a. (anterior pituitary) + inferior hypophyseal a. (posterior pituitary) → venous\ndrainage → cavernous sinus → IJV\nTumours:\nSecretory versus non-secretory\nSize: micro (<10mm) versus macro (>10mm)\nPresentation:\nMass effects:\nVisual status\nHeadache\nHypopituitism i.e. endocrine fx 2’ compression:\nGonadotrophins\nGH\nACTH → hypoadrenal state / Addisonian crisis\nCorrect hypocortisolism + hypoNa+ pre-op\nTSH\nSecreting microadenomas: prolactin / GH / ACTH / thyroid\nProlactin secreting: most common\nACTH secreting: → Cushings dz → OSA (70%), HTN, central obesity, diabetes\nGH secreting: → acromegaly → large tongue + narrow glottis\nIncidental finding\nPre-op considerations:\nAcromegaly:\nAirway: macrognathia, macroglossia, large epiglottis, OSA (70%) → difficult intubation / BVM 40%\nRespiratory: kyphoscoliosis, myopathy\nCVS: difficult IV access (tough skin), HTN, LVH, IHD, arrhythmia / heart block, cardiomyopathy, valve dz\nNeuro: entrapment syndromes (inc. RLN)\nEndo: diabetes\nRx: somatostatin analogue, dopamine agonists\nCushings disease:\nAirway: difficult positioning 2’ buffalo hump\nBody: truncal obesity, moon facies, friable skin, thin veins, osteoporosis, exophthalmos\nResp: OSA, proximal myopathy\nCVS: difficult IV CVC, HTN, LVH, diastolic impairment, high risk VTE, IHD\nEndo: diabetes, peptic ulceration\nHyperprolactinaemia: dopamine agonists → postural hypotension\nCentral DI / SIADH\nHyperthyroidism\nEmergency surgery: → consider hydrocortisone for acute insufficiency\nAcute pituitary haemorrhage\nInfarction (Sheehan syndrome)\nSickle cell crisis\nPre-op Ix:\nRoutine bloods + specific endocrine +/- treatment / correction\nTTE in acromegaly, cushings\nVisual field testing\nSurgical technique mainly transsphenoidal, occasionally craniotomy", "citations": [{"type": "pdf_page", "page": 161, "label": "p161"}]}
{"chunk_id": "SSUs_v1_p162_txt_00_fb6d83", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 162, "page_end": 162, "section_path": ["NEUROANAESTHESIA", "Transsphenoidal Pituitary Surgery", "Transsphenoidal Pituitary Surgery"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Transsphenoidal Pituitary Surgery", "keywords": [], "text": "Transsphenoidal Pituitary Surgery\nIntra-op:\nNeurosurg GA\nETT secured side opposite to surgeons dominant hand\nSupine + head up with relative hypotension\nIntranasal vasoconstrictor by surgeon (adrenaline, cophenylcaine or cocaine) – CVS management\nSteroid supplementation is controversial – d/w surgeon prior to giving\nThroat pack\nGlycaemic control esp. Cushings / acromegaly\nSmooth emergence: suction well (bloody +++) after removing throat pack + avoids CSF leak\nOccasionally requires intra-op MRI\nPost-op:\nNasal packing\nNeuro-emergence\nCPAP contra-indicated – care ++ with OSA\nICU\nComplications:\nCSF leak\nMeningitis\nHypopituitism\nDI\nCN injury\nCavernous sinus / ICA injury", "citations": [{"type": "pdf_page", "page": 162, "label": "p162"}]}
{"chunk_id": "SSUs_v1_p163_txt_00_b39a12", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 163, "page_end": 163, "section_path": ["NEUROANAESTHESIA", "Shunt Revision", "Shunt Insertion"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Shunt Insertion", "keywords": [], "text": "Shunt Insertion\nIndicated for relief of hydrocephalus and idiopathic intracranial hypertension\nMost common: ventriculoperitoneal shunt\nCatheter inserted via burr hole into lateral ventricle on non-dominant side\nTubing travels subcutaneously to epigastrium → peritoneal space\nOther shunts:\nDistal end: may be intrapleural, right atrial\nProximal end: may arise from lumbar spine\nAnaesthetic considerations:\nPre-op: cause of hydrocephalus\n?Congenital cardiac defects\nManagement of Rx: acetazolamide, frusemide, anticonvulsants\nNeuro exam + document ?SSx raised ICP\nPeri-operative management of raised ICP\nMaintain CPP\nNeuro GA +\nGastric decompression (avoid gastric puncture)\nMuscle relaxation to aid abdominal portion\nNursed flat post-op to avoid excessive rapid drainage of CSF\nMonitor for subdural haematoma / bleed from bridging veins", "citations": [{"type": "pdf_page", "page": 163, "label": "p163"}]}
{"chunk_id": "SSUs_v1_p163_txt_01_7097b6", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 163, "page_end": 163, "section_path": ["NEUROANAESTHESIA", "Shunt Revision", "Shunt Revision"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Shunt Revision", "keywords": [], "text": "Shunt Revision\nConsiderations:\nNeuro+\n•\nReason for VP shunt revision\no\n?Infection\no\n?ICP\n•\nReview previous anaesthetic chart\n•\nRSI if raised ICP\n•\nMaintain adequate CPP (MAP – ICP)", "citations": [{"type": "pdf_page", "page": 163, "label": "p163"}]}
{"chunk_id": "SSUs_v1_p164_txt_00_e4ca0c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 164, "page_end": 164, "section_path": ["NEUROANAESTHESIA", "Neurostimulation Devices", "Anaesthetic Considerations for Patients with Neurosurgical Implants"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Anaesthetic Considerations for Patients with Neurosurgical Implants", "keywords": [], "text": "Anaesthetic Considerations for Patients with Neurosurgical Implants\nNeurosurgical pts can be safely anaesthetised for non-neurosurg by adhering to general principles\nPre-op: routine +\nGCS + neurological deficits - documented\nNote location +/- path of shunt\nAssess device working (?SSx of raised ICP)\nDrug history:\nAntiplatelets: intracranial stents\nAnti-epileptics\nAnti-parkinsonian drugs", "citations": [{"type": "pdf_page", "page": 164, "label": "p164"}]}
{"chunk_id": "SSUs_v1_p164_txt_01_b9d910", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 164, "page_end": 164, "section_path": ["NEUROANAESTHESIA", "Neurostimulation Devices", "Shunts"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Shunts", "keywords": [], "text": "Shunts\nConsiderations:\nPeritoneal shunts:\nRisk of intracranial CO2 transmission with laparoscopic surgery\nLaparoscopic surgery not CI – one way valve can tolerate pressure <300mmHg no clamp required (plus\nclamping will cease draining + potentially damage device)\nPotential for retrograde infection → meningioencephalitis / ventriculitis\nPresence of shunt may risk presence of abdominal adhesions (especially if multiple revisions)\nVentriculo-plural shunts:\nCXR to assess for any pleural effusions (do not drain, seek neurosurg advice)\nPPV can cause shunt obstruction\nVentriculo-atrial shunts:\nAssess for pulmonary HTN\nIJ + subclavian lines should be avoided\nLumbar-peritoneal: must avoid hypotension, careful patient positioning", "citations": [{"type": "pdf_page", "page": 164, "label": "p164"}]}
{"chunk_id": "SSUs_v1_p164_txt_02_c4010c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 164, "page_end": 164, "section_path": ["NEUROANAESTHESIA", "Neurostimulation Devices", "Intracranial Stents"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Intracranial Stents", "keywords": [], "text": "Intracranial Stents\nMust know: why, when, anatomical location, potential consequences of stent occlusion, antiplt Rx\nOften placed to facilitate coiling of wide-necked aneurysms", "citations": [{"type": "pdf_page", "page": 164, "label": "p164"}]}
{"chunk_id": "SSUs_v1_p164_txt_03_a2c7f5", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 164, "page_end": 164, "section_path": ["NEUROANAESTHESIA", "Neurostimulation Devices", "Neurostimulation Devices"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Neurostimulation Devices", "keywords": [], "text": "Neurostimulation Devices\nTypes:\nVagal nerve stimulators: MOA poorly understood, modulates NT excitability\nDBS: stimulate thalamus/globus pallidus/subthalamic nuclei\nSpinal cord stimulators: stimulate spinal cord at selected levels\nNeuraxial not CI as long as away from stimulator – must obtain op report +/- imaging for details\nIntrathecal baclofen pumps: sited in abdomen s/c → connected to lumbar IT sac (malfunction can cause acute baclofen\nwithdrawal which is a medical emergency)\nNo current peri-op guidelines for neurosurgical stimulators. Check: type / location, date of implantation / last check, SSx control,\nprogrammability, SSx when off, current Rx\nManagement:\nLimit diathermy – place earth plate far from device\nDiscuss plan for defib if required\nMRI safety must be d/w radiology + device technician\nECT safe, turn device off prior", "citations": [{"type": "pdf_page", "page": 164, "label": "p164"}]}
{"chunk_id": "SSUs_v1_p165_txt_00_7ea58a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 165, "page_end": 165, "section_path": ["NEUROANAESTHESIA", "Traumatic Brain Injury", "Traumatic Brain Injury"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Traumatic Brain Injury", "keywords": [], "text": "Traumatic Brain Injury\nBased on brain trauma foundation guidelines. Three phases: treatment, monitoring, target thresholds\nHigh risk C-spine injury\nTreatment: AIM IS TO AVOID SECONDARY INJURY\nBilateral decompressive craniotomies to improve outcomes in pts with persistent ICP elevations (refractory to 1st line\ntreatment) is not recommended in pts without mass lesion(s) e.g. EDH, SDH\nRESCUE ICP trial: decompressive crani → mortality, functional dependence\nA large fronto-temporo-parietal decompression is recommended over a smaller one\nHypothermia: prophylactic not recommended\nHyperosmolar therapy:\nEffective for raised ICP (though avoid subsequent sBP <90mmHg)\nShould be restricted prior to ICP monitoring unless signs of herniation or progressive deterioration\nCSF drainage via EVD zeroed at midbrain:\nContinuous ICP monitoring > intermittent\nCSF drainage in first 12hr if GCS <6 may be considered\nExcessive drainage → herniation\nHyperventilation: only recommended as temporary temporising measure for reduction of ICP – should be avoided in first\n24hr when CBF often critically reduced\nBarbiturate therapy:\nProphylactic burst suppression not recommended without evidence of ICP\nRecommended for refractory ICP resistant to maximal medical therapy\nHaemodynamic stability prior to administration is essential\nSteroids: contra-indicated\nNutrition:\nRecommended by at least D5\nJejunal feeding recommended to reduce VAP\nInfection prophylaxis\nEarly tracheostomy if benefit thought to outweigh complications\nUse of povidone iodine oral care not recommended to reduce VAP and may cause an increase in ARDS\nAntimicrobial impregnated catheters reduce infection related to EVD\nDVT prophylaxis:\nLMWH/UFH +/- mechanical DVT prophylaxis may be used – weigh against risk of ICH expansion (risk v benefit)\nSeizure prophylaxis:\nProphylactic: no evidence\nPhenytoin can reduce early seizures\nNot enough evidence for keppra v phenytoin\nMonitoring:\nICP: indicated in salvageable patient + GCS ≤8 after resuscitation with →\nImaging:\nAbnormal CT scan: haematoma, contusion, swelling, herniation, compressed basal cisterns\nOR normal CT with ≥2: age >40yo, motor posturing, sBP <90mmHg\nShown to in hospital and 2 week mortality\nCPP: recommended, target 60 – 70mmHg\nSjvO2: may be considered\nBrain tissue O2 monitoring is not recommended\nTarget thresholds:\nsBP:\nAge: 15-49yo: ≥110mmHg, 50-69yo ≥100mmHg, >70yo ≥110mmHg\nIf other injury present – compromise sBP 90-100mmHg\nICP: treat if >22mmHg in combination with clinical and CT findings\nCPP: target 60 – 70mmHg – consider autoregulatory range for patient (though avoid aggressive attempts to maintain ≥70 →\nrisk of ARDS)\nOther:\nManage in specialist neurosurgical centre → aim to prevent secondary brain injury\nAvoid hypotonic fluids and albumin\nClassification of severity:\nMild\nGCS 13 – 15\nModerate\nGCS 9 – 12\nSevere\nGCS ≤8", "citations": [{"type": "pdf_page", "page": 165, "label": "p165"}]}
{"chunk_id": "SSUs_v1_p166_txt_00_f3d58e", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 166, "page_end": 166, "section_path": ["NEUROANAESTHESIA", "Endovascular Clot Retrieval", "Endovascular Clot Retrieval"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Endovascular Clot Retrieval", "keywords": [], "text": "Endovascular Clot Retrieval\nGuidelines for eligibility:\nIschaemic stroke with proven large vessel occlusion on CTA (ICA, MCA, basilar)\nIndependent pre-morbid function (MRS 0-2) – consider social and domestic interactions e.g. banking, shopping, driving\nNIHSS ≥5\nTime window: when procedure can be completed within 6 hours (up to 24 hours for basilar stroke)\nIntravenous thrombolysis commenced (if not CI) – alteplase 0.9mg/kg\nAccessible to clot retrieval + assessment by neuro-interventionalist\nConsiderations:\nRemote anaesthesia\nTime is brain – rapid pre-op assessment\nGCS useful for assessing awake versus asleep\nIf asleep – consider D/X blade if predicting difficult airway due to flat\nbed, limited ramping\nNIBP v art line: q1 min BPs and then transduce femoral access / site art line\nafter if safe, otherwise quick art line\nConsider room set up for monitoring – usually all lines on left\nNeuroprotective measures intra-op\nDuring retrieval: haemodynamics (BP target, pts can become vagal), emesis\nEmergence: try to control BP, agitation, neuro assessment (hydrocephalus, worsening ischaemia, rethrombosis)\nGA versus awake:\nPreviously data arguably skewed as more unwell patients more likely to have GA\nSIESTA: in centres with high quality, specialised neuroanaesthesia, GA treated ECR →\nSuperior recanalization rates\nBetter functional outcome at 3 months than patients with conscious sedation\nBlood pressure control:\nCan be loss of autoregulation + possibility of loss of compensatory vasodilatory capability distal to the occluded vessel\nCollateral flow can be compromised during hypotension\nProtect ischaemic penumbra before recanalization\nBP reduction prior to recanalization is associated with larger infarct volumes + worse functional outcomes\nRasmussen et al 2020: MAP <70 for >10mins & MAP >90 for >45mins associated with worse 90 day outcomes\nMAP <70 for 5 min showed shift towards a worse 90 day outcome\nFor each 10 mins MAP <70, odds of shifting towards worse outcomes increased by 30%\nFor every continuous 10 mins with MAP <70 worse outcomes increased by 62%\nMASTERSTROKE – induced targeted hypertension\nSNACC 2014 recommendations:\nChoice of anaesthetic technique should be individualised (propofol → improved functional independence)\nSBP 140-180, DBP <105 (post reperfusion adjust per interventionalist)\nSpO2 >92%, PaO2 >60mmHg\nPaCO2 35-45 (one study shown that mean ETCO2 sig higher in pts with favourable 90 day MRS)\nNormoglycaemia\nEuvolaemia\nPost-op:\nExtubate to assess neurology if able\nStroke unit or ICU\nLie flat for 6hr post-groin puncture\nAspirin at 24-48 hours\nComplete stroke work up\nComplications:\nAngiooedema 2’ thrombolysis\nContrast anaphylaxis\nVessel rupture / ICH +/- haemorrhagic transformation later\nGroin haematoma / vascular injury / retroperitoneal bleed\nECR versus thrombolysis:\nECR 33% v 19% functional independence\n(treatment within 6hr) (MR CLEAN\ntrial)\nECR disability at 90 days (NNT to reduce\ndisability by one level on modified\nrankin scale is 2.6)\nDoor-to-groin puncture time – 1hr\nincrease in onset of reperfusion time\n→ 38%  in good outcome", "citations": [{"type": "pdf_page", "page": 166, "label": "p166"}]}
{"chunk_id": "SSUs_v1_p167_txt_00_c23380", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 167, "page_end": 167, "section_path": ["NEUROANAESTHESIA", "Awake Craniotomy", "Awake Craniotomy"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Awake Craniotomy", "keywords": [], "text": "Awake Craniotomy\nIndication: epileptic foci, eloquent tumour resection (speech, motor, vision), DBS (PD, Tourette's, essential tremor, dystonia)\nScalp block: 7 nerves on each side\nSupraorbital n. (V1): supraorbital notch\n1mL\nSupratrochlear n. (V1): 1cm medial to supraorbital above eyebrow line\n0.5mL\nZygomaticotemporal n. (V2): groove lateral to eye, LOR\n2mL below fascia\nAuriculotemporal n. (V3): 1cm anterior to auricle/tragus, above TMJ\n1mL below, 1mL above fascia\nGreater occipital n. (C2-3): medial to occipital artery, above nuchal line\n5mL\nLesser occipital n. (C2-3): 2.5cm lateral to greater occipital n.\n5mL\nGreater auricular n.: 2cm posterior to auricle at level of tragus\n≤2.5mg/kg 0.2% ropivacaine with adrenaline 1:200,000\nTotal ~20mL\nPre-op:\nPatient selection crucial (must be able to tolerate awake)\nAirway assessment: limited airway access 2’ pins / frame\n+/- functional MRI\nIntra-op seizure foci: surgeons may discontinue or halve anti-epileptics for DBS – do not use benzo pre-med\nWada test: i.e. selective hemispheric testing\nCIs:\nAbsolute: patient refusal, inability to lie still, confusion\nRelative: cough, intellectual disability, inability to lie flat, ESL, OSA/obesity, difficult airway, large expected blood loss\nIntra-op:\nScalp block + local infiltration by surgeons – usually requires imaging prior to commencing\nMonitoring: routine + art line + BIS + capnography\nTechnique: MDT decision – asleep/awake or asleep/awake/asleep or awake throughout with sedation\nAnaesthetic agents: titratable, fast on/off with no effects after cessation (prop/remi/precedex)\nDeepen for: pins, incision, bone flap, dura – discontinue once bone flap removed\nLighten for: cortical mapping, resection\nDeepen for: closure\nEngage with patient, swab soaked with ice water, simple analgesia for back pain, keep warm + IDC (if long / mannitol)\nIntra-op complications:\nSeizures 3-16%: flood area with ice water, may need propofol (airway instrumentation not normally required)\nLoss of airway whilst in head holder: adjuncts + LMA - must know how to rapidly remove frame if needed\nIntracerebral haematoma: must manage hypertension (if substantial haematoma may need craniotomy for DBS)\nVAE 2’ spont venting\nPost-op:\nPONV + systemic analgesia\nICU + neuromonitoring", "citations": [{"type": "pdf_page", "page": 167, "label": "p167"}]}
{"chunk_id": "SSUs_v1_p168_txt_00_df4cf7", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 168, "page_end": 168, "section_path": ["NEUROANAESTHESIA", "Vasospasm", "Venous Air Embolism"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Venous Air Embolism", "keywords": [], "text": "Venous Air Embolism\nPathophysiology: surgery where operating field is above level of the heart or surgical site under pressure\nrisk 2’ major cerebral venous sinuses that are non-collapsible due to dural attachments i.e. venous pressure < atm pressure\nMost commonly: posterior fossa and cervical spine surgery (may also occur in supratentorial procedures)\nRFs: sitting position, posterior fossa surgery, hypovolaemia, CVC insertion / removal\nAll pts should have central access in place to aspirate air (tip 2cm distal to SVC-RA junction)\nPrevention: good surgical technique, volume, early detection + vigilance\nDetection: look for drop in two domains of ETCO2, PAP, CVP, BP, ECG, sats\nAt risk situations consider:\nTOE: gold standard (can detect as small as 0.02mL/kg air in RA)\nPre-cordial doppler (mill-wheel murmur)\nDetermined by volume of air + rate of accumulation (volume for fatal\nembolism 200-300mL)\nManagement:\nDeclare emergency\nPrevent further entrainment:\nInform surgeon\nFlood field with warm saline\nLower the head (below RA) + elevate legs\nTourniquet neck i.e. jugular venous compression\nsize: 100% O2, aspirate CVC, stop NO2\nOvercome mechanical obstruction: position, PEEP, vasopressors + inotropic support\nResuscitate: consider compressions to break up\nM&M 2’ hypoxia, pHTN +/- RHF, paradoxical air embolus\nParadoxical Air Embolism\nPFO ~25% all pts. Likely requires significant right heart pressure + air volume.\nRisk:\nby: PEEP (previously used to risk of VAE – now abandoned)\nby: generous fluid administration\nTreatment:\nHyperbaric O2 therapy: improves prognosis in cerebral gas embolism, start <8 hr", "citations": [{"type": "pdf_page", "page": 168, "label": "p168"}]}
{"chunk_id": "SSUs_v1_p168_txt_01_fbdb52", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 168, "page_end": 168, "section_path": ["NEUROANAESTHESIA", "Vasospasm", "Vasospasm"], "specialty_tags": ["NEUROANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Vasospasm", "keywords": [], "text": "Vasospasm\nDefinition: observed narrowing of intracranial arteries (though most occur in small vessels)\nPathophysiology: Hb breakdown byproduct → vessel spasm (volume of bleed ∝ vasospasm)\nPrevention: nimodipine 60mg q4 hourly for 21 days – commence within 48hr post-event (morbidity, but does not vasospasm\non DSA) – selective for cerebral circulation, improves outcomes 2’:\nDilation of small arteries not seen on angio\nCa2+ dependent excitotoxicity\nplt aggregation (~40% in cerebral infarction and poor outcomes)\nSSx: change in sensorium or new neurological deficit - commonly D4-14 (highest D7-10) but can persist up to D21\nDiagnosis:\nDSA (gold standard): up to 70% of patients with SAH detected on DSA – 30% have clinical symptoms\nDiagnostic +/- therapeutic via balloon angioplasty and/or intra-arterial vasodilators (CCB, milrinone, papaverine)\nManagement: triple H i.e. hypervolaemia, hypertension, haemodilution (new management suggests normovolaemia)\nFor surgery: aim for waking BP\nNo evidence for statins or MgSO4", "citations": [{"type": "pdf_page", "page": 168, "label": "p168"}]}
{"chunk_id": "SSUs_v1_p169_txt_00_b584e9", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 169, "page_end": 169, "section_path": ["NEUROANAESTHESIA", "Neurosurgery Cardiac Arrest", "Tension Pneumocephalus"], "specialty_tags": ["NEUROANAESTHESIA", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Tension Pneumocephalus", "keywords": [], "text": "Tension Pneumocephalus\nMostly occur in posterior fossa surgery and supratentorial surgery. Can use NO2 prior to closure (may have clinical advantage,\nmay resorb quicker), but do not use after. Mass effect likely worse post-op due to supine position + extubation. Rx: drill-hole +\ndural needle puncture. May also develop de novo if there is a residual dural defect between nasal sinuses + intracranial space.", "citations": [{"type": "pdf_page", "page": 169, "label": "p169"}]}
{"chunk_id": "SSUs_v1_p169_txt_01_2b8a3a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 169, "page_end": 169, "section_path": ["NEUROANAESTHESIA", "Neurosurgery Cardiac Arrest", "Seizures"], "specialty_tags": ["NEUROANAESTHESIA", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Seizures", "keywords": [], "text": "Seizures\nCan occur awake or anaesthetised (less common).\nCauses:\nNeurosurgical: cortical stimulation, high risk tumour resection (frontal, temporal), acute haemorrhage, ischaemia\nNon-neurosurgical: metabolic, hypocapnia, drug withdrawal, subtherapeutic anticonvulsants\nSSx: difficult if paralysed – may need to rely on tachycardia, hypertension, hypercapnia, EEG\nManagement:\nABCDE\nCease surgical cause if able\nCold saline irrigation\nRx: propofol (0.5 – 1mg/kg), midazolam (2-5mg), thio (2-5mg/kg)\nBite block\nMDT decision re: anticonvulsants", "citations": [{"type": "pdf_page", "page": 169, "label": "p169"}]}
{"chunk_id": "SSUs_v1_p169_txt_02_557ea6", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 169, "page_end": 169, "section_path": ["NEUROANAESTHESIA", "Neurosurgery Cardiac Arrest", "Neurosurgery Cardiac Arrest"], "specialty_tags": ["NEUROANAESTHESIA", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Neurosurgery Cardiac Arrest", "keywords": [], "text": "Neurosurgery Cardiac Arrest\nConfirm arrest (clinical signs, monitoring, O2 to 100%)\nInform team + eliminate surgical cause\nAsystole: consider retraction, instrumentation\nVAE: flood field with saline, put patient head down if possible\nBleeding: control haemorrhage as best able (whilst minimising trauma / contamination)\nIf CPR not effective/possible in patient’s position → flip patient +/- release pins – ensure head is supported\nSTART ALS with specific considerations\nGive initial adrenaline boluses of 50-100mcg IV (up to 1mg – if no ROSC subsequent 1mg doses in cycles)\nTTE ASAP to check for VAE", "citations": [{"type": "pdf_page", "page": 169, "label": "p169"}]}
{"chunk_id": "SSUs_v1_p170_txt_00_d1b0d6", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 170, "page_end": 170, "section_path": ["SIADH", "Diabetes Insipidus", "Hyponatraemia"], "specialty_tags": ["SIADH"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Hyponatraemia", "keywords": [], "text": "Hyponatraemia\nSeverity: mild 130 – 135, mod 126 – 129, severe <125\nHyponatraemia\nHypovolaemia\nNormovolaemia\nHypervolaemia\nCerebral salt wasting\nAdrenal insufficiency\nKetonuria\nGI losses\nSweating\nBlood loss\nDiuretics\nSIADH\nThiazides\nAdrenal insufficiency\nHypothyroidsm\nIatrogenic\nCCF\nRenal failure\nLiver failure\nIatrogenic\nIncidence: SAH 50%, TBI 20%, brain tumours 15%\nSIADH\nImpaired water excretion due to inability to suppress ADH\nNormovolaemia (or mild hypervolaemia)\nCauses: TBI, SAH, CNS tumour / infection, drug induced (AEDs), pulmonary pathology (particularly pneumonia)\nCause: ADH release at a lower threshold →\nSerum osmols <280mOsm/kg\nNa <135\nUrine osmolality > serum osmolality (i.e. inappropriately concentrated)\nUrine Na >18mM\nNormal renal, adrenal and thyroid function\nRx: treat cause, fluid restriction (self-limiting), hypertonic saline if severe\nCerebral Salt Wasting\nTriad: low or normal Na, high or normal serum osmols, volume contraction, high urine sodium (>50mM)\nCauses: SAH (correlated with symptomatic vasospasm), TBI, tumour, stroke, infection\nPathophysiology: BNP → aldosterone synthesis → renal sodium loss\nRx: IVF replacement with normal/hypertonic saline (endpoint – normovolaemia, normonatraemia), fludricortisone, sodium\ntablets", "citations": [{"type": "pdf_page", "page": 170, "label": "p170"}]}
{"chunk_id": "SSUs_v1_p170_txt_01_271d24", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 170, "page_end": 170, "section_path": ["SIADH", "Diabetes Insipidus", "Hypernatraemia"], "specialty_tags": ["SIADH"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Hypernatraemia", "keywords": [], "text": "Hypernatraemia\nDiabetes Insipidus\nCause: failure of ADH release from HPA\nDiabetes insipidus:\n>3L/day, or >4mL/kg/hr of abnormally dilute urine\nSerum sodium >145\nUrine osmols <350mmol/kg\nSerum osmols >310mmol/kg\nSSx: polyuria, polydipsia, thirst\nDI tri-phasic:\nPolyuria: 4-8 days due to HPA dysfunction\nAnti-diuretic phase: 2-14 days of uncontrolled ADH release\nRecurrence of DI: once store is depleted (often permanent)\nRx:\nIVF: hourly maintenance + 2/3 previous hour’s urine volume – type of fluid dictated by pt electrolytes\nDDVAP 200-400mcg IV q6-12hr (usually when hourly requirement is >400mL)", "citations": [{"type": "pdf_page", "page": 170, "label": "p170"}]}
{"chunk_id": "SSUs_v1_p171_txt_00_fa767a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 171, "page_end": 171, "section_path": ["OPTHALMOLOGY", "Opthalmology"], "specialty_tags": ["OPTHALMOLOGY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Opthalmology", "keywords": [], "text": "Opthalmology\nAnatomy:\n•\nOptic foramen:\no\nOptic nerve\no\nOphthalmic artery (ICA)\n•\nOrbit:\no\nDepth: 40-50mm\no\nVolume: 30mL\n▪\nGlobe 7mL\n▪\nAxial length (corneal surface → retina): 25mm (axial length >26mm i.e. myopia → subtenon or GA)\n•\nInnervation:\no\nMotor: all oculomotor (CN III) apart from:\n▪\nSO 4\n▪\nLR 6\n▪\nOrbicularis oculi CN 7\no\nSensory:\n▪\nV1\n▪\nV2\no\nAutonomic:\n▪\nSNS: ciliary nerves (superior cervical ganglion)\n▪\nPNS: oculomotor\nCompartments:\n•\nGlobe\n•\nPre-septal space\n•\nPeribulbar (extraconal):\no\nPosterior to septum outside cone\no\nContents: lacrimal and frontal nerves\no\nCN IV\n•\nRetrobulbar (intraconal)\no\nPosterior to septum within rectus muscles\no\nCN II, III, VI, nasociliary n., ciliary ganglion\no\nOphthalmic vessels\nOcular reflexes:\n•\nOculocardiac: trigeminal → vagus (release, LA, atropine) – avoid CO2\n•\nOculorespiratory: trigeminal → pons (control ventilation)\n•\nOculoemetic: trigeminal → vagus – best treated with regional block\nAbove common in strabismus Sx.", "citations": [{"type": "pdf_page", "page": 171, "label": "p171"}]}
{"chunk_id": "SSUs_v1_p172_txt_00_20baef", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 172, "page_end": 172, "section_path": ["OPTHALMOLOGY", "Intraocular Pressure", "Intraocular Pressure"], "specialty_tags": ["OPTHALMOLOGY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Intraocular Pressure", "keywords": [], "text": "Intraocular Pressure\nIOP: tension exerted by contents of the globe on surrounding corneo-scleral envelope\nNormal: 10-20mmHg; IOPP = MAP - IOP\nRole:\n•\nMaintain corneal curvature\n•\nMaintain refracting index\nContents are a fixed volume except:\n•\nAqueous humour: actively secreted by ciliary body (Na-K-ATPase, carbonic anhydrase)\no\nPosterior to anterior chamber via pupil → canal of schlemm → episcleral veins; production relatively constant\no\nImpaired drainage:\n▪\nOpen angle glaucoma: sclerosis of trabecular network\n▪\nClosed angle glaucoma: obstructed drainage\n▪\nCVP\n•\nChoroidal blood volume\nFactors affecting IOP:\n•\nStatic:\no\nwith age\no\nIOP  axial length\n•\nDynamic:\no\nDiurnal; highest in morning\no\nArterial blood: aurtoregulated, fall IOP\nAffect of anaesthesia:\nIOP\nIOP\nNo Effect on IOP\nHyperthemia\nForeign body\nSuxamethonium\nLaryngoscopy\nOcular blocks\nCO2, O2\nCoughing, straining, vomiting\nValsalva\nCVP\nSupine, prone, trendelenberg\nMechanical obstruction i.e. tube tie\nMetabolic alkalosis\nOpioids + sedation (except ket)\nAcetazolamide\nMannitol\nB-blockers\nMetabolic acidosis\nKetamine\nMidaz\nNon-depolarising NMBAs\nLMA\nMost important is episcleral venous pressure determined by CVP\nConsequences of IOP:\n•\nOpen eye injury → expulsion of contents\n•\nRetinal artery occlusion\n•\nRetinal ischaemia\n•\nVisual field loss\nAnaesthetic goals:\n•\nBalance aspiration risk with IOP risk; smooth induction\n•\nAvoid coughing / straining\n•\nBlunt HTN to laryngoscopy\n•\nLPV with normoxia, ETCO2 35 – 40\n•\nTape ETT\n•\nAvoid PONV\n•\nSmooth extubation", "citations": [{"type": "pdf_page", "page": 172, "label": "p172"}]}
{"chunk_id": "SSUs_v1_p173_txt_00_214eaa", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 173, "page_end": 173, "section_path": ["OPTHALMOLOGY", "Pre-Op Assessment", "Pre-Op Assessment"], "specialty_tags": ["OPTHALMOLOGY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pre-Op Assessment", "keywords": [], "text": "Pre-Op Assessment\nGoals:\n•\nOptimise\n•\nCounsel, consent\n•\nAscertain if suitable for day case\nASSESS:\n•\nHistory::\no\nAbility to lie flat + still (movement disorder, backpain, vertigo, claustrophobia)\no\nUrinary / faecal incontinence\no\nHearing impairment\no\nCognition / capacity\no\nCoagulation\no\nOpthal history: axial length, scleral buckle\n▪\nRisk of long axial length:\n•\nKnown myopia + history of vision improving with age\n•\nPrescription stronger than -4\n•\nExam:\no\nNystagmus\no\nFlat\no\nSingle eye → GA (do not risk block)\n•\nIx:\no\nCoags if indicated\no\nOpthal imaging (axial length)\nMANAGE:\n•\nContinue all meds\n•\nCoagulation as required (usually continue)\nDay of Surgery:\n•\nBP:\no\n>180 – defer\no\n<180 but high → give reg antihypertensives if missed, or treat aiming <160 + move later in list\n•\nMark side\n•\nEnsure no active infection\n•\nEnsure pre-op drops\no\nInadequate dilatation after phenylephrine:\n•\nBlock (may dilate)\n•\nIf still inadequate give IV labetalol aiming sBP <160 then administer phenylephrine 2.5% to anterior\nchamber\n•\nDon’t block until marked if toric lens\nIntra-op:\n•\nO2 under drapes\n•\nComfort padding / positioning\n•\nHead up slightly venous drainage\n•\nIf GA use TIVA →\no\nNeutral gaze (cf sevo)\no\nRemi reduces cough", "citations": [{"type": "pdf_page", "page": 173, "label": "p173"}]}
{"chunk_id": "SSUs_v1_p174_txt_00_38c62f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 174, "page_end": 174, "section_path": ["OPTHALMOLOGY", "Day Surgery", "Ophthalmic Drops"], "specialty_tags": ["OPTHALMOLOGY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Ophthalmic Drops", "keywords": [], "text": "Ophthalmic Drops\nClass\nExample\nUse\nSE\nBeta blockers\nTimolol, betaloc\nIOP\nBradycardia, bronchospasm\nPGs\nLantanoprost\nIOP\nBronchospasm\nCA inhibitors\nAcetazolamide,\nbrinzolamide\nIOP\nRenal H2O + electrolyte loss, hyperCl- metabolic\nacidosis\nNSAIDs\nDiclofenac\nAnalgesia\nGI upset, bronchospasm\nSympathomimetic\nPhenylephrine\nPupil dilation\nTachycardia, hypertension\nAntimuscarinics\nCyclopentolate, atropine\nPupil dilation\nDry MM, tachycardia, vomiting", "citations": [{"type": "pdf_page", "page": 174, "label": "p174"}]}
{"chunk_id": "SSUs_v1_p174_txt_01_3268ec", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 174, "page_end": 174, "section_path": ["OPTHALMOLOGY", "Day Surgery", "Day Surgery"], "specialty_tags": ["OPTHALMOLOGY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Day Surgery", "keywords": [], "text": "Day Surgery\nRCOA.\nAppropriate protocols, set up, pre-op assessment within 3mo.\nMonitoring: clinical, pulse ox, ECG, BP\nSuitably trained person for monitoring throughout anaesthesia + surgery\nEveryone trained in BLS, one person at least with ALS.\nDC: criteria, someone to accompany home, written instructions + emergency contact", "citations": [{"type": "pdf_page", "page": 174, "label": "p174"}]}
{"chunk_id": "SSUs_v1_p175_txt_00_1a7d4b", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 175, "page_end": 175, "section_path": ["OPTHALMOLOGY", "Retrobulbar Block", "Peribulbar Block"], "specialty_tags": ["OPTHALMOLOGY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Peribulbar Block", "keywords": [], "text": "Peribulbar Block\nI: intraocular surgery requiring anaesthesia + akinesia for <2hr\nCI: refusal, allergy, nystagmus, myopia (axial length >26mm), staphyloma, enophthalmos, extended surgery, coagulopathy\nPerformance: CIMPLE-D\n•\nAmethocaine 1% to globe\n•\nRopivacaine 1%:lignocaine 2% 50/50 + hyalase 15units / mL\n•\n25G 25mm needle – Atkinson needle\n•\nSupine, retract lower lid, 2/3 lateral from middle canthus to lateral canthus\n•\nOrbital floor – observe for globe movement\n•\nDirect 20 degrees up when past equator, <25mm\n•\n-ve aspiration\n•\nInject 5 – 8mL (reposition if resistance)\n•\nStop if lid closes quickly or globe is tense / proptosed\n+Top up: middle canthal ligament (up to 5mL)\nComplications:\n•\nGlobe perf\n•\nCentral spread\n•\nRetrobular haemorrhage\n•\nOptic nerve atrophy\n•\nMuscular palsy / myopathy\n•\nIV injection\n•\nChemosis (less than subtenon)", "citations": [{"type": "pdf_page", "page": 175, "label": "p175"}]}
{"chunk_id": "SSUs_v1_p175_txt_01_db1d39", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 175, "page_end": 175, "section_path": ["OPTHALMOLOGY", "Retrobulbar Block", "Retrobulbar Block"], "specialty_tags": ["OPTHALMOLOGY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Retrobulbar Block", "keywords": [], "text": "Retrobulbar Block\nI & CI as above\nDisadvantages:\n•\nHigher risk major complications\n•\nNo lid paralysis (may need to be supplemented)\n•\nSharp needle technique\nPerformance: CIMPLE-D\n•\nAs above +\n•\nPast equator direct towards apex\n•\nDepth 25 – 35mm\n•\n2-4mL LA\n+ facial nerve block: 1cm lateral to orbital rim 2 – 4mL LA\nComplications:\n•\nGlobe perf 0.5%\n•\nBrainstem anaesthesia 1/1000\n•\nRetrobular haemorrhage 1%\n•\nOptic nerve atrophy\n•\nMuscular palsy / myopathy\n•\nIV injection\nComplication\nSSx\nManagement\nRetrobulbar\nhaemorrhage\nProptosis, IOP, VA\nEarly:\n•\nExternal pressure (tamponade)\n•\nMannitol / acetazolamide\nSurgical:\n•\nLateral canthotomy\n•\nOrbital decompression\n+ continuous ECG – risk of oculocardiac reflex\nGlobe injury\nPain, VA\nImmediate opthal input\nBrainstem anaesthesia\nSupportive", "citations": [{"type": "pdf_page", "page": 175, "label": "p175"}]}
{"chunk_id": "SSUs_v1_p176_txt_00_e712fb", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 176, "page_end": 176, "section_path": ["OPTHALMOLOGY", "Intra-Ocular Gas", "Subtenon"], "specialty_tags": ["OPTHALMOLOGY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Subtenon", "keywords": [], "text": "Subtenon\nI: intraocular surgery requiring anaesthesia + akinesia for <2hr, adult strabismus, optic sheath fenestration\nCI: refusal, allergy, inability to lie still / flat, confusion, gross coagulopathy, perforated globe, trauma, scleral buckle, OI\nBenefits:\n•\nGood anaesthesia / akinesia\n•\nSafe in anticoagulation\n•\nrisk major complications\nPerformance:\n•\nTetracaine 0.5% to globe + iodine half strength 5%\n•\nDrape\n•\nBarraquer speculum\n•\nLook “up and out” to expose inferonasal quadrant\n•\nNon-toothed forceps – lift conjunctiva + tenons fascia from limbus\n•\nWescott scissors – small cut\n•\nBlunt dissect\n•\nSubtenon cannula 19G 25mm → posterior equator\n•\nLA solution 3 – 5mL\n•\nGentle pressure\nComplications:\n•\nMinor: chemosis, subconjunctival haemorrhage, disrupted conjunctiva\n•\nMajor: retrobulbar haemorrhage, globe injury, muscular palsy, myotoxicity, brainstem anaesthesia\nBenefits of hyalase:\n•\ntissue permeability\n•\ndispersion\n•\norbital pressure after injection\n•\nblock quality\n•\nspeed of onset\nMOA: hydrolysis of hyaluronic acid in ECM", "citations": [{"type": "pdf_page", "page": 176, "label": "p176"}]}
{"chunk_id": "SSUs_v1_p176_txt_01_be47a6", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 176, "page_end": 176, "section_path": ["OPTHALMOLOGY", "Intra-Ocular Gas", "Intra-Ocular Gas"], "specialty_tags": ["OPTHALMOLOGY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Intra-Ocular Gas", "keywords": [], "text": "Intra-Ocular Gas\nUsed for retinal tamponade.\nMay have to be prone for one week.\nAvoid N2O.\nUse peribulbar block (subtenon may increase risk of oedema → issues with ports, discuss with opthal)\nGases:\n•\nSulfur hexafluride (SF6) – 3 weeks\n•\nOctafluoropropane (C3P8) – 8 weeks\nAvoid air travel until an ophthalmologist has documented that the bubbles have completed absorbed\nLA\nOnset\nDuration\nLignocaine 2%\n5 – 10 min\n30 – 60 mins\nBupivacaine 0.5%\n10 – 15 min\n2 – 4 hours\nRopivacaine 0.75%\n10 – 15 min\n1.5 – 2 hours\n50:50 lig + ropiv\n5 – 10 min\n1 – 3 hours\n+/- clonidine, dexmed, HCO3 (avoid adrenaline)", "citations": [{"type": "pdf_page", "page": 176, "label": "p176"}]}
{"chunk_id": "SSUs_v1_p177_txt_00_a3602b", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 177, "page_end": 177, "section_path": ["OPTHALMOLOGY", "Penetrating Eye Injury", "Penetrating Eye Injury"], "specialty_tags": ["OPTHALMOLOGY"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Penetrating Eye Injury", "keywords": [], "text": "Penetrating Eye Injury\nEstablish mechanism of injury +/- other injuries\nGoal:\n•\nAvoid IOP and extrusion of contents\nPre-op:\n•\nVisual assessment should be documented\n•\nAssess all trauma imaging\n•\nOpen globe:\no\nExamine carefully to avoid extrusion of contents\no\nShield at all times – do not pad\n•\nAdditional management:\no\nAntibiotics: ciprofloxacin\no\nOndansetron\no\nTetanus\no\nPain relief\nIntra-op: regional usually CI\n•\nAvoid coughing / retching / straining / forceful blinking / crying\no\nExtreme caution with BVM – avoid eye\n•\nRSI if unfasted – MILS + X-blade if C-spine not cleared\no\nProfound analgesia / depth prior to laryngoscopy\no\nDexmedetomidine +/- IV lignocaine → significant IOP\no\nNMBA:\n▪\nNo published reports of extrusion 2’ sux if co-administered with adequate anaesthetic\n▪\nNon-depolarising: nerve stimulator to avoid laryngoscopy without paralysis\n•\nMaintenance: prop + remi TCI\n•\nPONV +++\n•\nSmooth extubation to avoid coughing, retching", "citations": [{"type": "pdf_page", "page": 177, "label": "p177"}]}
{"chunk_id": "SSUs_v1_p178_txt_00_be98be", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 178, "page_end": 178, "section_path": ["ORTHOPAEDICS", "Hip Arthroplasty", "Orthopaedics"], "specialty_tags": ["ORTHOPAEDICS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Orthopaedics", "keywords": [], "text": "Orthopaedics\nICAROS 2019: lower odds or no difference for most complications of hip/knee arthroplasty between spinal v GA except urinary\nretention in spinal group", "citations": [{"type": "pdf_page", "page": 178, "label": "p178"}]}
{"chunk_id": "SSUs_v1_p178_txt_01_cd6619", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 178, "page_end": 178, "section_path": ["ORTHOPAEDICS", "Hip Arthroplasty", "Hip Arthroplasty"], "specialty_tags": ["ORTHOPAEDICS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Hip Arthroplasty", "keywords": [], "text": "Hip Arthroplasty\nCI:\n•\nInfection – local or systemic\n•\nMedical CI\n•\nQuadriplegia\nPre-op:\n•\nStaph aureus decolonisation\n•\nPre-op chlorhexidine skin wash\n•\nAvoid shaving / hair removal\n•\n/cease opioid use\n•\nPrehabilitation\nIntra-op:\nRegional > GA – but mostly similar outcomes\n+PROSPECT 2021\nPre-op or intra-op:\n•\nParacetamol\n•\nNSAID\n•\nEducation\n•\nExercise\nIntra-op:\n•\nSpinal or GA\n•\nDex 8mg\n•\nSingle shot FIB or LA infiltration\n•\nConsider IT morphine 100mcg\nPost-op:\n•\nParacetamol\n•\nNSAID\n•\nRescue opioid\nNot recommended:\n•\nGabapentin\n•\nKetamine\n•\nOther nerve blocks\n•\nSurgical technique has minimal effect", "citations": [{"type": "pdf_page", "page": 178, "label": "p178"}]}
{"chunk_id": "SSUs_v1_p179_txt_00_4804ed", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 179, "page_end": 179, "section_path": ["ORTHOPAEDICS", "Hip Fracture Surgery", "Hip Fracture Surgery"], "specialty_tags": ["ORTHOPAEDICS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Hip Fracture Surgery", "keywords": [], "text": "Hip Fracture Surgery\nAssociation of Anaesthetists 2020 guidelines\nRecommendations:\n•\nExperienced surgeon + anaesthetist\n•\nAnaesthetists should participate in formal pathways\n•\nSurgery <36hr post injury (delay >24hr risk of delirium by 2x)\no\nHIP ATTACK: surgery <6hr did not significantly risk of mortality or composite of major complications\n▪\nBenefits: delirium, LOS, mobilisation\n•\nAim for early remobilisation + rehab\n•\nParticipation in peri-op data (focusing on first 5 post-op days)\n•\nAll trainees should receive specific training in NOFs\nPre-op:\n•\nPatient information + education\n•\nAssess: comorbidities, frailty, risk of delirium – mostly non-\nmodifiable\n•\n?other injuries\n•\nRisk:\no\nMortality: Nottingham Hip Fracture Score\no\nFrailty Score\n•\nMDT w/ orthogeris\n•\nNerve block: FIB with US – rpt after 6hr\n•\nTTE only if sig CVS decline or concern - shouldn’t delay surgery – rather should inform anaesthetic\n•\nResuscitation plan documented\nIntra-op:\n•\nGA or spinal: ASAP2 – no difference in mortality based on technique (mortality associated with hypotension)\no\nRegional: single shot FIB block should supplement either technique\no\nEnsure LCNT blocked either with FIB or separately\n•\nPropofol TCI sedation\n•\nAvoid intra-op hypotension → associated with mortality @ 5 and 30 days\no\nAssociated with higher doses of spinal LA – suggested 1.5mL bupivacaine 0.5% plain (7.5mg) + no opioid\no\nAim MAP >70 or within 20% baseline\n•\nrisk of bone cement implantation syndrome\n•\nHb target variable:\no\nAim Hb >90 if frail\n▪\n>100 if frail + IHD\no\nHb >70-80 if younger / robust\n•\nTXA: transfusion\nPost-op:\n•\nAim:\no\nMobilise by D1 post-op\n▪\nPrevent pain, hypotension, delirium\n•\nIf fatigue / dizziness delaying\nmobilisation → Hb >100\no\nRecommence ADLs by D2-D5\n▪\nPrevent constipation, urinary retention,\ndelirium\n•\n4As / CAM ICU\n•\nRehab\n•\nOrthogeris care\nAnticoagulation & spinal anaesthesia:\n•\nSingle antiplatelet: not a CI – must weigh risk / benefit\n•\nDAPT: GA unless very good reason not to\n•\nWarfarin:\no\nAF, DVT/PE: stop warfarin, check INR, give vit K 5mg\n▪\nRecheck INR 4-6hr: <1.5 → surgery, >1.5 further\nvit K 5mg or PCC\n▪\nSurgery if INR <2, INR <1.5 can have spinal\n▪\nRestart 12 hours post-op – consider bridging\no\nMechanical valves: haematologist involvement +\nbridging\n•\nDOACs: confirm last dose + document\no\nApixaban / rivaroxaban:\n▪\nGood renal function: wait 2x half lives (1x ½ life:\napixaban / rivaroxaban 12hr)\n▪\neGFR <60: wait 4x half lives\n▪\nOr monitor anti-Xa\no\nDabigatran (half life 15 hours) – cease on arrival, plan\nfor surgery following afternoon\n▪\nDOS: take TT if normal proceed, if prolonged\ncontact haematology +/- idarucizumab\nMonitor for vertebral canal haematoma: back pain, numbness,\nmotor weakness, bowel / bladder incontinence\n7 acceptable reasons to delay surgery: try to correct ASAP\n•\nHb <80\n•\nNa <120 or >150, K <3.8 or >6.0\n•\nUncontrolled diabetes\n•\nUncontrolled LV failure\n•\nCorrectable cardiac arrhythmia at >120bpm\n•\nChest infection with sepsis\n•\nReversible coagulopathy", "citations": [{"type": "pdf_page", "page": 179, "label": "p179"}]}
{"chunk_id": "SSUs_v1_p180_txt_00_ee7b97", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 180, "page_end": 180, "section_path": ["ORTHOPAEDICS", "Knee Arthroplasty", "Knee Arthroplasty"], "specialty_tags": ["ORTHOPAEDICS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Knee Arthroplasty", "keywords": [], "text": "Knee Arthroplasty\nCI:\n•\nInfection – local or systemic\n•\nMedical CI\n•\nSkin integrity breakdown at site\n•\nLL ischaemia\nPre-op:\n•\nStaph aureus decolonisation\n•\nPre-op chlorhexidine skin wash\n•\nAvoid shaving / hair removal\n•\n/cease opioid use\n•\nPrehabilitation\nIntra-op:\n•\nRegional > GA – but be patient specific\n•\nBlood loss:\no\nTourniquet\no\nTXA\n•\nDexamethasone\nRegional blocks:\n•\nFemoral: delayed mobilisation 2’\nquadriceps weakness\n•\nSciatic nerve: foot drop\n•\nAdductor canal block:\no\nBenefits: analgesia v placebo, quads weakness\no\nDisadvantages: 1/800 risk myotoxicity, medial knee only\n•\niPACK block:\no\nInterspace between popliteal artery and posterior capsule of knee\no\nMotor sparing sciatic block – spares tibial and peroneal nerves\n•\nLA by surgeons\nPost-op:\n•\nAnalgesia:\no\nParacetamol\no\nNSAIDs\no\nRescue opioids\no\nConsider adductor canal catheter\n•\nERAS\nNo evidence for gabapentinoids\nComplications:\n•\nNeuropathic pain 12%\n•\nHaematoma\n•\nDVT/PE\n•\nMACE\n•\nPRAE\n•\nPeroneal nerve palsy\n•\nBCIS\nSpinal\nBenefits\nComplications\n•\nDVT/PE\n•\ntransfusion requirement\n•\nrespiratory complications\n•\nLOS\n•\nIT opioid: urinary\nretention, resp\ndepression, pruritis", "citations": [{"type": "pdf_page", "page": 180, "label": "p180"}]}
{"chunk_id": "SSUs_v1_p181_txt_00_23ddeb", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 181, "page_end": 181, "section_path": ["ORTHOPAEDICS", "Shoulder Arthroplasty", "Shoulder Arthroplasty"], "specialty_tags": ["ORTHOPAEDICS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Shoulder Arthroplasty", "keywords": [], "text": "Shoulder Arthroplasty\nInnervation:\n•\nCervical plexus C3-C4:\no\nSupraclavicular nerve\n•\nBrachial plexus C5-C6:\no\nSuprascapular nerve\no\nAxillary nerve\no\nLateral pectoral nerve\no\nMusculocutaneous nerve\no\nSubscapular nerve\n•\nUpper arm:\no\nSuperior lateral cutaneous n. of arm\no\nMedia cutaneous n. of arm\no\nIntercostobrachial nerve\nBeach chair:\n•\nBenefits:\no\nImproved surgical access posteriorly\no\nVenous bleeding\n•\nRisks:\no\nPoor access to airway\no\nCerebral ischaemia\no\nPressure areas\no\nAir embolism\no\nBrachial plexus injury\nPre-op:\n•\nASSESS:\no\nSuitability for beach chair\no\nSuitability for beach chair i.e. risk of phrenic nerve block\nIntra-op:\n•\nInterscalene: pain, PONV, sedation, LOS\n•\nPositioning + padding in beach chair (including head foam – check eyes)\n•\nMonitoring: ANZCA standard, art line, NIRS, BIS\n•\nTarget high-normal CO2 to CBF\n•\nDexamethasone IV", "citations": [{"type": "pdf_page", "page": 181, "label": "p181"}]}
{"chunk_id": "SSUs_v1_p182_txt_00_30582d", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 182, "page_end": 182, "section_path": ["ORTHOPAEDICS", "Bone Cement Implantation Syndrome", "Bone Cement Implantation Syndrome"], "specialty_tags": ["ORTHOPAEDICS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Bone Cement Implantation Syndrome", "keywords": [], "text": "Bone Cement Implantation Syndrome\nReversible reaction to cementing.\nRisk factors:\n•\nPatient:\no\nAge\no\nASA 3-4\no\nSignificant cardiac disease\no\nPulmonary hypertension\no\nOsteoporosis\n•\nSurgical:\no\nPathological #\no\nIntra-trochanteric #\no\nLong stem arthroplasty\no\nNot previously instrumented\nGA v spinal – no effect on risk\nPathophysiology: likely combination embolic v anaphylactoid\nPrevention / risk : GOOD COMMUNICATION\n•\nAnaesthetic:\no\nPre-assign crisis roles\no\n≥1 risk factor: CO monitoring\no\nPrior to cementing: FiO2, adequate preload, vasopressor\no\nVigilance\n•\nSurgical:\no\nAvoid cement\no\nThorough intramedullary lavage (removes debris)\no\nVenting hole in distal femoral shaft (relieves pressure)\no\nVacuum cementing\no\nRetrograde insertion\nDetection:\n•\nClinical: hypotension, tachycardia, desaturation, ETCO2, cardiac arrest\n•\nInvestigations:\no\nTTE/TOE: right heart dysfunction\nSeverity:\n•\nGrade 1: mild (sats <94%, sBP >20%)\n•\nGrade 2: severe (sats <88%, sBP >40%)\n•\nGrade 3: cardiac arrest\nResuscitation / management:\n•\nA/B: 100% FiO2\n•\nC:\no\nRight heart support + PVR\no\nConsider TOE guided resus", "citations": [{"type": "pdf_page", "page": 182, "label": "p182"}]}
{"chunk_id": "SSUs_v1_p183_txt_00_cdf82e", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 183, "page_end": 183, "section_path": ["ORTHOPAEDICS", "Fat Embolisation Syndrome", "Fat Embolisation Syndrome"], "specialty_tags": ["ORTHOPAEDICS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Fat Embolisation Syndrome", "keywords": [], "text": "Fat Embolisation Syndrome\nPresence of fat globules in circulation.\nCauses:\n•\nTrauma: most\no\nLong bone or pelvic fracture (risk multiple long bone #)\n•\nNon-trauma:\no\nAcute illness e.g. pancreatitis, sickle cell, OM, DM, fatty liver disease\n•\nIatrogenic:\no\nSteroids\no\nLiposuction\no\nCosmetic surgery\nEpidemiology:\n•\nFemoral shaft # 98% of patients\n•\nMedullary reaming 88% of patients\nPathophysiology:\n•\nBM → venous circulation → 3 theories\no\nMechanical / embolic\no\nBiochemical / inflammatory\no\nCoagulation\n→\n•\nPulmonary: alveolar damage, hypoxia, ARDS, oedema, haemorrhage\n•\nSystemic organs\nPresentation: rare during surgery – usually 24 – 72 hr post injury\n•\nTriad: not all pts – same as GURD’s major criteria\no\nHypoxia (96%) – resp SSx most common + earliest\no\nCNS disturbance\no\nSkin rash\n+/- resp / cardiac / neurological / renal / jaundice / Purtsche’s retinopathy, anaemia / thrombocytopaenic, coagulopathy\nFulminant i.e. CVS collapse v rare\nGURD’s criteria: 1 major + 4 minor\n•\nMajor: (triad)\no\nHypoxia : hypoxaemia + bilateral imaging \no\nCNS signs\no\nSkin / rash petechiae\n•\nMinor:\no\nHR\no\nFever\no\nFundoscopic \no\nHct or plt\no\nESR\no\nFat globules in sputum\nRisk minimisation:\n•\nEarly surgical fixation of long bone #\n•\nintramedullary pressure in OT\nManagement (suuportive):\n•\nNIV/intubation\n•\nNeuroprotection\n•\nCVS: IVF, pressors, inotropes, pulmonary vasodilators +/- ECMO\n•\nDrugs:\no\nAspirin if CNS SSx\nNo benefit shown: heparin, steroids", "citations": [{"type": "pdf_page", "page": 183, "label": "p183"}]}
{"chunk_id": "SSUs_v1_p184_txt_00_46e2d3", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 184, "page_end": 184, "section_path": ["PAEDIATRIC ANAESTHESIA", "Paediatric Anaesthesia"], "specialty_tags": ["PAEDIATRIC ANAESTHESIA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Paediatric Anaesthesia", "keywords": [], "text": "Paediatric Anaesthesia\nAge Group\nA\nB\nC\nOther\nTopics\nPreterm\nNeonate\nDifficult\nETT 2.5 – 3.0\nStraight 0 blade\nSurfactant\nCLD\nApnoeas\nRisk of O2 toxicity\nBarotrauma\nPersistent PDA, PFO\nHR dependent CO\nNICU\nHypoglycaemia\nHypothermia\nPMA + day surg\nIH repair\nNeonate\nDifficult\nETT 3.0 – 3.5\nLarge occiput\nShoulder roll\nFloppy epi\nStraight 1 blade\nGastric insufflation\n(NGT)\nRapid desats\nO2 consumption\nDiaphragmatic vent\nCC > FRC (PEEP)\nApnoea risk\nHR dependent CO\nBrady with desats\nHypoglycaemia\nHypothermia\nPoor drug\nmetabolism\nPyloric stenosis\nOrchidopexy\nTOF\nCDH\nGastroschisis,\nomphalocele\nInfant /\ntoddler\nProne to\nobstruction\nLaryngospasm\nCurved 2 blade\n>1yo\nURTIs\nObligate nasal\nbreathers until 3 –\n6mo\nPFO closes 6 – 12\nmo\nIx murmurs <12 mo\nSeparation anxiety\n>6mo – parent for\ninduction\nTricky cannulation\nPaeds circuit system\nLaryngospasm\nAnxious parents\nMask induction\nPaeds murmurs\nNeurocog concerns\nof GA\nPre-school\nSpasm\nURTI +++\nBig tonsils/As\nSeparation anxiety\n(pre-med)\nDevelopmental\nconcerns\nForeign bodies\nPre-med\nURTI + GA\nT&As\nDental surgery\nStrabismus\nPrimary\nschool\nLoose teeth\nCurved 3 blade\n>8yo\nURTI\nAsthma\nPossibly able to be\nreasoned with\nPre-med\nDistraction\nOffer awake IVC\nProne to injuries\nEmergency surgery\nAppendix\nFractures\nTorsion\nAnaesthetic\nemergencies\nAnxious,\nuncooperative\nNeurodivergent\nTeens\nAnxiety\nAwake IVC\nChronic disease /\nPTSD\nInstitutionalised\nIlicit drug use\nScoliosis surgery\nConsent", "citations": [{"type": "pdf_page", "page": 184, "label": "p184"}]}
{"chunk_id": "SSUs_v1_p185_txt_00_650370", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 185, "page_end": 185, "section_path": ["PAEDIATRIC ANAESTHESIA", "Airway Assessment", "Fasting Guidelines"], "specialty_tags": ["PAEDIATRIC ANAESTHESIA", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Fasting Guidelines", "keywords": [], "text": "Fasting Guidelines\nAge <12mo:\n•\nFormula: 4 hr\n•\nBreast milk: 3hr\n•\nClear fluids: 1 hr (<3mL/kg/hr)\nAge >12mo:\n•\nSolids: 6 hr\n•\nBreast milk: 4 hr\n•\nClear fluids: 1 hr (<3mL/kg/hr)\nAspiration: 0.1% paediatrics – less severe, <20% require post-op ventilation", "citations": [{"type": "pdf_page", "page": 185, "label": "p185"}]}
{"chunk_id": "SSUs_v1_p185_txt_01_f5e7a0", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 185, "page_end": 185, "section_path": ["PAEDIATRIC ANAESTHESIA", "Airway Assessment", "Anaesthetic Assessment"], "specialty_tags": ["PAEDIATRIC ANAESTHESIA", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Anaesthetic Assessment", "keywords": [], "text": "Anaesthetic Assessment\nAssessment: must review medical record\n•\nHistory:\no\nBirth complications\no\nSyndromes / genetic abnormality\no\nSleep apnoea\no\nTrauma / type of surgery\no\nAge (<1 yr)\no\nASA 2-4\no\nAspiration risk: fasting, obstruction, pyloric stenosis\n•\nExamination:\no\nFacial dysmorphia\no\nStridor\no\nDysphonia / hoarse voice\no\nSwallowing / breathing difficulty\no\nObesity / under weight\no\nRoutine:\n▪\nMandible protrusion\n▪\nMallampati\n▪\nAO movement\n▪\nTongue / tonsil size\n▪\nMouth opening\n▪\nDentition\n▪\nThyromental distance\nAirway Assessment\nAirway differences:\n•\nAnatomical:\no\nObligate nose breathers\no\nLarge occiput, short neck\no\nLarge tongue, cephalad larynx (C2 – C3)\no\nLong U shaped epiglottis, 45 degree angle\n▪\nStraight blade <1y\n▪\nCurved blade >1y\no\nCricoid is narrowest part\no\ndiameter airway, prone to obstruction / high resistance\n•\nPhysiological:\no\nClosing capacity > FRV\no\nVO2 7mL/kg/min\no\nRapid desaturations → bradycardia\no\nPre-oxygenation is difficult\no\nHigh vagal tone – risk of bradycardia on laryngoscopy", "citations": [{"type": "pdf_page", "page": 185, "label": "p185"}]}
{"chunk_id": "SSUs_v1_p186_txt_00_6a55c0", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 186, "page_end": 186, "section_path": ["PAEDIATRIC ANAESTHESIA", "Threatened Airway"], "specialty_tags": ["PAEDIATRIC ANAESTHESIA", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Threatened Airway", "keywords": [], "text": "Airway\nAge equation after 1yo.\nLMA sizes\nClassic /\nAmbu\nWeight (kg)\n<5\n1.5\n5 – 10\n10 – 20 (pre-\nschool)\n2.5\n20 – 30 (prim)\n30 – 50\n50 - 70\n70 - 100\n>100\nNasal Intubation\nIndications:\n•\nICU ventilation\n•\nSurgical requirement\n•\nTrismus\n•\nMore secure e.g. when prone\nSize: cuffed size by 0.5 – 1.0\nDepth: age / 2 + 15\nComplications:\n•\nNasal:\no\nBleed / trauma / turbinate fracture\no\nCSF leak\no\nOlfactory n. injury\n•\nLaryngeal:\no\nInjury / perforation\nRSI\n•\nConsider 4 quadrant emptying\n•\nIf pre-ox important – ketamine 0.2mg/kg to facilitate mask\n•\nUnclear benefit of cricoid\n•\nNMBA:\no\nSux 2mg / kg + atropine\no\nRoc 1.2mg / kg\n•\nNMJ monitoring\n•\nGentle BVM if desats <12cmH2O\nThreatened Airway\n•\nAvoid pre-med + avoid stimulation\n•\nSecond skilled anaesthetist, IV access\n•\nEquipment:\no\nUsual emerg + T-piece + IO\no\nENT surgeon if indicated\n•\nTechnique:\no\nPosition child comfortably\no\n100% FiO2, increase sevo slowly, no N2O\no\nApply tight seal + CPAP\no\nMaintain spont vent do not assist\no\nIV access when deep\no\nTopical lignocaine to cords – max 4mg/kg\no\nAvoid NMBA until intubated\nOral Size\nDepth\nUncuffed: age / 4 + 4\nCuffed: age / 4 + 3.5\n(nasal by 0.5 – 1.0)\nOral: age / 2 + 12\nNasal: age / 2 + 15", "citations": [{"type": "pdf_page", "page": 186, "label": "p186"}]}
{"chunk_id": "SSUs_v1_p187_txt_00_94a2a4", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 187, "page_end": 187, "section_path": ["THRIVE"], "specialty_tags": ["THRIVE"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "THRIVE", "keywords": [], "text": "Awake Intubation\nFibreoptic scope:\n•\n2.2mm\nminimum 3.0 ETT\n•\n2.85mm\nminimum 3.5 ETT\n•\n3.8mm\nminimum 5.0 ETT\nTechnique:\n•\nSedation – options:\no\nPrecedex load + infusion\no\nEleveld remifentanil TCI – less used, risk of apnoea + bradycardia\n•\nOther medications:\no\nGlycopyrulate for secretions\no\nDexamethasone if indicated\n•\nOxygenation: HFNP, nasal cannulae\n•\nTopicalise: lignocaine 4mg/kg in paeds", "citations": [{"type": "pdf_page", "page": 187, "label": "p187"}]}
{"chunk_id": "SSUs_v1_p187_txt_01_41f659", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 187, "page_end": 187, "section_path": ["THRIVE", "Paeds Ventilation"], "specialty_tags": ["THRIVE"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Paeds Ventilation", "keywords": [], "text": "Paeds Ventilation\n6yo closing volume > FRC → airway closure (exacerbated by anaesthesia),\nA-a gradient\nLPV same as adults; accept sats >92%\nT-Piece\nUsed in patients <20kg.\nAdvantages:\n•\nLight weight\n•\nLow resistance, valveless\n•\nLow dead space\n•\nFast wash in → rapid induction\n•\nPortable\n•\nPEEP can be adjusted\n•\nGood feedback of compliance\nDisadvantages:\n•\nRisk of rebreathing if FGF not sufficient\n•\nHigh FGF required (2-3x minute ventilation)\no\nInfant + neonate: 3L/min\no\nChild: 6L/min\no\nAdolescent: 9L/min\n•\nTechnique is important\n•\nNo scavenging\nTHRIVE\nPhysiological effects:\n•\nDeadspace washout → alveolar ventilation, CO2 clearance\n•\nPEEP 4 – 6cmH2O → compliance, WOB\nUses:\n•\nApnoeic oxygenation → safe apnoea time, desaturations\n•\nTubeless anaesthesia for airway surgery\nFlow rate (based on weight):\n•\n0 – 12kg: 2L/kg/min (up to 24L/min)\n•\n13 – 15kg: 30L/min\n•\n15 – 30kg: 35L/min\n•\n30 – 50kg: 40L/min\n•\n>50kg: 50L/min\nVol\nNeonate\nAdult\nVT\n6.5 mL/kg\n6.5 mL/kg\nVD\n2.2 mL/kg\n2.2 mL/kg\nTLC\n65 mL/kg\n80 mL/kg\nVmin\n220 mL/kg\n100 mL/kg\nVA\n140 mL/kg/min\n60 mL/kg/min\nFRC\n30 mL/kg\n30 mL/kg\nVA / FRC\n5 : 1\n1.5 : 1", "citations": [{"type": "pdf_page", "page": 187, "label": "p187"}]}
{"chunk_id": "SSUs_v1_p188_txt_00_386bec", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 188, "page_end": 188, "section_path": ["THRIVE", "Deep Extubation", "Extubation"], "specialty_tags": ["THRIVE"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Extubation", "keywords": [], "text": "Extubation\nAwake Extubation\nFeatures: eye opening, facial grimace, movement other than coughing, conjugate gaze, purposeful movement, low volatile ET\n(sevo <0.2%), SpO2 >97%, TV >5mL/kg, +ve laryngeal stimulation test (wiggle tube → cough + breath hold <5s)\nWhen to awake extubate:\n•\nDifficult BVM / intubation\n•\nHigh risk reintubation\n•\nHigh risk aspiration\n•\nRisk of hypoventilation\n•\nNon-paediatric facility\n•\nOperator inexperience with deep extubation\nSuction deep\nUSE BITE BLOCK\nPre-extubation recruitment\nDeep Extubation\nIndications:\n•\nSurgery: neurosurg, ENT/H&N, plastics\n•\nPrevention of coughing / bucking: ICP, IOP, bleeding risk\n•\nPatient: reactive airways dz\nMethod:\n•\nSuction airway\n•\nReverse neuromuscular blockade\n•\nDepth of anaesthesia ≥1.0 MAC\n•\nIf volatile anaesthetic give 1-2mg/kg of propofol\n•\nStart spont venting\n•\n100% FiO2\n•\nExtubate +/- airway adjunct\n•\nBreath hold for 15 – 30s is normal\n•\nCease anaesthetic agent\n•\nHFNP or facemask\n•\nPosition: supine or recovery position", "citations": [{"type": "pdf_page", "page": 188, "label": "p188"}]}
{"chunk_id": "SSUs_v1_p189_img_77f9b34f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 189, "page_end": 189, "section_path": ["THRIVE", "Difficult Airway Algorithms", "Difficult Airway Algorithms"], "specialty_tags": ["THRIVE", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "algorithm_image", "modality": "image", "title": "Difficult Airway Algorithms", "keywords": [], "text": "Difficult mask ventilation (MV) — during routine CS APA genet induction of anaesthesia in a child aged 1 to 8 years Difficult MV => Give 100% oxygen => Call for help Step A Opt ¢ head position Check equipment Depth of anaesthesia Consider: Consider changing: + Adjusting chin liftjaw thrust + Circuit 5 5 5 + Inserting shoulder roll if <2 years + Mask Consider deepening anaesthesia + Neutral head position if >2 years + Connectors Use CPAP + Adjusting cricoid pressure if used If equipment failure is suspected, change to self-inflating bag and Ventilating using two person bag mask technique isolate from anaesthetic machine promptly Step B Insert oropharyngeal airway Call for help again if not arrived Assess for cause of difficult mask ventilation Maintain anaestesialPAP _ + Light anaesthesia Jeepen anaesthesia (Propofol first line) + Laryngospasm + If relaxant given — intubate * Gastric distension — pass OG/NG tube + If intubation not successful, go to unanticipated difficult tracheal intubation algorithm Step C Second-line: Insert SAD (e.g. LMA™) Insert SAD (e.g. LMA™) — not > 3 attempts + Consider nasopharyngeal airway + Release cricoid pressure Consider: + SAD (e.g. LM", "image": {"paths": ["p189_img1335.png", "p189_img1336.png"], "ocr_text": "Difficult mask ventilation (MV) — during routine\nCS APA genet\n\ninduction of anaesthesia in a child aged 1 to 8 years\n\nDifficult MV => Give 100% oxygen => Call for help\n\nStep A Opt ¢ head position Check equipment Depth of anaesthesia\nConsider: Consider changing:\n\n+ Adjusting chin liftjaw thrust + Circuit 5 5 5\n\n+ Inserting shoulder roll if <2 years + Mask Consider deepening anaesthesia\n\n+ Neutral head position if >2 years + Connectors Use CPAP\n\n+ Adjusting cricoid pressure if used If equipment failure is suspected, change to self-inflating bag and\n\nVentilating using two person bag mask technique isolate from anaesthetic machine promptly\n\nStep B Insert oropharyngeal airway Call for help again if not arrived\n\nAssess for cause of difficult mask ventilation Maintain anaestesialPAP _\n+ Light anaesthesia Jeepen anaesthesia (Propofol first line)\n\n+ Laryngospasm + If relaxant given — intubate\n* Gastric distension — pass OG/NG tube + If intubation not successful, go to unanticipated\n\ndifficult tracheal intubation algorithm\nStep C Second-line: Insert SAD (e.g. LMA™)\n\nInsert SAD (e.g. LMA™) — not > 3 attempts\n+ Consider nasopharyngeal airway\n+ Release cricoid pressure\n\nConsider:\n+ SAD (e.g. LMA™) malposition/blockage\n+ Equipment malfunction\n\n+ Bronchospasm\n\n+ Pneumothorax\n\nAttempt intubation\nConsider paralysis\n\nSpO, >80%\n\n‘SAD = supragiottic airway device"}, "citations": [{"type": "pdf_page", "page": 189, "label": "p189"}]}
{"chunk_id": "SSUs_v1_p190_img_3a2dc677", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 190, "page_end": 190, "section_path": ["THRIVE", "Difficult Airway Algorithms"], "specialty_tags": ["THRIVE", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "algorithm_image", "modality": "image", "title": "Difficult Airway Algorithms", "keywords": [], "text": "Cannot intubate and cannot ventilate (CICV) ina GS APA pare paralysed anaesthetised child aged 1 to 8 years Failed intubation => ty => inadequate ventilation Give 100% oxygen Call for help FiO, 1.0 Optimise head position and chin liftjaw thrust Insert oropharyngeal airway or SAD (e.g. LMA™) Ventilate using two person bag mask technique Manage gastric distension with an OGING tube Step B Attempt wake up if maintaining SpO, >80% (rrocuronium or vecuronium used, consider suggamadex (16mgikg) for full reversal) { Cannula cricothyroidotomy i Extend the neck (shoulder roll) H (Prepare for rescue techniques in case child deteriorates J Stabilise larynx with non-dominant hand Access the cricoithyroidotomy membrane | with a dedicated 14/16 gauge cannula Aim in a caudad direction Confirm position by air aspiration using a syringe with saline Connect to either: + adjustable pressure limiting device, set to lowest delivery pressure Step C Airway rescue techniques for CICV (SpO,, <80% and falling) and/or heart rate decreasing Call for help again if not arrived Consider: + Surgical tracheostomy + Rigid bronchoscopy + ventilate / jet ventilation (pressure limited) ENT available", "image": {"paths": ["p190_img1340.png"], "ocr_text": "Cannot intubate and cannot ventilate (CICV) ina\nGS APA pare\n\nparalysed anaesthetised child aged 1 to 8 years\n\nFailed intubation => ty =>\ninadequate ventilation Give 100% oxygen Call for help\n\nFiO, 1.0\nOptimise head position and chin liftjaw thrust\nInsert oropharyngeal airway or SAD (e.g. LMA™)\nVentilate using two person bag mask technique\nManage gastric distension with an OGING tube\n\nStep B Attempt wake up if maintaining SpO, >80%\n\n(rrocuronium or vecuronium used, consider suggamadex (16mgikg) for full reversal)\n\n{ Cannula cricothyroidotomy i\nExtend the neck (shoulder roll) H\n\n(Prepare for rescue techniques in case child deteriorates J\n\nStabilise larynx with non-dominant hand\n\nAccess the cricoithyroidotomy membrane |\nwith a dedicated 14/16 gauge cannula\n\nAim in a caudad direction\nConfirm position by air aspiration using\na syringe with saline\nConnect to either:\n\n+ adjustable pressure limiting\n\ndevice, set to lowest delivery\npressure\n\nStep C Airway rescue techniques for CICV (SpO,, <80% and\nfalling) and/or heart rate decreasing\n\nCall for help again if not arrived\n\nConsider:\n+ Surgical tracheostomy\n\n+ Rigid bronchoscopy + ventilate / jet\nventilation (pressure limited)\n\nENT available\n\nCall for spe\nENT assistance\n\nt\n\nContinue jet ventilation set to lowest\ndelivery pressure until wake up or\ndefinitive airway established\n\nor\n\n+ 4Bar O, source with a flowmeter |\n\n(match flow l/min to child's age) |\nand Y connector\n\nPercutaneous cannula\ncricothyroidotomy /\n\ntranstracheal jet ventilation\n(pressure limited)\n\nENT not available :\nCautiously increase inflation pressure/fiow !\nrate to achieve adequate chest expansion |\nWait for full expiration before next inflation :\nMaintain uper airway patency to aid\n\nexpiration\n\n+ Perform surgical cricothyroidotomy /\ntranstracheal and insertion of ETT /\ntracheostomy tube\"\n\n* Consider passive O, insufflation\nwhile preparing\n\n*Note: Cricothyroidotomy techniques can have serious complications and training is required —\nonly use in life-threatening situations and convert to a definitive airway as soon as possible"}, "citations": [{"type": "pdf_page", "page": 190, "label": "p190"}]}
{"chunk_id": "SSUs_v1_p191_txt_00_6826fb", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 191, "page_end": 191, "section_path": ["TIVA", "Choice of Anaesthesia"], "specialty_tags": ["TIVA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Choice of Anaesthesia", "keywords": [], "text": "Choice of Anaesthesia\nInhalational\nBenefits:\n•\napnoea 2’ slower onset\n•\nSlower CVS changes\n•\nagitation avoiding IV access\n•\nBronchodilation\nTIVA\nBenefits\nDisadvantages\n•\nRapid onset\n•\nFamiliar\n•\nDepth of anaesthesia not dependent on airway\n•\nFiO2 100% (i.e. no volatile)\n•\nairway reactivity  less PRAE\n•\nImproved ciliary function\n•\nBronchodilation\n•\nemergence delirium\n•\nSafe in: neuromuscular disorder, MH, core\nmyopathy\n•\ninterference with evoked potentials\n•\nTitratable via pump\n•\nenvironmental impact\n•\ncost\n•\nPONV\n•\nBacterial contamination risk\n•\nPain on injection\n•\nPRIS / lactic acidosis\n•\nIV access + pumps required – harder to identify\ntissued IVC\n•\nRisk of awareness – processed EEG is based on adult\nalgorithms, use with caution, keep IV visible\n•\nNo concentration monitoring\n•\nProgressive CSHT\n•\nDisposables usage high\n•\nVariable PK in neonates\n•\nVasodilation\n•\nInfusion line deadspace – flush end of case\n•\nNot suitable in metabolic disorders, ketogenic diets\nfor seizures, septic shock\nIndications:\n•\nPatient:\no\nMH\no\nMuscular dystrophy, core myopathy, NM disease\no\nPONV\no\nEmergence delirium\no\nFear of facemask\n•\nSurgical:\no\nAirway / neuro or raised ICP / middle ear surgery\no\nEvoked potential monitoring required\no\nHigh PONV risk – strabismus, T&A\no\nMuscle biopsy", "citations": [{"type": "pdf_page", "page": 191, "label": "p191"}]}
{"chunk_id": "SSUs_v1_p192_txt_00_b00424", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 192, "page_end": 192, "section_path": ["TIVA", "Anxiety Minimisation & Pre-Op Sedatives", "Anxiety Minimisation & Pre-Op Sedatives"], "specialty_tags": ["TIVA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Anxiety Minimisation & Pre-Op Sedatives", "keywords": [], "text": "Anxiety Minimisation & Pre-Op Sedatives\nComplications of peri-op anxiety:\n•\nEmergence delirium\n•\nanalgesic requirements\n•\nSleep disturbance\n•\nBed-wetting\n•\nPoor experience for child + parent\n•\nNegative behavioural changes\nRFs: age <4yo (separation anxiety), temperament, no pre-op preparation, anxious parents, previous negative experience\nAssessment:\n•\nPrevious pre-med + effect +/- adverse events\n•\nConfirm fasting status & monitoring available\n•\nCIs present\n•\nAllergies\nHave pre-determined bail out stage (?elective versus time sensitive) – should not be held down once has clear memory\nNon-pharmacological:\n•\nAge appropriate approach\n•\nPre-hospital education\n•\nPlay therapy / distraction\n•\nEngagement with anaesthetic technique\n•\nEnvironmental adjustment\n•\nActive involvement caregiver\n•\nCommunication aids\n•\nRelaxation techniques\n•\nParental presence at induction\n•\nQuiet pathway\nIndications for pharmacological management:\n•\nFailure of non-pharmacological management\n•\nPrevious traumatic experience\n•\nDevelopmental delay / autism\nClass\nDrug\nRoute\nAge\nDose\nOnset\nDuration\nAdvantages\nDisadvantages\nBenzodiazepines\nMidazolam\nOral\n1mo –\n18yo\n0.5mg/kg\nMax 20mg\n30 –\n45mins\n45 –\n60min\nPONV\nParadoxical\nexcitation\nUnpleasant taste\nStings\nBuccal\n6mo –\n18yo\n0.3mg/kg\nMax 10mg\n20 mins\n30 – 45\nmin\nQuick onset\nGood pt\ncompliance\nParadoxical\nexcitation\nTemaze\nPO\n12 –\n18yo\n10-20mg\n60 mins\n15 –\n140min\nUseful after\nmidaz\nLong time to onset\nAlpha2-agonists\nDexmed\nIN\nBuccal\n>1yo\n2mcg/kg\nMax\n200mcg\n25 mins\n40 –\n130min\nIN shorter ½ life\nIN doesn’t sting!\nCaution in pt with\ngrade 2/3 heart\nblock (unless\npaced), HTN,\ndigoxin, sleepiness\nRequires atomiser\nClonidine\nPO\n6mo –\n18yo\n4mcg/kg\nMax\n200mcg\n45 – 60\nmins\n45 – 90\nmins\nTasteless liquid\nLong action\nCaution in CVS\ninstability\nNMDA-R ant\nKetamine\nPO\n2 – 18yo\n5-8mg/kg\n10 mins\n3 hours\nQuick onset\nUseful with midaz\nsalivation\nHallucinations\nEmergence\ndelirium\nPONV at high\ndoses\nOpioid\nMorphine\n6mo –\n18yo\n0.2mg/kg\nMax 10mg\n30 mins\n1-2 hours\nAnalgesic\nproperties\nRisk of resp\ndepression\nContra-indications to pharmacological therapy:\n•\nDifficult airway\n•\nOSA / central sleep apnoea (consider ketamine + O2)\no\nOSA with large tonsils is okay if you can\nmonitor and manage\n•\nAspiration risk\n•\nRenal / hepatic impairment\n•\nGCS\n•\nICP\n•\nAcute systemic illness\n•\nSpO2\n•\nURTI\n•\nAllergy\n•\nPrevious adverse event\n•\nObesity", "citations": [{"type": "pdf_page", "page": 192, "label": "p192"}]}
{"chunk_id": "SSUs_v1_p193_txt_00_ef772c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 193, "page_end": 193, "section_path": ["TIVA", "IV Fluid Replacement", "IV Fluid Replacement"], "specialty_tags": ["TIVA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "IV Fluid Replacement", "keywords": [], "text": "IV Fluid Replacement\nTotal fluid requirement: replace deficit + maintenance + replace ongoing losses\n(This is different from resuscitation 20mL/kg and assess up to 3x)\nResus\n20mL/kg crystalloid\nDeficit\nDeficit = weight difference (kg) x % dehydration x 10 – give over 24 hours\nMaintenance\nIsotonic crystalloid (NS 0.9% / plasmalyte / Hartmanns) +/- glucose 5% (if no other source of glucose)\nNeonate\n24 hr maintenance\nHourly rate\nD1\n60 mL/kg/day\n2 mL/kg/hour\nD2\n80 mL/kg/day\n3 mL/kg/hour\nD3\n100 mL/kg/day\n4 mL/kg/hour\nD4 – 1yo\n120 mL/kg/day\n4 mL/kg/hour\nImmature RAAS. Post-natal diuresis.\nWeight (if >1y)\n24 hr maintenance\nHourly rate\n3 – 10 kg\n100 x weight mL/day\n4 x weight mL/hr\n10 – 20 kg\n1000 + (50 x weight) mL/day\n40 + 2x (weight – 10) mL/hr\n20 – 60 kg\n1500 + (20 x weight) mL/day\n60 + (weight – 20) mL/hr\n>60 kg\nMax 2400 mL/day\nMax 100 mL/hr\nOr just use 4 / 2 / 1 rule – max 100mL/hr\nRisk of water retention 2’ to non-osmotic ADH secretion → reduce to 2/3 maintenance:\n•\nCNS conditions (meningitis, tumours, head injury)\n•\nResp (pneumonia, bronchiolitis, ventilated)\n•\nPost-op\n•\nTrauma\n^use if unwell", "citations": [{"type": "pdf_page", "page": 193, "label": "p193"}]}
{"chunk_id": "SSUs_v1_p194_txt_00_c2ada2", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 194, "page_end": 194, "section_path": ["PONV", "PONV"], "specialty_tags": ["PONV"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "PONV", "keywords": [], "text": "PONV\nSimplified risk - POVOC Score → 1 point each\n•\nSurgery ≥30 mins\n•\nAge ≥3yo\n•\nStrabismus\n•\nHistory or FHx PONV\nRisk:\n•\nLow risk:\nscore 0 (9%)\n1 agent\nNone or dex or 5HT3\n•\nMedium risk\nscore 1(10%) or 2 (30%)\n2 agents\n5HT3 + dex\n•\nHigh risk:\nscore 3 (55%) or 4(70%)\n2 agents + TIVA 5HT3 + dex + TIVA\nPrevention:\n•\nPropofol TIVA\n•\nAvoid prolonged fasting + liberal IVF (30mL/kg versus 10mL/kg)\n•\nOpioid sparing + regional anaesthesia\nProphylactic anti-emetics:\n•\nDexamethasone\n0.15mg / kg\nmax 5mg\n•\nOndansetron\n0.1mg/kg\nmax 4mg\n•\nDroperidol\n15mcg/kg\nmax 1.25mg\n•\nAprepitant\n3mg/kg\nmax 125mg\n•\nGranisetron\n40mcg/kg\nmax 0.6mg\nRescue treatment: anti-emetic from different class\nTreatment:\n•\nMetoclopramide\n0.25mg/kg\nmax 10mg\n•\nDimenhydrinate\n0.5mg/kg\nmax 25mg\nNot recommended: prochlorperazine, cyclizine", "citations": [{"type": "pdf_page", "page": 194, "label": "p194"}]}
{"chunk_id": "SSUs_v1_p195_txt_00_7d467f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 195, "page_end": 195, "section_path": ["PONV", "Dexmedetomidine", "Emergence Delirium"], "specialty_tags": ["PONV"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Emergence Delirium", "keywords": [], "text": "Emergence Delirium\nUp to 80%. Definition:\n•\nTransient state of marked irritation and disassociation after the discontinuation of anaesthesia\n•\nDisorientation + altered perception\no\nHypersensitivity to stimuli\no\nHyperactive motor behaviour\n•\nDiagnosis of exclusion (Ix & treat pain, hypoglycaemia, hypoxia)\nScales: PAED, Cravero, Watcha\nRFs: preschool age, male, volatile anaesthetic, ENT / opthal surgery, pre-op anxiety, parental anxiety, poorly adaptable\ntemperament, inadequate analgesia on emergence\nComplications: self-injury, post-op maladaptive behavioural changes, dissatisfaction (everyone)\nNon Pharmacological\nADVANCE\nPharmacological\nEffective\nIneffective\n•\nAnxiety reduction\n•\nDistraction\n•\nVideo modelling +\neducation\n•\nAdding parents\n•\nNo excessive reassurance\n•\nCoaching\n•\nExposure shaping\n•\nTIVA > volatile\n•\nPropofol 1mg/kg end of case\n•\nPrecedex\n•\nClonidine (delayed discharge, BP)\n•\nMidaz end of case\n•\nAnalgesia: fent / ketamine\n•\nMagnesium\n•\nDexamethasone\n•\nNitrous washout\n•\nHalothane @ 50% rate\n•\nDesflurane, isoflurane\n•\nMidaz pre-med\n•\nParental presence at\nemergence\n•\nGradual sevo cessation\n•\nLower maintenance sevo [ ]\nTreatment:\n•\nExclude other causes\n•\nReassure parents\n•\nEnsure safety of child from injury\n•\nObserve\n•\nRx:\no\nPropofol\n1mg/kg\no\nFent\n1-2mcg/kg\no\nMidaz\n0.1mg/kg\no\nClonidine\n1mcg/kg\nDexmedetomidine\nUses in paeds:\n•\nPre-med: IN, buccal\n•\nAnalgesia / opioid sparing\n•\nSurgical:\no\nRigid bronch\no\nT&As\no\nHigh risk anterior mediastinal mass (in combination with ketamine)\no\nCardiac surgery → early extubation\no\nAwake craniotomy\no\nMRI (spont vent)\n•\nRegional / caudal analgesia adjunct → prolongs block\n•\nOSA\n•\nEmergence delirium\nRelative CI:\n•\nConduction abnormalities / concurrent treatments with bradycardic Rx\n•\nSeptic shock\n•\nChronic hypertension\n•\nHepatic disease", "citations": [{"type": "pdf_page", "page": 195, "label": "p195"}]}
{"chunk_id": "SSUs_v1_p196_txt_00_af6556", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 196, "page_end": 196, "section_path": ["PONV", "Effect of Anaesthesia on Developing Brain", "Effect of Anaesthesia on Developing Brain"], "specialty_tags": ["PONV"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Effect of Anaesthesia on Developing Brain", "keywords": [], "text": "Effect of Anaesthesia on Developing Brain\nStudy\nDetails\nOutcomes\nGAS Study\nRCT\nRegional v sevoflurane for inguinal hernia\nExposure <1hr\nNo difference in IQ at age 5\nMASK Study\nRetrospective cohort study\nMultiple exposures <3yo\nNo effect on IQ\nPossibly mild deficits in processing speed and fine\nmotor skills\nPANDA Study\nMatched cohort study\nSibling pairs (not twins) exposed v not exposed <3yo\nInguinal hernia surgery up to 4 hr\nNo difference\nProposed mechanism of neuronal toxicity:\n•\nAccelerated neuronal apoptosis\n•\nAltered dendrite morphology\n•\nDose, age and duration dependent\n•\nShown with multiple drugs\nSummary:\n•\nSingle, short exposure <3 hr <3yo is not associated with any significant deficit in any measurable domain\n•\nRepeated (≥2) exposures <3yo may risk of learning disability or behavioural disorder\no\nMultiple confounders not controlled for including comorbidity, illness, indication, surgery\n•\nMust weight risk of delaying surgery with small risk of neurocognitive effect\n•\nNo data on premature patients, neurological disease, CHD\nConsent:\n•\nSurgery is only when necessary\n•\nAnaesthetists prevent well-recognised complications\n•\nKnowledge is constantly growing\n•\nAssociation is not causation\n•\nDiscuss if:\no\nParent asks\no\nRepeated or prolonged exposure\no\nProcedure cannot be post-poned", "citations": [{"type": "pdf_page", "page": 196, "label": "p196"}]}
{"chunk_id": "SSUs_v1_p197_txt_00_35d166", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 197, "page_end": 197, "section_path": ["FLACC", "Revised FLACC", "Pain"], "specialty_tags": ["FLACC"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pain", "keywords": [], "text": "Pain\nInvolve parent. Self reported ≥4.\nAge\nTool\nPremature\nPremature Infant Pain Score\nNeonate\nNeonatal Pain Rating Scale (CRIES)\n1mo – 4yo\nFace Legs Activity Cry Consolability (FLACC)\n4 – 12yo\nFaces scale\n≥7yo\nVAS\nCognitive impairment\nRevised FLACC\nPremature Infant Pain Scale\nFor term + premature neonates. Assess physiology, behaviour and facial expressions.\nNeonatal Pain Rating Scale\nFeature\nCrying\nNo\nHigh pitched\nInconsolable\nRequires O2 (for SpO2 >95%)\nNo\nFiO2 <30%\nFiO2 >30%\nIncreased vital signs\nNo\n<20%\n>20%\nExpression\nNormal\nGrimace\nGrunt\nSleepless\nNo\nFrequent waking\nConstantly awake\nFLACC\nFeature\nFace\nNo particular expression or smile\nOccasional grimace, frown,\nwithdrawn, disinterested\nFrequent quivering, clenched jaw\nLegs\nNormal position, relaxed\nUneasy, restless, tense\nKicking, drawn up\nActivity\nLying quietly, normal position,\nmoves easily\nSquirming, tense\nArched, rigid, jerking\nCry\nNo cry\nMoans, whimpers\nSteady crying, screams, sobs,\ncomplains\nConsolability\nContent or relaxed\nReassurance possible\nDifficult to console\nFACES / VAS Scale\nRevised FLACC\nFeature\nFace\nNo particular expression or smile\nAppears sad or worried\nDistressed, expression of fright or panic\nLegs\nUsual tone & motion to limbs\nOccasional tremors\nMarked increase in spasticity, constant tremors\nor jerking\nActivity\nRegular, rhythmic respirations\nTense or guarded\nSevere agitation, head banging, shivering (not\nrigors), sharp breaths, splinting\nCry\nNo cry\nOccasional verbal outburst or\ngrunt\nRepeated outbursts, constant grunting\nConsolability\nContent or relaxed\nReassurance possible\nDifficult to console\nPushing away caregiver\nRevision – need to talk to primary care giver about normal behaviour for child", "citations": [{"type": "pdf_page", "page": 197, "label": "p197"}]}
{"chunk_id": "SSUs_v1_p198_txt_00_c87c87", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 198, "page_end": 198, "section_path": ["URTI", "URTI"], "specialty_tags": ["URTI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "URTI", "keywords": [], "text": "URTI\nrisk of PRAE e.g. laryngospasm, bronchospasm, breath holding, atelectasis, desaturation, pneumonia, unplanned admission\nRFs for adverse event: age <1yo, purulent nasal discharge (cf clear), productive cough, wheeze / creps, systemic features (T >38,\nmalaise, headache, poor feeding), parental concern parental smoking, airway anomaly, asthma, OSA / snoring, ex-premi,\ninexperienced anaesthetist, tracheal intubation\nPre-op:\n•\nHistory: SSx, frequency, RFs for adverse event, resp comorbid, previous cancellations\no\nBeware of croup – if intubated unlikely to be extubated\n•\nSurgery: urgency of surgery, previous cancellations\no\n?Implants required – may get infected\n•\nExam: vitals, resp exam (WOB, accessory muscles), examine throat\n•\nIx: leukocytosis, CXR changes\nCOLDS Score\nFeature\nLow risk (1)\nModerate risk (2)\nHigh risk (3)\nCurrent signs / symptoms\nNone\nClear sputum\nColoured sputum, fever\nOnset\n>4 weeks ago\n2 – 4 weeks ago\n<2 weeks ago\nLung Disease\nNone\nMild asthma\nAsthma, pHTN, CLD\nAirway Device\nMask\nLMA\nETT\nSurgery\nT&As, flex bronch\nCleft palate, rigid bronch,\nmax fax\nIncreased risk of PRAE with higher scores\nIntra-op:\n•\nPre-treat with salbutamol\n•\nAnti-sialogogue: glycol 4mcg/kg IV\n•\nInduction: IV > inhalational\n•\nAirway: facemask > LMA > ETT\n•\nConsider deep extubation (but no proven difference)\nIf post-poning: wait 2 – 4 weeks + symptom resolution", "citations": [{"type": "pdf_page", "page": 198, "label": "p198"}]}
{"chunk_id": "SSUs_v1_p199_txt_00_a78857", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 199, "page_end": 199, "section_path": ["URTI", "Murmur", "Murmur"], "specialty_tags": ["URTI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Murmur", "keywords": [], "text": "Murmur\nFeature\nInnocent\nPathological\nSymptoms\nAsymptomatic\nSymptomatic (SOB, URTI, fatigue, reduced ET,\nsyncope)\nTiming\nEarly systolic\nContinuous (venous hum)\nDiastolic\nPansystolic\nLate systolic\nOr location other than L sternal edge\nQuality\nBlowing\nMusical\nVibratory\nVariable\nHarsh\nLoud\nPrecordial thrill\nNO\nPresent\nVariation in\nposture\nOften\nRare (except HOCM)\nCauses\nVenous hum\nFlow\nAS\nHOCM\nCHD (septal defect, CoA)\nHistory:\n•\nConcerning: recurrent chest infection, cyanosis, RR, sweating, poor PO intake, FTT, age <1yo, syndromic, ET,\nsquatting posture during play (Tets spells), syncope, family history of sudden death\nExamination:\n•\nPulses all 4 limbs\n•\nThrills\n•\nMurmur location + features above\n•\nHepatosplenomegaly, ascites\n•\nClubbing\nReferral indications / red flags:\n•\nAny murmur if age <1yo\n•\nSymptoms / concerning features\n•\nSyndromic\n•\nFamily history\n•\nIx: ECG (LAD, LVH), TTE\nSevere causes to exclude:\n•\nAS\n•\nHOCM\n*Both have LAD / LVH on ECG\nNote: if emergency surgery main consideration is is there an undiagnosed condition limiting CO – ask if child can play, running &\nclimbing is reassuring. Screaming without fainting indicative of good CO. TTE may not be available overnight.", "citations": [{"type": "pdf_page", "page": 199, "label": "p199"}]}
{"chunk_id": "SSUs_v1_p200_txt_00_8ebc33", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 200, "page_end": 200, "section_path": ["URTI", "Consent", "Consent"], "specialty_tags": ["URTI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Consent", "keywords": [], "text": "Consent\n•\nA minor is ‘Gillick competent’ once they have reached sufficient maturity to understand fully the treatment proposed\nand its consequences. Once Gillick competent, they can consent to medical treatment\n•\nParents cannot veto a competent minor’s consent to treatment\n•\nThe laws governing a competent minor’s refusal of treatment that is considered to be in their best interests are\ncomplex and uncertain. Doctors faced with this scenario would be wise to seek legal advice before proceeding\n•\nThe rights of parents are qualified by the need to protect the health of the child\n•\nPhysical or chemical restraint to facilitate treatment is legal provided that the restraint is necessary and proportional to\nthe harm being prevented\nComponents of capacity:\n•\nUnderstand proposition and\n•\nRetain long enough to\n•\nWeigh risks + benefits and\n•\nCommunicate decision\nMinor <18yo. Young person 16 – 18yo. Laws around minors and consent are state based.\nWritten consent + signature should be from person consenting\nAny confusion – seek medicolegal advice", "citations": [{"type": "pdf_page", "page": 200, "label": "p200"}]}
{"chunk_id": "SSUs_v1_p201_txt_00_117dcf", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 201, "page_end": 201, "section_path": ["URTI", "Prematurity", "Prematurity"], "specialty_tags": ["URTI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Prematurity", "keywords": [], "text": "Prematurity\n<37 weeks:\n•\nMod – late: 32 – 37 weeks\nmortality 5.4 / 1000\n•\nVery preterm: 28 – 32 weeks\n•\nExtremely preterm: <28 weeks\nComorb:\n•\nCongenital defects\n•\nResp: alveoli bud at 24 weeks, surfactant sufficient at >35 weeks\no\nLess compliant lungs, VQ mismatch, PVR\no\nBronchopulm dysplasia (requires O2 >36/40 – prevented by steroids + surfactant)\no\nApnoeas: cessation of airflow ≥15s or ≥10s with bradycardia or desaturation\n▪\nAvoid triggers: GA / sedation, surgery, hypoxia, BSL, hypo/hyperthermia, anaemia, pain\n▪\nRx: methylxanthines (caffeine, theophylline), HFNP, monitor until 12 hour post-apnoea free interval\n▪\nApnoea treatment: stimulation, open airway, BLS if no recovery\n•\nCVS: assess for PDA, sensitive to iCa\n•\nNeuro: assess for IVH\n•\nGIT: NEC, jaundice, altered metabolism\n•\nRenal: risk of hypoNa, acidosis, poor renal clearance\n•\nMetabolic: hypothermia, hypoglycaemia\n•\nHaem: anaemia, possible coagulopathy 2’ vitamin K dependent factors\n•\nOther: retinopathy of prematurity\nAnaesthetic considerations:\n•\nPre-op:\no\nAssess for above, consider TTE if concerns for CVS\no\nSpecialist centre\no\nEquipment:\n▪\nMachine: neonatal circuit, suitable ventilator, T piece\n▪\nSuction: appropriate size for ETT, pressure <80mmHg\n▪\nMonitoring: routine + appropriate, pre- and post-ductal SpO2, temp, BSL, NIRS\n▪\nAirway: appropriate size\n▪\nIV: 22-24G, narrow bore vol extension, 4Fr CVC, art line 24G, glucose containing fluids, warmer\n•\nIntra-op:\no\nInduction: inhalational or IV\no\nAirway: tracheal intubation for all, SGA airway rescue an option for >1500g\n▪\nSmallest bronchoscope 2.2mm, 2.5ETT\no\nMaintenance: sevo 3.3%, prop Steur model\no\nVentilation: VCV 5mL/kg, RR 30 – 60, PEEP 6-8, SpO2 90-95%\no\nTemp control\no\nAnalgesia\no\nIVF: balanced crystalloid + 2.5% glucose @ 10mL/kg/hour\n▪\nBSL: 2mL/kg of dextrose 10%\n▪\nBolus IVF 10 – 20mL/kg\n•\nPost-op:\no\nNICU + apnoea monitoring for 24 – 48 hours in PMA ≤60 weeks", "citations": [{"type": "pdf_page", "page": 201, "label": "p201"}]}
{"chunk_id": "SSUs_v1_p202_txt_00_3733c9", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 202, "page_end": 202, "section_path": ["URTI", "Croup", "Croup"], "specialty_tags": ["URTI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Croup", "keywords": [], "text": "Croup\nViral laryngotracheitis → oedema of upper airway → narrowing\nCauses / viruses:\n•\nParainfluenza, RSV, adenovirus, coronavirus\nPresentation:\n•\nAge 6mo – 3y w/ preceding URTI\n•\nFever\n•\nStridor\n•\nBarking cough\n•\nHoarse voice\n•\nRespiratory distress\nTreatment:\n•\nDexamethasone:\no\n0.15mg/kg PO or IM\no\nSevere croup: 0.6mg/kg IV (max 12mg)\n•\nNebulised budesonide 2mg\n•\nNebulised adrenaline 0.5mg/kg (max 5mg)\n•\nConsider HFNP to help with O2 and WOB\nIntubation:\n•\nIndications: respiratory failure, stridor at rest refractory to medical management, GCS\n•\nTechnique:\no\nSecond anaesthetist/skilled assistant\no\nInhalational induction\n▪\nFiO2 100% + sevo only – aim to continue spont venting – can spray chords\n▪\nCan paralyse after ETT if needed\n▪\nHave IVC ready but important to not lose airway, only cannulate if very very deep\n▪\nReduce sevo once deep enough to maintain spont venting\no\nETT size by one size\no\nPrepare for slow + long induction\no\nENT present if able for rigid bronch – gold standard", "citations": [{"type": "pdf_page", "page": 202, "label": "p202"}]}
{"chunk_id": "SSUs_v1_p203_txt_00_9fef2c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 203, "page_end": 203, "section_path": ["URTI", "Epiglottitis", "Epiglottitis"], "specialty_tags": ["URTI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Epiglottitis", "keywords": [], "text": "Epiglottitis\nOFTEN REMOTE ANAESTHESIA.\nPre-OT:\n•\nCASH\n•\nAlert theatres + ENT\n•\nDifficult airway trolley, 2nd skilled assistant\n•\nAvoid stimulation/instrumentation: including examining + IV insertion\n•\nKeep patient sitting upright + 15L NRB\nOT:\n•\nSitting up until ready to induce\n•\nEmergency drugs including atropine\n•\nETT 1-2 sizes smaller\n•\nSpont vent induction sevo + FiO2 100% + CPAP\no\nIf difficulty finding laryngeal inlet can press on chest → look for bubbles\n•\nPrepare for FONA\no\nHave US available\no\nENT scrubbed + ready\n•\nIV ceftriaxone\nPost-intubation:\n•\nICU intubated\n•\nNasendoscopy + cuff leak prior to extubation", "citations": [{"type": "pdf_page", "page": 203, "label": "p203"}]}
{"chunk_id": "SSUs_v1_p204_txt_00_783ba9", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 204, "page_end": 204, "section_path": ["URTI", "Asthma", "Asthma"], "specialty_tags": ["URTI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Asthma", "keywords": [], "text": "Asthma\nPre-op:\n•\nAssess severity and control: triggers, frequency, parental smoking, medication use / frequency / compliance, recent\nsteroid use, recent exacerbations / worsening symptoms, hospitalisation / intubation, recent URTI, PEF / FEV1\n•\nMedications: continue all inhalers, cease theophylline night before\no\nConsider adding steroids if severe / poorly controlled\n•\nManagement:\no\nWell controlled → proceed\no\nRecent URTI → delay 2 – 4 weeks\no\nPoorly controlled → refer and optimise\nRisk of asthma → complications / events:\n•\nLowest risk: all symptoms resolved for 2/52\n•\nRisk x2: symptoms resolved but for less than 2/52, or persisting symptoms are mild (clear runny nose, dry cough, T <38)\n•\nRisk x4: symptoms are more severe (green runny nose, moist cough, T >38)\n•\nRisk x8: symptomatic asthmatic (→ 4x risk of laryngospasm, 10x risk bronchospasm)\nIntra-op:\n•\nSalbutamol prior to induction\n•\nMinimal airway manipulation: mask > LMA > ETT - regional anaesthesia if older\n•\nInduction: IV preferred, consider ketamine (avoid thiopentone)\n•\nMaintenance: sevoflurane\n•\nAvoid atracurium / mivacurium, neostigmine (use sugammadex), morphine & pethidine\n•\nRecognition of bronchospasm:\no\nDDx: endobronchial/oesophageal intubation, PTx, APO, kinked ETT, obstructed ETT, anaphylaxis\no\nManagement: FiO2 100%, confirm diagnosis, deepen anaesthetic (prop, ket, sevo)\n▪\nBronchodilators:\n•\nSalbutamol 12 puffs into circuit\n•\nVolatile\n•\nMagnesium IV: 0.2mM/kg → infusion 0.12mM/kg/hr\n•\nAnticholinergic IV: glycol 4mcg/kg, atropine 20mcg/kg\n•\nAdrenaline IV: 1-2mcg/kg\n•\nSalbutamol IV: load 10mcg/kg over 10 mins → 1-5mcg/kg/min\n•\nSteroid IV: hydrocort 4mg/kg\n▪\nNMBA to improve chest wall compliance\n▪\nVentilation:\n•\nPermissive hypercapnia – target pH >7.2, low rate, PIP 35cmH2O\n•\nLong I:E ratio 1:4, titrated O2, no PEEP\n•\nDisconnect circuit to allow passive expiration\n▪\nECMO if severe / refractory\nPost-op:\n•\nContinue regular inhalers\n•\nPICU if severe\n•\nAnalgesia, mobilisation, chest PT\nTreatment outside of OT:\n•\nMild:\no\nPO pred 2mg/kg (max 60mg)\no\nSalbutamol MDI q20min (<6yo 6 puffs, >6yo 12 puffs)\n•\nModerate: as above +\no\nOxygen\no\nIpratropium MDI (<6yo 4 puffs, >6yo 8 puffs)\n•\nSevere: as above +\no\nIV steroid: hydrocort 4mg/kg max 300mg or methylpred 1mg/kg IV max 60mg q6 hourly\no\nIV magnesium: 0.2mM/kg → infusion 0.12mM/kg/hr\no\nAminophylline: 10mg/kg (max 500mg) over 60 min → infusion\no\nSalbutamol IV: load 10mcg/kg over 10 mins → 1-5mcg/kg/min\no\nAdrenaline", "citations": [{"type": "pdf_page", "page": 204, "label": "p204"}]}
{"chunk_id": "SSUs_v1_p205_txt_00_ead222", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 205, "page_end": 205, "section_path": ["URTI", "OSA", "OSA"], "specialty_tags": ["URTI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "OSA", "keywords": [], "text": "OSA\nPeak 2 – 8yo, respiratory complications up to 25%.\nPathogenesis: upper airway resistance\nRFs: adenotonsillar hypertrophy, craniofacial abnormality, hypotonia, obesity, midface hypoplasia, macroglossia,\nmicro/retrognathia, glossoptosis, down syndrome, mucopolysaccharidosis, achondroplasia, passive smoking, ethnicity\nConsequences: hypoxia, hypercapnia, acidosis, pulmonary hypertension +/- cor pulmonale +/- RVH, LVH, metabolic syndrome,\nneurocognitive, pro-inflammatory, polycythaemia, opioid sensitivity\nPresentation:\n•\nHistory: behavioural / neurocognitive, poor school performance, enuresis, snoring, daytime sleepiness\n•\nExamination: hypertension, cor pulmonale, obesity, syndromic, craniofacial abnormality\n•\nInvestigations: polycythaemia +/- TTE\nTerms:\n•\nApnoea: flow >90% for ≥2 breaths\n•\nHypopnoea: flow >50% + SpO2 by 3% or arousal\nAHI (apnoea-hypopnoea index): combined average number of apnoeas and hypopnoeas per hour of sleep\nDiagnosis:\n•\nPolysomnography:\nSeverity\nAHI (children)\nAHI (adults)\nNone\n<5\nMild\n1 – 5\n5 – 14\nModerate\n6 – 9\n15 – 29\nSevere\n≥10\n≥30\nNocturnal oximetry:\n•\n≥3 events SpO2 ≤90%\n•\n≥1 event SpO2 <80%\nTreatment:\n•\nSurgical: adenotonsillectomy\n•\nMedical: NIV, airway splints, weight loss\nPre-op:\n•\nAssess: severity/AHI, management, nadir / duration of desaturations, evidence of cor pulmonale / pulmonary HTN\n•\nIx: if indicated – ECG, TTE, polysomnography if suspected and will change management\n•\nCaution with pre-meds\n•\nRisk factors for post-op complications i.e. not suitable for day stay: age <3yo, severe OSA, FTT, obesity, cardiac\ninvolvement, down syndrome, prematurity, craniofacial abnormality, neuromuscular disease, chronic lung disease,\nsickle cell disease\nIntra-op:\n•\nOpioid sparing: multimodal, regional, opioids by 50% (sensitivity)\n•\nAirway: prone to obstruction, adjuncts, CPAP, difficult airway equipment available, use adjuncts early\n•\nInduction: try to secure IV access prior\n•\nExtubate: awake + fully reversed paralysis\nPost-op:\n•\nContinuous sats monitoring\n•\nShort acting opioids if required\n•\nConsider CPAP", "citations": [{"type": "pdf_page", "page": 205, "label": "p205"}]}
{"chunk_id": "SSUs_v1_p206_txt_00_c570de", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 206, "page_end": 206, "section_path": ["URTI", "Cystic Fibrosis", "Cystic Fibrosis"], "specialty_tags": ["URTI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Cystic Fibrosis", "keywords": [], "text": "Cystic Fibrosis\n1/2500. Mostly detected by newborn screening. Carrier 1/25.\nMultisystem disease - CFTR gene mutation (autosomal recessive)\nCFTR: chloride channel mutation in all exocrine tissues → deranged transport of Cl- +/- other affected ions →\n•\nViscous secretions in lungs, pancreas, liver, intestines, and reproductive tract\n•\nIncreased salt content in sweat gland secretions\nDiagnosis: both of\n1. SSx consistent with CF in one organ system or +ve newborn screen (trypsinogen) or sibling with CF\n2. AND evidence of CTFR dysfunction (sweat chloride ≥60 mmol/L or 2x disease causing mutations or abnormal nasal\npotential difference)\nMethodology:\n•\nNewborn screening: Heel prick test for trysinogen levels\n•\nSweat test (from age >2 weeks): transdermal pilocarpine → sweat → Cl-\n•\nGenetic testing: D508 most common\nClinical presentation:\n•\nResp: chronic productive cough, sinus dz, nasal polyps (risk obstruction / epistaxis), bronchiolitis/asthma,\nhyperinflation, chronic bronchitis, Pseudomonas colonisation, Staph colonisation, bronchiectasis, clubbing, obstructive\nfeatures, pulmonary HTN\n•\nRenal: renal stones 2’ enteric hyperoxaluria ( fat malabsorption), hypocitraturia (chronic metabolic acidosis)\n•\nGIT: pancreatic insufficiency (exo malabsorption, endo diabetes), meconium ileus, ADEK vit deficiency, neonatal\njaundice, biliary cirrhosis, portal hypertension +/- varices, recurrent pancreatitis\n•\nGU: absent vas deferens, male infertility, female fertility\n•\nOther: serum Cl- & Na+, pseudotumour cerebri, OP, #, kyphoscoliosis, DVTs (highly associated with CVCs)\nTreatment options:\n•\nCFTR modulators (only certain genotypes) e.g. ivacaftor, lumacaftor, tezacaftor (new – no mortality data yet)\no\n→ exacerbations, spiro, QOL\n•\nAirway clearance:\no\nDornase alpha (Pulmozyme)\no\nHypertonic saline 6%, mannitol\no\nChest physio i.e. postural drainage, huffing, percussion vests, exercise\n•\nB2 agonists (prior to hypertonic substances + antibiotics to prevent constriction)\n•\nAnti-inflammatories:\no\nAzithromycin (effects attributed to anti-inflammatory effects must be colonised with P. aeruginosa)\no\nInhaled glucocorticoids (only if signs and symptoms of asthma - short term only)\no\nHigh dose ibuprofen (slows progression of disease – must monitor for side effects)\n•\nInhaled antibiotics if indicated: tobramycin\n•\nPrevention: exercise, vaccinations\n•\nGI: Creon (pancreatic enzymes), insulin (diabetes, OHGs ineffective), vitamins (ADEK + Ca2+), caloric supplementation\nPre-op:\n•\nHistory: medication, exacerbation, MRO, functional capacity\n•\nIx: CXR, spiro, ABG, routine + BSL, TTE, ECG\no\nFEV1 <1L → post-op ventilation\no\nFunctional capacity: 6MWT, CPET\n•\nDay case rarely appropriate unless mild / stable\n•\nOptimise: resp r/v, PT, treat infections, nutrition, neb drugs, glycaemic control\n•\nPre-med: neb bronchodilator / mucolytic\nIntra-op:\n•\nMonitoring: consider art line\n•\nAirway: LMA + spont vent, ETT requires suctioning\n•\nVentilation: LPV, frequent suctioning, volatile, intra-op PT, humidified gas\nPost-op: PT, early extubation, early mobilisation, ICU if FEV1 <1L or chronic hypoxaemia / hypercapnoea, poor functional status,\nmajor abdo/thoracic surgery", "citations": [{"type": "pdf_page", "page": 206, "label": "p206"}]}
{"chunk_id": "SSUs_v1_p207_txt_00_771391", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 207, "page_end": 207, "section_path": ["URTI", "Cerebral Palsy", "Down Syndrome"], "specialty_tags": ["URTI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Down Syndrome", "keywords": [], "text": "Down Syndrome\n1/700\nClinical features:\n•\nGeneral:\no\nAppearance: brachycephaly, flat nasal bridge, epicanthic folds, upslanting palpebral fissure, small mouth &\nears, single transverse palmar crease\no\nLow birth weight → obesity\no\nShort stature\n•\nAirway: macroglossia, narrow midface, oropharyngeal hypotonia, micrognathia, small mouth, short neck, adenotonsillar\nhypertrophy, subglottic / tracheal stenosis, atlantoaxial instability 15% →\nOSA, difficult BMV/intubation, ETT one size smaller, take care with neck movement\n•\nResp: OSA / CSA, frequent LRTI, GORD\n•\nCVS: up to 60% have CHD → AV canal defect (most common), ASD, VSD, PDA, TOF\no\n→ pulmonary hypertension +/- Eisenmenger syndrome\no\nConduction defects post-repair\no\nAdults → AR, MV prolapse\n•\nNeuro: neonatal hypotonia (careful positioning), intellectual impairment, sensory deficits (visual, hearing), generally\ncalm and good natured, peri-op anxiety / agitation, early onset alzheimers, epilepsy, low MAC requirement\n•\nGIT: GORD, atresia, Hirschsprungs disease, gallstones, coeliac disease, imperforate anus\n•\nImmune: recurrent chest infection\n•\nHaem: polycythaemia, leukaemia\n•\nEndo: congenital hypothyroidism, adolescent hyperthyroidism, diabetes\n•\nSpinal: atlanto-axial instability, spina bifida, cervical spondylosis\nPre-op:\n•\nAssess:\no\nAirway: ?tracheal stenosis (stridor, wheeze, cyanosis), seek previous airway management\no\nAtlanto-axial instability – screening XR\no\nCardiac: ?CHD, TTE\n•\nPre-med: indicated, usually become agitated – must monitor due to OSA\nIntra-op:\n•\nDifficult venous access – US nearby\n•\nC-spine: care with movement / positioning\n•\nAirway: difficult features but usually intubatable – have adjuncts, difficult airway trolley\n•\nMaintenance: lower MAC\n•\nPositioning: hypotonia (care)\nPost-op: Caregiver in recovery", "citations": [{"type": "pdf_page", "page": 207, "label": "p207"}]}
{"chunk_id": "SSUs_v1_p207_txt_01_d02430", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 207, "page_end": 207, "section_path": ["URTI", "Cerebral Palsy", "Cerebral Palsy"], "specialty_tags": ["URTI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Cerebral Palsy", "keywords": [], "text": "Cerebral Palsy\n1/500 live births. Risk much higher in premature babies.\nSpectrum of movement and posture disorders which result from pathological injury to the developing foetal or infant brain\nSSx: spasticity 80%, muscle contractures +/- neurological and other systems, epilepsy 50%\nTreatment is supportive: improve posture, spasticity and epilepsy treatment +/- surgery\nPre-op: routine+\n•\nAssess: level of cognition (very important), involve caregiver\nIntra-op:\n•\nDifficult IV access due to contractures\n•\nPropofol preferred agent (reactive airways)\n•\nHigh risk aspiration – consider RSI (sux not CI, non-depol have effect)\nPost-op:\n•\nPICU – prone to hypoxia, hypovolaemia, hypothermia, poor cough and reduced resp drive, retained secretions\n•\nAnalgesia: appropriate pain scales, involve caregiver\n•\nTreat pain + hypothermia – can trigger acute muscle spasms", "citations": [{"type": "pdf_page", "page": 207, "label": "p207"}]}
{"chunk_id": "SSUs_v1_p208_txt_00_a92b4e", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 208, "page_end": 208, "section_path": ["URTI", "Autism", "Autism"], "specialty_tags": ["URTI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Autism", "keywords": [], "text": "Autism\nDefinition: lifelong neurodevelopmental difference that influences the way a person interacts and communicates with others,\nand experiences the world around them - common themes, but different profiles\nEstimated significantly underdiagnosed in all age groups.\nTriad:\n•\nSocial communication\n•\nInteraction\n•\nSocial imagination\nConsequences:\n•\nMortality gap up to 30y\n•\nBarriers to healthcare\n•\n2x risk of dying as inpatient after emergency admission\nSPACE FRAMEWORK:\n•\nSensory needs: noise / lights / smell / touch may make clinical encounter difficult\n•\nPredictability: intolerance of uncertainty\n•\nAcceptance: repetitive behaviour e.g. stimming is soothing, interest in single topic areas – use to build rapport\n•\nCommunication: may be non-verbal, may prefer writing\n•\nEmpathy: common misconception that lack empathy, may be hyperempathetic\n+:\n•\nphysical space\n•\nprocessing space\n•\nemotional space\nPre-op:\n•\nAssessment:\no\nCommunication needs e.g. picture chart\no\nSyndromes\no\nPsychological & physical needs\no\nDevelopmental level\no\nCo-existing conditions: obesity, diabetes, hypertension, Parkinsons, mental health, ADHD, hypermobility\nsyndromes, autonomic dysfunction, chronic pain\no\nMust ascertain capacity\n•\nQuiet stream\n•\nPreparation\n•\nPre-med: disguise in food / drink – administer pre-hospital if necessary\n•\nMinimise waiting times\n•\nCare with physical contact\n•\nMinimise distractions\nPost-op:\n•\nDifficult to assess pain / nausea – use appropriate scales + engage caregiver", "citations": [{"type": "pdf_page", "page": 208, "label": "p208"}]}
{"chunk_id": "SSUs_v1_p209_txt_00_64d3df", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 209, "page_end": 209, "section_path": ["URTI", "Obesity", "Obesity"], "specialty_tags": ["URTI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Obesity", "keywords": [], "text": "Obesity\nDefined by age & sex specific BMI\nClass\nPercentile / BMI\n5yo\n5 – 14yo\nUnderweight\n<5th\nNormal weight\n5th – 85th\nOverweight\n85th – 95th\n>2sd\n>1sd\nObese\n≥95th\n>3sd\n>2sd\nSevere class 2 obesity\n≥120th OR BMI >35\nSevere class 3 obesity\n≥140th OR BMI >40\nComorbidities: same as adults – HTN, OSA (→ biventricular impairment, LVH, pulmonary HTN), T2DM, chol, GORD,\npsychological, NAFLD\nPre-op:\n•\nWeight, height, BMI\n•\nScreen for comorbidities: BP, ECG, BSL, chol\n•\nAssess: GORD, diabetes, OSA, functional capacity\n•\nAvoid pre-med or use non-resp depressant\nIntra-op:\n•\nHover mat if >120kg, check max weight of operating table\n•\nHave US available for difficult IV access – IV > inhalational if able\n•\nInduction: ramp, good pre-oxygenation, RSI aspiration risk, adjuncts, ETT > LMA (lung compliance, PEEP)\n•\nVentilation: lung protective, higher PEEP (beware risk PRAE)\n•\nCVS: appropriate BP size\n•\nPositioning: pressure areas, manual handling, restraint for trendelenberg & lateral\n•\nDrug dosing: TBW can lead to overdosing – use IBW/LBW (sux – TBW), TIVA use BIS and titrate\n•\nExtubate: awake and fully reversed\nPost-op:\n•\nrisk PRAE – monitor appropriately\n•\nOpioid-sparing analgesia, PONV\n•\nIf OSA – overnight stay with continuous sats monitoring +/- HDU\n•\nVTE prophylaxis", "citations": [{"type": "pdf_page", "page": 209, "label": "p209"}]}
{"chunk_id": "SSUs_v1_p210_txt_00_37eb97", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 210, "page_end": 210, "section_path": ["URTI", "Diabetes", "Diabetes"], "specialty_tags": ["URTI"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Diabetes", "keywords": [], "text": "Diabetes\n>97% of paediatric diabetes is type 1\nPeri-op considerations:\n•\nSurgical stress → hyperglycaemia\n•\nTarget BSL 5 – 10mM\n•\nActive treatment threshold: <5mM, >14mM\n•\nMonitor hourly\nPathogenesis + diagonisis – see diabetes\nPre-op:\n•\nAssess: HbA1c (>7 suggests suboptimal control), micro & macro complications, comorbidities\no\nIf poor control consider deferring: rationale for peri-op euglycaemia – wound infection, LOS, myocardial events\n•\nHypos + awareness\n•\nMedication regime + insulin plan – if on insulin pump print settings\no\nPremix insulin by 50%, long acting keep basal dose\no\nPump: same principles, keep basal + reg BSL checks, must check pump (may kink with positioning)\n•\nAim morning surgery, minimise fasting times\n•\nGive parent / caretaker plan for peri-op hypos\n•\nIndication for insulin infusion: prolonged starvation, PONV, longer surgery, emergency surgery, DKA\nIntra-op:\n•\nInduction: RSI, monitoring for autonomic instability, 5 lead ECG if IHD (beware silent MI)\n•\nMaintenance: TIVA due to PONV risk (due to no dex, ensure good visible drip), BSL +/- ketone checks\n•\nBSL: poor control – insulin / dex infusion w/ q1 hourly BSL checks – start with daily total insulin and divide by 24 for\nhourly rate\nPost-op:\n•\nEarly PO intake w/ usual long acting + normal s/c with food – if on infusion cease 2hr post oral intake", "citations": [{"type": "pdf_page", "page": 210, "label": "p210"}]}
{"chunk_id": "SSUs_v1_p211_txt_00_17d877", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 211, "page_end": 211, "section_path": ["AIR v MH", "Neuromuscular Disorders"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Neuromuscular Disorders", "keywords": [], "text": "Neuromuscular Disorders\nPathophysiology:\n•\nAcetylcholine e.g. myasthenia gravis\n•\nPost-synaptic membrane e.g. channelopathies\n•\nMyofibrils: dystrophy, myotonia\n•\nMitochondrial: mitochondrial myopathy\nPre-op:\n•\nHistory: diagnosis, progression, stability / flares, duration\n•\nFunctional capacity including OSA, bulbar function\n•\nFamily history\n•\nPrevious GA: ?hyperthermia, requirement for post-op ventilation support\n•\nExam: hypertrophied calves, syndromic appearance, cough effectiveness, cardiac / resp\n•\nIx: routine+, ECG, EMG, CK, lactate +/- TTE / spiro / sleep study\no\nGenetic testing may supplant muscle biopsy need\n•\nMinimise fasting, IVF + glucose if metabolic disorder\nConsiderations:\n•\nAppropriate facility (paeds ICU / HDU), paeds anaesthetist\n•\nSensitivity to NMBA – use nerve stimulator\n•\nCI drugs:\no\nAvoid sux in all except MG (resistance)\no\nAvoid acetylcholinesterases in myotonia\no\nMH risk: King-Denborough syndrome, central core disease, evans myopathy, hypokalaemic periodic paralysis\no\nrisk of propofol infusion syndrome in mitochondrial disorders\n•\nAspiration risk: ?GORD, RSI\n•\nAnaesthesia induced rhabdomyolysis: DMD, Beckers\nReason for surgery:\n•\nMuscle biopsy\n•\nComplication of disorder e.g. contractures\n•\nUnrelated\nIntra-op:\n•\nAvoid pre-meds\n•\nPrepare machine to eliminate volatile if MH / AIR\n•\nConsider regional technique\n•\nGA: RSI if aspiration risk, doses (sensitivity), IV induction to avoid MH/AIR (sedation to facilitate IV access) – PO, IM\nor N2O\n•\nIf NMDA required: roc + sugammadex, use lower doses, nerve stimulator\n•\nAnalgesia: multimodal, opioid-sparing + regional where able\n•\nPositioning: care with contractures, pressure areas\n•\nTemp: monitor, avoid hyperthermia\nAIR v MH\nAIR\nMH\nClinical\n-\nRigidity\nMasseter spasm\nECG\nPeaked T waves\nBradycardic arrest\nTachycardia\nSpO2\nNormal\nReduced\nCO2\nNormal (increases late)\nETCO2\nBloods\nK+\nCK >1000\nAcidosis\nK+\nMetabolic\nHyperthermia\nMyoglobinaemia\nHyperthermia\nMyoglobinaemia\nDIC", "citations": [{"type": "pdf_page", "page": 211, "label": "p211"}]}
{"chunk_id": "SSUs_v1_p212_txt_00_5a2f67", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 212, "page_end": 212, "section_path": ["AIR v MH", "Congenital Heart Disease", "Congenital Heart Disease"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Congenital Heart Disease", "keywords": [], "text": "Congenital Heart Disease\n1/125 live births. Most common birth defect.\nLow Risk – Safe to Proceed\nMedium Risk – D/w Specialist +/- t/f\nHigh Risk – t/f to tertiary centre\n•\nWell compensated\n•\nMinor surgery\n•\nAge >2yo\n•\nElective surgery\n•\nASA 1 - 3\n•\nWell compensated\n•\nSimple lesion\n•\nMajor surgery\n•\nAge <2yo\n•\nEmergency surgery\n•\nPre-op stay >10 days\n•\nASA 4 - 5\n•\nPhysiologically poorly compensated\n•\nComplications: cardiac failure,\npulm HTN, arrhythmias, VEBs,\ncyanosis\n•\nComplex lesions: single ventricle,\nbalanced circulation,\ncardiomyopathy, aortic stenosis\nPossible reason for t/f:\n•\nMajor surgery: major\nabdo/thoracic, vascular, predicted\nmajor blood loss\n•\nAge <2yo\n•\nEmergency surgery\n•\nPre-op patient >10 days\n•\nASA 4 – 5\nClassification of lesions:\n1. Shunts:\na. L → R Shunts : VSD, ASD, PDA, AV canal →\ni. VSD\nii. ASD\niii. PDA\niv. AV canal\n→ pulmonary congestion, LV volume overload, pulmonary blood flow, pulmonary vascular resistance, pulmonary\nhypertension, systemic perfusion\nb. R → L shunts:\ni. Tetralogy of Fallot\nii. Pulmonary Atresia / VSD\niii. Eisenmenger complex\n→ cyanosis and RV failure\n2. Mixing lesions\na. Transposition of the great arteries\nb. Tricuspid atresia\nc.\nAnomalous venous return\nd. Single ventricle\n3. Obstructive Lesions\na. Interrupted aortic arch\nb. Critical aortic stenosis\nc.\nCritical pulmonary stenosis\nd. Hypoplastic left heart syndrome\ne. Coarctation of the aorta\nf.\nMitral stenosis\n4. Regurgitant valves\na. Ebstein anomaly\nDuct Dependence\n•\nDuct dependent pulmonary flow\no\nCritical pulmonary stenosis / atresia\no\nTV stenosis / atresia without VD\no\nSevere ToF\no\nTransposition\n→ differential / reverse cyanosis\n•\nDuct dependent systemic flow\no\nHypoplastic left heart\no\nCritical AS\n→ differential cyanosis\no\nInterrupted aortic arch\n→ differential cyanosis\no\nCoarctation of aorta\n→ differential cyanosis\no\nTransposition\n→ differential / reverse cyanosis", "citations": [{"type": "pdf_page", "page": 212, "label": "p212"}]}
{"chunk_id": "SSUs_v1_p213_txt_00_ba67a6", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 213, "page_end": 213, "section_path": ["AIR v MH", "Congenital Heart Disease"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Congenital Heart Disease", "keywords": [], "text": "Coarctation of Aorta\nDescending aortic flow is duct\ndependent → femoral pulses\nTransposition of Great Arteries\nTetralogy of Fallot\nLarge VSD\nOverriding aorta\nRVOT obstruction\nRVH\nBlalock-Taussig shunt →\nflow to lungs\nEbstein Anomaly\nFailed tricuspid\ndelamination\nAtrialised RV\nRV impairment\nPre-op:\n•\nCardiac history: lesion, physiology, complications, operations, functional status, medications +/- compliance\n•\nOther paed: recent illness, feeding, FTT\n•\nVenous access\n•\nNeed for IE prophylaxis:\no\nAny prosthetic valve / material\no\nPrevious IE\no\nType of CHD: cyanotic lesion unrepaired, repair <6mo (lifelong if residual shunt / regurgitation)\no\nCardiac transplant with valvuloplasty\n•\nExamination: cardiac failure, cyanosis\n•\nIx: ECG, routine bloods + gas, TTE\nIntra-op: 3x B’s (balance PVR / SVR, antiBiotics, Bubbles)\n•\nIV access prior to induction: if R → L shunt place air filter to prevent paradoxical air embolus\n•\nInduction: avoid propofol – ketamine, opioid, sevo OK\n•\nCVS: consider art line + careful management of PVR, SVR, inotropy, ventilation\n•\nIE prophylaxis if indicated:\no\nDental: i.e. gingival manipulation, periapical, perf of oral mucosa\namoxicillin 50mg/kg max 2g\no\nResp: i.e. incision or biopsy of mucosa, T&As, active resp infection\no\nSkin / soft tissue: if infected\nAntibiotics not required for GI or GU unless infection is present", "citations": [{"type": "pdf_page", "page": 213, "label": "p213"}]}
{"chunk_id": "SSUs_v1_p214_txt_00_42dc08", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 214, "page_end": 214, "section_path": ["AIR v MH", "Seizure", "Epilepsy"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Epilepsy", "keywords": [], "text": "Epilepsy\n1% of children.\nCauses:\n•\nPre-natal: inborn error of metabolism, chromosomal abnormality, infection (TORCH), tuberous sclerosis, cortical\ndysplasia, AVM, neurofibromatosis\n•\nPeri- and post-natal: hypoglycaemia, Ca2+, HIE, IVH, infection, venous sinus thrombosis, trauma, malignancy, fever\n•\nUnknown cause\nTreatment with anti-epileptics – most are hepatic enzyme inducers\nCan cause: hepatotoxicity, myelosuppression, thrombocytopaenia\nDrug SEs:\n•\nPhenytoin 20mg/kg: enzyme induction, megaloblastic anaemia, haemolysis in G6PD\n•\nSodium valproate: enzyme induction, plt, hepatotoxicity\n•\nCarbamazepine: enzyme induction, pancytopaenia, hepatotoxicity / cholestasis, Na+, sedation\n•\nPhenobarbital 20mg/kg: enzyme induction, sedation, megaloblastic anaemia\n•\nClonazepam: sedation\n•\nEthosuximide: hepatotoxicity, leukopaenia, thrombocytopaenia, sedation\n•\nLamotrigine: GI, sedation / dizziness\n•\nTopiramate: NAGMA, enzyme inhibition\nPre-op:\n•\nAssess: cause, type, frequency, treatment + side effects, associations\n•\nIx: routine+ AED levels, coags, TTE if associated disorder\n•\nTreat: continue AED (unless ceasing for seizure surgery), peri-op give NG/IV – d/w neurologist\n•\nPre-med: indicated, avoid hyperventilation (but avoid if seizure surgery)\nIntra-op:\n•\nIncreased anaesthetic requirements\n•\nProp, sevo, N2O okay\n•\nmetabolism of NMBA: use nerve stimulator\no\nAvoid sux (hyperkalaemia), atracurium (laudanosine)\n•\nVentilation: normocapnia\n•\nOther drugs to avoid: ketamine, alfentanil, pethidine\n•\nIntra-op seizure:\no\nSSx: ETCO2, HR, hypertension, muscle tone, pupil dilatation, VO2\no\nTreatment:\n▪\nDeepen\n▪\nFiO2 100%\n▪\nCorrect: hypoxia, CO2, BSL, Na+, temp\nPost-op: continue or restart AED asap\nSeizure\nABCD + check BSL, IV access\nSeizure termination:\n1. Midaz 0.1mg/kg IV OR 0.5mg/kg buccal OR diazepam 0.5mg/kg PR (can also use lorazepam)\n2. Midaz 0.1mg/kg IV OR paraldehyde 0.8mg/kg in 50:50 mixture with oil PR\n3. Anti-epileptic + senior help must be present at this stage\na. Phenytoin 20mg/kg IV over 20 mins\nb. Phenobarbitone 20mg/kg over 20 mins\nc.\nLevetiracetam IV 40mg/kg\nd. Sodium valproate IV\n4. Raised ICP – ICP management\na. RSI with thiopentone 5mg/kg then 3 – 5mg/kg/hr\nb. Midaz up 20mcg/kg/hr\nStatus epilepticus: 8% mortality\n•\nContinuous seizure ≥30 min OR\n•\n2 seizures without complete recovery between", "citations": [{"type": "pdf_page", "page": 214, "label": "p214"}]}
{"chunk_id": "SSUs_v1_p215_txt_00_4de503", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 215, "page_end": 215, "section_path": ["AIR v MH", "Sickle Cell Anaemia", "Sickle Cell Anaemia"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Sickle Cell Anaemia", "keywords": [], "text": "Sickle Cell Anaemia\nMost common inherited haemoglobinopathy. Abnormal B-chain → homozygous HbSS.\nPathophysiology: abnormal B-chain → HbS → B chains that polymerise at lower O2 tensions i.e. ‘sickling’ → vicious cycle of\nvenous stasis, hypoxia, further sickling + capillary congestion → microcirculatory infarction\nClinical presentation when HbF → HbS @ ~6mo.\nDiagnosis:\n•\nBlood spot on neonatal screening\n•\nHaem: anaemia, macrocytic, high retic #, film, folate deficiency, iron overload from transfusion\nSickling triggers: hypoxia, acidosis, hypothermia, dehydration\nComplications: vascular occlusion (stroke, organ infarct, pulmonary HTN, CKD), chronic haemolysis (transfusions, gallstones),\npriapism, OM / avascular necrosis, splenic sequestration (→ functional asplenia)\nManagement:\n•\nEducation\n•\nVaccination: Strep pneumoniae and Haemophilus influenzae, meningitis, Hep B, flu\n•\nProphylactic penicillin\n•\nMelaena prophylaxis\n•\nFolate supplementation\n•\nHydroxyurea → HbF\nManagement of acute complications 2’ vaso-occlusive episodes:\n•\nAntibiotics for acute chest syndrome, incentive spiro\n•\nIVF, O2, analgesia\n•\nTransfusion target >100\nPre-op:\n•\nSpecialist centre if possible, day case contra-indicated\n•\nAssess: disease, complications\n•\nFirst on list – avoid dehydration, prolonged fasting\n•\nHb:\no\nTransfuse if Hb <100\no\nExchange transfusion aiming HbSS <60%\no\nTAPs study: pre-op transfusion associated with peri-op complications\n•\nIx: FBC, EUC (?CKD), X-match (?Abs), TTE, CXR / spiro, transcranial doppler within 12mo, electrophoresis for HbSS %\nIntra-op:\n•\nAvoid triggers\n•\nPONV prevention to allow post-op oral hydration\n•\nTourniquet: benefit of blood loss, but risk of sickling (distal + after let down) – prevented by hydration, normal acid-\nbase + short duration\n•\nCell salvage contra-indicated\nPost-op:\n•\nComplications: infection / sepsis, ACS, vaso-occlusion, stroke\n•\nQ2 hourly incentive spiro\n•\nKeep hydrated; IVF if needed + PONV\n•\nSupplemental O2, ICU / HDU\n•\nPhysiotherapy\n•\nMultimodal analgesia\no\nConsider vasodilation with heat pads for pain", "citations": [{"type": "pdf_page", "page": 215, "label": "p215"}]}
{"chunk_id": "SSUs_v1_p216_txt_00_da5c52", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 216, "page_end": 216, "section_path": ["AIR v MH", "Neonatal Resuscitation at Birth", "Neonatal Resuscitation at Birth"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Neonatal Resuscitation at Birth", "keywords": [], "text": "Neonatal Resuscitation at Birth\nEpidemiology:\n•\n85% initiate spont ventilation within 30s\n•\n10% require drying / stimulation\n•\n3% require PPV\n•\n2% intubation\n•\n0.1% CPR\nRFs:\n•\nMaternal: prolonged ROM >18hr, bleeding, hypotension, substance abuse, drug therapy, diabetes, chronic illness,\nfever, infection / chorioamnionitis, sedation, previous foetal demise, no antenatal care\n•\nFoetal: multiple birth, pre- or post-dates, small or large BW, poly- or oligohydramnios, haemolytic dz, DFM, congenital\nabnormality, infection, hydrops\n•\nIntrapartum: non-reassuring CTG, abnormal presentation, cord prolapse, prolonged or rapid labour, haemorrhage,\nmeconium, narcotic, assisted delivery, GA\nNeopuff settings:\n•\nFiO2 21%\n•\nPIP 30cmH2O (25cmH2O if preterm)\n•\nPEEP 5cmH2O\nIntubation:\n•\nETT size: gestational age (weeks) / 10\n•\nLaryngoscope:\no\n00: ELBW\no\n0: preterm <32 weeks\no\n1: term\n•\nDepth: weight (kg) + 6 (8-9cm at term)\n•\nSuction: 2x ETT size in Fr\n•\nLMA: size 1 option for rescue airway if >2kg, >34 weeks\nCPR:\n•\nCommence if HR <60\n•\nTwo thumb techqniue\n•\nRatio 3:1 compressions:breaths – 0.5s pause for breath\n•\nRate 90bpm, 120bpm if intubated\nDrugs:\n•\nAdrenaline:\no\nIV: 10-30mcg/kg\no\nETT: 50 – 100mcg/kg\n•\nIVF: 10mL/kg crystalloid\n•\nNaloxone: 10mcg/kg or 200mcg IM\n•\nGlucose 10%: 2.5mL/kg\nDrugs that can be given via ETT = ALIEN (atropine, lignocaine, isoprenaline, epinephrine, naloxone)\nVascular access:\n•\nUmbilical vein (2 arteries + 1 dilated vein in cord)\no\n5Fr catheter flushed (3.5Fr if preterm)\no\nDepth 5cm\no\nSecure with tape around umbilicus", "citations": [{"type": "pdf_page", "page": 216, "label": "p216"}]}
{"chunk_id": "SSUs_v1_p217_txt_00_3375ca", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 217, "page_end": 217, "section_path": ["AIR v MH", "Circulatory Changes at Birth"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Circulatory Changes at Birth", "keywords": [], "text": "APGAR Scores\nScore: 0 – 10 at 1 and 5 mins post-birth\n•\n7 – 10: reassuring\n•\n4 – 6: abnormal\n•\n0 – 3: concerning\nCriteria\nColour\nPale / cyanotic\nPeripheral cyanosis\nPink\nPulse\n<100bpm\n>100bpm\nGrimace / reflex irritability\nNo response\nGrimace / weak cry\nCry\nTone / activity\nFloppy\nMild flexion\nFlexion + resists extension\nRespiration\nApnoea\nSlow regular\nCry\nA\nappearance\nP\npulse\nG\ngrimace\nA\nactivity\nR\nrespiration\nCirculatory Changes at Birth\nAt birth – gas exchange transferred from placenta to neonatal lungs\nFoetal\nNeonatal\nDiagram\nCirculation\nParallel\nSeries\nFoetal\ndistinctions\n•\nUA x 2 – internal iliacs to placenta\n•\nUV x 1 – placenta to IVC / liver\n•\nDuctus venosus – UV → IVC\n•\nFO – RA → LA\n•\nDA – PA → aorta\nO2\nPlacenta\nLungs\nRoute\n•\n50% IVC via ductus venosus\n•\n50% hepatoportal system\nRA →\n•\n60% LA via foramen ovale (more oxygenated\nblood sats 65-70%) → brain and upper\nextremities\n•\n40% less oxygenated blood → RV →\no\n10% pulmonary circulation (so little because\nlungs are collapsed)\no\n90% ductus arteriosus (PA → descending\naorta) → systemic circulation → umbilical\nartery for reoxygenation\nSame as adult circulation after PDA closes\nPressure\nHigh\nLow\nFlow\nLow\nHigh\nTransition steps: 2’ change in circulatory resistance\n1. Low resistance placenta is excluded 2’ clamping → ↑SVR + ↑LV EDP\n2. ↓RA pressure 2’ ↓IVC flow\n3. → expansion of lungs and ↓PVR → ↓RV EDP\n4. PVR decreases further with ↑PaO2 and pH and ↓PaCO2 (PA pressure falls to adult values within 2 weeks)\n5. ↑LA pressure 2’ ↑flow through lungs + ↑LV EDP\n6. Other changes weeks later include ↓RV wall thickness, ↑LV wall thickness", "citations": [{"type": "pdf_page", "page": 217, "label": "p217"}]}
{"chunk_id": "SSUs_v1_p218_txt_00_deef43", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 218, "page_end": 218, "section_path": ["AIR v MH", "Circulatory Changes at Birth"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Circulatory Changes at Birth", "keywords": [], "text": "Functional and permanent closure:\nStructure\nFunctional\nPermanent\nUmbilical arteries\nMinutes\n(Clamp, hypothermia contraction of Wharton’s\njelly, ↑PaO2)\nDays\n(Fibrosis)\nUmbilical vein\nHours\n(Clamp, hypothermia contraction of Wharton’s\njelly)\n3-10 days\n(Fibrosis)\nDuctus venosus\nHours\n(Stasis)\n3-10 days\n(Fibrosis → ligamentum teres)\nForamen ovale\nMinutes; when LAP > RAP\n(↓PVR, ↑SVR)\n4-6 weeks\n(Fibrosis)\nDuctus arteriosus\n12-24hrs\n(↑PaO2, ↓PG)\n2-3 weeks\n(Fibrosis)\nVariations to above:\n•\nElevation of RAP → persistence of foramen ovale\n•\nDecrease PVR → persistence of ductus arteriosus\n•\nProstaglandins and hypoxia → inhibit closure of ductus arteriosus", "citations": [{"type": "pdf_page", "page": 218, "label": "p218"}]}
{"chunk_id": "SSUs_v1_p219_txt_00_37c57a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 219, "page_end": 219, "section_path": ["AIR v MH", "Collapsed Newborn", "Collapsed Newborn"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Collapsed Newborn", "keywords": [], "text": "Collapsed Newborn\nCauses\nPresentation\nManagement\nSepsis\nPoor feeding, lethargy, fever, resp distress\n•\nBlood cultures\n•\nImmediate broad spectrum abx\n•\nResuscitate\nCongenital Heart\nDisease\nCyanosis, murmur, shock\nPGE1 to maintain ductal patency\nInotropic support\nConsult cardio\nMetabolic\nDisorders\nLethargy, seizures, hypoglycaemia, acidosis\nCorrect, consult metabolic specialist\nRespiratory\nTachypnoea, grunting, retractions, cyanosis\nO2, CPAP +/- mechanical ventilation, cause (e.g.\nsurfactant for RDS)\nNAI\nInconsistent history, injury pattern, bruising,\nfractures\nStabilisation, reporting child to child protection, MDT", "citations": [{"type": "pdf_page", "page": 219, "label": "p219"}]}
{"chunk_id": "SSUs_v1_p220_txt_00_d7edc8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 220, "page_end": 220, "section_path": ["AIR v MH", "Cardiac/Respiratory Arrest", "Cardiac/Respiratory Arrest"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Cardiac/Respiratory Arrest", "keywords": [], "text": "Cardiac/Respiratory Arrest\nPaediatric differences:\n•\nResp causes > cardiac causes\n•\nAsystole and PEA most common initial rhythms (85%)\no\nVF presents commonly in congenital heart disease, cardiac meds, channelopathies\n•\nHypoxia and hypovolaemia most common causes (4Hs and 4Ts + HOCM / channelopathies)\n•\n2 rescue breaths prior to compressions, ratio 15:2\n•\nCompression depth: 1/3 AP distance\n•\nCompression technique: infant – 2 fingers / 2 thumbs, child – one or two hands\n•\nPaddle size: use largest pads that fit without touching each other\no\n<10kg: 4.5 cm\no\n>10kg: 8 – 12 cm\no\nAge >8yo: adult pads\n•\nIntubation:\no\nCuffed & uncuffed both acceptable\no\nDeflate stomach with OG / NG after intubation\no\nAvoid hyperventilation post intubation\n•\nCirc: IO if pIVC/CVC not in place\n•\nFamily presence should be facilitated with an allocated staff member\n•\nUse of real-time audiovisual feedback and prompt devices for quality assurance is\nArrest drug doses: (if weight unknown use tape – non-obese use actual body weight, obese use IBW)\n•\nDefib: 4J/kg\n•\nAdr: 10mcg/kg\n•\nAtropine: 20mcg/kg\n•\nAmio: 5 mg/kg\n•\nFluid 20mL/kg\nSpecific drugs:\n•\nCalcium (Ca2+, Mg2+/K+, CCB overdose):\no\nCaCl 10%: 0.2mL/kg\no\nCa Gluconate 10%: 0.7mL/kg\n•\nGlucose 10%: 2mL/kg\n•\nLignocaine (VF, VT): 1mg/kg\n•\nPotassium (K+):\no\nMild: 0.2 – 0.5 mM/kg/hr (max 1mmol/kg)\no\nSevere: 0.03 – 0.07 mmol/kg\n•\nSodium bicarb (TCA overdose, K+): 0.5 – 1mmol/kg – ANZCOR recommends not giving for paeds cardiac arrest, only\nTCA overdose and hyperkalaemia\nPost-care:\n•\nNo evidence for hypothermia, aim <37.5C\n•\nNormal oxygen, normocapnia (unless chronic lung dz, single ventricle, raised ICP)\n•\nsBP >5th percentile for age\n•\nBSL: 3 – 8 mM\n•\nSedation + analgesia\nIx: full bloods, ECG, CXR, TTE", "citations": [{"type": "pdf_page", "page": 220, "label": "p220"}]}
{"chunk_id": "SSUs_v1_p221_txt_00_77d01b", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 221, "page_end": 221, "section_path": ["AIR v MH", "Tracheostomy Emergency", "Tracheostomy Emergency"], "specialty_tags": ["AIR v MH", "crisis", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Tracheostomy Emergency", "keywords": [], "text": "Tracheostomy Emergency\nEmergency management:\n•\nO2 to trache + face\n•\nRemove inner cannula if present and insert new one\n•\nPass suction catheter\n•\nTube change:\n1. Same size\n2. 0.5 size\n3. Suction + down further 0.5 size\n•\nPRIMARY emergency O2: cover stoma → supraglottic technique with BMV / LMA\n•\nSECONDARY emergency O2:\n1. Oral intubation (0.5 size, advance beyond stoma)\n2. Stoma intubation with 3.0 tube\n3. Advanced:\n▪\nStoma bougie/AEC technique\n▪\nFibreoptic scope", "citations": [{"type": "pdf_page", "page": 221, "label": "p221"}]}
{"chunk_id": "SSUs_v1_p222_txt_00_380a58", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 222, "page_end": 222, "section_path": ["AIR v MH", "Anaphylaxis", "Anaphylaxis"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Anaphylaxis", "keywords": [], "text": "Anaphylaxis\n2.7 / 100,000 – 4x rarer than adults (NMBA with highest anaphylaxis in NAP6 was atracurium)\nPresenting symptom: bronchospasm, high airway pressures, hypotension, tachy/brady, rash, oedema, ETCO2\nMost broncospasm in paeds is not due to anaphylaxis, but most common presenting feature is bronchospasm (64%).\nHypotension presents early in 75% of cases.\nGrades:\n1. Mild: general mucocutaneous signs\n2. Mod: hypotension, tachycardia, bronchospasm, cough, mucocutaneous\n3. Life-threatening: severe hypotension, tachy- or bradycardia, arrhythmias, bronchospasm +/- cutaneous\n4. Arrest\nManagement:\n•\nCall for help – if refractory call paeds early\n•\nRemove trigger\n•\nStop procedure, titrate anaesthetic\n•\nEstablish airway, 100% O2\n•\nCVS:\no\nElevate legs\no\n20 – 40mL/kg crystalloid\no\nAdrenaline\n▪\nIM: <6y 150mcg, 6. – 12y 300mcg, >12y 500mcg\n▪\nIV:\n•\nGrade 2: 2mcg / kg\n•\nGrade 3: 4 – 10mcg/kg\n•\nGrade 4: 10mcg/kg\n▪\nInfusion:\n•\nStart at 0.1mcg/kg/min → max 2mcg/kg/min\no\nNorad: 0.1 – 2mcg/kg/min\no\nVasopressin: bolus 0.04 units / kg → infusion 0.02 – 0.06 units/kg/hr\no\nGlucagon: 40mcg/kg (max 1mg) IV\n•\nBronchospasm: resistant more likely than with adults\no\nSalbutamol: <6yo 6 puffs, >6yo 12 puffs\no\nMgSO4: 50mg/kg (max 2g) over 20 mins\no\nAminophylline: 10mg/kg (max 500mg) over 1 hr\n•\nOther:\no\nHydrocort: 2.4mg/kg (max 200mg)\nTryptases at 0, 1, 4 and 24\nRefractory paeds anaphylaxis – call paeds early", "citations": [{"type": "pdf_page", "page": 222, "label": "p222"}]}
{"chunk_id": "SSUs_v1_p223_txt_00_49686b", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 223, "page_end": 223, "section_path": ["AIR v MH", "Meningococcal Sepsis", "Meningococcal Sepsis"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Meningococcal Sepsis", "keywords": [], "text": "Meningococcal Sepsis\nMeningitis triad not always present\nSepticaemia usually presents with fever + shock\nPetechial rashes first present in areas of pressure i.e. elastic clothing\nManagement: (right)\n•\nABC\n•\nEarly antibiotics following cultures – do not delay for LP\n•\nNasopharyngeal swab\nCI to LP: SSx raised ICP, extensive purpura, convulsions, coagulopathy, local infection, resp insufficiency", "citations": [{"type": "pdf_page", "page": 223, "label": "p223"}]}
{"chunk_id": "SSUs_v1_p224_txt_00_e595e5", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 224, "page_end": 224, "section_path": ["AIR v MH", "Paediatric Trauma", "Paediatric Trauma"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Paediatric Trauma", "keywords": [], "text": "Paediatric Trauma\nLeading cause of morbidity and mortality age <1yo. 80% blunt, 20% penetrating. Usually multiple injuries.\nHead injury cause of 75% of deaths.\nTrimodal mortality:\n•\n50% at scene (brain, bleed)\n•\n30% within hours (brain, bleed, airway)\n•\n20% late (organ failure, sepsis)\nMechanisms: non-accidental injury, falls, MVA, sports, drowning, fires\nDifferences to adult trauma injuries:\n•\nEnergy dispersed over larger area → multiple injuries are common\n•\nHead & abdomen proportionally larger → more common injury\n•\nBony structures → organ injuries without fracture\n•\nProne to hypothermia\nPre-arrival preparation:\n•\nStaff: paeds ED, paeds speciality, PICU, anaesthetics, nursing, radiology, pathology / blood bank\n•\nEquipment: Broslow tape, warmers\n•\nWeight estimate:\no\nInfant: (months + 9) / 2\no\n1 – 10yo: (age + 4) x 2\no\n>10yo: age x3\n•\nCalculate:\no\nDoses for IVF, blood, drugs – NETS calculator for simplicity\no\nETT size, ETT depth\nPrimary survey:\n•\nC-spine (use soft collar, if unconscious use sandbags) + control haemorrhage\n•\nAirway:\no\nOral > nasal in trauma\no\nIndications for intubation: resp failure, GCS <8, ICP, transport, OT required\no\nRSI with MILS\no\nInduction: ketamine 1-2mg/kg, fentanyl 1mcg/kg, sux 2mg/kg, atropine 10-20mcg/kg\no\nDecompress stomach with OGT\n•\nBreathing:\no\nAssess for: pneumothorax, haemothorax, flail chest\no\nLung protective ventilation with appropriate RR\n•\nCirculation:\no\nRemember hypotension is a late sign\no\nIV or IO access\no\nWarmed isotonic crystalloid 20mL/kg\no\nHaemorrhage control + blood 10mL/kg\no\nPermissive hypotension sBP 80mmHg if no TBI\no\nEnd point: HR, clear sensorium, pulses, colour/warmth/cap refill, sBP, UO (?response, transient, non-response)\n•\nDisability:\no\nGCS / AVPU / pupils – d/w caregiver if there + ?moving all 4 limbs\no\nBSL\no\nAnalgesia\no\nWARM\nInvestigations:\n•\nBloods + blood gas + G&H\n•\nImaging: CXR, pelvis +/- C spine\no\nIndications for CT brain: GCS <12, LOC, skull #, retrograde amnesia, neurology, severe injury\nSecondary survey:\n•\nHead & neck\no\nSoft tissue and bone\no\nNeuro including cranial nerves", "citations": [{"type": "pdf_page", "page": 224, "label": "p224"}]}
{"chunk_id": "SSUs_v1_p225_txt_00_4a6bf0", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 225, "page_end": 225, "section_path": ["AIR v MH", "Traumatic Brain Injury"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Traumatic Brain Injury", "keywords": [], "text": "SCIWORA – Spinal Cord Injury Without Radiological Evidence\n50% of SCI. MRI + C-spine protection. Objective signs without XR or CT evidence.\nSpecific organ systems:\n•\nChest trauma 3%: blunt trauma can cause organ injury without fracture\n•\nAbdominal 10%: indication for laparotomy → haemodynamically unstable with swollen abdomen, peritonitis,\npneumoperitoneum, renal vascular injury\n•\nLimbs involved 10-15%\nNon-Accidental Trauma\nFeatures: (have high index of suspicion in unusual injuries)\n•\nRetinal haemorrhage\n•\nFemoral shaft # <3yo\n•\nBruising finger or hand shaped\n•\nBites\n•\nBurns\n•\nDelayed presentation\n•\nIncompatible history\n•\nChild demeanour\n•\nMultiple injuries of different ages\n→ d/w paediatrician + mandatory reporting\nOther injury includes sexual, emotional, neglect + fabricated illness\nRFs:\n•\nChild: disability, behavioural, prematurity, LBW, unplanned child\n•\nParental: step-parent, teenage parent, substance abuse, mental health, generational abuse, parental disability\n•\nFamily / social: single parent, DV, unemployment, poverty, social isolation\nTraumatic Brain Injury\nRaised ICP management: target <20mmHg\n•\nSigns of impending herniation (HTN + brady, severe headache, coma, abnormal breathing, decorticate posturing)\no\nRSI with MILS\no\nOsmotherapy + hyperventilate to PaCO2 30 – 35mmHg\n•\nNo impending herniation → CT brain → surgery if lesion amenable to surgery\n•\nICP monitoring indications: TBI with GCS <8, impending herniation, condition that will require ICP monitoring\no\nICP >20mmHg: osmotherapy + hyperventilate\no\nAcute obstructive hydrocephalus on imaging → EVD + drain\n•\nAvoid boluses of midaz + fent as they may CBF\nDecisions by neurosurg: thiopentone coma, decompressive craniotomy, hypothermia (32-33), hyperventilation <PaCO2 30mmHg\nManagement: neuroprotective measures, stabilise, control ICP +\n•\nHb >70mmHg\n•\nTreat seizures\nOsmotherapy:\n•\nMannitol: 0.25 – 1g/kg\n•\nNaCl 3% 5mL/kg\no\nRefractory raised ICP: saline 23.4% 0.5mL/kg max 30mL – avoid Na >170 for >72 hr (risk of thrombocytopaenia,\nanaemia, DVT)\n•\nPaCO2 35 – 40mmHg, 30 – 35mmHg if very bad\n•\nCPP:\no\n0 - 5yo: 40 – 50mmHg\no\n6 – 17yo: 50 – 60mmHg\no\n≥18yo: 60 – 70mmHg", "citations": [{"type": "pdf_page", "page": 225, "label": "p225"}]}
{"chunk_id": "SSUs_v1_p226_txt_00_6acafa", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 226, "page_end": 226, "section_path": ["AIR v MH", "Neonatal Surgeries", "Neonatal Surgeries"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Neonatal Surgeries", "keywords": [], "text": "Neonatal Surgeries\nConsiderations:\n•\nAirway:\no\nLarge occiput - careful positioning\no\nFloppy U shaped epiglottis – straight blade\no\nShort neck\no\nLarge tongue\no\nSmall airway\no\nCricoid narrowest part\no\nShort trachea – secure at appropriate depth\no\nUpper airway vagal reflex - atropine\no\nSub-glottic stenosis\no\nRisk of gastric insufflation\no\nHigh risk laryngospasm\n•\nResp:\no\nApnoea risk – require apnoea monitoring post-op\no\nHigh VO2 – shorter safe apnoea time + desaturations\no\nDiaphragmatic breathing + risk of fatigue 2’ type 1 fibres\no\nRR + WOB\no\nCompliant chest wall, horizontal ribs, CC > FRC – high PEEP\no\nRisk with circuit deadspace\no\nVentilator can have poor accuracy – transcutaneous CO2 monitoring\n•\nCVS:\no\nAssess for congenital heart disease\no\nPatent shunts: pre- and post-ductal SpO2\no\nStiff, non- compliant ventricle\no\nFixed SV; HR dependent CO – avoid bradycardia\no\nHigh VO2\n•\nRenal:\no\nconcentrating capacity\no\nPoor Na handling\no\ndrug clearance\no\nRisk of hyponatraemia\n•\nHepatic:\no\nglycogen stores – monitor and manage BSL, early feeding, minimise fasting\no\nImmature enzymes – reduced metabolism\n•\nRisk of hypothermia – warm\n•\nHaem:\n•\nTransfusion thresholds:\no\nPRBCS:\n▪\nAcute blood loss >10% circ volume\n▪\nHb <80g/L in stable newborn\n▪\nHb <120g/l if resp distress, CHD, resp therapy\no\nPlatelets: >100 for surgery, ABO + Rh D compatible, CMV -ve, single donor apheresis\no\nFFP: ABO compatible\nMain anaesthetic issues: above +\n•\nTransitional circulation\n•\nPost-op apnoea risk\n•\nHypothermia\n•\nShort apnoea time prior to desaturation", "citations": [{"type": "pdf_page", "page": 226, "label": "p226"}]}
{"chunk_id": "SSUs_v1_p227_txt_00_f8bb34", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 227, "page_end": 227, "section_path": ["AIR v MH", "Neonatal Surgeries"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Neonatal Surgeries", "keywords": [], "text": "Pre-op:\n•\nPregnancy + delivery, birth weight, APGARs, postmenstrual age, gestational age, syndromes\n•\nResp distress: surfactant, airway, ventilation +/- level of support\n•\nCVS: ?support, coagulopathy\n•\nIV access\n•\nIx: routine + gas +/- CXR +/- TTE – crossmatch if indicated\n•\nTransfer: consider if risk of deterioration, intubate prior to transfer, consider operation in NICU\nIntra-op:\n•\nExperienced staff, paediatric anaesthetist\n•\nPaediatric equipment\n•\nAvoid hypothermia: warm IVF, forced air, room temp room (27C), minimise exposure, humidified gas\n•\nMonitoring: routine + as indicated, pre- and post-ductal SpO2, transcutaneous CO2\n•\nNGT prior to induction + 4 quadrant rotation\n•\nPre-oxygenation\n•\nInduction: IV or inhalational\n•\nAirway: ETT\n•\nVentilation: pay close attention, may need NICU ventilator, minimise dead space, PEEP, lung protective ventilation\n•\nIVF: equation. Laparotomy 10mL/kg/hr +/- resus boluses\n•\nBlood: weigh swabs, measure suction, aim Hb >120, transfusion trigger is 10% (i.e. 10mL/kg)\n•\nAnalgesia: regional, paracetamol, opioids\nPost-op:\n•\nNICU\n•\nApnoea monitoring:\no\nDefinition: no respiratory effort for ≥20s, or ≥10s with SpO2 or bradycardia\no\nRFs: postmenstrual age <56 weeks (preterm), <44 weeks (term), anaemia, history of apnoea, GA > spinal, BSL,\ncomorbid\no\nTreatment: stimulation, O2, BMV, CPAP, caffeine\n•\nAnalgesia:\no\nParacetamol: 28 – 32 weeks 7.5mg/kg q8 hourly, 33 – 36 weeks q6 hourly, >37 weeks 10 – 15mg/kg q6 hourly\n•\nBSL monitoring\nDay Surgery\n•\nEx-premature: PMA >54 – 60 weeks\n•\nTerm baby: PMA >46 weeks", "citations": [{"type": "pdf_page", "page": 227, "label": "p227"}]}
{"chunk_id": "SSUs_v1_p228_txt_00_75e19f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 228, "page_end": 228, "section_path": ["AIR v MH", "Necrotising Enterocolitis", "Inguinal Hernia Repair"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Inguinal Hernia Repair", "keywords": [], "text": "Inguinal Hernia Repair\nEpidemiology: 6% males, <1% females\nRF: male, preterm, LBW, congenital abnormalities, FHx\nPresentation: painless groin swelling +/- incarceration +/- bowel obstruction +/- strangulation\nRx: surgery – balance risk of anaesthesia against risk of incarceration\nAnaesthetic technique:\n•\nGA + caudal / ilioinguinal block\n•\nNeuraxial: spinal, caudal, epidural", "citations": [{"type": "pdf_page", "page": 228, "label": "p228"}]}
{"chunk_id": "SSUs_v1_p228_txt_01_cd12ed", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 228, "page_end": 228, "section_path": ["AIR v MH", "Necrotising Enterocolitis", "Necrotising Enterocolitis"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Necrotising Enterocolitis", "keywords": [], "text": "Necrotising Enterocolitis\nIncidence 2/1000 live births. Mostly preterm infants. Ischaemia 2’ mesenteric blood flow.\nCauses:\n•\nO2 delivery / blood flow: CO (hypotension, cardiac failure, arrhythmia), hypoxia\nOther contributing factors: enteral feeding, hyperosmolar formula, intestinal dysfx, bacterial infection, CHD\nIschaemia → necrosis +/- perf +/- septic shock\nDiagnosis: via imaging – dilation of bowel with intramural gas\n50% managed conservatively: decompression of stomach, broad spectrum abx, correction of fluid / electrolyte abnormalities\nIf requires emergency laparotomy:\n•\nProblems of prematurity\n•\nLarge fluid losses\n•\nUsually thrombocytopaenic + coagulopathic\n•\nNo N2O – intramural gas in bowel", "citations": [{"type": "pdf_page", "page": 228, "label": "p228"}]}
{"chunk_id": "SSUs_v1_p229_txt_00_52d9f0", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 229, "page_end": 229, "section_path": ["AIR v MH", "Congenital Diaphragmatic Hernia Repair", "Congenital Diaphragmatic Hernia Repair"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Congenital Diaphragmatic Hernia Repair", "keywords": [], "text": "Congenital Diaphragmatic Hernia Repair\nIncidence: 1/3600, mortality 30%, morbidity 87%\nRFs: genetic 10% (trisomy, fryns, cornelia de lange, beckwith-wiedemann, CHARGE), M > F\nCan have additional systems abnormalities (CVS, GU, limb, CNS)\nClassification:\n•\nA: small defect entirely surrounded by muscle\n•\nB: <50% chest wall with absent diaphragm\n•\nC: >50% chest wall\n•\nD: absent hemidiaphragm\n80% are left sided\nType:\n•\nBochdalek (foramen): 95%, failed fusion of pleuroperitoneal folds\n•\nMorgagni (foramen): right sided, anterior, better outcomes\n•\nBilateral 1% - usually fatal\nSuspect if maternal polyhydramnios.\nPrognostic factors:\n•\nAntenatal: liver herniation, early gestational age at diagnosis\n•\nPostnatal: defect size, cardiac involvement, pulmonary HTN, LBW, low APGAR, small contralateral lung, bilateral defect\nAntenatal diagnosis: US screening, MRI\nFoetal surgery: (TOTAL trial)\n•\nFoetoscopic endoluminal tracheal occlusion: treats most severe cases, reversible tracheal occlusion → development\nof foetal lung + improved survival\n•\nPlaced at 27 – 29 weeks, removed ~34/40\nPost-natal diagnosis: resp distress +/- scaphoid abdomen, CXR\nTreatment:\n•\nIntubation + lung protective ventilation (RR 50 – 100 / HFOV)\n•\nNG insertion to decompress bowel\n•\nTTE: ?cardiac abnormality, pulmonary HTN, shunt\n•\nRx:\no\nPulmonary vasodilators (PVR and improve PPHN): sildenafil, prostacyclin (note: NO → mortality)\no\nInotropes\no\nNMBA (O2 consumption, and airway pressures)\n•\nECMO if required\nTiming of surgery – once medically optimised. Can be open or thorascopic.\nAim: normal MAP, sats 85 – 90% on <50% FiO2, lactate <3, UO >1mL/kg/hr; may be on ECMO\nMonitor for abrupt deterioration: ?contralateral tension PTx, pulmonary hypertension causing R → L shunt\nIntra-op:\n•\n2 anaesthetists\n•\nTranscutaneous CO2 (ventilation and CO2 removal can be difficult)\n•\nInhaled NO\n•\nPulmonary hypertension may worsen\n•\nRisk of abdominal compartment syndrome on closure\nPost-op:\n•\nICU ventilated\n•\nSame as pre-op management (including pulmonary hypertension management)", "citations": [{"type": "pdf_page", "page": 229, "label": "p229"}]}
{"chunk_id": "SSUs_v1_p230_txt_00_1aefe8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 230, "page_end": 230, "section_path": ["AIR v MH", "Pyloric Stenosis", "Pyloric Stenosis"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pyloric Stenosis", "keywords": [], "text": "Pyloric Stenosis\nPyloric stenosis: hypertrophy of smooth muscle of gastric outlet → outflow obstruction\nIncidence: 1.5/1000\nRFs: male (4:1), 1st born, genetic\nPresentation: most often 2-3mo w/ projectile vomiting, non-bilious, weight loss, failure to thrive, dehydration, palpable “olive”\nDiagnosis: ultrasound, barium study if needed (“string sign”)\nMedical issues / sequelae: **medical emergency\n•\nHypochloraemic, hypokalaemia metabolic alkalosis\n•\nSubsequent respiratory acidosis → hypoventilation, apnoeas\n•\nDehydration: aldosterone → renal K+ wasting\n•\nParadoxical acidic urine 2’ fluid conservation\nResuscitation:\n•\nIVF:\no\nBolus 20mL/kg bolus NaCl 0.9%\no\nDeficit replaced over 1 – 2 days – NaCl 0.45% + glucose 5% + KCl 10mM/500mL @ 150mL/kg/day\n•\nEnd points: normal pH (HCO3 <30), normal chloride (>90), BE -4 – 2.5, K 3.5 – 5.0, UO 1mL/kg/hr (further replace K+\nwhen UO is established)\nPre-op:\n•\nResuscitation prior to OT – risk of CVS collapse on induction\n•\nHigh aspiration risk: NG with 4 quadrant drainage before induction (supine, R lateral, prone, L lateral)\no\nConsider gastric US to confirm\nIntra-op:\n•\nModified RSI: IV preferred, adequate NMB to avoid aspiration, microcuff ETT\n•\nAnalgesia: paracetamol, LA / regional\n•\nLaparoscopic or open: if laparoscopic aim <10cmH2O, adjust ventilation\n•\nExtubation: awake + NMBA fully reversed\nPost-op:\n•\nApnoea monitoring 12 hours (prone to hypoventilation 2’ alkaline CSF)\n•\nEarly feeding", "citations": [{"type": "pdf_page", "page": 230, "label": "p230"}]}
{"chunk_id": "SSUs_v1_p231_txt_00_c71a38", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 231, "page_end": 231, "section_path": ["AIR v MH", "Cleft Lip/Palate", "Cleft Lip/Palate"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Cleft Lip/Palate", "keywords": [], "text": "Cleft Lip/Palate\nDefinition:\n•\nFissure in upper lip / palate (complete fissure enters nasal cavity)\n•\nUnilateral or bilateral\n•\nLip and / or palate\nIncidence: 1/700 - cleft lip more common in males, cleft palate more common in females\nPathophysiology: fusion usually occurs 6/40, hard + soft palate 10/40\nRFs: genetic, environmental (maternal age, smoking, EtOH, drugs, nutrition, infection, teratogen), syndrome\nTiming of surgery:\n•\nLip: primary repair 6 weeks – 6mo\n•\nPalate: 6 – 12 mo\nPre-op: routine +\n•\nComprehensive airway assessment, URTI (chronic rhinorrhoea common), feeding issues\n•\nElective – delay until optimised\n•\nTertiary centre\nIntra-op:\n•\nInduction: based on suspected airway difficulty\n•\nAirway: south oral RAE or reinforced ETT\n•\nShared airway considerations: blood, access (draping), debris (throat pack + sticker), dislodgement (gag, positioning)\n•\nMaintenance: volatile or TIVA, consider remi infusion\n•\nAnalgesia: paracetamol, NSAIDs, opioids, LA infiltration, dexmed, steroid\no\nNerve blocks: infraorbital, palatine, nasopalatine, maxillary\n•\nPONV: dex, ondans\n•\nFluid: IVF + BSL monitoring\n•\nTemp control + monitoring\n•\nEmergence: inspect + suction, care not to disrupt suture line (avoid OPA), nasal airway may be placed by surgeons,\nsmooth extubation to avoid coughing / straining, can be deep or awake (consider bleeding)\nPost-op:\n•\nAppropriate ward, likely 1-3 days\n•\nMonitoring for airway compromise for 24hr\n•\nDC when feeding well\n•\nSuture removal under GA 1/52 later", "citations": [{"type": "pdf_page", "page": 231, "label": "p231"}]}
{"chunk_id": "SSUs_v1_p232_txt_00_bf1850", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 232, "page_end": 232, "section_path": ["AIR v MH", "Removal of Foreign Body", "Removal of Foreign Body"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Removal of Foreign Body", "keywords": [], "text": "Removal of Foreign Body\nCommon <3y.\nCulprit: food, hardware, toys, medications / pills, button batteries\nLocation:\n•\nHighest mortality: larynx 3%, trachea 13%\n•\nMostly main bronchus: right lung 60%, left lung 23%, bilateral 2%\nPresentation:\n•\nWitnessed choking episode\n•\nCough / stridor / wheeze (may be unilateral +/- reduced AE)\n•\nSalivation\n•\nHaemoptysis\n•\nCyanosis\nIx:\n•\nCXR: PA + lateral\n•\nCT\n•\nBronchoscopy\nManagement: above +\n•\nRigid bronchoscopy / suspension laryngoscope – allows surgery through lumen\n•\nThoracotomy for those that can’t be removed\n•\nECMO if complete loss of airway", "citations": [{"type": "pdf_page", "page": 232, "label": "p232"}]}
{"chunk_id": "SSUs_v1_p233_txt_00_528ead", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 233, "page_end": 233, "section_path": ["AIR v MH", "Magnets"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Magnets", "keywords": [], "text": "Risk with surgery is complete obstruction of airway → asphyxiation – ensure surgeon is scrubbed and ready\nGoals:\n•\nMaintain spontaneous ventilation (PPV can force FB deeper)\n•\nTopicalise airway (rigid bronch very stimulating, MAD device during laryngoscopy + spont vent)\no\nLignocaine max 4mg/kg\n•\nAim for RR close to normal – careful titration of opioid / anaesthetic\n•\nMaintain adequate depth to prevent coughing\n•\nOxygenation:\no\nTHRIVE\no\nVentilating bronchoscope\no\nTube through nose in posterior pharynx\n•\nCommunication with ENT surgeon\n•\nDexamethasone to oedema\nPost-op:\n•\nIntubate + PEEP to reinflate lung\n•\nFollow up flexible bronchoscopy\n•\nUsually extubate\n•\nNebulised adrenaline for post-op stridor\nBattery Ingestion\nPotentially life threatening. Button batteries generate OH- ions at the -ve pole → localised alkaline caustic injury → tissue\nliquefaction and necrosis. Corosive injury can occur within 2hr of ingestion.\nLocation:\n•\nOesophageal impaction ++ risk\n•\nStomach causes less damage\nCo-ingestion with a magnet risk of perforation.\nAny suspicion of ingestion →\n•\nHistory\n•\nExamination\n•\nXray of neck, chest and abdomen (button batteries have double halo sign)\nIndication for urgent removal <2hr in button battery ingestion:\n•\nBattery in oesophagus\no\nSucralfate 10mL q10 min until removed\n•\nBattery in stomach + symptoms\n•\nKnown GI tract abnormalities i.e. Meckel’s\n•\nCo-ingestion of button battery + magnet\nCylindrical batteries:\n•\nOesophagus: remove <24 hours\n•\nStomach:\no\nSymptomatic: remove asap\no\nAsymptomatic: no intervention but monitor for SSx\nAnaesthetic management: if requires urgent removal proceed unfasted\nMagnets\nSingle magnet should pass spontaneously if not impacted.\nPossible harm if:\n•\nMultiple magnets\n•\nMagnet + another metallic object\n•\n≥2x neodymium magnets (strong forces)\nMechanism of injury: attractive forces can cause trapped bowel → pressure\nnecrosis, ischaemia\nManagement: symptomatic or ‘red flag’ features → urgent intervention", "citations": [{"type": "pdf_page", "page": 233, "label": "p233"}]}
{"chunk_id": "SSUs_v1_p234_txt_00_08533f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 234, "page_end": 234, "section_path": ["AIR v MH", "Dental Surgery", "Grommets"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Grommets", "keywords": [], "text": "Grommets\nPre-op:\n•\nPatients often have recurrent URTIs and otitis media\no\n2-7x risk of laryngospasm, coughing, breath-holding, obstructed airway. Further risk with intubation (11x)\no\nrisk of intra-op and post-op hypoxia\n▪\nWhen to cancel patient? (Remember most children have 4-6 URTIs / year)\n•\nCOVID (look at new ANZCA guideline 2023)\n•\nT >38\n•\nProductive cough + coloured sputum / nasal discharge\n•\nEvidence of chest infection\n•\nLooks lethargic or unwell (if child happy and energetic they will usually be okay)\n•\nRequires intubation for surgery\n•\n<1yo\nConsider location + availability of post-op support, should have discuss with surgical team + parent(s). If cancelled, re-schedule\n4-6 weeks post-resolution of symptoms.\nIntra-op:\n•\nConsider Mapleson circuit – very quick procedure\n•\nPre-grommet insertion is very stimulating, have patient very deep but with short acting agents – no pain after grommet\nis placed", "citations": [{"type": "pdf_page", "page": 234, "label": "p234"}]}
{"chunk_id": "SSUs_v1_p234_txt_01_b03004", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 234, "page_end": 234, "section_path": ["AIR v MH", "Dental Surgery", "Dental Surgery"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Dental Surgery", "keywords": [], "text": "Dental Surgery\nPre-op:\n•\nAssess need for pre-med\n•\nAssess for swelling / associated infection / trismus – assess possibility of doing procedure under LA if concern for airway\n(note: it is possible to drain submandibular swelling under LA)\n•\nAscertain type of surgery:\no\nSimple extractions: may be done under LA\no\nMultiple extractions: LMA or nasal intubation\no\nRestorations: nasal intubation\n•\nChoose appropriate centre for patient i.e. OSA, paeds\nIntra-op:\n•\nAirway as above\n•\nEnsure not extubated when neck extended\n•\nGag: check airway pressure\n•\nThroat pack if indicated – throat pack precautions\n•\nSimple extractions often don’t need abx\n•\nDexamethasone\n•\nExtubation:\no\nSuction coroners clot\no\nEither awake or deep\no\nConsider left lateral, head down", "citations": [{"type": "pdf_page", "page": 234, "label": "p234"}]}
{"chunk_id": "SSUs_v1_p235_txt_00_347fd3", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 235, "page_end": 235, "section_path": ["AIR v MH", "LBO (Laryngobronchoesophagoscopy)", "LBO (Laryngobronchoesophagoscopy)"], "specialty_tags": ["AIR v MH", "crisis", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "LBO (Laryngobronchoesophagoscopy)", "keywords": [], "text": "LBO (Laryngobronchoesophagoscopy)\nIssues:\n•\nShared airway\n•\nLoss of airway + oxygenation\n•\nMust be deep enough to maintain spont vent + deep enough for rigid bronch\n•\nNo ETCO2\no\nTranscutaneous CO2 monitoring available but not generally needed / won’t change management\no\nExpect ETCO2 to be high at end (may be slow to wake)\nCan be elective or emergency. Tertiary centre where able.\nTechnique:\n•\nMonitoring: routine +\no\nRR from ECG impedance\n•\nGas down with 100% O2 → IVC when deep + sevo 4%\n•\nLaryngoscopy – also used to assess how deep\no\nNormal laryngoscopy\no\nParsons laryngoscope allows delivery of O2 via tubing from T piece from CGO + can be suspended\n•\nSpray cords\n•\nENT →\no\nSpray beyond cords\no\nRigid bronch – O2 on side port\n•\nMaintenance of anaesthesia:\no\nPrecedex\no\nPropofol infusion (high rate 1mL/kg/hour or high TCI on paedsfuser) – titrate\n•\nDexamethasone: high dose\n•\nEnd of case: depends on procedure + patient\no\nUsually BVM wake up spont venting holding airway\no\nSome will go to ICU intubated if indicated by procedure\nIntra-op issue:\n•\nComplete loss of airway\no\nIf obstruction at carina communicate to surgeons → try to push into one main bronchus\no\nAnaesthesia take over airway → OLV", "citations": [{"type": "pdf_page", "page": 235, "label": "p235"}]}
{"chunk_id": "SSUs_v1_p236_txt_00_72ed35", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 236, "page_end": 236, "section_path": ["AIR v MH", "Adenotonsillectomy", "Adenotonsillectomy"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Adenotonsillectomy", "keywords": [], "text": "Adenotonsillectomy\nIndications: OSA, recurrent tonsillitis\nPre-op:\n•\nAssessment: indication, ?OSA, airway +/- syndrome, routine, ?recent URTI, airway reactivity, bleeding disorders\n•\nAvoid pre-med\n•\nIndications for planned admission: age ≤3yo, severe OSA, comorbid disease, social (e.g. proximity to hospital)\nIntra-op:\n•\nInduction: inhalational or IV +/- adjuncts\n•\nAirway: south oral RAE or reinforced LMA, high risk difficult airway, caution with mouth gag may compress ETT, throat\npack sticker\n•\nPONV prophylaxis: 2 agents (high risk)\n•\nIVF: 20mL/kg crystalloid\n•\nAnalgesia: paracetamol +/- NSAID (safe, usually based on surgeon preference), clonidine or dexmed, dexamethasone\n0.3mg/kg, local anaesthetic, fent 1-2mcg/kg, tramadol 1mg/kg, ketamine 0.1 – 0.5 mg/kg\n•\nExtubation: awake to PRAE, suction + assess for coroner’s clot, remove throat pack, observe – high risk for\nlaryngospasm\nLMA\nETT\nAdvantages\n•\nSmooth emergence\n•\nNo paralysis\n•\nMinimal airway trauma\n•\nMore secure\n•\nGood surgical access\nDisadvantages\n•\nLess secure\n•\nMay impair surgical access\n•\nAirway trauma\n•\nRisk of oesophageal / bronchial intubation\n•\n+/- paralysis\n•\nAirway soiling\n•\nExtubation\nPost-op:\n•\nHigh risk PRAE\n•\nAvoid excessive opioids (reduce by 50%)\n•\nHDU admission for: syndrome, severe OSA, PRAE\nComplications:\n•\nImmediate: trauma, burns, airway fire, displaced/kinked airway device, bleeding\n•\nIntermediate (<24hr): emergence delirium, pain, PRAE (5%), PONV, primary bleeding, death\n•\nDelayed (>24hr): pain, N&V, dehydration, poor PO intake, secondary bleeding (within 28 days, peak 5 – 7 days), speech\ndisorder, nerve injury, persistent OSA, stenosis, infection, IJ thrombus", "citations": [{"type": "pdf_page", "page": 236, "label": "p236"}]}
{"chunk_id": "SSUs_v1_p237_txt_00_3c590c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 237, "page_end": 237, "section_path": ["AIR v MH", "Post-Tonsillectomy Bleed"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Post-Tonsillectomy Bleed", "keywords": [], "text": "Post-Tonsillectomy Bleed\nDefine:\n•\nPrimary: within 24 hr (more serious)\n•\nSecondary: within 28 days (usually day 7-10 days, can be infection related)\nIssues:\n•\nBlood loss / hypovolaemia\n•\nDifficult airway\n•\nFull stomach (blood)\n•\nUncooperative child\nPre-op:\n•\nAssess (including anaesthetic record) + resuscitate 20mL/kg bolus\n•\n2x IV → send bloods, coags, cross-match +/- administer blood products\n•\nNo pre-med\nIntra-op:\n•\nRoutine monitoring\n•\nAirway – suction ready, ENT in room – scrubbed, difficult airway equipment, smaller ETT x2 (in case blocked)\no\nFirst attempt: direct laryngoscopy – aim for bubbles\n•\nInduction:\no\nIV RSI preferred, head down or left lateral\no\nInhalational: L lateral or head down, FiO2 100%, no N2O\n•\nCVS: IVF (resus as needed), fluid warmer +/- blood, vasopressor ready (metaraminol 10mcg/kg) + dilute adrenaline,\nnormothermia\n•\nExtubation: empty stomach prior with OGT, awake extubation in left lateral position, extended stay in recovery for\nmonitoring, check Hb / gas", "citations": [{"type": "pdf_page", "page": 237, "label": "p237"}]}
{"chunk_id": "SSUs_v1_p238_txt_00_5c7a0c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 238, "page_end": 238, "section_path": ["AIR v MH", "Retinoblastoma", "Strabismus"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Strabismus", "keywords": [], "text": "Strabismus\nIssues:\n•\nMay occur with other illness e.g. craniosyntosis, craniofacial abnormalities, chromosomal\n•\nOcculocardiac reflex (trigeminal V1 → vagus)\no\nRx: release traction, atropine 20mcg/kg, glycol 10mcg/kg, regional can block afferent limb\n•\nPONV +++\n•\nCardiovascular effects of topical ocular medications e.g. phenylephrine\n•\nPainful: paracetamol, NSAID +/- longer acting opioid\n•\nRare association with MH – avoid sux, monitor temp", "citations": [{"type": "pdf_page", "page": 238, "label": "p238"}]}
{"chunk_id": "SSUs_v1_p238_txt_01_e20cb5", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 238, "page_end": 238, "section_path": ["AIR v MH", "Retinoblastoma", "Traumatic Eye Injury"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Traumatic Eye Injury", "keywords": [], "text": "Traumatic Eye Injury\nIssues:\n•\nPolytrauma likely\n•\nAvoid IOP (ketamine, suxamethonium)\n•\nUnfasted patient\nPlan:\n•\nRSI with roc\n•\nControl IOP: normocapnia, smooth induction / emergence, no external pressure on eyes", "citations": [{"type": "pdf_page", "page": 238, "label": "p238"}]}
{"chunk_id": "SSUs_v1_p238_txt_02_3ebd58", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 238, "page_end": 238, "section_path": ["AIR v MH", "Retinoblastoma", "Retinoblastoma"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Retinoblastoma", "keywords": [], "text": "Retinoblastoma\nIntra-arterial chemotherapy (melphalan):\n•\nRemote anaesthesia / IR\n•\nHeparin to avoid ophthalmic artery thrombosis\n•\nGA with NMBA – frequent vent on / vent off\n•\nMelphalan → orbital swelling + vomiting → PONV +++\n•\nSEs: life threatening autonomic cardioresp reflexes (MOA not fully understood) – have adrenaline prepared, atypical\nbronchospasm, atropine for bradycardia", "citations": [{"type": "pdf_page", "page": 238, "label": "p238"}]}
{"chunk_id": "SSUs_v1_p239_txt_00_0563db", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 239, "page_end": 239, "section_path": ["AIR v MH", "Tracheostomy", "Tracheostomy"], "specialty_tags": ["AIR v MH", "crisis", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Tracheostomy", "keywords": [], "text": "Tracheostomy\nIndications: long term resp support, secretion clearance, fixed upper airway obstruction, airway protection, trauma, surgical\nindication, EXIT procedure\nEpidemiology: 30% <1y, 65% <4y, 25% have difficult / impossible intubation\nTracheostomy tubes:\n•\nClassified by internal diameter\n•\nMost have no inner cannula due to small internal diameter\n•\nMost are uncuffed\n•\nShorter length for neonates\n•\nMost are NOT MRI safe\nIntra-op procedure:\n•\nSupine, shoulder roll\n•\nLA + adrenaline\n•\nETT withdrawn, trache tube inserted → ventilator\n•\nFibreoptic scope evaluation\n•\nMaturation sutures – safety for paeds traches – sutures between anterior tracheal wall and skin to hasten maturation\n•\nPost-op CXR\n•\nStay sutures removed at 1/52\nPost-op:\n•\nICU\n•\nEmergency trache box: TT same size + half size down, round ended scissors, tape, dressing, KY jelly, syringe + saline,\nsuction catheter\n•\nBedhead signs: details, type, size, length, suction catheter size, info on upper airway patency\n•\nMature at days 3 – 7, safe to change\nComplications:\n•\nImmediate: loss of airway, bleeding, pneumothorax, pneumomediastinum, surgical emphysema, oesophageal injury,\nRLN damage\n•\nIntermediate (<2/52): tube dislodgement before stoma maturation, obstructed tube, bleeding, infection\n•\nLate: granuloma, vascular erosion, suprastomal collapse, swallowing issues, skin integrity, tracheal stenosis, trachea-\noesophageal fistula\nAnaesthetic management of trache:\n•\nPre-op:\no\nAssess medical conditions +/- critical illness weakness ?home ventilation\no\nTrache: indication, brand, size, type, complications, maturation, suction catheter size, last change\no\nRespiratory management: O2 requirement, bronchodilators, infections\n•\nIntra-op:\no\nEmergency trache box\no\nLeave in or change for cuffed\no\nInhalational induction via trache\no\nReinsert usual tube end of case\n•\nPost-op:\no\nLocation: appropriate ward or ICU\no\nSigns + emergency box", "citations": [{"type": "pdf_page", "page": 239, "label": "p239"}]}
{"chunk_id": "SSUs_v1_p240_txt_00_79c828", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 240, "page_end": 240, "section_path": ["AIR v MH", "Neurosurgery", "Neurosurgery"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Neurosurgery", "keywords": [], "text": "Neurosurgery\nPaediatric neurophysiology:\n•\nCBF: higher than adults, lower in neonates\n•\nCMRO2: higher than adults, lower in neonates\n•\nPaCO2: less responsive in neonates i.e. hyperventilation less effective\n•\nPaO2: more responsive in neonates\n•\nAutoregulation unknown: MAP 20 – 40\n•\nICP:\no\nBefore suture fusion skull can in size if gradual\no\nPosterior fontanelle closure @ 6mo\no\nAnterior fontanelle closure @ 12-18mo\no\nSuture closure @ 10y\no\nNormal ICP: neonate 0 – 6mmHg, child 5 – 15mmHg\nSSx raised ICP: irritability, poor feeding, GCS, vomiting, full fontanelle, wide cranial sutures, headache, diplopia, papilloedema\nCPP goals:\n•\n<1yo: 45 – 50mmHg\n•\n1 – 10yo: 50 – 60mmHg\n•\n>10yo: 60 – 70mmHg\nSurgical issues: paeds/neonate, bleeding, VAE, ICP + CPP management\nPre-op:\n•\nAssess ICP\n•\nCVS: assess for murmur +/- TTE (risk in shunt + VAE)\n•\nAnticonvulsant therapy\n•\nFluid / electrolyte\nIntra-op:\n•\nSimilar goals to adult neuroanaesthesia\n•\nSmooth gas induction if required – sevo only is okay (no N2O)\n•\nMaintenance: TIVA + remi or sevo <1 MAC\n•\nDrugs: mannitol 0.25 – 1g/kg, PONV, analgesia\n•\nMonitoring: invasive BP +/- CVC (esp if risk of VAE), VAE monitoring (precordial doppler, ETCO2), neurophys monitoring\nif indicated, BSL control\n•\nIVF: avoid IV glucose + other hypotonic fluids\nPost-op:\n•\nLikely ICU\nRaised ICP management: must first confirm transducer height + zeroed\n•\nPhysical: head up 30 degrees, avoid obstruction to venous drainage (neutral, no ETT tapes), drain CSF if EVD in situ,\nensure ETT not obstructed (clear secretions / suction, treat bronchospasm)\n•\nPhysiological: temp, normoxia, PaCO2 35 – 40, high-normal sodium, normovolaemia\n•\nPharmacological: adequate sedation, paralysis, treat seizures, osmotherapy (mannitol 20% 0.25 – 0.5g/kg, NaCl 3%\n3mL/kg), steroids if tumour but avoid if TBI, barbiturate coma if refractory\n•\nSurgical: EVD, decompressive craniotomy", "citations": [{"type": "pdf_page", "page": 240, "label": "p240"}]}
{"chunk_id": "SSUs_v1_p241_txt_00_f8511a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 241, "page_end": 241, "section_path": ["AIR v MH", "Craniotomy for Tumour"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Craniotomy for Tumour", "keywords": [], "text": "Craniotomy for Tumour\nCNS tumours are second most common paediatric malignancy. 60% posterior fossa.\nPre-op: routine +\n•\nFocused neuro history: evidence of raised ICP, focal neurology, bulbar signs, SSx DI\n•\n?Cardiac defect (due to risk of VAE)\nIntra-op:\n•\nConsider inhalational induction if IV traumatic and concerns for raised ICP\n•\nOpioid to blunt SNS\n•\nReinforced ETT secured with waterproof tape\n•\nTIVA maintenance\n•\nNeuroprotective measures\n•\nICP management\n•\nMonitor for VAE\nPost-op:\n•\nMost extubated\n•\nPICU\n•\nMaintenance fluids", "citations": [{"type": "pdf_page", "page": 241, "label": "p241"}]}
{"chunk_id": "SSUs_v1_p242_txt_00_567c9f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 242, "page_end": 242, "section_path": ["AIR v MH", "Scoliosis Surgery for Cerebral Palsy", "Scoliosis Surgery"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Scoliosis Surgery", "keywords": [], "text": "Scoliosis Surgery\nDiagnosis: Adam’s forward test 7 (exam)/Cobb angle 10 (radiograph)\nMost common cause: adolescent idiopathic scoliosis\nSurgery: posterior spinal fusion under intra-operative skull femoral traction\n•\nMetal rods adjacent to spine bilaterally\n•\nRods rotated to realign spine → secured\n•\nLower back pain comparable to general population\nPre-op:\n•\nPain: education 2/52 prior with family\no\nStart gabapentin pre-op\n•\nPre-op aprepitant\n•\nProne consent: PION, stroke (2’ arterial occlusion in neck), injury for inhibition of venous drainage, peripheral\nneuropathy\nIntra-op:\n•\nBlood management: active warming, TXA\n•\nMonitoring: art line, SSEPS + MEPS\no\nTIVA to avoid interference\n•\nProne: padding/pressure, check eyes\n•\nGDFT using SVV: LOS, APO, ileus, and avoids AKI\n•\nAnalgesia: paracetamol, NSAID, IT morphine, ketamine, gabapentin\n•\nPONV +++\n•\nAntibiotic prophylaxis ++\nPost-op:\n•\nPCA + APS\n•\nEarly physiotherapy + IDC out\n•\nPONV\nScoliosis Surgery for Cerebral Palsy\nPre-op:\n•\nASSESS:\no\nCP: type, severity\no\nComorbidities: respiratory dysfunction, CVS status, nutritional status, previous surgeries\no\nNeurological: spasticity, seizures, cognitive function\no\nIx: routine +\n▪\nPFTs + CXR\n▪\nTTE\no\nDifficulty of airway\n•\nMANAGE:\no\nNutrition + hydration\no\nPhysical therapy\no\nOptimise seizure management\no\nEducate family + patient\n•\nREFER:\no\nMDT: ortho, neurology, physio\nIntra-op:\n•\nIntubation: difficult airway – may require FOB\n•\nNormothermia\n•\nRegional analgesia\nPost-op:\n•\nAPS\n•\nIncentive spirometry +/- CPAP\n•\nERAS + physio", "citations": [{"type": "pdf_page", "page": 242, "label": "p242"}]}
{"chunk_id": "SSUs_v1_p243_txt_00_649b8e", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 243, "page_end": 243, "section_path": ["AIR v MH", "Paediatric Blood Management", "Paediatric Blood Management"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Paediatric Blood Management", "keywords": [], "text": "Paediatric Blood Management\nMaximum allowable blood loss = ((Hb initial – Hb low) / Hb initial) x estimated blood volume\nEstimated blood volume:\n•\nPreterm: 100 mL/kg\n•\n<3 mo: 80 mL/kg\n•\n>3 mo: 70 mL/kg\nHct targets:\n•\nWell child: 20 – 25%\n•\nTarget Hb:\no\nWell: 70 – 80\no\nCyanotic heart disease: 100 -120\nManagement:\n•\nRestrictive transfusion strategy recommended, usually indicated if Hb <70 but may be well tolerated\n•\nVolume to transfuse:\no\n<20 kg: calculated based on weight and desired increment\nVolume to transfuse (mL) = weight (kg) x desired increment (g/L) x 0.4\nOR increment of 10 g/L = 4 mL/kg\no\n>20 kg: transfuse single unit i.e. 10 mL/kg\n•\nRate: 5 – 6 mL/kg/hr\nMassive transfusion:\n•\n50% TBV in 3 hours\n•\n100% TBV in 24 hours\n•\n>10% TBV over 10 minutes\n•\n40mL/kg blood loss\nMTP volumes:\n•\npRBC: 20 – 25 mL/kg OR 1 unit / 10 kg weight\n•\nPlatelets: 10 – 15 mL/kg OR 1 unit / 30 kg weight\n•\nFFP: 15 mL/kg OR 1 unit / 20 kg weight\n•\nCryo: 5mL/kg OR 1 unit / 10 kg weight\n•\nTXA: 15 mg/kg loaded over 10 minutes → 2mg / kg / hr for 8 hours\n(max 125 mg / hour same as adults)\n•\nProthrombinex: 25 – 50 units/kg\n•\nFibrinogen concentrate: 70 mg/kg\n•\nFactor VII: 90 mcg/kg\nRatio:\npRBC : FFP : platelets\n2: 1: 1\nTherapeutic targets:\n•\nHb >80\n•\nFibrinogen >2\n•\nPT: <1.5\n•\nPlatelets >75 (>100 in TBI)\nEquipment:\n•\nFluid warmer\n•\nRapid infuser", "citations": [{"type": "pdf_page", "page": 243, "label": "p243"}]}
{"chunk_id": "SSUs_v1_p244_txt_00_d29194", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 244, "page_end": 244, "section_path": ["AIR v MH", "Paediatric Blood Management"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Paediatric Blood Management", "keywords": [], "text": "Calcium replacement\nIonised calcium\nCaCl replacement\nCaGluconate replacement\n0.9 – 1.0\n10 mg/kg\n30 mg/kg\n0.8 – 0.9\n20 mg/kg\n60 mg/kg\n<0.8\n30 mg/kg\n90 mg/kg\nComplications:\n•\nTransfusion reaction: allergic, haemolytic (acute, delayed), febrile\n•\nImmunological: TRALI, TRIM, GVHD, infection\n•\nMetabolic: Ca2+, Mg2+, K+, alkalosis / acidosis, hypothermia\n•\nOther: TACO, coagulopathy, air embolism", "citations": [{"type": "pdf_page", "page": 244, "label": "p244"}]}
{"chunk_id": "SSUs_v1_p245_txt_00_75acc5", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 245, "page_end": 245, "section_path": ["AIR v MH", "Paediatric Regional Anaesthesia", "Paediatric Regional Anaesthesia"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Paediatric Regional Anaesthesia", "keywords": [], "text": "Paediatric Regional Anaesthesia\nEvidence for RA in infants → haemodynamic stability, post-op respiratory complications, stress response, faster return of gut\nfunction and feeding\nDifferences of US imaging:\n•\nAnatomical:\no\nSmaller, more superficial structures\no\nLess endoneurium\no\nIncomplete myelin sheath\no\nDural sac S3-4 (S2 in adults)\no\nSpinal cord L3 (L1 in adults) – most cephalad spinal space without major risk for cord damage is L3/4\no\nCSF volume 4mL/kg (2mL/kg in adults)\n•\nPhysiological:\no\nCO → LA absorption, cardiac sensitivity\no\nhepatic metabolism <9mo\no\nalpha1 acid glycoprotein → free fraction\no\nspinal sympathetic nervous system maturity\nImplications:\n•\nrisk of nerve injury from needle\n•\nFaster onset block\n•\nLower LA concentrations required\n•\nProlonged motor block\n•\nSpinal: below L4, less hypotension\n•\nrisk of cardiac toxicity\n•\nrisk accumulation with infusion / repeat doses\n•\nOften performed sedated / under GA\nMajor plexus blocks:\nComplications: 1/1000\nDoses:\n•\nUpper / lower limbs:\nropivacaine 0.2%\n0.5-1.5 mL/kg\n•\nFascial plane:\nropivacaine 0.2%\n0.2-0.75 mL/kg\nContinuous Infusions\nAge\nRopivacaine 0.1%\nBupivacaine\n<3 mo\n0.375 mg/kg/hr\n0.25 mg/kg/hr\n>3 mo\n0.5 mg/kg/hr\n0.5 mg/kg/hr\nPeripheral adjuvants:\n•\nClonidine / dexmed", "citations": [{"type": "pdf_page", "page": 245, "label": "p245"}]}
{"chunk_id": "SSUs_v1_p246_txt_00_ae70dd", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 246, "page_end": 246, "section_path": ["AIR v MH", "Spinal Anaesthesia", "Anatomy of Neonatal Spine and Spinal Cord"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Anatomy of Neonatal Spine and Spinal Cord", "keywords": [], "text": "Anatomy of Neonatal Spine and Spinal Cord\nNote: an imaginary line drawn between the two superior iliac crests (intercristal line) is below the lower level of the spinal cord\nat any age.\nSpinal Anaesthesia\nIndications: inguinal, urological, lower limb\nSpinal doses: bupivacaine 0.5%\n•\n<5kg:\n1mL/kg\n•\n5–15kg:\n0.4mL/kg\n•\n>15mg:\n0.3mL/kg\nDuration of effect: 45 – 60min, longer with adjuvants\nAdjuvants:\n•\nIntrathecal morphine: 10-20mcg/kg\n•\nFentanyl: 0.2mcg/kg\n•\nClonidine: 1-2mcg/kg\n•\n?Adrenaline: 2-4mcg/kg\nProcedure:\n•\nEMLA to site\n•\nOral sucrose sedation\n•\nFully flexed spine by assistant\n•\nPaeds spinal needle: 25G 25mm (or 27G)\n•\nL4/5 or L5/S1\nBenefits:\n•\nGA / sedation  possibly neuro effects\n•\npain\n•\ninflammatory response\n•\nAvoid airway manipulation +/- post op ventilation\n•\nMaintain spontaneous ventilation\n•\nileus\nNo benefit: post-op apnoea incidence\nComplications:\n•\nPDPH: blood patch 0.1-0.2mL/kg (headache rare in young children, more common in teens)\n•\nFailure: up to 20%", "citations": [{"type": "pdf_page", "page": 246, "label": "p246"}]}
{"chunk_id": "SSUs_v1_p247_txt_00_4ee196", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 247, "page_end": 247, "section_path": ["AIR v MH", "Caudal Block"], "specialty_tags": ["AIR v MH", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Caudal Block", "keywords": [], "text": "Epidural Anaesthesia\nDepth from skin to epidural space: 1mm/kg (10mm in neonate) – measure prior with US\nLigamentum flavum is softer in children – use LOR with saline\nCan do lumbar or thoracic\nIncidence of serious and major complications are less than in adults:\n•\nFailure 5%\n•\nTechnical 11%\n•\nDural tap: 0.1-0.5% - higher in neonates\n•\nEpidural abscess is very rare\nConfirmation of catheter tip position:\n•\nEpidurography: contrast dye\n•\nECG guidance\n•\nNerve stimulation: stimulation through epidural catheter → myotome specific activity\n•\nUltrasound\nDose:\n•\nLoad: 1.5 – 2mg/kg bupivacaine / ropivacaine\nAvoid epidural additives <6mo 2’ risk of spinal cord toxicity and risk of apnoea\nFor all epidural + regional – total infusion bupivacaine 0.125% 0.3mL/kg/hr – split between all catheters\nCaudal Block\nIndications: analgesia for sub-umbilical surgery – analgesia or sole anaesthetic\nProcedure: epidural space access via sacral hiatus – commonly landmark technique\nAccess epidural space caudally – single shot block into space\nCI: normal epidural CI, spinal dysraphism, inspect for nappy rash\nAnatomical considerations:\n•\nSacrum does not fuse posteriorly until the late teens – can do until teens but uncommon\n•\nSacral hiatus results from failure of fusion of the posterior arches of the fifth\n(occasionally fourth and third) sacral vertebrae; it is covered by the sacrococcygeal\nmembrane\n•\nSacral hiatus is relatively larger and higher in neonates (sacral anomalies are found in ∼5% of children)\n•\nNeonatal epidural space contains less fat and fibrous tissue → easier to insert catheters to higher levels from lower\napproaches\nSacrococcygeal membrane:\n•\nNeonate: 5mm\n•\n<2yo: 10mm\nFeel for pop or give.\nDose: ropivacaine 2mg/kg\nVolume:\n•\n0.5mL/kg → L1 blockade\n•\n1mL/kg → T10 blockade (umbilicus)\nComplications: injection in wrong location, infection (including sacral OM), hypotension, nerve roots injury, antesacral injection\nwith rectal perforation, haematoma, LAST, delayed resp depression, urinary retention (check urination before discharge in day\nsurgery)", "citations": [{"type": "pdf_page", "page": 247, "label": "p247"}]}
{"chunk_id": "SSUs_v1_p248_txt_00_ea8063", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 248, "page_end": 248, "section_path": ["PLASTICS AND BURNS", "Flaps", "Flaps"], "specialty_tags": ["PLASTICS AND BURNS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Flaps", "keywords": [], "text": "Flaps\nTransfer of tissue with intrinsic blood supply (excludes skin grafts)\nClassification:\n•\nBlood supply:\no\nAxial: regional blood vessel (named)\n▪\nPedicled: remains connected to origin\n▪\nFree: disconnected and reconnected micro-surgically\nProximity: local, regional, distant\nDissected vascular tissue is denervated but still responds to physical, chemical and humoral stimuli\nPre-op:\n•\nAssess:\no\nCI: hypercoaguable, sickle cell, polycythaemia\n•\nManage:\no\nSmoking cessation 4/52 weeks: nicotine flap perfusion\no\nWeight loss\no\nNutritional (particularly head & neck)\no\nEtOH cessation\n•\nRefer\nIntra-op goals: flow = PR2 / 8ul\n•\nMaintain perfusion pressure (full, hyperdynamic circulation)\no\nMAP\no\nLow venous pressure\nManagement:\n•\nRadius:\no\nWarm\no\nNormovolaemia\no\nAvoid indiscriminate pressor use (optimise causes of hypotension)\no\nNormocapnoea\n•\nIVF:\no\nAvoid hypervolaemia → interstitial oedema; goal directed fluid therapy\n•\nMaintain O2 delivery:\no\nHb, HcT 30 – 35%\no\nSaO2\no\nNormovolaemic haemodilution\n•\nPrevent thrombosis: s/c heparin\n•\nLong surgery: warm +\no\nMonitoring: art line, temp, IDC + UO\no\nPositioning: eyes, nerves, pressure areas\no\nConsider wake up\no\nMulti-modal analgesia\n•\nExtubation: avoid straining\nPost-op:\n•\nAdequate analgesia: SNS, flap perfusion\n•\nKeep warm\n•\nAppropriately skilled location + monitor flap\no\nArterial failure: cool, pale, slow cap refill, no bleed on pin prick, loss of doppler\no\nVenous failure: warm, congested, blue, brisk cap refill, rapid bleeding, loss of venous doppler\no\n→ surgical management", "citations": [{"type": "pdf_page", "page": 248, "label": "p248"}]}
{"chunk_id": "SSUs_v1_p249_txt_00_93d652", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 249, "page_end": 249, "section_path": ["TRAUMA AND RESUS", "Trauma and Resus"], "specialty_tags": ["TRAUMA AND RESUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Trauma and Resus", "keywords": [], "text": "Trauma and Resus\nCriteria:\n•\nMechanism of injury:\no\nMVA >55km/hr\no\nMBA >30km/hr\no\nCyclist >30km/hr\no\nPedestrian v vehicle >30km/hr\no\nChild v vehicle at any speed\no\nFall >3m\no\nCrush / entrapment\no\nEjection from vehicle\no\nPenetrating injury\no\nBurns ≥10% BSA\no\nInhalational or facial burns\no\nTraumatic asphyxiation\no\nDeath in some vehicle / collision\n•\nVital signs:\no\nAirway compromise\no\nRR <10 or >30\no\nSpO2 <90%\no\nsBP <90\no\nHR <50 or >120\no\nGCS <14\no\nSeizure\no\nPupils dilated or non-reactive\no\nShock index i.e. HR / sBP = >0.9\n•\nOther:\no\nPregnant\no\nAge >65\no\nSCI\no\n≥2 long bone fractures\nPreparation:\n•\nTeam: assemble team + brief if info known\n•\nRoles: assign - including team leader\n•\nEquipment\n•\nDrugs\n•\nAlert: OT, radiology, blood bank, surgeons, anaesthetics, ICU\n•\nPlan: airway, access, drug\n•\nPPE\n•\nReceive handover (prior unless impending airway issue or catastrophic haemorrhage)\nInjury severity score - 6 regions – scored 0-6:\n•\nHead & neck\n•\nFace\n•\nChest\n•\nAbdomen\n•\nExtremity + pelvis\n•\nExternal\nScore 0 – 75 based on three most injured regions → A2 + B2 + C2\nIf any injury is unsurvivable score is 75/75 – futility in further medical care\nPRIMARY SURVEY 6 killers – ATOM-FC\n•\nAirway obstruction or disruption\n•\nTension pneumothorax\n•\nOpen pneumothorax\n•\nMassive haemothorax\n•\nFlail chest\n•\nCardiac tamponade", "citations": [{"type": "pdf_page", "page": 249, "label": "p249"}]}
{"chunk_id": "SSUs_v1_p250_txt_00_6d390f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 250, "page_end": 250, "section_path": ["TRAUMA AND RESUS", "Damage Control Surgery", "Damage Control Resuscitation"], "specialty_tags": ["TRAUMA AND RESUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Damage Control Resuscitation", "keywords": [], "text": "Damage Control Resuscitation\nGoals:\n•\nRapid control of haemorrhage (pressure, tourniquet, haemostatic agents)\no\nTXA 1g over 10 mins then 1g over 8 hours if within 3 hours of injury\no\nPelvic binder over greater trochanters\no\nREBOA in extreme circumstances\no\nFactor VIIa only if all other haemostatic interventions fail\n•\nPermissive hypotension (vital organ perfusion)\no\nsBP 80-90, MAP 50-60+ restrictive volume until bleeding controlled\no\neFAST to exclude other fatal causes of hypotension: ATOM-FC\n•\nPrevention of coagulopathy\no\nAcute traumatic coagulopathy:\n▪\nEarly acute hyperfibrinolysis + hypocoaguable state\no\nResuscitation-associated / dilutional coagulopathy:\n▪\nRestrictive crystalloid\n▪\nHb 70-90\n▪\n1:1:1 transfusion (PROPPR - mortality from bleeding at 24hr) or ROTEM guided\n▪\nWarm T >35\n▪\nCorrect acidosis pH >7.2, lactate >4, BE <-6\n▪\niCa >1.1, fibrinogen >2, INR <1.5\no\nTrauma induced coagulopathy: activated protein C → DIC + hyperfibrinolysis\n▪\nHyperfibrinolysis\n▪\nConsumption of clotting factors\n▪\nPlatelet dysfunction\n▪\nHypocalcaemia\n+ other:\n•\nA/B:\no\nMILS, assume C-spine injury\no\nLPV\n•\nC: as above+\no\nWide bore access +/- sheath + art line + CVC\n▪\nBlood warmer + rapid infuser + cell saver\n▪\nBair hugger + warm theatre\no\nPressor only if life-threatening hypotension\no\nROTEM", "citations": [{"type": "pdf_page", "page": 250, "label": "p250"}]}
{"chunk_id": "SSUs_v1_p250_txt_01_374caa", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 250, "page_end": 250, "section_path": ["TRAUMA AND RESUS", "Damage Control Surgery", "Damage Control Surgery"], "specialty_tags": ["TRAUMA AND RESUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Damage Control Surgery", "keywords": [], "text": "Damage Control Surgery\nGoals:\n•\nHaemostasis\n•\nLimit contamination\n•\nOperating time <90mins\n•\nDelay definitive repair until stabilised\nDamage control surgery:\n•\nSurgeons scrubbed – prep and drape\n•\nPrepare - midline laparotomy may release tamponade\n•\n4 quadrant packing + exploration + bleeding control (resection, packing, ligation / shunting)\n•\nControl contamination\no\nSeal / resect perforated hollow viscera\no\nAvoid / delay re-anastomosis if risk of dehiscence whilst unstable\n•\nTemporary abdominal closure i.e. VAC\n+/-\n•\nThoracotomy\n•\nDecompressive craniectomy / evacuation of haematoma\n•\nExtremity: splinting, traction or ex-fix, fasciotomy of ischaemic limb\nTBI:\n•\nBP targets:\no\nsBP >100mmHg (50-69yo)\no\nsBP >110mmHg (<50yo or ≥70yo)\n•\nHb >90\n•\nPlatelet >100\n•\nTBI-induced coagulopathy: thromboplastin\nrelease → widespread clotting activation →\nrapid depletion of fibrinogen\nHarmful effects of crystalloid in bleeding trauma patient:\n•\nHaemodilution / dilutional coagulopathy\n•\nBlood loss under pressure through lacerated\nvessel / dislodges formed clot\n•\nTissue oedema →\no\nTissue hypoxia (+/- worsening acidosis)\no\nAbdominal compartment syndrome\no\nCerebral oedema (disrupted BBB)", "citations": [{"type": "pdf_page", "page": 250, "label": "p250"}]}
{"chunk_id": "SSUs_v1_p251_txt_00_9433a9", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 251, "page_end": 251, "section_path": ["TRAUMA AND RESUS", "Trauma Induced Coagulopathy", "Trauma Induced Coagulopathy"], "specialty_tags": ["TRAUMA AND RESUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Trauma Induced Coagulopathy", "keywords": [], "text": "Trauma Induced Coagulopathy\nDescription: multifactorial biochemical response to tissue injury and shock mediated by →\n•\nDysregulated coagulation\n•\nAltered fibrinolysis\n•\nSystemic endothelial activation\n•\nInflammatory response to injury\n•\nPlatelet dysfunction\nEstablished within minutes of injury\nRFs:\n•\nHypotension\n•\nHypoperfusion\n•\nHigh injury severity score\n•\nMetabolic acidosis\n•\nTBI\nWorsened by resuscitation associated / dilutional coagulopathy\nMechanism:\n•\nactivated protein C → FVa, FVIIIa, plasminogen inhibitors → hyperfibrinolysis\n•\nEndothelial dysfunction + glycocalyx disruption → endogenous heparinoids + activation of protein C\n•\nPlatelet dysfunction\n•\nConsumption of clotting factors\n•\nDilutional coagulopathy\n•\nHypocalcaemia\nDiagnosis:\n•\nStandard coags: PT >18s, INR >1.5, aPTT >60, fibrinogen <2.0, plt, D-dimer\n•\nPOC:\no\nFibtem A5 <10mm\no\nExtem:\n▪\nML: ≥5%\n▪\nA5: <35mm\n▪\nCT: >90s", "citations": [{"type": "pdf_page", "page": 251, "label": "p251"}]}
{"chunk_id": "SSUs_v1_p252_txt_00_f88455", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 252, "page_end": 252, "section_path": ["TRAUMA AND RESUS", "eFAST", "eFAST"], "specialty_tags": ["TRAUMA AND RESUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "eFAST", "keywords": [], "text": "eFAST\nEvidence: sensitivity 80%, specificity 99%\nBenefits:\n•\nFast (3 – 4 mins)\n•\nBedside in ED\n•\nNon-ionising\n•\ntime to operation (every 3 min delay to OT for damage control laparotomy → mortality by 1%)\nIndications:\n•\nHaemodynamically unstable (stable patient should have CT)\n•\nAssess for pneumothorax\nLimitations:\n•\nDoes not identify or grade solid organ injury\n•\nDoes not identify retroperitoneal bleed\n•\nCannot detect <400mL fluid\nProcedure:\n•\nUS probes:\no\nCurvilinear 3-5Hz for abdomen\no\nPhased array 3-4.5Hz for chest\nLocation\nAssessing\nProbe Placement\nProbe Image\nUS Image\nRUQ\nMorrison’s\npouch\nAnt - mid axillary line longitudinal\n7-8th IC space\nLUQ\nPerispleen\nLeft posterior axillary line\n7-8th IC space\nPelvis\nPouch of\nDouglas\nAbove pubic symphysis\nCardiac\nPericardium\nSubcostal / parasternal long axis\n4-5th IC space L sternum\nLung\nPTx\nApices to assess for lung sliding", "citations": [{"type": "pdf_page", "page": 252, "label": "p252"}]}
{"chunk_id": "SSUs_v1_p253_txt_00_04cf4b", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 253, "page_end": 253, "section_path": ["TRAUMA AND RESUS", "Haemorrhagic Shock", "Haemorrhagic Shock"], "specialty_tags": ["TRAUMA AND RESUS", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Haemorrhagic Shock", "keywords": [], "text": "Haemorrhagic Shock\nRemember possible other kinds of shock\nMTP definitions:\n•\nAdults:\no\nReplacement of >50% blood volume (≥ 10 pRBCs) in 4 hours OR\no\nReplacement of >1x blood volume in 24 hours (70mL/kg)\n•\nChildren\no\nTransfusion of >40mL/kg (*paediatric blood volume 80mL/kg, or 90mL/kg in neonates)\nMTP trigger is institution dependent, may include:\n•\nGestalt (senior clinician)\n•\nPre-hospital vitals: HR >120, BP <90, GCS <8, penetrating injury\n•\nUnstable pelvic #\n•\n+ve FAST scan in ED\nMust remember to terminate MTP, reasons may include:\n•\nControl\n•\nTargets met (clinical, biochemical)\n•\nFutility\n•\nAgreement", "citations": [{"type": "pdf_page", "page": 253, "label": "p253"}]}
{"chunk_id": "SSUs_v1_p254_txt_00_76d7db", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 254, "page_end": 254, "section_path": ["TRAUMA AND RESUS", "Pelvic Fracture", "Pelvic Fracture"], "specialty_tags": ["TRAUMA AND RESUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pelvic Fracture", "keywords": [], "text": "Pelvic Fracture\nMortality 5 – 15%. Bleeding usually from pre-sacral venous plexus (pelvic cavity + retroperitoneal space)\nYoung and Burgess classification:\n•\nAnteroposterior compression\n•\nLateral compression\n•\nVertical sheer\nManagement:\n•\nAssume other injuries including C-spine\n•\nPelvic binder over greater trochanters – remove <24hr when stable / corrected coagulopathy\n•\nTraction if vertical displacement\n•\nAvoid log rolls\n•\nStability\no\nStable → CT\no\nUnstable → eFAST to exclude other life-threatening causes (ATOM-FC)\nTreatment:\n•\nIR embolisation\n•\nLaparotomy + pelvic binding (may require diverting colostomy)\n•\nSurgical stabilisation\n•\nSurgical fixation\nNote: bleeding usually from presacral venous plexus – can be catastrophic as pelvic cavity + retroperitoneal space can\naccommodate an entire blood volume before any tamponade effect\nAnaesthesia for surgical fixation:\n•\nPre-op:\no\nInjuries ?C spine and need for MILS\no\nHb, coagulation + G&H\no\nD/w urology if IDC CI\n•\nIntra-op:\no\nHaemorrhage management +\n▪\nRIC / sheath + level 1 tubing + Belmont\n▪\nCell saver\n▪\nTXA if not already given\no\nCareful positioning\n•\nPost-op:\no\nDVT prophylaxis\no\nMultimodal analgesia", "citations": [{"type": "pdf_page", "page": 254, "label": "p254"}]}
{"chunk_id": "SSUs_v1_p255_txt_00_061bff", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 255, "page_end": 255, "section_path": ["REBOA", "REBOA"], "specialty_tags": ["REBOA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "REBOA", "keywords": [], "text": "REBOA\nsubdiaphragmatic haemorrhage whilst proximal perfusion\nNo high grade evidence for REBOA over manual aortic occlusion via thoracotomy\nZones – descending aorta:\n•\nZone 1: left subclavian artery to coeliac artery - subdiaphragmatic bleeding, coronary perfusion\n•\nZone 2: coeliac artery to lowest renal artery – never inflated here\n•\nZone 3: lowest renal artery to aortic bifurcation - pelvic bleeding\nDecision tree →\nStages following insertion:\n•\nC-REBOA (complete): inflate until proximal\nimprovement in BP + distal flat line – restricted to\n20mins (transducers either side of balloon)\no\n>45 mins is fatal → spinal cord + abdominal\nischaemia\n•\nP-REBOA: balloon deflation until distal pulsatility +\ndistal MAP is 10mmHg greater than C-REBOA\nPeri-op management:\n•\nIdeally induce after balloon inflated\n•\nPermissive hypotension before haemostasis\n•\nKetamine 0.5-1mg/kg + roc 1mg/kg – if peri-arrest less\nketamine\n•\nMAC 0.3-0.5 when appropriate\n•\nEnsure transducers flushed regularly\n•\nPrepare for reperfusion (vasoplegia, arrhythmias)\n•\nSurgical closure of insertion site +/- thrombectomy (commonly needed)", "citations": [{"type": "pdf_page", "page": 255, "label": "p255"}]}
{"chunk_id": "SSUs_v1_p256_txt_00_3be0d8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 256, "page_end": 256, "section_path": ["REBOA", "Penetrating Neck Trauma", "Blunt Neck Trauma"], "specialty_tags": ["REBOA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Blunt Neck Trauma", "keywords": [], "text": "Blunt Neck Trauma\nRisk of SCI. Immobilise.\nRed flags:\n•\nSSx: stridor, dysphonia, dyspnoea, dysphagia, odynophagia\n•\nExam: resp distress, ecchymosis on neck, surgical emphysema, tracheal deviation, haemoptysis, expanding haematoma\nBlind ETT dangerous: risk of false passage, worsening bleeding\nAirway:\n•\nCooperative: AFOI or surgical trache under LA (avoid HFNP >30L flow)\n•\nUncooperative: mRSI without cricoid + VL + oral FB\nInflate cuff beyond injury", "citations": [{"type": "pdf_page", "page": 256, "label": "p256"}]}
{"chunk_id": "SSUs_v1_p256_txt_01_785f89", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 256, "page_end": 256, "section_path": ["REBOA", "Penetrating Neck Trauma", "Penetrating Neck Trauma"], "specialty_tags": ["REBOA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Penetrating Neck Trauma", "keywords": [], "text": "Penetrating Neck Trauma\nDeep to platysma. SCI uncommon cf blunt trauma. Routine immobilisation not recommended.\nAnatomical zones:\n•\nZone 1: clavicle to cricoid (highest mortality)\n•\nZone 2: cricoid to angle of mandible\n•\nZone 3: angle of mandible to skull base\nSigns:\n•\nVascular trauma: haemorrhage, expanding neck haematoma, hypovolaemic shock\n•\nAerodigestive tract trauma: airway compromise, subcut emphysema, bubbling / sucking around wound, haemoptysis\nGoals:\n•\nDetermine urgency of secure airway – if intubated place cuffed tube in lumen distal to injury\n•\nAvoid exacerbating injury or tube migration\n•\nAvoid exacerbation of subcut emphysema\nIf possible only remove penetrating foreign body in theatre\nOption\nConsiderations\nAirway Options\nCrack On\nIndications:\n•\nIn extremis\n•\nSevere hypoxaemia\n•\nAirway obstruction\n•\nDecreased LOC\n•\nShock\n•\nCardiac arrest\n•\nExpected rapid deterioration i.e. stridor, respiratory\ndistress, subcut emphysema, expanding neck\nhaematoma/swelling, inability to lie flat\n•\nRSI (VL + FB – 2 person technique w/ MILS, avoid\ncricoid / HFNP, use nasal cannulae at 15L/min)\n•\nFONA double set up\n•\nImmediate FONA\n•\nIntubation through neck wound into trachea\nAWAKE + SPONT VENT IS IMPRACTICAL\nStay and\nPlay\nRisk of transfer > advantage of transfer\nTime to:\n•\nGather equipment + personnel\n•\nIx: nasendoscopy, bedside XR, airway US\n•\nNo evidence of rapid deterioration\n•\nOther injuries: haemorrhage, TBI, smoke/thermal\ninhalation\nCompliance:\n•\nCompliant: awake (VL or FONA with LA)\n•\nNon-compliant: spont vent (FB, VL, FONA) or RSI (VL +/-\nFB assisted)\nHead for\nHome\nStable enough for transfer to OT\nTime for comprehensive assessment including CT,\nnasendoscopy, CXR, airway US\nCompliance:\n•\nCompliant: as above – +/-remifentanil assisted\n•\nNon-compliant: as above\nFailure plan for all is eFONA\nConservative management:\n•\nObserved critical care location\n•\nHumidified inspiratory gases\n•\nQ2 – 4 hourly neb saline, PPI\n•\nDaily nasendoscopy", "citations": [{"type": "pdf_page", "page": 256, "label": "p256"}]}
{"chunk_id": "SSUs_v1_p257_txt_00_d3281e", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 257, "page_end": 257, "section_path": ["REBOA", "Blunt Aortic Trauma", "Thoracic Trauma"], "specialty_tags": ["REBOA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Thoracic Trauma", "keywords": [], "text": "Thoracic Trauma\nAssess for immediately life-threatening injuries of chest can also use ATOM-FC:\n•\nAortic injury\n•\nThorax (hemothorax, pneumothorax)\n•\nOesphageal perforation\n•\nMuscle - diaphragmatic injury\n•\nFistula (bronchopleural) and other tracheobronchial injury\n•\nContusion / cardiac tamponade\nBlunt Thoracic Trauma\nBlunt Aortic Trauma\n80% die at scene.\nMechanism: rapid deceleration / collision\nIx:\n•\nCXR: widened mediastinum, obscured aortic tubercle, left apical cap, L haemothorax, R deviation NGT, R tracheal\ndeviation, R mainstem bronchus deviated down, wide left paravertebral stripe\n•\nCT scan if stable\nManagement:\n•\nMinor aortic injury: <1cm intimal abnormality, localised intramural haematoma, no external contour deformity\n→ conservative management\n•\nSignificant aortic injury: active bleeding, full thickness rupture, pseudoaneurysm\n→ urgent repair\nGrading:\n•\nType 1: intimal tear\nconservative, anti-impulse therapy\n•\nType 2: intramural haematoma\n→ surgical repair (emergent or delayed)\n•\nType 3: pseudoaneurysm\n→ surgical repair (emergent or delayed)\n•\nType 4: rupture\n→ surgical repair (urgent)\nSurgical repair can be endovascular or open\nManagement:\n•\nABCs\n•\n2x large bore access + arterial line + CVC\n•\nBlood pressure: anti-impulse therapy – lower targets – see vascular notes\no\nTarget: sBP <100mmHg, HR <100bpm\n•\nNOTE: REBOA is CI\n•\nImmediate surgical repair if haemodynamically unstable\nBlunt Cardiac Trauma\nRFs: anterior chest pain, sternal fracture, cardiac symptoms / signs, major mechanism\nTypes of injury: myocardial rupture, septal / valvular injury, MI, myocardial contusion, arrhythmia\nIx:\n•\nTroponin\n•\nECG: usually RBBB (RV closest to sternum – LBBB rare) +/- arrhythmia including ectopy, ST changes\n•\nTTE: RWMAs, valve function, tamponade\nManagement:\n•\nIf ECG and troponin changes – admit and monitor with telemetry for 48 hours\n•\nTamponade: pericardiocentesis, thoracotomy\n•\nValve / septal injury: CTSx review\ncMRI adds little if TTE already performed", "citations": [{"type": "pdf_page", "page": 257, "label": "p257"}]}
{"chunk_id": "SSUs_v1_p258_txt_00_b41d26", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 258, "page_end": 258, "section_path": ["REBOA", "Penetrating Thoracic Trauma"], "specialty_tags": ["REBOA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Penetrating Thoracic Trauma", "keywords": [], "text": "Blunt Pulmonary Trauma\nAssess for:\n•\nPneumothorax\n•\nHaemothorax\n•\nPulmonary contusion: irregular, non-lobular opacification or radiology (analgesia, chest PTx, may need vent support)\no\nCan be very serious\n•\nTracheobronchial injury\n•\nDiaphragmatic rupture\n•\nOesophageal rupture\n•\nChest wall injury: sternal, thoracic spine, scapular, rib, flail chest, sternoclavicular dislocation, clavicle\nPenetrating Thoracic Trauma\nLocation:\n•\nChest wall:\no\nIntercostal artery / vein injury\no\nRib fractures\n•\nLung:\no\nPneumothorax / haemothorax\no\nPulmonary contusion / laceration\n•\nHeart:\no\nTamponade\no\nMyocardial rupture\no\nGreat vessel injury\n•\nTracheobronchial injury\n•\nOesophageal injury\n•\nDiaphragmatic injury", "citations": [{"type": "pdf_page", "page": 258, "label": "p258"}]}
{"chunk_id": "SSUs_v1_p259_txt_00_58713a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 259, "page_end": 259, "section_path": ["REBOA", "Chest Drain Insertion"], "specialty_tags": ["REBOA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Chest Drain Insertion", "keywords": [], "text": "Needle Thoracostomy\nIndication: haemodynamically unstable tension pneumothorax\nLocation:\n•\n2nd intercostal space mid-clavicular line\n•\n5th intercostal space mid-axillary line\nProcedure:\n•\nSkin prep\n•\nStandard or long 14-16G cannula\n•\n10mL syringe with several mL of normal saline\n•\nInsert over superior border of 3rd rib\n•\nAspirate until air bubbles in syringe\n•\nDisconnect syringe → whoosh of air\n•\nProceed to intercostal catheter insertion\nChest Drain Insertion\nIndications:\n•\nPneumothorax\n•\nHaemothorax\n•\nPleural effusion / empyema\n•\nPleurodesis\n28 – 32Fr used in trauma\nCI: coagulopathy, localised skin infection\nProcedure:\n•\nIV antibiotics, LA, skin prep + drape\n•\n5th intercostal space mid-axillary line\n•\nTechniques:\no\nBlunt dissection:\n▪\n2-3cm incision parallel to intercostal space\n▪\nBlunt dissect to rib with curved clamp\n▪\nBlunt dissect over rib through parietal pleura\n▪\nOpen clamp to spread muscle / pleura\n▪\nInsert finger into pleural space\n▪\nClamp tube at insertion end and insert into space (direct apically or basally)\n▪\nUnclamp\n▪\nAdvance until >2cm in cavity\n▪\nConnect to collection system / underwater seal\n▪\nSuture + CXR to confirm position\no\nSeldinger:\n▪\nIntroducer needle – aspirating for air / blood\n▪\nGuidewire\n▪\nSequential dilators\n▪\nTube\n▪\nRemove guidewire\n▪\nSuture\n▪\nCXR", "citations": [{"type": "pdf_page", "page": 259, "label": "p259"}]}
{"chunk_id": "SSUs_v1_p260_txt_00_c32329", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 260, "page_end": 260, "section_path": ["REBOA", "Resuscitative Thoracotomy"], "specialty_tags": ["REBOA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Resuscitative Thoracotomy", "keywords": [], "text": "Resuscitative Thoracotomy\nDefinition: anterolateral chest incision to control exsanguinating haemorrhage or other life-threatening chest injuries\nIndications:\n•\nPenetrating thoracic trauma with haemodynamic instability\n•\nBlunt thoracic trauma with cardiac tamponade\n•\nPenetrating abdominal injury with exsanguinating haemorrhage\n•\nAppropriate resources for continued resuscitation and repair available (4Es)\n•\nAfter arrest:\no\nPenetrating: <15 minutes\no\nBlunt: <10 minutes\nContraindications:\n•\nNo signs of life at scene\n•\nAsystole without pericardial tamponade\n•\nProlonged arrest >15 minutes\n•\nNon-survivable injury\nGoals:\n•\nRelief of cardiac tamponade → pericardotomy\n•\nControl of haemorrhage → aortic XC\n•\nOpen cardiac massage\nUsually thoracostomy performed first\nTechnique:\n•\nLung isolation (endobronchial, DLT, bronchial blocker)\n•\nSkin prep/drape\n•\nLeft anterolateral → ventilation of left lung\n•\nExtend thoracostomy incision transverse, enter pleural cavity\n•\nInsert rib spreader (handle in axilla – do not block access to clamshell)\n•\nArtery forceps to pick up pericardium → incise to make window to relieve tamponade and access heart (cephalad to\ncaudal incision to avoid transection/injury to left phrenic nerve traversing pericardium)\n•\nDelivery heart from pericardium to inspect for injuries\n•\nInsert hand along posterior aspect of left pleural cavity until you find the descending aorta → manual occlusion\n(afterload → perfusion to coronaries and brain)\n•\nOpen cardiac massage\n•\nInternal defib if indicated\n•\nExtend thoracotomy to\nclamshell if potential pathology\nis in contralateral cavity, may\nneed Gigli saw to bisect\nsternum\n•\n→ OT for definitive repair\n4Es:\n•\nExpertise\n•\nEquipment\n•\nEnvironment\n•\nElapsed time\nSurvival:\n•\nPenetrating cardiac 35%\n•\nPenetrating chest 15%\n•\nBlunt chest 2%", "citations": [{"type": "pdf_page", "page": 260, "label": "p260"}]}
{"chunk_id": "SSUs_v1_p261_txt_00_f9df9d", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 261, "page_end": 261, "section_path": ["REBOA", "Traumatic Cardiac Arrest", "Traumatic Cardiac Arrest"], "specialty_tags": ["REBOA", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Traumatic Cardiac Arrest", "keywords": [], "text": "Traumatic Cardiac Arrest\nLikely one of:\n•\nHaemorrhage\n•\nOxygenation\n•\nTension\n•\nTamponade\nManagement: defer CPR and defibrillation\n•\nFirst priority – stop bleeding\n•\nA: secure ETT\n•\nBilateral thoracostomies on spec\n•\nUS ?tamponade\n•\nEmergency thoracotomy → within 10 mins of arrest (more clearly defined role in penetrating trauma cf blunt trauma\nwhere mortality 8x higher from thoracotomy)\nAfter ROSC:\n•\nClamp RIMA /\nLIMA\n•\nCaution adr\nadministration\n•\nTreat K+ and\nacidosis\n•\nDebrief", "citations": [{"type": "pdf_page", "page": 261, "label": "p261"}]}
{"chunk_id": "SSUs_v1_p262_txt_00_83632a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 262, "page_end": 262, "section_path": ["REBOA", "Rib Fractures", "Rib Fractures"], "specialty_tags": ["REBOA"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Rib Fractures", "keywords": [], "text": "Rib Fractures\nRisk:\n•\n5 rib fractures: mortality 10%\n•\n8 rib fractures: mortality 34%\n•\n1st rib fracture: marker of severe chest trauma because protected by clavicle\no\n10% aortic transection\no\n2% bronchial tear\nComplications: atelectasis, pneumonia / contusion, ARDS, PE, pneumothorax, haemothorax, altered lung mechanics, pain\nFlail chest:\n•\nRadiological: 3 contiguous rib # in ≥2 places\n•\nClinically: paradoxical chest wall movement during spontaneous ventilation\n•\nMortality 35%\n•\nMay need surgical fixation (only indicated in flail chest requiring mechanical ventilation – but not prolonged ventilation)\nRisk factors:\n•\nInjury factors:\no\nRib # as above\no\nBilateral fractures\no\nFlail segment, sternal #, scapula #,\no\nPulmonary contusion\n•\nPatient factors:\no\nAge ≥65\no\nFrail\no\nCCF\no\nRespiratory disease\no\nDiabetes\n•\nClinical factors:\no\nPaCO2 >45\no\nPaO2 <60\nAnalgesia in pain notes", "citations": [{"type": "pdf_page", "page": 262, "label": "p262"}]}
{"chunk_id": "SSUs_v1_p263_txt_00_c1b532", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 263, "page_end": 263, "section_path": ["NEXUS", "Canadian C-Spine Rules", "Acute Spinal Cord Injury"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Acute Spinal Cord Injury", "keywords": [], "text": "Acute Spinal Cord Injury\n30% also have non-spinal injuries\nImmobilisation: cervical collar, spinal board, log rolls\nAvoid secondary injury: avoid hypoxia, hypotension, hypercapnia, hyperthermia - no evidence for steroids or hypothermia\nAirway:\n•\nAlways assume unstable C-spine\n•\nIntubation indications: hypoxia, reduced GCS, C3-C5 injury\n•\nTechnique: MILS, RSI (sux contra-indicated 48hrs – 6mo), VL or fibreoptic\no\nJaw thrust okay, avoid chin lift and head tilt\n•\nBeware:\no\nAssociated maxfax trauma +/- blood / vomit in airway\no\nCricoid pressure\no\nBradycardia with laryngoscopy (give atropine on induction)\nBreathing:\n•\nAvoid hypoxia → secondary injury\n•\nHigh injury – ventilation improved in supine position as diaphragm breathing improved\nCardiovascular: aim MAP >85mmHg for 7 days post-injury\n•\nNeurogenic shock:\no\nBradycardia: atropine, pacing\no\nHypotension: vasopressors\no\nAvoid excessive IVF: minimise ARDS, spinal cord oedema – goal directed therapy\n•\nHaemorrhagic shock / tamponade / PTx may coexist\n•\nInvasive monitoring\n•\nInsert IDC to monitor UO and aid overdistension\nExamination: look for diaphragmatic breathing, hypotension / bradycardia, priapism, flaccid areflexia, loss of pain below a level\nInvestigations: normal + trauma + early MRI", "citations": [{"type": "pdf_page", "page": 263, "label": "p263"}]}
{"chunk_id": "SSUs_v1_p263_txt_01_28ae3a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 263, "page_end": 263, "section_path": ["NEXUS", "Canadian C-Spine Rules", "C-Spine Clearance"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "C-Spine Clearance", "keywords": [], "text": "C-Spine Clearance\nDecision tools not applicable if: paediatric, direct blow to neck, penetrating neck trauma, reduced GCS, age >60\nNEXUS low risk criteria: “NSAID” (NPV 99%) – applicable >1yo\n•\nN\nNormal neurology\n•\nS\nNo spinal midline tenderness\n•\nA\nAlert, age <60yo\n•\nI\nNot intoxicated\n•\nD\nNo distracting injury\nCanadian C-Spine Rules (99.4% sensitive)\n1. Image if:\na. >65yo\nb. Dangerous mechanism\ni. Fall >1m\nii. Axial load to head\niii. MVA >100km/hour\niv. Motorised recreational vehicle accident\nv. Ejection\nvi. Bicycle crash\nc.\nParasthesia in extremities\n2. Assess for low risk features:\na. Simple rear end MVA\nb. Sitting in ED\nc.\nAmbulatory at any time\nd. Delayed onset neck pain\ne. Absent midline cervical tenderness\n3. Able to rotate neck 45 degrees to each side\nDoes not meet low risk criteria → IMAGE\nApproach to C spine XRAY: lateral\n•\nDemographics\n•\nObvious injuries\n•\nA: alignment of 3 vertebral columns\n•\nB: bones outlines\no\nShould be able to count out all C vertebrae\n•\nC: cartilage – spacing between bones\n•\nSoft tissue", "citations": [{"type": "pdf_page", "page": 263, "label": "p263"}]}
{"chunk_id": "SSUs_v1_p264_txt_00_887118", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 264, "page_end": 264, "section_path": ["NEXUS", "Jellyfish", "Envenomation"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Envenomation", "keywords": [], "text": "Envenomation\nSnakes\nLethal: taipan, brown, tiger, death adder, black, rough scaled, sea snakes\nIssues:\n•\nThrombotic microangiography\n•\nMyotoxicity\n•\nSystemic symptoms including neurotoxic paralysis: headache, diaphoresis, respiratory distress, LOC\n•\nVenom-induced consumptive coagulopathy\nManagement:\n•\nFirst aid:\no\nBroad pressure bandage (prevent lymphatic spread not blood – start at bite)\no\nImmobilise joints either side\no\nImmobilise patient (lay)\no\nDo not remove until at centre with full facilities and after anti-venom – do not wash or clean in case venom\ndetection kit required (can clear afterwards)\n•\nResuscitation:\no\nABC\no\n2x pIVCs + take bloods (FBC, EUC, coags, fibrinogen, CK – will need serial)\no\nSystemic effects:\n▪\nCardiovascular collapse\n▪\nDIC\n▪\nNerve paralysis → respiratory failure\n▪\nRhabdomyolysis\n▪\nHaemolysis / MAHA\n•\nPrepare for anaphylactic reaction, give antivenom (in consultation with clinical toxicologist)\no\nDilute in normal saline – give over 15 mins\no\nIf cardiac arrest give antivenom as push – it is not weight-based, same dose for all\no\nIf child critically unwell retrieval team should bring to regional location for treatment prior to transfer\n•\nObserve and further resuscitate\n•\nVenom-induced coagulopathy: not aided by more antivenom – takes 10-20 hours to improve, up to 30 hours for full\nresolution, role of FFP and cryo is controversial – generally only indicated if bleeding\n*If anaphylaxis occurs there is high risk of ICH with adrenaline + coagulopathy – consider titrated adrenaline infusion\nSpiders\nLethal: funnel web, red back\nFirst aid:\n•\nFunnel web: pressure and immobilise\n•\nOther spiders: ice/cold compress\nJellyfish\nLethal:\n•\nBox: respiratory and cardiac arrest\n•\nIrukandji syndrome\nFirst aid:\n•\nVinegar\n•\nAntivenom for box jellyfish\nBlue-ring jellyfish and cone shell:\n•\nPressure immobilisation (risk of respiratory failure)", "citations": [{"type": "pdf_page", "page": 264, "label": "p264"}]}
{"chunk_id": "SSUs_v1_p265_txt_00_13087c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 265, "page_end": 265, "section_path": ["NEXUS", "Drowning", "Drowning"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Drowning", "keywords": [], "text": "Drowning\nRespiratory impairment due to submission / immersion in liquid\nRFs: age (toddler or adolescent), male, aquatic occupation, aquatic exposure, alcohol / drugs, medical comorbidity, trauma,\nassault, hypothermia\nSequence of events: water enters mouth → next conscious response is to hold breath (~1min) until respiratory drive too high to\nresist → water aspirated into airways → coughing reflex +/- laryngospasm → hypoxaemia → LOC and apnoea\nFinal mode of death: tachycardia → bradycardia → PEA → asystole\nPathophysiology\n•\nRespiratory:\no\nLaryngospasm → hypercarbia, hypoxia, acidosis (breaks due to hypoxia)\no\nPulmonary aspiration – recovery position if spont venting\no\nALI: pulmonary oedema, bronchospasm, acute emphysema +/- inhaled toxins e.g. chlorine\no\nV:Q mismatch\no\ncompliance\no\nRespiratory infection (freshwater > sea water)\n•\nMetabolic:\no\nHypothermia\no\nLactic acidosis\n•\nCVS:\no\nDiving reflex: triggered by cold water on face (via trigeminal n.) → apnoea, bradycardia, vasoconstriction\no\nCatecholamine surge: → vasoconstriction, arrhythmia, cardiac failure\no\nVF common <28 degrees\n•\nCNS:\no\nCerebral global hypoxia → oedema\n•\nHaem:\no\nHaemolysis\no\nDIC\nManagement:\n•\nFirst aid:\no\nRemove from water\no\nCheck for response (pulse, ventilation)\no\n5 rescue breaths\no\nCPR / ALS\no\nRhythm: usually PEA\n•\nHospital:\no\nABCs + C spine precautions\no\nRewarming to 32-34 degrees (therapeutic hypothermia) for 24 hours\n▪\nPassive:\n•\nRemove wet clothing\n•\nInsulating cover\n▪\nActive:\n•\nForced air warmer\n•\nRadiant heater\n•\nWarmed IVF\n•\nHumidified inspiratory gases\n•\nLavage\n•\nECMO/bypass\no\nVentilation: lung protective, avoid permissive hypercapnoea due to CNS injury\n•\nAssess for:\no\nTrauma\no\nUnderlying cause e.g. medical episode\nFurther management:\n•\nNeuro: neuroprotective measures, MAP 80\n•\nRenal: manage AKI +/- rhabdo\n•\nInfection: consider antibiotics if grossly submerged in contaminated water", "citations": [{"type": "pdf_page", "page": 265, "label": "p265"}]}
{"chunk_id": "SSUs_v1_p266_txt_00_aa16b7", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 266, "page_end": 266, "section_path": ["NEXUS", "Hypothermia", "Hypothermia"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Hypothermia", "keywords": [], "text": "Hypothermia\nDefinitions:\n•\nMild\n32 – 35\n•\nMod\n28 – 32\n•\nSevere <28\nMortality of mod-severe is 40%\nCauses: exposure, drowning, therapeutic hypothermia, disease (infection, hypoglycaemia, adrenal\ninsufficiency, hypothyroidism, overdose)\nIatrogenic: deep hypothermic cardiac arrest\nIx:\n•\nRoutine bloods + TFTs + toxicology + CK + lipase + cortisol\n•\nECG: J wave\nSystem\nMild\nMod\nSevere\nCNS\nConfusion, slurred speech\nImpaired judgement\nAmnesia\nParadoxical undressing\nLethargy, hallucinations\nLoss of pupils reflexes\nEEG changes\nreflexes\nLoss of CVS regulation\nComa\nLoss of ocular reflexes\nCVS\nTachycardia + SVR → CO\nBradycardia\nCO, SVR\nArrhhythmias, J waves\nProlonged intervals\nCO, SVR\nVF\nAsystole\nRESP\nTachypnoea, bronchorrhoea\nMV, O2 consumption\nCO2 production\nLoss of cough reflex\nApnoea\nPulmonary oedema\nRenal\nCold diuresis\nCold diuresis\nOliguria\nrenal blood flow\nGIT\nIleus\nPancreatitis\nStress ulcers\nHepatic dysfunction\nMSK\nShivering\nshivering\nMuscle rigidity\n“Pseudo rigor mortis”\nMetabolic\nmetabolic rate\nHyperglycaemia\nmetabolic rate\nHAEM\nHct, plt, WCC\nDIC\nBleeding despite normal coag studies\nManagement:\nAvoid jostling / moving → may precipitate AF\n•\nA/B:\nIntubation\n•\nC:\nCPR (may be prolonged)\nWarmed IV crystalloid + pressors + inotropes\nSevere hypothermia – CPR may be delayed / intermittent to facilitate rescue\n•\nD:\nMeasure core temp (oesophageal, rectal, bladder)\nRewarming:\nPassive external: remove wet clothes, insulated blanket\nActive external: forced air warmer\nActive internal: warm fluids, warm humidified O2, pleural / peritoneal lavage, endovascular warmer\nECMO / CPB\nComplications:\n•\nCore temperature after drop: fall in core T when peripheries are warmed (beware hypotension, acidosis, VF)\n•\nBurns from rewarming\n•\nTakatsubos\n•\nElectrolyte abnormalities\n•\nRhabdo\n•\nCardiac arrhythmias: refractory until patient warmed\n•\nFrostbite", "citations": [{"type": "pdf_page", "page": 266, "label": "p266"}]}
{"chunk_id": "SSUs_v1_p267_txt_00_fedbb5", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 267, "page_end": 267, "section_path": ["NEXUS", "Crush Injury", "Crush Injury"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Crush Injury", "keywords": [], "text": "Crush Injury\nMajor issues:\n•\nProlonged ischaemic + muscular damage → rhabdo + reperfusion injury on release\n•\nLimb damage (often numb + peripheral pulse) → rapid swelling with compartment syndrome\nField management:\n•\nFull monitoring\n•\n1L crystalloid prior to extrication\n•\n500mL crystalloid alternating with 500mL 5% dextrose per hour\nHospital management:\n•\nMyoglobinuric renal failure:\no\nBicarb as indicated to maintain urinary pH >6.5 if rhabdo + induce polyuria\no\nIf urinary pH >7.45 give acetazolamide\no\nContinue until urine is myoglobin-free\n•\nLimb care:\no\nSplinting:\n▪\nSplint in functional position\n▪\nActive & passive movement as pain allows\n▪\nContractures and paralysis dealt with late reconstructive surgery\no\nCompartment syndrome / fasciotomies (see below)\no\nHyperbaric oxygen therapy: no large scale studies of use in crush injury but listed for approved use\n▪\nCan be used during impending compartment syndrome (before established)\n▪\n3x treatments at 2.5atm for 90-120mins\n▪\nShould never delay fasciotomy in established CS\n▪\nUse post-fasciotomy: useful for ischaemic muscle, unclear demarcation of viable muscle, massive\nswelling, ischaemia >6hr, vascular compromise of flap/graft, and residual neuropathy", "citations": [{"type": "pdf_page", "page": 267, "label": "p267"}]}
{"chunk_id": "SSUs_v1_p268_txt_00_5cae5d", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 268, "page_end": 268, "section_path": ["NEXUS", "Compartment Syndrome", "Compartment Syndrome"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Compartment Syndrome", "keywords": [], "text": "Compartment Syndrome\npressure within a closed compartment and compromises circulation\nCompartments:\n•\nOsseofascial (foot, hand)\n•\nCranium\n•\nEye\n•\nSpine\n•\nAbdomen\n•\nChest\n•\nPericardium\nPathophysiology: in tissue volume with externally applied pressure\nCauses:\n•\nTrauma: fracture, crush, burns\n•\nVascular: ischaemia, reperfusion, haemorrhage\n•\nIatrogenic: tourniquet, cast, extravasation, prolonged Lloyd-Davis / trendelenberg\nCompartments:\n•\nThigh:\no\nAnterior: femoral + saphenous n.\no\nPosterior: sciatic n.\no\nMedial: obturator n.\n•\nLeg\no\nAnterior: deep peroneal n.\no\nLateral: superficial peroneal n.\no\nDeep posterior: tibial n.\no\nSuperficial posterior: no nerves\n•\nArm:\no\nAnterior: ulnar and median n.\no\nPosterior: radial n.\n•\nForearm:\no\nAnterior (deep & superficial): ulnar and median n.\no\nPosterior: radial n.\nPresentation:\n•\nPain out of proportion, worse with passive muscle stretch\n•\nParaesthesia\n•\nWeakness / paralysis\n•\nSwelling\n•\nPallor\n•\nPulselessness\nDiagnosis:\n•\nClinical\n•\nCompartment pressure\no\nNormal <12 – 15mmHg\no\nFasciotomy if dBP – CP = <30mmHg\nTreatment:\n•\nRelease external pressure\n•\nKeep at level of the heart\n•\nMaintain BP\n•\nFasciotomy and debridement\n•\nTreat underlying cause\n•\nTreat complications e.g. rhabdomyolysis\n5 Ps:\n•\nPain\n•\nParesis\n•\nPulselessness\n•\nPallor\n•\nParaesthesia", "citations": [{"type": "pdf_page", "page": 268, "label": "p268"}]}
{"chunk_id": "SSUs_v1_p269_txt_00_3b2656", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 269, "page_end": 269, "section_path": ["NEXUS", "Burns Management – Emergency Department / Pre-Transfer", "Burns"], "specialty_tags": ["NEXUS", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Burns", "keywords": [], "text": "Burns\nBurn\nDescription\nSkin Layer\nDescription\nManagement\nSuperficial\nEpidermis\nonly\nRed, dry, no blisters\nNot counted\nin rule of 9s\nSuperficial\npartial\nthickness\nDermis\n(Superficial)\nPink, blister\nPainful\nHeals\nwithout\nscarring\nDeep\npartial\nthickness\nDermis (deep)\nLobster/cherry red\nCap refill +ve\nLess painful\nMay need\ngrafting\nFull\nthickness\nEntire\nthickness of\ndermis\nWaxy, white, charred\nNot painful\nNeeds\nexcision and\ngrafting\nFirst aid:\n•\nCool water 20 mins\n•\nCling wrap\n•\nWarm\n•\nRemove contaminated clothing\n•\nIrrigate chemical burns: acid 45 minutes, alkali 60 minutes\nBurns Management – Emergency Department / Pre-Transfer\n•\nMIST handover +\no\nTime of burn (for IVF calculation)\no\nEntrapment?\n•\nMDT management with critical care specialties: ED + second skilled anaesthetist +/- ICU\n•\nRemove burned clothing + jewellery\n•\nMonitoring: sats, ECG if possible, art line + CVC + temp probe + BIS (high risk awareness in ED)\n•\n2x long 16G IVC + ketamine 0.5mg/kg for severe pain\n•\nA/B:\no\n>25% TBSA → SIRS response + high risk of airway oedema later → will require intubation\n▪\nAssess airway: usually minimal inflammation early\n▪\n20mL/kg crystalloid if hypotensive prior to induction\n▪\nMidazolam 0.1mg/kg, ketamine 1mg/kg + fentanyl 2mcg/kg + rocuronium 1.2mg/kg\n▪\nX-blade + stylet, ETT size 7/8 + difficult airway trolley\n▪\nTape ETT + wire to teeth to avoid dislodgement\n▪\nPropofol + fentanyl infusion maintenance\n▪\nTreat bronchospasm: salbutamol, ketamine, magnesium\n▪\nLPV\n•\nC:\no\nAvoid fluid creep: modified parkland: BSA% x 3mL x weight = crystalloid / 24hr\n▪\n50% 1st 8hr – this is from time of burn\n▪\n50% remaining 16hr\no\nAdditional titrated to UO 0.5mL/kg/hr\no\nLow dose metaraminol infusion if required MAP >65\n•\nD/E:\no\nABG:\n▪\nCO poisoning: FiO2 100% until COHb <3%\n▪\nCyanide toxicity: persistent lactataemia → hydroxycobalamin\no\nTemperature: keep warm (fluid warmer, forced air, heating lights)\no\nCircumferential assessment:\n▪\nEscharotomy of any full thickness circumferential burns (extend 1cm at sides)\n▪\nElevate limbs\no\nTetanus injection\no\nGastric decompression\no\nSend full bloods + monitor EUC for risk of rhabdo\no\nRule out other injuries: full examination + CXR\nIndication for transfer to burns centre:\n•\nDermal burns >10% BSA, full thickness\n>5% BSA\no\nAll burns >5% in paeds\n•\nFace, arms, feet, perineum, over a joint\n•\nCircumferential\n•\nInhalational or other\n•\nElectrical / chemical\n•\nSuspected NAI\nBSA:\nPalm + fingers 1% +\nRule of 9s:\n•\nHead 9%\n•\nChest 18%\n•\nBack 18%\n•\nArm 9%\n•\nLeg 18%\n•\nPerineum 1%", "citations": [{"type": "pdf_page", "page": 269, "label": "p269"}]}
{"chunk_id": "SSUs_v1_p270_txt_00_2d8b47", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 270, "page_end": 270, "section_path": ["NEXUS", "Burns Hospital"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Burns Hospital", "keywords": [], "text": "Burns Hospital\nGoal: remove full thickness burn and cover, save zone of sepsis\n•\nPartial burns: remove superficial portion, apply biobrane (silicone + porcine collagen) and monitor\n•\nFull thickness burns: early burn excision → necrotic load, infection risk, SIRS, blood loss, improved aesthetic and\nfunctional outcomes\nIf very large full thickness burns delay grafting until off inotropes (grafts fail) – cover with BTM\nPre-op:\n•\nVolume status\n•\nCardiac fx (early may have takastubos)\n•\nDo not fast if tubed, aspirate NGT\n•\nExact plan from surgeons\nIntra-op:\n•\nRSI if no NGT, avoid sux after 48 hours\n•\nBlood loss: previously 4% blood volume / 1% area excised – slightly reduced now with tumescent mixtures\no\nBlood management bundle including rapid transfuser\no\n+ limb tourniquets, compression bandages, topical adrenaline / thrombin\n•\nTemperature:\no\nWarm +\no\nCool if >39.5: debulk dressings, ice to non-burned skin, bladder irrigation, cool IVF\n•\nFluid management: balanced crystalloid +/- albumin\no\nUO: 0.5 – 1mL/kg/hr\no\nLactate\no\nHct\no\nCO monitoring\n•\nMultimodal analgesia\nPost-op:\n•\nNutrition: early enteral\no\nDietician for caloric requirements: 55% glucose, 30% lipids, protein 2g/kg/day + micronutrients\n•\nItch: PO antihistamine, gabapentin, laser therapy, pressure garments\n•\nExtubation:\no\nCuff leak\no\nConsider AEC\nComplications:\n•\nImmune: infections, toxic shock\n•\nCVS: IHD, CCF, CVA, myocardial fibrosis, ET\n•\nGIT: diabetes, GI disease\n•\nMSK: fractures, mobility\n•\nCNS: seizures, migraines\nOther: death, cancer risk, PTSD / anxiety / depression, chronic pain, pruritis", "citations": [{"type": "pdf_page", "page": 270, "label": "p270"}]}
{"chunk_id": "SSUs_v1_p271_txt_00_3a7278", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 271, "page_end": 271, "section_path": ["NEXUS", "Burns Hospital"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Burns Hospital", "keywords": [], "text": "System\nEarly <48hr\n“Burn shock”\nLate 48hr – 1 year\nHypermetabolic\nCVS\n•\nHR, SVR (vasoconstriction), Hct\n•\nSV, CO, SvO2\n•\nHR, CO, SvO2\n•\nSVR\n•\nSubclinical myocardial dysfunction\n•\nHyperdynamic circulation\nResp\n•\nPVR\n•\nBronchospasm, APO / ARDS\n•\nmucociliary clearance →\n•\nVentilation\n•\nBronchospasm, APO / ARDS\n•\nPneumonia\nEndo\n•\ncortisol, RAAS, catecholamines\n•\ncortisol, RAAS, catecholamines\n•\nglucagon, insulin → hyperglycaemia\n•\nMuscle catabolism, lipolysis\nGIT\n•\nIleus\n•\nGI stress +/- ulceration\n•\nHypoalbuminaemia\n•\nGluconeogenesis\n•\nhepatic blood flow\n•\nFatty liver\n•\nAltered drug metabolism\nRenal\n•\nOliguria +/- AKI\n•\nMyoglobinuria\n•\nurinary Na excretion\n•\nGFR\n•\ntubular function\nHaem\n•\nGeneralised oedema\n•\nHct\n•\nCoagulation factors\n•\nHaematopoiesis, anaemia\n•\nImmunosuppression\nOther\n•\nHypothermia\n•\nVO2\n•\nHyperthermia\n•\nWeight loss\n•\nImpaired wound healing\nPharm\n•\nalbumin, AAG\n•\nVd\n•\nCO\n•\nhepatic / renal clearance\n•\nSux CI (although first case report of hyperK 9\ndays)\n•\nhepatic / renal clearance\n•\nPhase 1 reactions\n•\ndose non-depolarising muscle relaxants\n•\npropofol, opioid requirements\n•\ncatecholamine sensitivity", "citations": [{"type": "pdf_page", "page": 271, "label": "p271"}]}
{"chunk_id": "SSUs_v1_p272_txt_00_39bf10", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 272, "page_end": 272, "section_path": ["NEXUS", "Burns Analgesia"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Burns Analgesia", "keywords": [], "text": "Burns Analgesia\nType of pain/discomfort:\n•\nBackground\n•\nBreakthrough\n•\nProcedural\n•\nNeuropathic\n•\nHyperalgesia / allodynia\n•\nItch\nTreatment:\n•\nNon-pharmacological:\no\nDressings: draft + contact pain\n▪\nBiosynthetic dressings time to healing and pain during dressings changes (L1)\n▪\nVR distraction, augmented reality techniques and multimodal distraction methods pain and\nunpleasantness during burns dressings (L1)\no\nPositioning\no\nCutaneous stimulation\no\nAcupuncture\no\nCBT\no\nHypnosis / virtual reality (L1)\no\nDistraction\n•\nPharmacological:\no\nRegular paracetamol\no\nOpioids: infusion or PCA (avoid IM/subcut due to poor absorption)\no\nKetamine / precede / benzos\nOpioid tolerance → rotate, or use opioid sparing techniques\nNeuropathic pain:\n•\nPregabalin (level 2 evidence), gabapentin (level 3 evidence)\n•\nKetamine\nProcedural pain:\n•\nOpioids\n•\nKetamine\n•\nPrecedex (poor evidence)\n•\nN2O / methoxyflurane\n•\nBiosynthetic dressings\n•\nTopical agents e.g. lignocaine spray\nNo evidence for IV lignocaine\nProcedural anxiolysis:\n•\nPropofol\n•\nBenzos – lorazepam\nItch:\n•\n1st line: citrizine, cimetidine, gabapentin\n•\n2nd line: loratadine", "citations": [{"type": "pdf_page", "page": 272, "label": "p272"}]}
{"chunk_id": "SSUs_v1_p273_txt_00_c21586", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 273, "page_end": 273, "section_path": ["NEXUS", "Electrocution", "Electrocution"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Electrocution", "keywords": [], "text": "Electrocution\nEntry + exit point\nElectrical injury:\n•\nTissue with greatest resistance will heat the most I.e. bone, and adjacent deep muscle will cook leading to rhabdo and\ncompartment syndromes will consequences of both (I.e. renal failure, hyperK, fasciotomies +/- limb loss)\n•\nIf involves the heart - might have reduced function in setting of normal ECG and no trop rise\no\nConsider doing a TTE and delay surgery if able until cardiac function improves (usually 48 hours)\nDegree of electrocution:\n•\n0.1mA – to myocardium = VF\n•\n1000A – severe burn, loss of limb (high tension injury)\n•\n>12,000A – lightning (coma, severe burns, loss of limb)\nManagement:\n•\nECG\n•\nTTE\n•\nCT of extremities\n•\nCK levels\n•\nUrinary myoglobin\n•\nOpthalmic examination (if indicated)\n•\nMonitor for compartment syndrome\nSpecific management:\n•\nIntubation if airway burns\n•\nDebridement and amputation of damaged muscle\n•\nFasciotomy of limbs\n•\nVigorous fluid resuscitation + management of rhabdo + acid-base balance\n•\nMalignant cardiac rhythm: defib indicated\n•\nTetanus shot\nSupportive management:\n•\nFAST HUGS", "citations": [{"type": "pdf_page", "page": 273, "label": "p273"}]}
{"chunk_id": "SSUs_v1_p274_txt_00_12146c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 274, "page_end": 274, "section_path": ["NEXUS", "Altitude Sickness", "Altitude Sickness"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Altitude Sickness", "keywords": [], "text": "Altitude Sickness\nPartial pressure of O2:\n•\n80mmHg @ 5500m\n•\n48mmHg @ 8900m (summit of Everest)\nHypobaric hypoxia causes:\n•\nPrimary trigger for altitude acclimatisation\n•\nHigh altitude illness\nAltitude Acclimatisation\nCompensatory responses to acute hypobaric hypoxia (begins within minutes at a new altitude)\nAcclimatisation:\n•\nImproves but does not normalise hypoxia\n•\nComplete compensation is not possible >5500m\n•\nPast acclimatisation has no effect on subsequent acclimatisation\n•\nLost within weeks of descent\nProcesses:\n•\nventilation to improve hypoxaemia\n•\nRespiratory alkalosis (requires compensation)\no\ncarbonic anhydrase in renal tubular cells → HCO3 excretion (days)\nOther responses to hypobaric hypoxia:\n•\nSNS stimulation\n•\nErythropoeisis\n•\n2,3-DPG\n•\nVO2 max (severely reduced at 4500m)\nHigh Altitude Illness\n•\nHAPE\n•\nHACE\nRFs: rapid ascent, lack of acclimatisation period, past history of HAI\nNot associated with age, fitness or smoking history\nProphylaxis: when >3000m ascending <500m / 24hr\nAcute Mountain Sickness and HACE (different severities of same spectrum of disease)\n•\nAMS: headache + PONV, insomnia, dizziness – common - 25% @ 3000m, >50% >4000m\n•\nHACE: CBF 2’ hypoxia → cerebral oedema +/- ICP +/- brain herniation and death (up to 4%)\no\nSSx: encephalopathic symptoms i.e. ataxia, lassitude, cognition, LOC (may not have AMS pro-drome)\nPrevention: Rx with acetazolamide (only if history of AMS)\nManagement:\n•\nAvoid further ascent\n•\nSimple analgesia + anti-emetics\nIf severe:\n•\nRapid descent >1000m\n•\nDexamethasone 8mg + 4mg q6 hour until descent complete\n•\nSupplemental O2 +/- hyperbaric O2 therapy\nHAPE\nUncommon <4500m. Up to 15% at 5500m. Non-cardiogenic pulmonary oedema 2’ HPV at pulmonary arterioles\nSSx: SOB out of proportion to exertion, non-productive cough, frank haemoptysis\nRisk of AMS and HACE is markedly increased.\nPrevention: salbutamol (in some people), pulmonary vasodilators, dexamethasone\nManagement:\n•\nRapid descent\n•\nSupplemental oxygen – preferably hyperbaric O2\n•\nRx: pulmonary vasodilators (nifedipine, PDE5)", "citations": [{"type": "pdf_page", "page": 274, "label": "p274"}]}
{"chunk_id": "SSUs_v1_p275_txt_00_1d61d2", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 275, "page_end": 275, "section_path": ["NEXUS", "Hyperbaric Oxygen Therapy"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Hyperbaric Oxygen Therapy", "keywords": [], "text": "Hyperbaric Oxygen Therapy\nExposure to O2 partial pressure >1 atm\nClinical effects:\n•\ndissolved O2 (>3tm dissolved O2 enough to supply body at rest i.e. can support body oxygenation without Hb)\no\nE.g. severe anaemia in Jehovah’s witness patient\n•\nrate of O2 diffusion into tissues\no\nwound healing and collagen formation\no\ntissue oedema\no\npost-reperfusion injury\n•\nArteriolar vasoconstriction (overall SVR with inotropic support, improvement in acidaemia)\n•\nKilling of bacteria from super peroxidation\nNote: pressure alone only effective in treating gas embolism\nClinical applications:\n•\nAcute decompression illness\n•\nMassive haemorrhage without transfusion (has been effective in Jehovah’s witnesses with massive haemorrhage)\n•\nCarbon monoxide poisoning: CO >25% or >20% if pregnant, GCS, pH <7.1\n•\nGas gangrene\n•\nNecrotising fasciitis\n•\nOsteomyelitis\n•\nCompartment syndrome and reperfusion\n•\nEnhanced wound healing / flap compromise\nCI:\n•\nAbsolute: pneumothorax, premature infants, bleomycin, disulfuram, cisplatin\n•\nRelative: obstructive lung disease, sinus infection / URTI, recent ear or thoracic surgery, fever, claustrophobia, seizure\ndisorder, pregnancy, asthma, CO2 retention, spherocytosis, optic neuritis\nChamber types:\n•\nMonoplace: for one patient, portable for remote rescue, can be compressed with air or oxygen\n•\nMultiplace: >1 patient\nDrug interactions:\n•\nSympathomimetics: effects\n•\n and  blockers: effects\n•\nAcetazolamide: cerebral oxygen delivery\n•\nOpioids, benzos, barbiturates and propofol: safe\n•\nInsulin: may need to due to BSL in O2 therapy\n•\nCI: doxorubicin, cisplatin, disulphuram\nAdverse effects:\n•\nPressure changes:\no\nRisk of tympanic membrane perforation – common to perform prophylactic myringotomies +/- grommets\n•\nDecompression illness:\no\nIf supplied air instead of oxygen\no\nIf rapid decompression of chamber necessary in fire or cardiac arrest\n•\nOxidative damage\no\nCNS O2 toxicity (improved by short 5 min breaks breathing air q30 mins)\no\nPulmonary O2 toxicity (vital capacity - recovers between treatments)\n•\nMyopia\n•\nCataract maturation\n•\nHypoglycaemia\n•\nSystemic vasoconstriction, bradycardia (can worsen CCF)\nNormobaric O2 therapy uses:\n•\nSubcut emphysema\n•\nPneumothorax\n•\nCO poisoning\n•\nCluster headaches\n•\nPONV\n•\nsurgical site infection\n•\nanastomotic integrity", "citations": [{"type": "pdf_page", "page": 275, "label": "p275"}]}
{"chunk_id": "SSUs_v1_p276_txt_00_95b609", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 276, "page_end": 276, "section_path": ["NEXUS", "Corrosive Ingestion", "Corrosive Ingestion"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Corrosive Ingestion", "keywords": [], "text": "Corrosive Ingestion\nInjury patten:\n•\nAlkalis: adhere to oral / oesophageal mucosa → severe local injuries (stomach sparing)\n•\nAcids:\no\nStrong acids: irritant & cause coagulative necrosis + eschar +/- gastric perforation & stricture\no\nWeak acids: localised laryngeal injury\n•\nNeutral pH: less extensive injury but can cause airway oedema\nAcute management:\n•\nPPE to prevent damage to staff\n•\nAssess for airway compromise\n•\nNasendoscopy if compliant patient\n•\nIV corticosteroids\n•\nNebulised adrenaline\n•\nDo not delay endotracheal intubation if evolving injury or worsening oedema\no\nEarly call to ENT\n•\nVomiting can cause further damage → ++ anti-emetics\n•\nAvoid activated charcoal\n•\nCXR: to rule out perf\no\nAntibiotics only if evidence of GI perf\n•\nNGT under direct vision (blind may cause injury)\nFurther management:\n•\nGastroscopy within 24hr (to assess extent of injuries)\n•\nDexamethasone for 3 days if grade 2b oesophagitis\n•\nMay require tracheostomy (1%)\n•\nPsychological support\n1000x risk of oesophageal cancer", "citations": [{"type": "pdf_page", "page": 276, "label": "p276"}]}
{"chunk_id": "SSUs_v1_p277_txt_00_c7f311", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 277, "page_end": 277, "section_path": ["NEXUS", "Paracetamol Toxicity", "Organophosphate Poisoning"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Organophosphate Poisoning", "keywords": [], "text": "Organophosphate Poisoning\nSource:\nInsecticides\nNerve agents\nMechanism:\nAbsorbed via skin, lungs, GIT\nInhibit acetylcholinesterase → cholinergic crisis\nInitially reversible, becomes irreversible\nPresentation: cholinergic excess systems effects\nCVS: bradycardia, conduction block, QTc prolongation\nResp: secretions, bronchoconstriction\nCNS: miosis, respiratory depression\nRenal: diuresis\nGIT: diarrhoea, vomiting, salivation\nMSK: weakness, diaphoretic\nManagement:\nA/B:\nIntubation (avoid sux, dose on non-depolarising)\nC:\nAtropine: high dose i.e. 50mcg/kg IV\nDouble q5 min until effect\nMay require infusion\nPralidoxime: cholinesterase reactivator\n30mg/kg AFTER atropine for MSK weakness\nD:\nSeizures: benzos\nDecontaminate\nActivated charcoal 1g/kg", "citations": [{"type": "pdf_page", "page": 277, "label": "p277"}]}
{"chunk_id": "SSUs_v1_p278_txt_00_37616c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 278, "page_end": 278, "section_path": ["NEXUS", "Adult Resuscitation Guidelines", "Adult Resuscitation Guidelines"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Adult Resuscitation Guidelines", "keywords": [], "text": "Adult Resuscitation Guidelines\nChain of survival:\nEarly recognition + help\nEarly CPR\nEarly defib\nPost resus care\nResuscitation:\nAirway:\nCapnography should be used to confirm ETT placement + quality of CPR + ROSC\nBreathing:\nCirculation:\nChest compressions:\nHigh quality: 30:2, 1/3 depth with adequate recoil\nRate 100 – 120bpm\nInterruptions <5s (only after defib charged)\nDefib: avoid devices, consider 3 stacked shocks if witnessed VF/pVT arrest, biphasic 200J\nEquipment (monitoring):\nETCO2 with waveform capnography\nBlood sampling + analysis\nArt line\nUltrasound\nPost-resus care:\nBSL 6 – 10mM\nT <37.5\nUnable to prognosticate <72hr", "citations": [{"type": "pdf_page", "page": 278, "label": "p278"}]}
{"chunk_id": "SSUs_v1_p279_txt_00_dc80b8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 279, "page_end": 279, "section_path": ["NEXUS", "Interhospital Transfer", "Interhospital Transfer"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Interhospital Transfer", "keywords": [], "text": "Interhospital Transfer\nTransfer exposes patient to additional risk\nMust have accurate assessment / optimisation prior to transfer\nLevel of care must be at least equal to that of the point of referral\nCentralised coordination of transport services\nChoice of hospital based on:\nType of illness\nImpact of transport environment (road, air)\nUrgency\nDistance + transport time\nWeather conditions\nAviation restrictions / landing facilities\nResources at referring site\nFatigue limitations\nTransport vehicle requirements:\nSafety\nSpace\nPower\nGas supply\nSuction\nRestraints\nAcceptable noise / vibration levels\nSpeed / response time\nCommunication equipment\nMonitoring\nSupplies in excess of maximum travel time\nAir transport considerations:\nReduced partial pressure of O2\nPressurisation / rapid desaturation\nExpansion of air filled cavities and equipment\nLimb swelling under casts\nWorsening: air embolism, decompression sickness\nDanger if agitated patient\nNoise\nTemperature\nAcceleration, deceleration, turbulence, vibration\nMotion illness", "citations": [{"type": "pdf_page", "page": 279, "label": "p279"}]}
{"chunk_id": "SSUs_v1_p280_txt_00_4804fb", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 280, "page_end": 280, "section_path": ["NEXUS", "Mass Casualty", "Mass Casualty"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Mass Casualty", "keywords": [], "text": "Mass Casualty\nTimeline:\nInitial response\nConsolidation phase\nRecovery phase\nRestoration of normality\nInitial priorities:\nSave life\nRelieve suffering\nPrevent escalation of incident\nProtect environment\nPreserve infrastructure / property\nRestoration of normality\nEnquiry into incident\nApproach – CSCATTT\nCommand and control\nEstablish responsibility roles and command\nSet up inner and outer cordons\nEstablish operational areas, casualty stations, entry and exit points\nSafety: self, scene, survivors\nPPE\nStructural integrity\nCommunications\nCoordination + dissemination of information\nAssessment of the scene\nTriage\nPrimary triage:\nDistributive justice: maximum benefit for maximum amount of people\nEstablish priority levels and colour coded labels\nDead: black/white\nImmediate: red\nUrgent: yellow\nDelayed: green\nNon-injured → survivor reception area\nUrgent care\nTourniquets\nAirway adjuncts\nPlace in recovery position\nSecondary triage: Triage Revised Trauma Scale 0-12\nRR, GCS, sBP\nTreatment and transport\nStabilise ABC\nTransfer to appropriate location\nTransportation of the dead", "citations": [{"type": "pdf_page", "page": 280, "label": "p280"}]}
{"chunk_id": "SSUs_v1_p281_txt_00_d19532", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 281, "page_end": 281, "section_path": ["NEXUS", "Mass Casualty"], "specialty_tags": ["NEXUS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Mass Casualty", "keywords": [], "text": "Trial\nDescription\nOutcome\nCRASH2\nTxA versus placebo\nTxA 1g IV over 10 mins then\n1g IV over 8 hours\nsBP <90mmHg and/or HR\n>110bpm\n•\nall cause mortality @ 28 days\n•\ndeath due to bleeding – best within 1hr, benefit <3hr\n•\nmortality if administered >3hr from injury\n•\nNo difference: transfusion, surgical intervention, vascular occlusive episodes\nTBI:\n•\nICH expansion, neurosurg, mortality\n•\nNo improvement in neurosurg outcomes\nCRASH3\nTxA versus placebo\nTBI within 3hr of injury\n(exclusions: GCS 3, fixed\ndilated pupils, patients with\nmajor extra-cranial bleeding)\n•\nGCS 9-15:  head injury related death\n•\nEarly treatment <1hr better than later treatment 1-3hr post-injury\n•\nHarm if TxA given >4 hours after injury\n•\nGCS 4-8: no difference with TxA\nOther outcomes: no sig difference in all-cause mortality, disability, thrombosis,\nseizures\nPATCH\nTXA versus placebo\nWithin 3hr of injury (blunt /\npenetrating trauma, burns)\n•\nNo improved patient survival with favourable functional outcome\nNote: many protocol violations – other studies have shown benefit within 1hr &\n<3hr\nTrial\nName\nDescription\nOutcome\nPAMPer\nPrehospital Air Medical trial\nCrystalloids versus\nplasma\n•\n30-day mortality in plasma group (NNT\n10)\nCRISTAL\nColloids v Crystalloids for Resus of\nCritically Ill\nAlbumin versus\ncrystalloid\n•\nNo mortality benefit\n•\nmortality with albumin in TBI\nPROPPR\nPragmatic Randomised Optimal\nPlatelet and Plasma Ratios Trial\npRBC : FFP : plt\n1:1:1 versus 2:1:1\n•\nNo difference in 30-day mortality\n•\nmortality from bleeding at 24hr with\n1:1:1\nPROMMTT\nProspective Observational\nMulticentre Major Trauma\nTransfusion\nratio FFP/plt : pRBC\n•\n6 hour mortality\n•\nNo difference at 24 hours or 30 days", "citations": [{"type": "pdf_page", "page": 281, "label": "p281"}]}
{"chunk_id": "SSUs_v1_p282_txt_00_86fe79", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 282, "page_end": 282, "section_path": ["PAIN", "Pain"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pain", "keywords": [], "text": "Pain\nDefinition: an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or\npotential tissue damage\nPain duration:\nAcute pain: 0 – 6 weeks\nSub-acute: 6 – 12 weeks\nChronic pain: >12 weeks\nTypes of pain:\nNociceptive: caused by inflammation or damage to tissues\nSomatic: localised, dull ache, sharp exacerbations (mechanical, MSK)\nVisceral: poorly localised, cramping, dull (associated with nausea, sweating)\nNeuropathic: caused by nerve damage, lesion in somatosensory system\nNociplastic: persistent pain from altered nociception without evidence of actual or threatened tissue damage\nSensitisation:\nLowered threshold\nAmplified response\nWidened receptive field\nAltered sensation:\nAllodynia: pain with non-noxious stimuli (e.g. paint brush stroke)\nHyperalgesia: pain with normally non-pain inducing noxious stimuli (e.g. BSL prick)\nHyperpathia: repetitive nociceptive stimuli → exaggerated level of pain", "citations": [{"type": "pdf_page", "page": 282, "label": "p282"}]}
{"chunk_id": "SSUs_v1_p283_txt_00_0f7ce1", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 283, "page_end": 283, "section_path": ["PAIN", "Neuropathic Pain", "Neuropathic Pain"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Neuropathic Pain", "keywords": [], "text": "Neuropathic Pain\nDefinition (IASP): pain caused by a lesion or disease of the somatosensory nervous system\nFurther divided into central and peripheral according to site of lesion\nHallmark characteristics:\nAllodynia\nHyperalgesia\nDysaesthesia\n+ pain descriptors (burning, shooting), regional autonomic features (colour & temp changes, sweating)\nNeuropathic pain often poorly managed – only 35 – 50% of patients benefit from 1st line analgesics.\nCombination therapy > monotherapy. Pain phenotyping may allow for more stratified and personalised therapies.\nManagement:\nMedical\nPsychological\nNICE Guideline:\n1st line: gabapentinoids (gabapentin, pregabalin), antidepressants (amitriptyline, duloxetine)\nSpecial cases:\nCarbamazepine 1st line for trigeminal neuralgia\nLignocaine patch 5% for post-herpetic neuralgia\n2nd line: trial an alternative 1st line agent (trial all 4 if needed)\n3rd line: opioids (buprenorphine > others)\nAcute rescue therapy: tramadol is effective (L1)\nAlternative therapy:\nCapsaicin cream: for localised neuropathic pain wishing to avoid PO medications\nHigh [ ] 8% capsaicin patches\nCombination therapy:\nWHO recommends ≥2 agents (limited efficacy with single agents, dose-related SEs)\nAvoid drugs with similar adverse effects\nGood approach is sequential combo therapy – if only partial response to single agent add a second\nNovel agents:\nTapentadol: can be considered as single agent in difficult to treat patients\nCannabinoids: weak evidence, may play a role in weaning from high dose opioids or in combo therapy\nSubcut lignocaine\nTopical clonidine (thought to be peripherally mediated)\nMultiagent creams: ket 10%, gabapentin 10%, imipramine 3%, bupivacaine 5%\nShould not be started outside specialist setting:\nCannabis sativa extract\nCapsaicin patch\nLacosamide\nLamotrigine\nKeppra\nMorphine\nOxcarbaepine\nTopiramate\nVenlafaxine\nLong-term tramadol\nInterventional therapy (adjuncts / refractory pain):\nESP for thoracic NP\nDorsal root entry zone ablation for complex, resistant segmental pain after SCI\nDBS for refractory chronic pain", "citations": [{"type": "pdf_page", "page": 283, "label": "p283"}]}
{"chunk_id": "SSUs_v1_p284_txt_00_8199d4", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 284, "page_end": 284, "section_path": ["PAIN", "Chronic Pain", "Chronic Pain"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Chronic Pain", "keywords": [], "text": "Chronic Pain\nPain lasting >3 months. ~20% population.\nNot every acute pain patient will develop chronic pain, but every chronic pain patient had an acute pain\nRisk factors for developing chronic pain:\nSeverity of injury\nType of surgery\nPre-existing pain\nSevere, uncontrolled acute pain → most consistent predictor of developing chronic pain i.e. intensity = risk\nAnxiety and catastrophisation\nCompensation status\nBlame attribution and justice\nChronic neuropathic pain:\nIV lignocaine is effective\nPain management programmes:\nPatient behaviours and coping styles will determine functioning and QoL\nPain management programmes aid to focus on QoL through self-management and broaden the agenda away from pain\ncontrol alone\nMDT input is essential\nClinical strategies in chronic pain:\nUnhelpful:\nRepeated investigations\nEscalating analgesia focused on short-term pain relief\nReassuring results from investigations explained as “nothing wrong”\nPersuading distressed patients that pain may be caused by emotions\nAdvising patients that they need to ‘learn to live with their problem’\nHelpful:\nInvestigations + explanations that chronic pain may exist without overt pathology\nFocus on long term functioning with medication deprescribing as important as prescribing\nClarify absence of malignant problems whilst addressing normal changes (i.e. degeneration)\nExplain that thoughts and feelings do not cause pain but psychological management may be central to living with it\nIntroduce self-management carefully (e.g. exercise, goal-setting, understanding that hurt doesn’t equal harm, pain\ndoes not necessarily need ‘rescuing’)", "citations": [{"type": "pdf_page", "page": 284, "label": "p284"}]}
{"chunk_id": "SSUs_v1_p285_txt_00_96e9b5", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 285, "page_end": 285, "section_path": ["PAIN", "Chronic Post-Surgical Pain", "Chronic Post-Surgical Pain"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Chronic Post-Surgical Pain", "keywords": [], "text": "Chronic Post-Surgical Pain\nComponents:\nPain after surgical procedure\nArea of surgery\nPersisting beyond healing process (≥3mo)\nNot better explained by another cause\nMay continue from acute PSP or may have pain-free interval. Often neuropathic component.\nCharacteristics:\n•\nSensory abnormalities\n•\nNeuropathic\n•\nSomatic / nociceptive\nMechanism: central and peripheral sensitisation\nPost-surgical persistent pain risk factors:\nPre-op:\nMod-severe pain >1mo\nRepeat surgery\nPsychological vulnerability (eg catastrophising)\nAnxiety\nFemale sex\nYounger age (adults)\nWorkers’ compensation\nGenetic predisposition (e.g. COMT)\nOpioid use (particularly if ineffective)\nIntra-operative:\nNerve injury\nRecovery:\nSeverity of acute pain (esp neuropathic like SSx)\nChemoradiotherapy\nCatastrophisation\nPatients with legal issues\nPrevention:\n•\nPre-op identification of at risk individuals\n•\nRoutine post-op:\no\nEffective management of acute pain\no\nLimiting opioid exposure + multimodal analgesia\no\nRegional analgesia\no\nPsychological support + rehab\n•\nSpecific (4)\no\nRegional\no\nPharmacotherapy\no\nModification of surgical approach\no\nNon-pharmacological\nType of Analgesia\nDefinition\nPre-emptive\nTreatment/analgesia prior to incision / insult (e.g. paracetamol, NSAID, opioid, epidural)\nPreventive\nAnalgesia intended to reduce short and long-term post surgical pain – timing is not important, but effect of intervention is observed\nat a point in time that exceeds the duration of action of the target agent (defined as analgesia that lasts >5.5 half lives of the\nmedicine)", "citations": [{"type": "pdf_page", "page": 285, "label": "p285"}]}
{"chunk_id": "SSUs_v1_p286_txt_00_344f38", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 286, "page_end": 286, "section_path": ["PAIN", "Chronic Post-Surgical Pain"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Chronic Post-Surgical Pain", "keywords": [], "text": "Specific interventions:\nRegional\n•\nBenefit in 3 procedures:\no\nThoracotomy: epidural\no\nBreast cancer: PVB\no\nC-section\n•\nPossible benefit:\no\nOpen bowel resection: epidural\no\nAmputation: epidural\n•\nLA infiltration:\no\nBreast ca\no\nIliac crest bone graft\no\nCraniotomy\nPharmacotherapy\n•\nKetamine:\no\n<24 hour infusion: CPSP at 6mo\no\n>24hr infusion: CPSP at 3mo\no\nNo benefit at 12 months\no\nMost efficacious and safe\n•\nOpioids:\no\nHigh dose: pain (i.e. remifentanil)\n•\nGabapentinoids: weak evidence, unlikely to benefit\n•\nIV lignocaine: CPSP at 3mo\n•\nVenlafaxine:\no\nMasctectomy: 37.5mg/day for 10 days started pre-op → CPSP at 6mo\n•\nN2O: CPSP in Chinese patients", "citations": [{"type": "pdf_page", "page": 286, "label": "p286"}]}
{"chunk_id": "SSUs_v1_p287_txt_00_7ac10f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 287, "page_end": 287, "section_path": ["PAIN", "Complex Regional Pain Syndrome", "Complex Regional Pain Syndrome"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Complex Regional Pain Syndrome", "keywords": [], "text": "Complex Regional Pain Syndrome\nPost-traumatic disorder:\nNon-dermatomal\nSevere + continuous in affected limb\nAssociated sensory, motor, vasomotor, sweat gland and trophic disturbances\nMay exhibit:\nHypersensitivity and / or allodynia\nTemperature differences between affected and contralateral limb\nOedema\nChanges in hair and nail growth\nin symptoms after exercise\nTwo types:\nCRPS 1: no demonstrable nerve lesion\nCRPS 2: demonstrable nerve lesion\nPathophysiology: 4 component model\n•\nLocal tissue damage\n•\nPathological pain processing\n•\nAutonomic dysregulation\n•\nImmune dysfunction\nMultifactorial, likely an exaggerated inflammatory response, certain HLA loci may be susceptible\nVitamin C >500mg / day initiated immediately after surgery and continued for 50 days may risk\nClinical diagnosis (IASP):\nContinuing disproportionate pain to inciting event\nMust have one symptom in 3 of the following 4 categories:\nSensory: hyperaesthesia, allodynia\nVasomotor: temperature asymmetry, skin colour changes\nSudomotor / oedema: sweating changes, oedema\nMotor / trophic: ROM, motor dysfunction, trophic changes (hair, nail, skin)\nMust have one sign in 2 or more of the categories above\nNo other diagnosis better explains SSx\nManagement categories:\nAnti-inflammatories: steroids\nRegional osteopaenia: bisphosphonates\nAnalgesics: gabapentinoids\nVasodilators: CCB, alpha blocker, PDE5 inhibitor\nMuscle relaxants / spasmolytics: try PO prior to intrathecal baclofen, IM botox\nPsychological → referral for CBT, education\nInvasive treatment only if above fails e.g. spinal cord stimulator\nPrognosis: varied", "citations": [{"type": "pdf_page", "page": 287, "label": "p287"}]}
{"chunk_id": "SSUs_v1_p288_txt_00_0e4aca", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 288, "page_end": 288, "section_path": ["PAIN", "Stellate Ganglion Block"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Stellate Ganglion Block", "keywords": [], "text": "Sympathetic Blocks\nRationale:\nVascular pain 2’ poor blood supply\nNeuropathic pain\nIndications: depends on level\nPVD\nVisceral pain\nHyperhydrosis\nNeuropathic pain (including CRPS)\nMethod: sedation, aseptically, adequate resus available\nType of block:\nDiagnostic: assess effect, aiming for no somatic block – often inaccurate\nPrognostic: should do >1 and results should be consistent prior to neuroablation\nTherapeutic: neurolysis\nStellate Ganglion Block\nFusion of 1st thoracic and inferior cervical sympathetic ganglia\nRelations:\n•\nPosterior to subclavian artery + SCM\n•\nAnterior to 1st rib, vertebral artery, anterior scalene\n•\nMedial to superior intercostal vessels\n•\nLateral to thoracic duct, vertebrae, oesophagus\n•\nSuperior to dome of pleura\nIndications above +\nRaynauds\nAngina / chest pain\nRefractory arrythmias\nCI:\n•\nCoagulopathy\n•\nLocal infection / cancer\n•\nAnatomical / vascular abnormality\n•\nRecent MI\n•\nGlaucoma\n•\nContralateral phrenic nerve palsy\nComplications:\n•\nHorner’s\n•\nNerve injury: brachial plexus, RLN, phrenic nerve\n•\nOrgan injury: pleura, pneumothorax, trachea, oesophagus\n•\nVascular\n•\nIntrathecal injection", "citations": [{"type": "pdf_page", "page": 288, "label": "p288"}]}
{"chunk_id": "SSUs_v1_p289_txt_00_d14ec8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 289, "page_end": 289, "section_path": ["PAIN", "Lower Back Pain", "Lower Back Pain"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Lower Back Pain", "keywords": [], "text": "Lower Back Pain\nASSESS:\n•\nHistory:\no\nSOCRATES\no\nFunction / impact on daily life: BPI\no\nPrevious treatments: medications, physio, surgery\no\nAssociated symptoms: numbness / tingling, bowel / bladder dysfunction\n•\nExamination:\no\nInspect: posture, gait, deformities\no\nPalpation: tenderness, muscle spasms, abnormalities\no\nROM\no\nNeuro examination\n•\nPsychosocial:\no\nAddress hindering features: fear-avoidance behaviours, depression, social withdrawal\n•\nInvestigations: only if red flags present (e.g. trauma, malignancy, infection, neurology)\no\nImaging: xray, CT, MRI, NCS\nMANAGE:\n•\nEducation + reassurance: information, importance of exercise, avoid bed rest\no\nTargeted reassurance improves fear, worry, anxiety, catastrophisation and healthcare utilisation (L1)\no\nEducation using “biopsychosocial/neuroscience” anxiety, worry, fear, distress and healthcare utilisation (L1)\n•\nPharmacological treatment:\no\nParacetamol + NSAIDs\no\nNeuropathic: amitriptyline, pregabalin, gabapentin\no\nOpioids only for severe pain unresponsive to other treatment, careful monitoring\n•\nNon-pharmacological treatment:\no\nPhysical therapy\no\nManual therapy e.g. massage\no\nCBT\no\nMindfulness\n•\nInterventional:\no\nInjections: epidural steroid, facet joints\no\nRadiofrequency ablation: if refractory\n•\nMDT: physiotherapy, psychology, OT, pain specialists\no\nSpecialist if complex\n•\nFollow-up", "citations": [{"type": "pdf_page", "page": 289, "label": "p289"}]}
{"chunk_id": "SSUs_v1_p290_txt_00_9da525", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 290, "page_end": 290, "section_path": ["PAIN", "Spinal Cord Stimulator"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Spinal Cord Stimulator", "keywords": [], "text": "Spinal Cord Stimulator\nSuperior to repeat surgery. Stimulation of dorsal column fibres (placement in dorsal epidural space) effectively reduces pain in\nmany neuropathic and ischaemic pain syndromes.\nIndications:\nFailed back surgery syndrome (disabling back or radicular pain despite adequate surgery)\nComplex regional pain syndrome type 1\nChronic leg ischaemia\nChronic angina refractory to treatment\nCase reports in: diabetic neuropathy, post-herpetic neuralgia, post-amputation pain (lack evidence)\nPrior: should have trial, MRSA eradication\nSpecial considerations:\nMRI: controversial, may cause damage (newer may be MRI compatible)\nDiathermy: avoid, bipolar, away from device\nPPM / ICD: requires communication with cardiology team – relatively CI (demand mode may sense SCS)\nSCS must not prevent use of external defib\nPregnancy: unknown data, no data to suggest adverse outcomes (but also none in support of safety)\nNeuraxial anaesthesia: risk of damage to device – must be done completely sterile under radiological guidance\nAnaesthetic considerations:\nPre-op:\nContact pain team, interrogate, turn off prior to anaesthesia (prevents inadvertent reprogramming, interference\nwith ECG leads)\nIntra-op:\nAntibiotics only if otherwise indicated\nCareful positioning and padding\nDiathermy: avoid if able, bipolar > monopolar, away from device\nLithotripsy: turn off\nNeuraxial anaesthesia: risk of damage to device – best avoided, may also introduce infection\nIf done – d/w pain specialist, must be done completely sterile under radiological guidance, may cause\npatchy anaesthesia due to fibrosis\nPost-op:\nTurn back on and pain team interrogate", "citations": [{"type": "pdf_page", "page": 290, "label": "p290"}]}
{"chunk_id": "SSUs_v1_p291_txt_00_25b449", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 291, "page_end": 291, "section_path": ["PAIN", "Chronic Headache", "Chronic Headache"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Chronic Headache", "keywords": [], "text": "Chronic Headache\nASSESS:\n•\nHistory\no\nPain history: site, onset, character, radiation, associations, time course, exacerbating / relieving factors,\nseverity\no\nOther features: photophobia, visual changes, aura, N&V\no\nEffect on function\no\nImpact on daily life\no\nRed flags\no\nOther related medical conditions\no\nEfficacy of previous treatments\n•\nExamination:\no\nNeurological\no\nHead & neck\n•\nInvestigations:\no\nRed flags: worsening unrelenting symptoms, fever, recent procedure, immunosuppressed\n▪\nCT / MRI\nMANAGE:\n•\nEducation and reassurance\n•\nPharmacological treatments:\no\nAcute: paracetamol, NSAIDs\no\nMedication overuse headache: educate, manage withdrawal\n•\nNon-pharmacological treatments\no\nCBT\no\nPhysiotherapy (address MSK)\no\nRelaxation: mindfulness\no\nLifestyle modification: sleep hygiene, regular exercise, reduce etoh / sugar / caffeine\n•\nMDT: consider specialised referral if refractory\n•\nFollow up to assess efficacy\nSpecific:\n•\nMigraine:\no\nAcute: triptans, anti-emetics\no\nPreventative: beta-blockers\no\nLifestyle / triggers\n•\nTension-type: stress management, physical therapy\n•\nCluster:\no\nAcute: oxygen, sumatriptan\no\nPreventative: verapamil\nIndividualised, evidence-based, patient-centred", "citations": [{"type": "pdf_page", "page": 291, "label": "p291"}]}
{"chunk_id": "SSUs_v1_p292_txt_00_e0dbff", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 292, "page_end": 292, "section_path": ["PAIN", "Migraine", "Migraine"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Migraine", "keywords": [], "text": "Migraine\nTreatment:\n•\nAcute headache:\no\nAspirin 1000mg (L1)\no\nIbuprofen 400 – 800mg (L1) – soluble faster onset\no\nParacetamol 1g (effective but less than other analgesic, efficacy with metoclopramide L1)\no\nAddition of caffeine to simple analgesics efficacy and better tolerability (L1)\no\nTriptan (5HT1) – highest withdrawal + MOH\n▪\nSubcut sumatriptan has fastest onset and highest efficacy (L1)\n▪\nIncreased efficacy combined with naproxen than alone (L1)\n▪\nAll triptans are superior to placebo however 40% of patients may not respond (L1)\no\n+/- anti-emetic (improves absorption + efficacy)\n▪\nMetoclopramide and droperidol (L1)\n▪\nPhenothiazines and butyrophenones are effective but more side effects (L1)\no\nSome opioids are more effective than placebo in treatment of acute migraine (L1) but associated with\nsignificant side effects and poor outcomes\n▪\nPethidine should not be used (L1)\nSingle adequate dose > multiple suboptimal doses\nAbove ineffective during aura phase, must wait for headache\nAcute treatments associated with medication overuse headache – limit to 2x per week + start preventative\nHyperbaric O2 is effective in pain but no other outcomes (L1)\nThere is significant placebo effect in migraine treatment (L1)\n•\nPreventative (if >4 attacks/month):\no\nB-blockers: metoprolol, propranolol\no\nAnti-epileptics: valproate, topiramate\no\nAmitriptyline\no\nBisoprolol\nIf >3 above failed can consider:\n▪\nBotox\n▪\nGreater occipital nerve block\n▪\nOccipital nerve stimulation\nAcupuncture:\n•\nMay frequency of tension headaches and migraine (L1)\n•\nMay be tolerated better than pharmacological prophylaxis in migraines (L1)", "citations": [{"type": "pdf_page", "page": 292, "label": "p292"}]}
{"chunk_id": "SSUs_v1_p293_txt_00_d65c56", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 293, "page_end": 293, "section_path": ["PAIN", "Post-Herpetic Neuralgia", "Herpes Zoster"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Herpes Zoster", "keywords": [], "text": "Herpes Zoster\nShingles\nPrevention: vaccination\nTreatment:\n•\nAntiviral within 72 hours of rash onset → accelerates resolution\n•\nSimple analgesia + PRN opioid\n•\nPrednisone may pain\n•\nGabapentin pain\n•\nTopical lignocaine\n•\nTopical aspirin\n•\nNerve blocks\nPost-Herpetic Neuralgia\nVaricella zoster virus may cause post-herpetic neuralgia:\n•\nPersists for >3mo after onset of shingles\n•\nRFs: age >50yo, prodromal pain, severe acute pain, severe rash, ophthalmic involvement\nPrevention:\n•\nVaccination\n•\nNerve block: epidural, PVB\n•\nAmitriptyline 25mg PO for 90 days\nIn-effective for prevention of pain:\n•\nAntiviral\n•\nSteroids\nTreatment:\n•\nTopical capsaicin / lignocaine 5%\n•\nAnti-neuropathic:\no\nGabapentin 300 – 600mg TDS\no\nPregabalin\no\nAmitriptyline\n•\nAnti-epileptic: valproate, carbamazepine, lamotrigine\n•\nSNRI\n•\nIntrathecal steroid\n•\nBotox\n•\nNeuromodulation, neurostimulation", "citations": [{"type": "pdf_page", "page": 293, "label": "p293"}]}
{"chunk_id": "SSUs_v1_p294_txt_00_f1ae09", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 294, "page_end": 294, "section_path": ["PAIN", "Trigeminal Neuralgia", "Trigeminal Neuralgia"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Trigeminal Neuralgia", "keywords": [], "text": "Trigeminal Neuralgia\nUnilateral pain characterised by brief electric shock like pain, abrupt in onset / offset, in the distribution of one or more\ntrigeminal nerve\nAetiology:\n•\nUnclear\n•\nHyper-excitable neurons in trigeminal root ganglion\n•\nCentral sensitisation\n•\nDemyelination\nRisk factors:\n•\nVascular compression of trigeminal nerve\n•\nMultiple sclerosis\n•\nTumours\n•\nTrauma\n•\nStroke\nDiagnosis:\n•\nParoxysmal attacks lasting up to 2 minutes in ≥1 trigeminal division plus:\no\nPain is:\n▪\nIntense, sharp, superficial, stabbing\n▪\nPrecipitated by a trigger\no\nStereotyped\n•\nNo neurological defect\n•\nNo other apparent cause\nClassification:\n•\nClassical: no apparent cause i.e. paroxysmal\n•\nSymptomatic: secondary to another cause i.e. MS\nTreatment:\n•\nPharmacological:\no\nCarbamazepine MR 100mg BD up to 400mg BD (NNT 1.8) – many SEs\n▪\nOxcarbazepine better tolerated\no\nOther Rx: gabapentinoids, amitriptyline, baclofen, phenytoin, topiramate, duloxetine\no\nMotor cortex stimulation\no\nBotox\n•\nSurgical:\no\nPeripheral: laser, EtOH, neurectomy\no\nGasserian ganglion: at foramen ovale under fluoroscopy\n▪\nThermal, mechanical (balloon), chemical\no\nPosterior fossa:\n▪\nMicrovascular decompression (most successful)\n▪\nStereotactic radiosurgery\nDuration of relief:\n•\nPeripheral: 6 – 12 mo\n•\nGanglion balloon compression: 4 – 5 years\n•\nNeurosurgical: up to 10 years", "citations": [{"type": "pdf_page", "page": 294, "label": "p294"}]}
{"chunk_id": "SSUs_v1_p295_txt_00_d1c6fa", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 295, "page_end": 295, "section_path": ["PAIN", "Buprenorphine", "Methadone"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Methadone", "keywords": [], "text": "Methadone\n50 – 120mg / day.\nPre-op:\n•\nSUD\n•\nECG: QTc\n•\nOpioid induced hyperalgesia\n•\nContinue methadone\n•\nREFER: D&A, APS, pharmacy\nIn-hospital:\n•\nNo exact conversion: IV ~0.7x oral dose s/c q6 hr divided doses\n•\nAvoid QTc prolonging drugs\nPost-op:\n•\nDivide daily methadone into TDS dosing as analgesic effect is shorter than withdrawal prevention effect\n•\nAvoid QTc prolonging drugs + APS review", "citations": [{"type": "pdf_page", "page": 295, "label": "p295"}]}
{"chunk_id": "SSUs_v1_p295_txt_01_db9be2", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 295, "page_end": 295, "section_path": ["PAIN", "Buprenorphine", "Buprenorphine"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Buprenorphine", "keywords": [], "text": "Buprenorphine\nPeri-op concerns:\n•\nWithdrawal\n•\nInadequate analgesia\n•\nOverdose and respiratory depression\n•\nRelapse of substance use disorder\n8 – 32mg s/l or s/c injection – ½ life 28 hours\nPre-op:\n•\nScreen for ORT\n•\nDosing / frequency / duration / compliance / extra opioid use\n•\nOther substance\n•\nWithdrawal symptoms\n•\nAssociated comorbidities\n•\nAnticipated degree of pain post-op\n•\nRefer for post op HDU bed\n•\nD/w surgeons minimally invasive technique\nOptimise:\n•\nContinue buprenorphine at same dose\n•\nInvolve D&A + pain specialist\n•\nConsider tapering to 16mg/day if high post-op pain anticipated\nIntra-op / post-op:\n•\nMultimodal analgesia\no\nRegional + consider catheter\no\nKetamine, lignocaine, dexmedetomidine, clonidine, magnesium\no\nNon-pharmacological: ice, position changes, relaxation, peer recovery support, distraction\n•\nIf using opioid use opioid with high affinity:\no\nFentanyl\no\nHydromorphone\no\nSplit / increase dose of bup\nPost-op:\n•\nHDU: pain / resp / withdrawal monitoring\n•\nAPS + D&A\n•\nTransitional analgesia + DC planning → taper to pre-op dose + d/w GP / specialist", "citations": [{"type": "pdf_page", "page": 295, "label": "p295"}]}
{"chunk_id": "SSUs_v1_p296_txt_00_116432", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 296, "page_end": 296, "section_path": ["PAIN", "IV Lignocaine", "Gabapentinoids"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Gabapentinoids", "keywords": [], "text": "Gabapentinoids\nMOA: modulates GABA via alpha-2-delta ligand binding to calcium channels – mechanism poorly understood\nConsiderations:\n•\nHigh NNT\n•\nExtensive side effect profile\n•\nMany studies are poor quality\nBenefits:\n•\nopioid consumption\n•\nPONV\nAdverse effects:\n•\nSedation\n•\nVisual disturbance\n•\nResp depression, OIVI\n•\nAbuse potential\nEvidence of benefit:\n•\nBreast ca surgery, hysterectomy, C-section, spinal, THR/TKR\n•\nChronic: chronic neuropathic pain, fibrolyalgia", "citations": [{"type": "pdf_page", "page": 296, "label": "p296"}]}
{"chunk_id": "SSUs_v1_p296_txt_01_cbdab6", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 296, "page_end": 296, "section_path": ["PAIN", "IV Lignocaine", "IV Lignocaine"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "IV Lignocaine", "keywords": [], "text": "IV Lignocaine\nMOA: binds to voltage gated sodium channels (+ anti-inflammatory, anti-hyperalgesic)\nAdverse effects:\n•\nSedation\n•\nCNS/CVS toxicity\nBenefits:\n•\nAcute pain: small benefit, <1/10 pain score reduction\n•\nileus\n•\nPONV\n•\nopioid requirements\n•\nCPSP\n•\nchronic neuropathic pain\nEvidence of benefit in: bowel resection, mastectomy, prostatectomy, nephrectomy, cystectomy, bariatric", "citations": [{"type": "pdf_page", "page": 296, "label": "p296"}]}
{"chunk_id": "SSUs_v1_p297_txt_00_869af7", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 297, "page_end": 297, "section_path": ["PAIN", "Opioids", "Opioids"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Opioids", "keywords": [], "text": "Opioids\n2019 Australian National Survey on Drug Use & Health:\n9.7M people >12yo misused pain relief in past year\n>50% surveyed were given by, bought from or took from friend/relative\nOnly 35% surveyed received via prescription from one doctor\nOther statistics:\nUS data on opioid-related deaths: 40% from non-prescribed opioids - 70% of those sourced from friend/family on a\nlegitimate Rx\n>10% of patients still using opioids after surgery at 90 days in Australia\nDefinitions:\nMisuse: opioid use contrary to the prescribed pattern of use, regardless of the presence or absence of harm or AEs\nAbuse: intentional use of the opioid for non-medical purpose e.g. euphoria or altering state of consciousness\nAddiction: pattern of continued use with experience of, or demonstrated potential for harm\nChemical coping: the use of opioids to cope with emotional distress → inappropriate and/or excessive opioid use\nIssues with pre-op opioid use:\nOpioid-induced hyperalgesia\nOpioid-induced ventilatory impairment\nOpioid misuse, diversion risk\nPersistent opioid use\nOpioid efficacy:\nAcute pain: effective, up to 70% pain reduction, dose-responsive relationship\nPersistent/chronic pain: less effective, 30% pain reduction\nThere is no quality evidence for opioid use beyond 1y.\nRelevance for anaesthetists:\nNew persistent opioid use post-op ~5%\nIatrogenic opioid dependence or abuse ~5% patient prescribed opioids for pain i.e. surgery is a potential gateway\nPredicted that excess unused opioid occurs in 70% of patients, with only 5% safely disposed\nFactors influencing over- and under-prescription:\nUnder prescription: guidelines, institutional limits, state law, prescriber monitoring, reactionary fear → potential acute +\nchronic pain\nOver prescription: patient satisfaction, minimising prescriber inconvenience → misuse, overuse + unused residual opioid\nOptions for opioid disposal:\nPharmacy return\nFlush down toilet\nLandfill disposal\nBurn\nIf you suspect opioid misuse in a patient assess:\nPain\nIndication + consumption\nHabituation\nExpectation\nEducation", "citations": [{"type": "pdf_page", "page": 297, "label": "p297"}]}
{"chunk_id": "SSUs_v1_p298_txt_00_978d6f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 298, "page_end": 298, "section_path": ["PAIN", "Opioid Stewardship", "Opioid Stewardship"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Opioid Stewardship", "keywords": [], "text": "Opioid Stewardship\nCoordinated interventions designed to improve use of opioids in order to protect human health\nTargets: persistent post-op use, OIVI, opioid misuse and diversion, drug driving\nDischarge opioids:\nEnsure continuation of multi-modals with communicated stop date\nEnsure discharge amount reflects inpatient use in last 24 hours\nConsider prescription of shorter duration i.e. 3 days + GP follow up\nNote: there are prescribing recommendations on OPEN based on type of surgery\nOpioid-free anaesthesia:\nNoble but has limits\nDoes not allow analgesic titration based on patient needs\nIs unclear about optimal components and role in different surgeries/settings\nDo not serve to decrease the risk of persistent opioid use\nCan distract from optimising pain relief and minimising realistic long term harms\nOpioid-free dexmed v remifent trial stopped early due to 5 cases of severe bradycardia/hypoxaemia in dexmed group\nJAMA June 2023: reduced opioid administration during surgery may have unintended outcome of post-op pain + opioid\nconsumption. Improvements in long term outcomes may be achieved by optimising opioid administration during surgery\nOPIOID CRISIS MANAGEMENT\nUpstream\nMidstream\nDownstream\n•\nAbuse deterrent formulations\n•\nIdentifying high risk patients\n•\nUp-scheduling\n•\nReducing pack sizes\n•\nEducation\n•\nPharmacist involvement\n•\npresciptions\n•\nOpioid-sparing analgesia\n•\nOpioid stewardship\n•\nSafe drug disposal\n•\nFollow up\n•\nTransitional clinics\n•\n“Opioid exit plan”", "citations": [{"type": "pdf_page", "page": 298, "label": "p298"}]}
{"chunk_id": "SSUs_v1_p299_txt_00_f6a819", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 299, "page_end": 299, "section_path": ["PAIN", "Opioid-Induced Hyperalgesia", "Opioid-Related Risks"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Opioid-Related Risks", "keywords": [], "text": "Opioid-Related Risks\nDose dependent.\nSide effects:\nResp depression: 1-12%\nExcessive sedation: 5%\nPruritis: 15% (higher with PCA) – opioid antagonists and ondansetron are effective treatments (L1)\nVomiting: 20%\nNausea: 30%\n+/- urinary retention\n+/- constipation (opioid antagonists > laxatives)\nOpioid-sparing / side effects with NSAIDs, gabapentin, pregab, IV lignocaine, ketamine (paracetamol pain scores but not\nopioid use)\nTapentadol similar efficacy to conventional opioids with GI side effects\nRisks:\nOverdose / abuse\nTolerance (highest with morphine)\nFractures\nAMI\nSexual dysfunction\nPeri-op risks: above +\n•\nOIH\n•\nOIVI\n•\nPersistent post-op opioid use\n•\nMisuse / diversion\n•\nPoorer pain control and reduced functional outcome\n•\nInfection / immunosuppression\n•\nEndocrine issues (HPA suppression including adrenal suppression, bone weakness)\nCurrently insufficient evidence to associate opioid use with cancer promotion / spread.\nOpioid-Induced Hyperalgesia\nOIH: state of sensitivity to noxious stimuli occurring after exposure to high dose opioids (usually remifentanil)\nNociceptive sensitisation 2’ opioids → paradoxical response to opioid agonist → increased pain perception\nOIH → pain tolerance to noxious thermal stimuli but not electrical stimuli – pain detection thresholds unchanged\nHigh risk remifentanil use:\nDose duration >1-2 hours\n>20mcg/kg total\nInfusion at >0.1mcg/kg/min\nPlasma [ ] >2.7ng/mL\nDevelopment of remifentanil tolerance/OIH by:\n(L1) Ketamine, magnesium, propofol\n(L2) Pregab, NO2\nRemi is associated with development of chronic pain\nImportant – but nearly impossible – to distinguish from pharmacological tolerance (may require quantitative sensory testing).\nTolerance: analgesia may improve with dose escalation\nOIH: analgesia may improve with dose reduction\nIf patient on opioids sustains new injury:\nReasonable to trial dose increase\nIf worsens or fails to respond – consider OIH\nMust also consider other reasons:\nNeuropathic pain\nMajor psychological stress\nDrug seeking behaviour", "citations": [{"type": "pdf_page", "page": 299, "label": "p299"}]}
{"chunk_id": "SSUs_v1_p300_txt_00_7c83f8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 300, "page_end": 300, "section_path": ["PAIN", "Persistent Post-Discharge Opioid Use"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Persistent Post-Discharge Opioid Use", "keywords": [], "text": "Persistent Post-Discharge Opioid Use\nContinuation of opioids >90 days after surgery\nMinor surgery just as vulnerable as major surgery\nRisk factors:\nPatient-related:\nPsychological comorbidity\nPre-op benzos, anti-depressants\nPre-op tobacco use, EtOH, substance use disorders\nPre-existing chronic pain\nPre-admission opioid use (aim to wean prior to surgery)\nLower age\nFemale\nLow SES\nModifiable – relate to prescribing practices:\nLong-term pre-admission opioid sue\nPsychological comorbidities\nExpectations\nChasing pain scores\nAbnormal trajectories\nOver-reliance on opioids\nUse of MR preparations\nLarge quantity on discharge\nRepeat prescriptions\nLack of deprescribing advice\nMitigating harm:\nAvoidance of modifiable risk factors\nEducation\nCommunication with GP\nReferral to specialist services if needed i.e. chronic pain specialist, psychologist, addiction medicine", "citations": [{"type": "pdf_page", "page": 300, "label": "p300"}]}
{"chunk_id": "SSUs_v1_p301_txt_00_a480a8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 301, "page_end": 301, "section_path": ["PAIN", "Misuse and Diversion"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Misuse and Diversion", "keywords": [], "text": "Opioid-Induced Ventilatory Impairment\nOIVI 2’ three main interlinked mechanisms:\nCentral resp depression\nSedation\nSGA muscle tone → upper airway obstruction\nHighest incidence first 24h post-surgery\nRisk factors:\nPatient: elderly, female, obesity, neuro dz, cardiac dz, pulmonary dz, OSA, high dose opioids\nModifiable: coadministration of sedatives, multiple opioid agents, continuous infusions, long acting opioids (e.g.\nmethadone), multiple prescribers, reliance on unidimensional pain scores, using opioids for non-opioid responsive pain\nRisk is less with atypicals i.e. tramadol, tapenatdol, bup (patches only)\nMonitoring:\nRR limited value; hypoxic episodes can occur with normal RR (no reliable correlation with PaCO2)\nContinuous pulse ox detection of desaturation, continuous capnography is superior\nGreatest correlation between sedation score and PaCO2\nRegular appropriate sedation scores – AVPU and GCS not sensitive enough, do not describe ability to remain awake\nIn adults patient age rather than weight is a better predictor of opioid requirements (although large interpreter variation)\nMost sensitive way to detect opioid-related sedation is sedation score\nMisuse and Diversion\nQuantity prescribed on discharge often far exceeds requirement → risk for patient and others\n>50% of adults who misuse obtain from family & friends\nRequires education about storage\nRisk of misuse and diversion less with atypicals", "citations": [{"type": "pdf_page", "page": 301, "label": "p301"}]}
{"chunk_id": "SSUs_v1_p302_txt_00_cc8b8c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 302, "page_end": 302, "section_path": ["PAIN", "Opioid Tolerant Patient", "Opioid Tolerant Patient"], "specialty_tags": ["PAIN"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Opioid Tolerant Patient", "keywords": [], "text": "Opioid Tolerant Patient\nGoals:\n•\nMDT care\n•\nEffective analgesia\n•\ntolerance and OIH\n•\nPrevent withdrawal\n•\nDC planning\n•\nOutpatient follow up\nPain assessment:\n•\nCurrent treatment, allergies\n•\nPain history\n•\nExpectations\n•\nGoals of care\n•\nSupport systems following DC\n•\nChronic non-cancer pain:\no\nDiagnosis, pain scores, functional status, prognosis, psychospiritual, invasive treatments, medication misuse\nSubstance use disorder:\n•\nSubstitution therapy + dose\n•\nOther drugs: prescribed, diverted, illicit + routes of administration, nicotine, EtOH\n•\nPrescriber + dispenser\n•\nMedical comorbidity: blood borne viruses, cirrhosis, chronic pain\n•\nPsychological comorbidities\nManagement:\n•\nOpioids:\no\ndose requirement\no\nIV PCA, otherwise PO / SL\no\nMaintain >50% baseline dose to prevent withdrawal\n▪\nAvoid antagonists\no\nOpioid rotation: incomplete cross-tolerance - dose by 30 – 50%\no\nConsider HDU for monitoring\no\nAPS\no\nDC planning: reverse analgesia ladder → pre-op regimen\nReduction of tolerance and OIH:\n•\nNMDA-R antagonist: magnesium, ketamine\n•\nOpioid rotation\n•\nAdjuvants", "citations": [{"type": "pdf_page", "page": 302, "label": "p302"}]}
{"chunk_id": "SSUs_v1_p303_txt_00_bec809", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 303, "page_end": 303, "section_path": ["TENS", "Physical Therapy", "Non-Pharmacological Pain Interventions"], "specialty_tags": ["TENS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Non-Pharmacological Pain Interventions", "keywords": [], "text": "Non-Pharmacological Pain Interventions\nOptions:\n•\nPsychological\n•\nTENS\n•\nAcupuncture / acupressure\n•\nPhoto-biomodulation\n•\nPhysical therapy", "citations": [{"type": "pdf_page", "page": 303, "label": "p303"}]}
{"chunk_id": "SSUs_v1_p303_txt_01_76b707", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 303, "page_end": 303, "section_path": ["TENS", "Physical Therapy", "Psychological"], "specialty_tags": ["TENS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Psychological", "keywords": [], "text": "Psychological\nTypes:\n•\nInformation provision\n•\nRelaxation techniques\n•\nAttention strategies (i.e. mindfulness, VR, music)\n•\nCBT\nApplied pre- or post-op\nOften reduce pain score without reduction in opioid use", "citations": [{"type": "pdf_page", "page": 303, "label": "p303"}]}
{"chunk_id": "SSUs_v1_p303_txt_02_6e9843", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 303, "page_end": 303, "section_path": ["TENS", "Physical Therapy", "TENS"], "specialty_tags": ["TENS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "TENS", "keywords": [], "text": "TENS\nEvidence:\n•\nEffective: most major specialties, phantom limb, shingles\n•\nNot effective: ACL repair, Colle’s #, labour", "citations": [{"type": "pdf_page", "page": 303, "label": "p303"}]}
{"chunk_id": "SSUs_v1_p303_txt_03_aad06b", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 303, "page_end": 303, "section_path": ["TENS", "Physical Therapy", "Acupuncture / Acupressure"], "specialty_tags": ["TENS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Acupuncture / Acupressure", "keywords": [], "text": "Acupuncture / Acupressure\nEvidence:\n•\nEffective: most major specialties including spinal + crani\n•\nNot effective: laparoscopic surgery\n•\nPossible benefit in labour", "citations": [{"type": "pdf_page", "page": 303, "label": "p303"}]}
{"chunk_id": "SSUs_v1_p303_txt_04_fae7bd", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 303, "page_end": 303, "section_path": ["TENS", "Physical Therapy", "Photobiomodulation"], "specialty_tags": ["TENS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Photobiomodulation", "keywords": [], "text": "Photobiomodulation\nEvidence:\n•\nEffective: mucositis / stomatitis, maxfax / ENT, tonsillectomy, vascular access, sternotomy\n•\nNot effective: ankle sprain, episiotomy", "citations": [{"type": "pdf_page", "page": 303, "label": "p303"}]}
{"chunk_id": "SSUs_v1_p303_txt_05_b7c750", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 303, "page_end": 303, "section_path": ["TENS", "Physical Therapy", "Physical Therapy"], "specialty_tags": ["TENS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Physical Therapy", "keywords": [], "text": "Physical Therapy\nIncludes:\n•\nActive:\no\nExercise: TKR, period pain, labour (birth ball)\no\nPrehab: THR\no\nRehab: spinal surgery, trauma\n•\nPassive:\no\nMassage\no\nManual therapy\no\nTemperature therapy\n▪\nWarmth: labour\n▪\nCold: cannulation, TKR, ACL", "citations": [{"type": "pdf_page", "page": 303, "label": "p303"}]}
{"chunk_id": "SSUs_v1_p304_txt_00_ada189", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 304, "page_end": 304, "section_path": ["TENS", "Epidural Review", "Acute Pain Services"], "specialty_tags": ["TENS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Acute Pain Services", "keywords": [], "text": "Acute Pain Services\nReasons to establish an acute pain service:\npain relief\nincidence of adverse effects\npost-op morbidity/mortality\nInstitution of analgesic techniques that may reduce persistent pain post-op\nCost-effective patient care\nopioid use on discharge after surgery\nAims of an acute pain service:\nRelieve suffering\npsychological stress response to pain\nPromote functional recovery\nPrevent transition from acute → chronic pain\nPrevent harm from acute opioid side effects\nAvoid prolonged inappropriate use", "citations": [{"type": "pdf_page", "page": 304, "label": "p304"}]}
{"chunk_id": "SSUs_v1_p304_txt_01_011c1a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 304, "page_end": 304, "section_path": ["TENS", "Epidural Review", "Epidural Review"], "specialty_tags": ["TENS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Epidural Review", "keywords": [], "text": "Epidural Review\nBromage score:\n•\n0: free movement\n•\n1: feet + knee flex (just)\n•\n2: feet flex, not knee\n•\n3: unable to move legs\nInvestigating LL weakness in epidural:\n1. Leg weakness → contact APS + switch off\n2. APS aspirate catheter\na. CSF: remove + reassess q30 min + systemic opioids\nb. No CSF: assess q30 mins\ni. Leg strength improved → recommence at lower dose\nii. >2hr lapsed without improvement → investigate for epidural haematoma\nNote: low [ ] TEA should not cause LL motor weakness – LL exam should be normal, low lumbar may occasionally cause LL\nweakness but again low concentrations should not\nNHMRC – How to develop a guideline\nDetermine need + scope: existing guidelines, reason, desired outcomes\nBest evidence: lit review\nMDT input: include allied health\nFlexibility + adaptability\nEconomic impact\nDissemination: make accessible + inform target audience\nEvaluation\nRevision: schedule review", "citations": [{"type": "pdf_page", "page": 304, "label": "p304"}]}
{"chunk_id": "SSUs_v1_p305_txt_00_0f424b", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 305, "page_end": 305, "section_path": ["TENS", "Assessment of Suicidality in Chronic Pain", "Psychosocial Impact on Pain"], "specialty_tags": ["TENS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Psychosocial Impact on Pain", "keywords": [], "text": "Psychosocial Impact on Pain\nImportant points (5):\nPersonal experience influenced by varying degrees of biological, physiological, and social factors\nIndividuals learn concept of ‘pain’ through life experience\nA person’s report of pain should be respected\nPain is meant to be adaptive / protective, but may have adverse effects on function, social and psychological well-being\nVerbal description is only one of several ways to express pain, inability to communicate must be considered and does not\nnegate experience of pain\nEvidence:\nPre-op psychological interventions may be effective at pain, LOS and negative effect (L1)\nMay not be effective after cardiac surgery (L1)\nDistraction and hypnosis needle related pain and distress in children (L1)\nHypnosis may also procedural pain and anxiety, postop pain, anxiety and analgesia consumption in labour (L1)\nMusic produces small pain, analgesic requirements and emotional distress (L1)\nPatient education may pain and anxiety but does not affect analgesic use (L1)\nTraining in coping methods or behavioural instruction prior to surgery pain, negative affect and analgesic use (L1)\nRelaxation techniques pain but does not affect analgesic use (L1)", "citations": [{"type": "pdf_page", "page": 305, "label": "p305"}]}
{"chunk_id": "SSUs_v1_p305_txt_01_b4c4c8", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 305, "page_end": 305, "section_path": ["TENS", "Assessment of Suicidality in Chronic Pain", "Assessment of Suicidality in Chronic Pain"], "specialty_tags": ["TENS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Assessment of Suicidality in Chronic Pain", "keywords": [], "text": "Assessment of Suicidality in Chronic Pain\n2x higher in chronic pain. Up to 14% of chronic pain patients attempt suicide in their lifetime.\nRisk factors:\nPain related:\nIntensity\nSleep disturbance / insomnia\nCatastrophising\nOpioid use\nGeneral suicide risk factors\nProtective factors:\nProblem solving\nCoping skills\nPositive future thinking and relationships\nAccess to support and care\nNo evidence for any questionnaires, must perform assessments\nLook for warning signs – though may not be present (stating want to hurt or kill self, stockpiling, writing or talking about suicide)\nProcess:\nAssess for intent:\nImminent risk: refer to local crisis team / ED (if patient leaves clinic contact police)\nNot at imminent risk but limited barriers: probe, monitor, contact primary care clinician\nNot at imminent risk and barriers: establish safety plan if risk increase\nSafety plan:\nIndividualised barriers\nDistractors\nRestriction of access\nContacts for support", "citations": [{"type": "pdf_page", "page": 305, "label": "p305"}]}
{"chunk_id": "SSUs_v1_p306_txt_00_eb55b0", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 306, "page_end": 306, "section_path": ["INTENSIVE CARE", "Apache II", "SOFA Score"], "specialty_tags": ["INTENSIVE CARE"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "SOFA Score", "keywords": [], "text": "SOFA Score\nShould not influence medical management or assess affect of intervention. Should just be used to determine level of acuity and\nmortality risk. May be used to provide family with prognosis, or for clinical trials.\nVariables (use worst values in last 24 hours):\n•\nP:F ratio\n•\nMechanical ventilation (including CPAP)\n•\nPlatelets\n•\nGCS\n•\nBilirubin\n•\nMAP (including pressor doses)\n•\nCreatinine", "citations": [{"type": "pdf_page", "page": 306, "label": "p306"}]}
{"chunk_id": "SSUs_v1_p306_txt_01_b48692", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 306, "page_end": 306, "section_path": ["INTENSIVE CARE", "Apache II", "Apache II"], "specialty_tags": ["INTENSIVE CARE"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Apache II", "keywords": [], "text": "Apache II\nSeverity of disease score applied within 24 hr of admission. >16yo. Score 0 – 71.\nUses:\n•\nMay restrict certain procedures / medications\n•\nPredicted mortality based on morbidity\nThree major categories:\n•\nAcute physiology score (blood biomarkers, vitals, GCS)\n•\nAge\n•\nChronic health", "citations": [{"type": "pdf_page", "page": 306, "label": "p306"}]}
{"chunk_id": "SSUs_v1_p307_txt_00_910f97", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 307, "page_end": 307, "section_path": ["INTENSIVE CARE", "Sedation in Intensive Care", "Sedation in Intensive Care"], "specialty_tags": ["INTENSIVE CARE"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Sedation in Intensive Care", "keywords": [], "text": "Sedation in Intensive Care\nRAAS Score (Richmond Agitation Sedation Score)\nDexmed: conscious sedation which resembles natural sleep, no resp depression, anxiolysis, analgesia\nEffects: decongestant, anti-sialogue, analgesia, hypotension/bradycardia, diuretic, bowel motility, shivering\nNo clinically significant adrenal suppression (despite being an imidazole)\nICU uses:\n•\nAnalgesia\n•\nAnxiolysis\n•\nBridge to extubation\n•\nRisk of delirium\n•\nTolerance of NIV\nPeri-op use:\n•\nSedative pre-med\n•\nAnalgesia\n•\nSympatholysis\n•\nAFOI\n•\nRA adjuncts", "citations": [{"type": "pdf_page", "page": 307, "label": "p307"}]}
{"chunk_id": "SSUs_v1_p308_txt_00_3c3c70", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 308, "page_end": 308, "section_path": ["INTENSIVE CARE", "Blood Management in Intensive Care", "Blood Management in Intensive Care"], "specialty_tags": ["INTENSIVE CARE"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Blood Management in Intensive Care", "keywords": [], "text": "Blood Management in Intensive Care\nPatient blood management aims:\n•\nOptimise blood volume and red cell mass\n•\nblood loss\n•\nOptimise tolerance of anaemia\nRecommendations:\n•\nCritical ill – restrictive transfusion strategy should be employed\n•\nPacked cells:\no\nHb alone should not be trigger, look at clinical status\no\nSingle unit → reassess\no\nHb\n▪\n<70: transfusion likely appropriate\n▪\n70-90: no mortality benefit – indication should be clinical\n▪\n>90: transfusion generally unnecessary\no\nACS Hb:\n▪\n<80: transfusion associated with mortality\n▪\n80-100: effect of transfusion on mortality is uncertain; may be associated with risk MI\n▪\n>100: transfusion associated with mortality\no\nRisks: infection, VAP, ARDS/ALI\n•\nEPO:\no\nCritically ill anaemia: does not transfusion cf restrictive, may VTE\no\nTrauma: possible mortality, no effect on transfusion\no\nUse of iron in both groups uncertain\n•\nFFP:\no\nIdentify cause of coagulopathy\no\nRisk of ARDS, ALI – must consider\no\nINR <2 can generally undergo procedures without serious bleeding risk\n•\nCryo / fibrinogen:\no\nIdentify cause of coagulopathy\no\nRisks uncertain\n•\nPlatelets:\no\nIf not bleeding, transfusion may be appropriate in plt <20\no\nPlt >50 can generally undergo procedures in ICU without significant bleeding\no\nRisks / reactions uncertain\n•\nTXA:\no\nTrauma: within 3hr mortality, acutely bleeding no effect on transfusion,\no\nUGIB: critically ill can consider\n•\nCell salvage:\no\nTrauma: no effect on mortality, transfusion\no\nRuptured AAA: effect on mortality uncertain, may transfusion – reasonable to consider use", "citations": [{"type": "pdf_page", "page": 308, "label": "p308"}]}
{"chunk_id": "SSUs_v1_p309_txt_00_0a6daf", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 309, "page_end": 309, "section_path": ["INTENSIVE CARE", "Parenteral Nutrition", "Nutrition"], "specialty_tags": ["INTENSIVE CARE"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Nutrition", "keywords": [], "text": "Nutrition\nIn critically unwell catabolism > anabolism\nEffect on outcomes:\n•\nEnteral feeding\no\ninfection (gut immune function, anti-inflammatory) esp cf parenteral\no\nBorderline significant mortality\no\nEarly better than late initiation\no\nStrengthens GI anastomosis\n•\nParenteral feeding\no\nEarly: no mortality benefit, possible infection risk\nIndications:\n•\nEnteral: unless CI\n•\nParenteral: after 1 -2 weeks", "citations": [{"type": "pdf_page", "page": 309, "label": "p309"}]}
{"chunk_id": "SSUs_v1_p309_txt_01_96222e", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 309, "page_end": 309, "section_path": ["INTENSIVE CARE", "Parenteral Nutrition", "Enteral Nutrition"], "specialty_tags": ["INTENSIVE CARE"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Enteral Nutrition", "keywords": [], "text": "Enteral Nutrition\nComplications:\n•\nAspiration\n•\nDiarrhoea\n•\nMetabolic abnormalities\n•\nMechanical complications: catheter related, constipation\nCI:\n•\nRisk of bowel ischaemia: HD unstable, not adequately resuscitated\n•\nNon-functioning gut: bowel obstruction, ileus, upper GI bleed, vomiting / diarrhoea, GI ischaemia, high output fistula", "citations": [{"type": "pdf_page", "page": 309, "label": "p309"}]}
{"chunk_id": "SSUs_v1_p309_txt_02_3aebaa", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 309, "page_end": 309, "section_path": ["INTENSIVE CARE", "Parenteral Nutrition", "Parenteral Nutrition"], "specialty_tags": ["INTENSIVE CARE"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Parenteral Nutrition", "keywords": [], "text": "Parenteral Nutrition\nComplications:\n•\nBloodstream infection\n•\nMetabolic abnormalities: hyperglycaemia, electrolyte abnormalities, nutrient excess / deficiency, refeeding syndrome,\nwernicke’s encephalopathy, hepatic dysfunction\n•\nVenous central access complications\nCI:\n•\nHyperosmolality, severe hyperglycaemia\n•\nSevere electrolyte disturbance\n•\nVolume overload\n•\nInadequate IV access\n•\nInadequate attempt to feed enterally\n•\nSepsis / SIRS\n•\nShort illness + recovery expected\nRequirements:\n•\nDietician involvement\n•\nCalories:\no\nLow calorie > high calorie feeding – most are 1kCal/mL\n▪\nStart 8 – 10kCal/kg/day\n▪\nGoal: 25kCal/kg/day i.e. 1mL/kg/hour\n•\nProtein:\no\nMild illness: 1g/kg/day\no\nSevere illness: 1.5g/kg/day\no\nBurns: 2g/kg/day\n•\nCarbohydrates: min 2g/kg/day\n•\nLipids: 1g/kg/day\no\nOmega-6 i.e. linoleic acid ~10g/day\no\nOmega-3 i.e. a-linoleic acid ~2g/day\n•\nRatio: carbs:fat 70:30", "citations": [{"type": "pdf_page", "page": 309, "label": "p309"}]}
{"chunk_id": "SSUs_v1_p310_txt_00_ae1cf1", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 310, "page_end": 310, "section_path": ["INTENSIVE CARE", "Sepsis", "Sepsis"], "specialty_tags": ["INTENSIVE CARE"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Sepsis", "keywords": [], "text": "Sepsis\nSIRS criteria - ≥2 of:\n•\nT <36 or >38\n•\nHR >90bpm\n•\nRR > 20 or PaCO2 <32mmHg\n•\nLeuks <4000 or >10,000 or >10% immature forms\nSepsis: life-threatening organ dysfunction caused by a dysregulated host response to infection (i.e. SIRS + infection)\n•\nOrgan dysfunction: SOFA score ≥2 (mortality risk 10%)\nSeptic shock: profound circulatory, cellular, and metabolic abnormalities\nPressors to maintain MAP >65 or\nLactate >2 (in absence of hypovolaemia)\nQuick SOFA Score\nFor use outside of the ICU. Does not require lab results – clinical. Quickly identifies patients at risk of dying from sepsis at the\nbeside. Greater than or equal to 2 of:\n•\nsBP <100\n•\nGCS <15\n•\nRR >22\nShould prompt immediate investigation\nSurviving Sepsis Guidelines 2021:\n•\nUse sepsis screening tools\n•\nRecommends against using qSOFA cf SIRS, NEWS or MEWS as single screening tools\na. qSOFA predicts mortality and ICU stay (+ve if 2 out of 3 of RR >22, GCS <15, sBP <100)\nb. qSOFA and SIRS yield different results – must know limitations\n•\nMeasure lactate: lactate if elevated\n•\nImmediate resuscitation and management\n•\nHypoperfusion or septic shock:\na. 30mL/kg of crystalloid in first 3hr (balanced crystalloid > normal saline)\ni. Albumin if large volumes of crystalloid used (advise against starches, gelatin)\nii. Insufficient evidence for liberal or restrictive fluid strategy in first 24hr\nb. MAP 65\nc.\nHaemodynamic measurement > physical examination or static parameters\nd. Use cap refill to guide resuscitation as adjunct to other measures\ne. Admit to ICU within 6hr\nf.\nHigh\n•\nIf unconfirmed infection – continuously re-evaluate for other cause\n•\nAntibiotics\na. Septic shock + high likelihood of infection → immediate antibiotics (within 1hr of recognition)\nb. Sepsis without shock: rapid evaluation – if concern for infection persists administer antibiotics within 3hr\nc.\nLow likelihood of infection – do not administer antibiotics\nd. Advise against using procalcitonin to decide on commencing antimicrobials\ni. If optimal duration of antibiotic therapy is unclear procalcitonin can be used in conjunction with\nclinical evaluation to decide on appropriate discontinuation (over clinical evaluation alone)\ne. Known or high risk MRSA use empiric + MRSA coverage (low risk don’t cover for MRSA)\nf.\nHigh risk of MDR suggest two antimicrobials with gram -ve coverage (low risk use one agent)\ng.\nHigh risk of fungal infection administer empiric fungal therapy (low risk don’t cover for fungal infection)\nh. No recommendation on use of antivirals\ni.\nFor sepsis or septic shock suggest prolonged infusion of beta-lactam after initial bolus > further boluses\nj.\nDaily assessment and de-escalation\n•\nSource control:\no\nRecommend identifying any infection that requires source control\no\nPrompt removal of IV access if possible source\n▪\nMidline < pIVC < PICC < tunnelled CVC < art line < CVC < PAC\n•\nPressors: start peripherally if no CVC\no\n1st line: norad\no\nIf norad inadequate add vasopressin (advise against terlipressin)\no\nCardiac dysfunction despite above consider: norad + dobutamine or adrenaline alone\n▪\nAdvise against levosimenden", "citations": [{"type": "pdf_page", "page": 310, "label": "p310"}]}
{"chunk_id": "SSUs_v1_p311_txt_00_d05714", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 311, "page_end": 311, "section_path": ["INTENSIVE CARE", "Sepsis"], "specialty_tags": ["INTENSIVE CARE"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Sepsis", "keywords": [], "text": "o\nIf ongoing pressors required give IV corticosteroids\n•\nArterial line insertion\n•\nVentilation:\na. No recommendation on restrictive FiO2 if hypoxaemic\nb. HFNP > NIV\nc.\nNo recommendation for NIV v ETT (patient dependent)\n•\nARDS: ARDSnet lung protective ventilation\n•\nRecommendations against:\na. Polymyxin B haemoperfusion\nb. IVIg\nc.\nVitamin C\nd. Sodium bicarb\ni. Only if shock + pH <7.2 + AKI\n•\nRecommendations for:\na. Stress ulcer prophylaxis\nb. Pharmacological DVT prophylaxis unless CI (LMWH > unfractionated heparin)\ni. Recommend against pharmacological + mechanical\nc.\nCRRT > IHD\nd. Initiating insulin therapy at BSL >10mM\ne. Enteral nutrition if not CI\nf.\nEarly discussion re: goals of care with family <72hr\ng.\nIntegration of palliative care principles where appropriate to address suffering + formal palliative care consult\nh. Screen families for economic and social support\ni.\nWritten education for families + integration into shared decision making\nj.\nSurvivors →\ni. Referral to peer support groups\nii. Comprehensive discharge information\niii. Support + follow up for impairments\niv. Follow up for physical, cognitive and emotional issues post discharge\nv. Rehabilitation if ventilated for >48hr or in ICU for >72hr", "citations": [{"type": "pdf_page", "page": 311, "label": "p311"}]}
{"chunk_id": "SSUs_v1_p312_txt_00_dc16ad", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 312, "page_end": 312, "section_path": ["INTENSIVE CARE", "Shock", "Shock"], "specialty_tags": ["INTENSIVE CARE", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Shock", "keywords": [], "text": "Shock\nState of cellular / tissue hypoxia due to either:\n•\nO2 delivery\n•\nO2 consumption\n•\nInadequate O2 utilisation\n•\nOr combination of above\nEpidemiology:\n•\nHypovolaemic\n36%\n•\nSeptic\n33%\n•\nCardiogenic\n29%\n•\nOther\n2%\nCauses:\n•\nDistributive: septic versus non-septic\n•\nCardiogenic: cardiomyopathic, arrhythmia, mechanical\n•\nHypovolaemic: haemorrhagic versus non-haemorrhagic\n•\nObstructive: pulmonary vascular, mechanical (eg tension, tamponade, abdominal compartment syndrome, aortocaval\ncompression)\n•\nOther:\no\nEndocrine: adrenal insufficiency, thyrotoxicosis\no\nMetabolic: severe acidosis, hypothermia\nVariable +\nMeasurement\nPreload\nPCWP\nPump Function\nCO / CI\nAfterload\nSVR\nTissue Perfusion\nSVO2\nHypovolaemic\n\n\n\n<65%\nCardiogenic\n\n\n\n>65%\nDistributive\n\n or \n\n>65%\nObstructive\n\n\n\n>65%\nTamponade\n\n\n\n<65%\nCellular\n-\n-\n-\n>65%\nStages:\n•\nCompensated (pre-shock)\n•\nDecompensated (shock) – evidence of organ dysfunction\n•\nProgressive / irreversible: organ damage, multiorgan failure, death", "citations": [{"type": "pdf_page", "page": 312, "label": "p312"}]}
{"chunk_id": "SSUs_v1_p313_txt_00_b52766", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 313, "page_end": 313, "section_path": ["INTENSIVE CARE", "Cardiogenic Shock", "Cardiogenic Shock"], "specialty_tags": ["INTENSIVE CARE", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Cardiogenic Shock", "keywords": [], "text": "Cardiogenic Shock\nDefinition:\n•\nCI <2.2\n•\nPCWP >15mmHg (LV)\n•\nCVP > 10mmHg (RV)\n•\nCVO2 <65%\n•\nSVR\nMechanism:\n•\nLV failure: large infarct (≥40% of LV), small infarct + pre-existing dysfunction, infarct extension, re-infarction\n•\nMechanical complication: acute MR (papillary rupture or dysfunction), VSD, LV free wall rupture, pericardial tamponade\n•\nRV infarction\nIx:\n•\nFull bloods + trops\n•\n12-lead ECG\n•\nTTE +/- TOE\n•\nCXR +/- angiogram\nManagement:\n•\nA/B: may require NIV for pulmonary oedema + LV afterload +/- intubation\n•\nC:\no\nResuscitation: treat hypo / hypervolaemia\no\nBlood pressure support: norad, vasopressin\no\nAfterload reduction if not hypotensive: GTN, SNiP\no\nInotrope: dobutamine, adrenaline, milrinone, levosimendan\no\nMechanical support: IABP, ECMO\no\nMonitoring: PiCCO line, PAC, arterial line, CVP\no\nMI: DAPT load\no\nRevascularisation: PCI, CAGS, thrombolysis", "citations": [{"type": "pdf_page", "page": 313, "label": "p313"}]}
{"chunk_id": "SSUs_v1_p314_txt_00_cd8503", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 314, "page_end": 314, "section_path": ["INTENSIVE CARE", "Cardiac Output Monitoring"], "specialty_tags": ["INTENSIVE CARE"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Cardiac Output Monitoring", "keywords": [], "text": "Cardiac Output Monitoring\nCardiac output: volume of blood ejected from heart per unit time (flow cf pressure, usually L/min) – normal value ~5L/min\nThermodilution is via right heart catheterisation is currently the gold standard method\nPA catheter (PAC):\n•\nInserted in IJ or subclavian veins → floated through RA → RV → PA\n•\nProximal lumen ideally opens in RA– monitors CVP or used to administer injectate\n•\nAnother lumen contains 2x insulated wires → thermistor ~3.7cm from catheter tip (proximally connected to CO\nprocessor)\nMechanism:\n•\nDistal balloon filled with 1.5mL – catheter ‘sails’\n•\nDistal lumen attached to pressure transducer – monitors waveforms as PAC advanced\n•\nMean pressure of 4-12mmHg indicates PCWP (surrogate for LA filling pressure) → balloon deflated and catheter floats\nback into PA\n•\n10mL of cold normal saline (injectate) administered in proximal lumen → temperature-time curve as detected by\nthermistor → calculation of CO (usually mean of three readings taken)\no\n↑CO → quicker “washout” of cold fluid\nModification of indicator dilution technique, instead of dye, cold fluid with known temp and heat capacity known.\nMathematical derivation:\n•\nSingle compartment model (the heart) ∴ clearance = dose / AUC\no\nDose = heat from indictor\no\nAUC = area under temp-time curve\n∴ CO = clearance = volume x (Tinjectate – Tblood) / area under temp-time curve (Stewart Hamilton equation for thermodilution)\nSources of Error\n•\nMeasurement: thermistor, dead-space of line, calculation errors\n•\nAssumptions:\no\nInjectate and blood have same density and heat capacity\no\nThermal equilibrium established by time mixture reaches thermistor\no\nInjectate is warmed by blood (not true in low flow states, also warmed by wall of vessels / myocardium)\no\nUnidirectional flow of blood (untrue in TR)\no\nCold injectate doesn’t depress CO (may transiently)\nAdvantages\n•\nEasy to repeat\n•\nNo blood sampling\n•\nNo toxic dye\n•\nNo recirculation error (cf dye-dilution, lithium)\nDisadvantages\n•\nInvasive – risks associated with PAC insertion\n•\nCold fluid can cause cardiac depression, arrhythmias\n•\nFluid load (though small)", "citations": [{"type": "pdf_page", "page": 314, "label": "p314"}]}
{"chunk_id": "SSUs_v1_p315_txt_00_ab1321", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 315, "page_end": 315, "section_path": ["HFNP", "HFNP"], "specialty_tags": ["HFNP"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "HFNP", "keywords": [], "text": "HFNP\nTriad:\n•\nHumidification\n•\nHigh FiO2\n•\nImproved compliance\nFeatures & effects:\n•\nWarmed humidified gas:\no\nReduced airway surface dehydration\no\nImproved secretion clearance\n•\nGas flow up to 60L/min\no\nCO2 washout, anatomical dead space\no\nO2 reservoir\no\nAllows FiO2 close to 1.0 to be delivered\n•\nProvides PEEP (variable, relies on closed mouth breathing)\no\nend expiratory lung volume\no\nAlveolar recruitment\nIndications:\n•\nAcute hypoxic respiratory failure\no\nFLORALI:\n▪\nHFNP can intubation rates in non-cardiogenic ARF with P:F ratio <200 (no difference >200)\n▪\nmortality (ICU and 90 days)\no\nParticular benefits: pts with high secretions, cardiogenic pulmonary oedema\n•\nApnoeic oxygenation\n•\nPost-op hypoxaemia (2’ derecruitment, atelectasis, altered mechanics from pain)\nOther potential benefits: ICU bronch, palliative care\nTips:\n•\nStart lower flows (25L/min) and 31°C for the first 15 min → improves patient compliance\n•\nTitrate temp to 34-37°C in first half an hour to maximise therapeutic benefit\nCI:\n•\nSevere type 1 or type 2 resp failure requiring mechanical ventilation\n•\nCI to PEEP\n•\nEpistaxis\n•\nFacial injury\n•\nAirway obstruction", "citations": [{"type": "pdf_page", "page": 315, "label": "p315"}]}
{"chunk_id": "SSUs_v1_p316_txt_00_926353", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 316, "page_end": 316, "section_path": ["ARDS", "ARDS"], "specialty_tags": ["ARDS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "ARDS", "keywords": [], "text": "ARDS\nAcute, diffuse, inflammatory lung injury leading to increased pulmonary vascular permeability, lung weight and loss of aerated\ntissue\nDiagnostic criteria – Berlin criteria:\n•\nAcute (triggering insult within 7 days)\n•\nBilateral process (opacity on CXR not due to lung collapse, effusion or nodules)\n•\nHypoxaemia with PEEP ≥5cmH2O\no\nMild: PaO2:FiO2 ≤300 mmHg\no\nMod: PaO2:FiO2 ≤200 mmHg\no\nSevere: PaO2:FiO2 <100 mmHg\n•\nNot caused by cardiac pathology (no obvious cause on echo)\nStages:\n•\nExudative: 0-7 days\n•\nProliferative: 7-14 days\n•\nFibrotic: 14+ days\nRisk & progression\nMild\nModerate\nSevere\n%\n30%\n45%\n25%\nRisk of progression\n25%\n12.5%\nN/A\nICU mortality\n30%\n35%\n45%\nHospital mortality\nICU mortality + 5%\nSurviving Sepsis Ventilation Guidelines for ARDS + sepsis:\n•\nVt 6mL/kg IBW\n•\nPlateau pressure <30cmH2O: barotrauma → pneumomediastinum, PTx, pneumopericardium, pulmonary interstitial\nemphysema, systemic air embolism\n•\nHigher PEEP > lower PEEP: PEEP atelectotrauma → alveolar collapse, recruitment, shifts fluid into interstitium,\nTLV/FRC, shunt, improved V:Q matching\no\nUse ARDSNET tables\no\nEffect of PEEP on ICP is minimal (difference in ICP with PEEP 0 → 25cmH2O is <5mmHg\no\nBeware of paradoxical hypoxia due to creation of ‘West Zone 1’ with high PEEP\n•\nTraditional recruitment manoeuvres (recommend against incremental PEEP titration / strategy)\n•\nMod – severe ARDS prone for 12 hours daily\n•\nIntermittent NMBA > continuous infusion\n•\nVV ECMO when conventional mechanical ventilation fails\nOxygenation:\n•\nMean airway pressure can be  by i-time (same peak pressure)\n•\nMay CO2 clearance +/- gas trap\nPermissive hypercapnia:\n•\nPotential harms of ventilating to paCO2 may outweigh permissive hypercapnia\n•\nARDSNET aim was pH >7.3 but even with significant hypercapnia (respiratory acidosis pH 7.2) patients still had better\nmortality outcome than traditional ventilation group (unless hypercapnia harmful for other reasons i.e. raised ICP)\n•\nMax RR 35, if pH <7.1 Vt by 1mL/kg\nParalysis:\n•\nPros: MRO2 → acidosis, spont breathing (desynchrony, volutrauma), chest wall compliance\n•\nCons: critical illness myopathy, longer vent wean, pressure injuries, awareness/PTSD, DVT/PE\nPositioning:\n•\nSupine: 45 degrees head up → lower leads to more VAP, higher leads to worse pressure injuries\n•\nProne (relieves weight of mediastinum + improves V:Q mismatch): NNT 6, fewer cardiac arrests, though risk pressure\ninjury and airway pressures\no\nEffect of PEEP in prone dependent on patient pathology – may recruit or may worsening V:Q mismatch\nSeverity: P:F ratio\n•\nMild:\n200 – 300\n•\nMod:\n100 – 200\n•\nSevere: <100", "citations": [{"type": "pdf_page", "page": 316, "label": "p316"}]}
{"chunk_id": "SSUs_v1_p317_txt_00_142fa2", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 317, "page_end": 317, "section_path": ["ARDS"], "specialty_tags": ["ARDS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "ARDS", "keywords": [], "text": "ARDS management:\n•\nTreat underlying cause\n•\nEmpiric antibiotics covering bacterial pneumonia\n•\nVentilation per above\n•\nNeuromuscular blockade:\no\nACURASYS: 24 – 48hr of continuous cisatracurium in mod-severe ARDS has significant 90-day mortality benefit\n•\nEnteral feeding if possible\n•\nDVT prophylaxis\n•\nStress ulcer prophylaxis\n•\nGlucocorticoids\n•\nRestrictive fluid therapy\n•\nRescue therapy:\no\nProne: PROSEVA 16hr / day → improved all-cause mortality at 28 days\no\nRecruitment\no\nInhaled vasodilators\no\nECMO\nEOLIA: severe ARDS early initiation of VV-ECMO (<D7) showed no statistical difference in mortality cf conventional ventilation at\nday 60\n•\nECMO group:\no\nLess treatment failure\no\nrisk CRRT\no\nMore severe thrombocytopaenia\no\nMore bleeding events\no\nLess ischaemic stroke\nVent strategy for VV ECMO to aid lung recovery: RR, Vt (<4mL/kg), low FiO2, Pplat, long I time, PEEP 5 - 15\nAPRV:\n•\nPressure control mode of ventilation – almost continuous positive pressure, short releases at lower pressure\no\nP high: plateau pressure <30cmH2O\no\nP low: 0cmH2O\no\nT high: 5s (recruits slow time constant areas)\no\nT-low: 0.5s → check low enough to terminate at 75% of peak exp flow during pressure release breath – if too\nlow reduce the time\n•\nLonger I time → mean airway pressure → oxygenation\no\nMaximises recruitment\n•\nBrief releases clear Co2: tolerate\nhypercapnoea (pH >7.25)\n•\nSpontaneous breathing on top is encouraged\n(stop paralysis, wean sedation)\n•\nConsiderations:\no\nCVS effects of intrathoracic pressure\no\nRaised ICP relative CI\n•\nNot a substitute for prone positioning (for\nwhich there is robust evidence in severe ARDS)\n– can be instituted in addition\nAdvantages of APRV:\n•\nImproved O2 at lower airway pressures\n•\nImproved V:Q matching\n•\nReduced sedation; enables spont venting\n•\nReduced haemodynamic compromise", "citations": [{"type": "pdf_page", "page": 317, "label": "p317"}]}
{"chunk_id": "SSUs_v1_p318_txt_00_f95423", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 318, "page_end": 318, "section_path": ["ARDS", "Severe Asthma", "Severe Asthma"], "specialty_tags": ["ARDS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Severe Asthma", "keywords": [], "text": "Severe Asthma\nPathophysiology:\n•\nairflow resistance 2’ bronchial SM constriction, mucosal oedema / inflammation, mucous plugging\n•\nintrathoracic pressure → WOB, preload, afterload\n•\nDepletion of endogenous catecholamines\n•\nDehydration\nManagement:\n•\nSupplemental O2 as required\n•\nTreat underlying cause / trigger\n•\nBronchodilator therapy:\no\nSalbutamol inhaled\no\nInhaled muscarinic antagonist\no\nMagnesium sulfate 2g over 20 mins\n•\nGlucocorticoids:\no\nPrednisone\no\nHydrocortisone\n•\nRescue:\no\nVolatile anaesthetics\no\nKetamine\no\nIV beta agonists: salbutamol, adrenaline, terbutaline\no\nHeliox\n•\nBiPAP for WOB as bridge to intubation\n•\nECMO if unable to ventilate / oxygenate\nVentilation strategy:\n•\nInduction agent: ketamine + rocuronium\n•\nMost experienced airway operator\n•\nPre-oxygenation\n•\nInduce upright, supine once unconscious\n•\nLargest possible diameter ETT\n•\nIndication: impending respiratory arrest, 3-5% of presentations require intubation\nVentilation:\n•\nRR 10-12\n•\nVt 6-8mL/kg\n•\nI:E at least 1:3\n•\nPEEP <80% iPEEP, target iPEEP <10cmH2O\n•\nFiO2 titrated to PaO2 >60mmHg\n•\nMode SIMV\n•\nPermissive hypercapnoea\n•\nInspiratory flow 60L/min\n•\nMeasure pPlat, target <30cmH2O\nTrouble-shooting:\n•\nHigh peak airway pressures: important to do plateau pressure as most pressure is used to overcome upper airway\nobstruction\n•\nDesynchrony: ineffective triggering, cough, low inspiratory flow rate, inadequate sedation – consider paralysis\n•\nDynamic hyperinflation: CV collapse, barotrauma, WOB → temporarily disconnect ventilator\n•\nPneumothorax\nTry:\n•\ntidal volume → I time and E time\n•\nRR → E time\n•\nOptimise trigger sensitivity\n•\ninspiratory flow rate → I time and E time", "citations": [{"type": "pdf_page", "page": 318, "label": "p318"}]}
{"chunk_id": "SSUs_v1_p319_txt_00_e6c61a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 319, "page_end": 319, "section_path": ["ARDS", "Pulmonary Embolism", "Pulmonary Embolism"], "specialty_tags": ["ARDS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Pulmonary Embolism", "keywords": [], "text": "Pulmonary Embolism\nClassification:\n•\nHigh risk (massive): with haemodynamic instability\n•\nIntermediate risk (sub-massive): evidence of RV strain\no\nIntermediate-high: trop rise\no\nIntermediate-low: no trop rise\n•\nLow risk: no evidence of RV strain\nPathophysiology:\n•\nInfarction\n•\nVQ mismatch\n•\nPVR\nRisk stratification: Well’s score\nIx:\n•\nImaging: CT-PA, lower limb dopplers\n•\nECG\n•\nTTE if concerns for RV strain\n•\nBloods: FBC, ABG, trop\n•\nStratify risk of bleeding\nTreatment:\n•\nRespiratory support\n•\nCVS support including mechanical (i.e. ECMO)\n•\nAnticoagulation\no\nThrombolysis in high risk\no\nUFH or clexane\no\nTransition to PO anticoagulation\nIf anticoagulation CI:\n•\nCatheter directed thrombolysis\n•\nEmbolectomy\n•\nIVC filter", "citations": [{"type": "pdf_page", "page": 319, "label": "p319"}]}
{"chunk_id": "SSUs_v1_p320_txt_00_06f49c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 320, "page_end": 320, "section_path": ["ARDS", "VAP", "VAP"], "specialty_tags": ["ARDS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "VAP", "keywords": [], "text": "VAP\nDefinition:\n•\nMechanical ventilation ≥48 hours\n•\nNew or progressive infiltrate\n•\nSSx infection\n•\n+ve resp specimens (neutrophils or positive growth)\nFeatures:\n•\nClinical: fever, tachypnoea, sputum production, haemoptysis, rhonchi / crackles, reduced breath sounds,\nbronchospasm\n•\nVentilator: Vt, airway pressures (i.e. compliance)\n•\nIx: PaO2, A-a gradient, WCC\n•\nImaging: new/progressive infiltrate\n•\nResp tract cultures: suction, mini-BAL, BAL\n•\nBlood culture\nCommon pathogens:\n•\nStaph aureus, Pseudomonas, Gram -ve bacilli, Enterobacter\nRisk factors: mechanical ventilation, age, chronic lung disease, aspiration, surgery, gastric pH (PPI, H2Ra), antibiotic exposure,\nARDS, ventilator circuit changes, trauma, paralysis, glucocorticoids, ICP monitor, malnutrition, renal failure\nPrevention:\n•\nNIV > intubation\n•\nMinimise transport of ventilated patient\n•\nEarly weaning / extubation\n•\nMinimise sedation / paralysis\n•\nElevate head of bed 30-45 degrees\n•\nMaintain circuit\n•\nPhysiotherapy\n•\nSuction around cuff\n•\nMaintain cuff pressure 20-30cmH2O\nTreatment:\n•\nObtain cultures before antibiotics if possible\n•\nTazocin / cefepime for 7 days – involve ID\n•\nMRSA – vancomycin\n•\nGram -ve resistance: gentamicin", "citations": [{"type": "pdf_page", "page": 320, "label": "p320"}]}
{"chunk_id": "SSUs_v1_p321_txt_00_37b3cd", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 321, "page_end": 321, "section_path": ["ARDS", "Bronchoscopy in ICU", "Bronchoscopy in ICU"], "specialty_tags": ["ARDS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Bronchoscopy in ICU", "keywords": [], "text": "Bronchoscopy in ICU\nTypes:\n•\nRigid: useful for massive haemoptysis, removal of large foreign body, dilatation, stents\n•\nFlexible\nIndications for flexible bronch:\n•\nAspiration: bronch with lavage rarely helpful, but may help if large particulate matter\n•\nInfection\no\nBAL:\n▪\nNo evidence over something less invasive i.e. blind catheter brushings\n▪\nPCP: gold standard\n•\nLobar collapse: local directed suctioning + saline / mucolytics (e.g. NAC)\n•\nAssessment of airway e.g. injury\n•\nAid in techniques for OLV\n•\nHaemorrhage (diagnosis, management)\nCI:\n•\nInexperienced personnel\n•\nInadequate facilities, equipment\n•\nInability to oxygenate and ventilate the patient\nOptimise as much as able prior\nComplications: safe, mortality 0.01%\n•\nECG changes\n•\n5% mortality within 30 days of MI\n•\nRaised ICP\nProcedure:\n•\nETT: >2mm diameter than bronch\n•\nAspirate NG / fasting\n•\nSedation\n•\nFiO2 100%\n•\nVolume target, pressure-limiting mode\n•\nAdequate sterilisation / decontamination of bronch\n•\nBAL: 60 – 180mL normal saline + suctioned\n•\nBrushings: cytological diagnosis – malignancy, infection\n•\nBiopsy: rarely done in ICU", "citations": [{"type": "pdf_page", "page": 321, "label": "p321"}]}
{"chunk_id": "SSUs_v1_p322_txt_00_8c2771", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 322, "page_end": 322, "section_path": ["ARDS", "Tracheostomy", "Tracheostomy"], "specialty_tags": ["ARDS", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Tracheostomy", "keywords": [], "text": "Tracheostomy\nIndications:\n•\nAcute respiratory failure with prolonged mechanical ventilation ≥7 days and expected to make a meaningful recovery\no\nFacilitates weaning of ventilator and sedation\n•\nUpper airway obstruction\n•\nAirway protection i.e. post-op, neuromuscular disease\n•\nNeed for more effective pulmonary hygiene\nCI:\n•\nUnstable C-spine (need to extend neck)\n•\nUncontrolled coagulopathy\n•\nInfection @ insertion site\n•\nDifficult anatomy\n•\nUnable to withstand period of apnoea\nTechnique:\n•\nOpen\n•\nPercutaneous\nLocation: between 2nd and 3rd tracheal rings\nProcedure:\n•\nExtend neck\n•\nParalyse and sedate\n•\nBronchoscopic vision of trachea\n•\nDeflate ETT cuff and withdraw under vision\n•\nInsert needle into trachea under bronch vision\n•\nGuidewire / Seldinger\n•\nDilate\n•\nInsert trache tube\n•\nRemove sheath, wire and trocar\n•\nInflate trache cuff\n•\nConnect to trache circuit\n•\nConfirm with capnography + bronchoscope\n•\nSecure trache\n•\nRemove ETT\nPost-procedure care:\n•\nDo not change until ≥7 days after\n•\nCuff pressure 20-30cmH2O\n•\nInner cannula cleaned and replaced q4 hourly\n•\nDressing change q24 hours\n•\nChange Velcro ties every 7 days\n•\nPRN suctioning: replace fenestrated with non-fenestrated inner cannula prior to suctioning (can cause severe tracheal\ndamage)\nComplications:\n•\nEarly: bleeding, obstruction, dislodgement, subcut emphysema / pneumothorax\n•\nLate: trachea-inominate fistula, trachea-oesophageal fistula, tracheal stenosis, phonation\nDe-cannulation:\n•\nIndications: weaned from MV, no upper airway obstruction, ability to clear secretions, effective cough\n•\nTechnique: progressive decrease in size, cuff deflation trials until tolerating 24 – 48 hours", "citations": [{"type": "pdf_page", "page": 322, "label": "p322"}]}
{"chunk_id": "SSUs_v1_p323_txt_00_d6781f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 323, "page_end": 323, "section_path": ["ARDS", "Tracheostomy Emergency"], "specialty_tags": ["ARDS", "crisis", "airway"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Tracheostomy Emergency", "keywords": [], "text": "Tracheostomy Emergency\nIssues:\n•\nPatient not breathing:\no\nChange fenestrated inner cannula for non-fenestrated\no\nCheck patency with suction catheter\no\nInflate cuff if deflated\no\nOnly ventilate if able to pass suction catheter\n•\nObstructed trache:\no\nCauses: occluded inner cannula, occluded trache, cuff herniation, dislodgement, kinked, anatomical\nabnormality\no\nChange cannula (non-fenestrated)\no\nAttempt to suction\no\nApply O2: trache, mouth, laryngectomy stoma\n•\nTracheostomy bleed:\no\nInflate cuff\no\nApply O2\no\nSuction\no\nApply gauze\n•\nAccidental decannulation:\no\n≤7 days: cover and apply O2 from above\no\n>7 days: reconsider recannulation", "citations": [{"type": "pdf_page", "page": 323, "label": "p323"}]}
{"chunk_id": "SSUs_v1_p324_txt_00_c4ec72", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 324, "page_end": 324, "section_path": ["ARDS", "Acute Renal Failure", "Acute Renal Failure"], "specialty_tags": ["ARDS"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Acute Renal Failure", "keywords": [], "text": "Acute Renal Failure\nKDIGO classification: combination of RIFLE and AKIN\nStage\nSerum Cr\nUO Criteria\nCr 1.5 – 1.9x from baseline over 24 hr\nOR\n26μmol/L over 48 hr\n<0.5mL/kg/hr for 6 – 12 hr\nCr 2.0 – 3.0x\n<0.5mL/kg/hr for >12 hr\nCr 2.0 – 3.0x\nOR\nCr up to 354μmol/L\nOR\nInitiation of CRRT\n<0.3mL/kg/hr\nOR\nAnuria for 12 hr\nPre-Renal\nRenal\nPost-Renal\n•\nHypovolaemia\n•\nHeart failure\n•\nHepatorenal syndrome\n•\nDrugs: NSAIDs, IV contrast,\nACEi/ARB (all cause altered\nregulation)\no\nIf high risk AKI use low-osmolar\ncontrast\n•\nIntrinsic vascular: vasculitis, MAHA,\nTTP/HUS, scleroderma, athero-\nembolic, malignant hypertension,\naortic dissection, acute renal vein\nthrombosis\n•\nIntrinsic glomerular:\no\nPrimary idiopathic\nglomerulonephritis\no\nSecondary: anti-GBM,\ngranulomatosis with\npolyangiitis, SLE, IgA/HSP,\ninfection / post-strep,\ncomplement mediated, drugs\n•\nIntrinsic tubular / interstitial:\nischaemia, nephrotoxic drugs,\ntumour lysis syndrome\n•\nObstruction of any cause i.e.\nprostate, cancer, retroperitoneal\nInvestigations:\n•\nHistory\n•\nMedications ?drug cause\n•\nUA: microscopy, protein:Cr ratio, sediment – red cells / casts\n•\nRenal tract US\n•\nNon-con CT\n•\nBladder scan\n•\nRenal biopsy\n•\nOther: serum protein electrophoresis (myeloma), serology (autoimmune)", "citations": [{"type": "pdf_page", "page": 324, "label": "p324"}]}
{"chunk_id": "SSUs_v1_p325_txt_00_5b5197", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 325, "page_end": 325, "section_path": ["CRRT"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "CRRT", "keywords": [], "text": "Indications for dialysis:\n•\nA: acidaemia pH <7.1\n•\nE: electrolytes i.e. K >6.5 or >5.5 and expected to rise\n•\nI: intoxication i.e. acute poisoning\n•\nO: overload / oedema\n•\nU: uraemic complications – pericarditis, encephalopathy\nManagement:\n•\nStop nephrotoxic agents: avoid aminoglycosides if alternative available\n•\nCorrect hypotension / hypovolaemia / hypervolaemia\no\nAvoid IVF if overloaded or anuric\no\nOverloaded and not anuric:\n▪\nFrusemide 80mg IV or double usual dose (dose 1/ GFR)\n▪\nDiuretics should not be used unless treating overload\no\nCRRT\no\nDaily weights + strict fluid balance\n•\nHyperPO4: binders\n•\nHypoCa2+: phosphate binders, measure iCa, IV calcium replacement\n•\nAcidaemia: NaHCO3, CRRT\n•\nNutrition: restrict K, PO4, and Na, dietician review, 30kCal/kg/day", "citations": [{"type": "pdf_page", "page": 325, "label": "p325"}]}
{"chunk_id": "SSUs_v1_p325_txt_01_f42810", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 325, "page_end": 325, "section_path": ["CRRT", "CRRT"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "CRRT", "keywords": [], "text": "CRRT\nFeatures:\n•\nCircuit runs continuously\n•\nSlow blood flow rate 100 – 200mL/min\n•\nSlow dialysate flow 1000 – 2000mL/hour (up to 3000)\n•\nDialysate fluid bags\nNo proven advantage of CRRT > SLED, IHD\nTheoretical advantage:\n•\nContinuous like kidneys\n•\nHaemodynamic stability\nMinor disadvantages:\n•\nInefficient dialysis: low counter-current\n•\nAnticoagulation required\n•\nImmobility – confined to bedspace\n•\nHypothermia\n•\nnursing workload\n•\ncost\nAnticoagulation:\n•\nNo anticoagulation (if severe coagulopathy, liver failure, thrombocytopaenia)\n•\nAnticoagulation:\no\nSystemic: heparin (CI in HITS)\no\nRegional:\n▪\nCitrate/calcium: avoid if liver disease\n•\nMust monitor iCa\n▪\nHeparin/protamine: if citrate toxicity or CI\nStarting:\n•\nEarly not superior to delayed in AKI\n•\nCRRT dose = effluent rate\no\n25mL/kg/hour\nCitrate Toxicity\nFeatures:\n•\nHAGMA or metabolic alkalosis\n•\nLow iCa with high/normal total calcium\nManagement:\n•\nGive calcium\n•\nDecrease citrate dose\n•\nDecrease blood flow rate\n•\nChange anticoagulant", "citations": [{"type": "pdf_page", "page": 325, "label": "p325"}]}
{"chunk_id": "SSUs_v1_p326_txt_00_d61784", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 326, "page_end": 326, "section_path": ["CRRT"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "CRRT", "keywords": [], "text": "Terminology:\n•\nCVVHD: diffusive dialysis (movement of solutes from high [] to low [] across semi-permeable membrane)\n•\nCVVHF: convective dialysis (movement of molecules through semipermeable membrane associated with fluid loss via\nultrafiltration)\n•\nCVVHDF: high ultrafiltration rate + diffusion. Replacement fluid added.", "citations": [{"type": "pdf_page", "page": 326, "label": "p326"}]}
{"chunk_id": "SSUs_v1_p327_txt_00_e5360f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 327, "page_end": 327, "section_path": ["CRRT", "Rhabdomyolysis", "Rhabdomyolysis"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Rhabdomyolysis", "keywords": [], "text": "Rhabdomyolysis\nMuscle necrosis with release of intracellular components.\nCauses:\n•\nTraumatic: crush injury, prolonged immobilisation, compartment syndrome, ischaemia / reperfusion, electrocution\n•\nNon-traumatic\no\nExertional: extreme exertion, metabolic myopathy, heat stroke, seizures, psychosis / amphetamines, malignant\nhyperthermia, NMS\no\nNon-exertional:\n▪\nDrugs: statins, colchicine, dapto, MH, drug induced agitation / immobilisation\n▪\nToxins: envenomation\n▪\nInfection / sepsis\n▪\nEndocrine: DKA, HHS, thyroid\n▪\nInflammatory myopathy\nPresentation: muscle pain, weakness, dark urine\nExam: muscle tenderness / swelling, induration / skin changes, hypovolaemia\nIx:\n•\nSerum:\no\nCK: 5x ULN (>1500)\no\nLFTs\no\nAKI\no\nPO4\no\nHypocalcaemia early, hypercalcaemia late\n▪\nAvoid replacing calcium, may exacerbate muscle injury\no\nHyperuricaemia\no\nHAGMA\no\nDIC if severe\n•\nUrine: myoglobinuria, proteinuria\n•\nECG: hyperK+\nManagement:\n•\nIdentify / treat cause\n•\nIdentify / monitor / treat compartment syndrome\n•\nCorrect electrolyte abnormalities\no\nAllopurinol for hyperuricaemia\no\nHyperK+\n•\nPrevent AKI: start fluids <6 hours if possible\no\nCorrect hypovolaemia:\n▪\n1-2L/hour if CK >5000\n▪\nMonitor volume status\n▪\nLoop diuretics for hypervolaemia\n▪\nIDC for UO monitoring\no\nPrevent intratubular cast formation\n▪\nurine flow rate\n▪\nTarget UO 200 – 300mL/hour (>3mL/kg/hour)\n▪\nForced alkaline diuresis with sodium bicarb\n•\nNo good evidence for this, but probably not harmful\n•\nDialysis removes myoglobin – high-permeability membrane filter (even if not available standard CVVHDF AKI)", "citations": [{"type": "pdf_page", "page": 327, "label": "p327"}]}
{"chunk_id": "SSUs_v1_p328_txt_00_7d7e36", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 328, "page_end": 328, "section_path": ["CRRT", "Renal Transplant", "Renal Transplant"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Renal Transplant", "keywords": [], "text": "Renal Transplant\nPre-op:\n•\nIndication + comorbidities + optimise\n•\nHaemodialysis: modality, frequency, access\n•\nIx:\no\nBloods: FBC, EUC, LFTs, HbA1c, coags, G&H, iron studies\n▪\nEPO + iron if indicated\no\nECG: 12-lead\no\nTTE only if indicated\n•\nContinue regular mediations unless CI\n•\nManage anxiety\n•\nConsent\nImmediately pre-op:\n•\nOrganise pre-op haemodialysis check post-dialysis acid-base status + potassium + urea\n•\nCheck volume of ultrafiltrate\nIntra-op:\n•\nIV access: avoid forearm (in case future need for AV fistula)\n•\nMonitoring: ANZCA routine + 5 lead ECG + temp\no\nArt line only if indicated\no\nNIBP on non-fistula arm\n•\nETT:\no\nModified RSI if gastric emptying (uraemia + diabetic neuropathy) – can use roc + sugammadex\no\nNo RSI: cisatracurium\n•\nCVC: CVP aim 8-12mmHg\n•\nFluid: balanced crystalloid – aim ~1.5L prior to transplantation (avoid tubular necrosis)\n•\nImmunosuppression: prior to implant anastomosis\no\nMethylpred: 500mg IV\no\nBasiliximab 20mg IV\no\nIf high risk: thymoglobulin 1mg/kg\n•\nFrusemide (surgeon discretion)\n•\nAnalgesia: paracetamol +\no\nPre-incision TAP blocks (risk of injury to anterior transplanted kidney)\no\nFentanyl (non-renal dependent)\n•\nEnsure full reversal with nerve stimulator\n•\nCheck fistula thrill pre- & post-op - document\nPost-op:\n•\nMonitor fluid balance + UO; IVF per renal team\n•\nMonitor renal function – may require dialysis\n•\nFentanyl PCA + pain team review\n•\nImmunosuppression triple therapy: dosed by transplant team\no\nTacrolimus\no\nMMF\no\nSteroids\n•\nOther:\no\nNilstat for 1mo\no\nPPI SUP for 6-12mo\no\nInfection prophylaxis:\n▪\nPCP for 12 mo: Bactrim\n▪\nCMV: valganciclovir\n•\nVTE prophylaxis\n•\nConfirm CVC on CXR\nComplications:\n•\nAcute rejection\n•\nAntibody mediated rejection\n•\nLeukopaenia\n•\nCMV", "citations": [{"type": "pdf_page", "page": 328, "label": "p328"}]}
{"chunk_id": "SSUs_v1_p329_txt_00_c4b036", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 329, "page_end": 329, "section_path": ["CRRT", "Hyponatraemia", "Hyponatraemia"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Hyponatraemia", "keywords": [], "text": "Hyponatraemia\nNa <135:\n•\nMild: 130 – 134\n•\nMod: 120 – 129\n•\nSevere: <120\nChronicity:\n•\nAcute: <48hrs\n•\nChronic: >48hrs\nEvaluate:\n•\nFluid status\n•\nSerum osmols: normal 270\n•\nUrine osmols\no\nLow: <100mOsm/L\no\nHigh: >100mOsm/L\n•\nUrine Na:\no\nLow: <40mOsm/L\no\nHigh: >40mOsm/L\nOther: TFTs, LFTs, serum protein, serum TGs, VBG, random cortisol, short synacten test\nSSx: ranges from nausea, confusion, thirst → vomiting, seizures, coma\nCauses:\n•\nHyper/iso-osmotic: sOsm >270\no\nAdded osmols: mannitol, BSL, lipids, TGs, post-TURP, radiocontrast, paraproteins\n•\nHypoosmotic:\no\nLow urine osmols:\n▪\nDiet: beer potomania, anorexia nervosa\n▪\nPsychogenic polydipsia\n▪\nEcstacy\no\nHigh urine osmols:\n▪\nLow urine sodium:\n•\nTrue hypovolaemia\n•\nCCF, cirrhosis\n•\nPsychogenic polydipsia\n•\nEcstacy\n▪\nHigh urine sodium:\n•\nCerebral salt wasting\n•\nSIADH\n•\nDiuretics\n•\nAdrenal insufficiency\n•\nSevere hypothyroidism\n•\n“reset osmostat”\n•\nRenal failure", "citations": [{"type": "pdf_page", "page": 329, "label": "p329"}]}
{"chunk_id": "SSUs_v1_p330_txt_00_a32965", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 330, "page_end": 330, "section_path": ["CRRT", "Osmotic Demyelination Syndrome"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Osmotic Demyelination Syndrome", "keywords": [], "text": "Fluid status\nHypovolaemic\nEuvolaemic\nHypervolaemic\nCauses\nRenal Na+ loss:\n•\nNephropathy\n•\nCerebral salt wasting\n•\nDiuretics\n•\nFluid restriction\nNon-renal Na+ loss:\n•\nGIT\n•\nSweat\nSIADH\nRenal, heart and liver failure\nManagement\nNormal saline\nFluid restriction\nHypertonic saline\nFluid restriction\nDiuretics\nManagement:\n1. Determine duration (acute v chronic)\n2. Determine severity\na. Signs of raised ICP (i.e. seizures, obtunded, coma, resp failure, headache, N&V, tremor, gait disturbance\nconfusion)\nCorrection:\n•\nSevere: rapidly raise Na+ by 4 – 6mM/L to prevent herniation\no\n50-100mL bolus NaCl 3% over 10 mins\n▪\nRepeat up to 2 times\n•\nCorrect Na (no signs of pre-herniation):\no\nRate:\n▪\n<10mM in first 24 hours\n▪\nSubsequently <8mM/24 hours\no\nEither fluid restrict or hypertonic saline\n•\nTreat underlying cause\nOsmotic Demyelination Syndrome\nRapid correction of sodium → rapid cellular shifts → cellular apoptosis\nSSx: seizures, parkinsonism, dysarthria, quadriplegia, spastic hypertonia, coma, death, locked in\nRisk factors:\n•\nRapid rise in Na\n•\nAssociated with: EtOH, liver disease, thiazides, anti-depressants\nRx:\n•\nRelower Na+\no\nStop sodium replacement\no\nDextrose 5%\no\nConsider DDAVP", "citations": [{"type": "pdf_page", "page": 330, "label": "p330"}]}
{"chunk_id": "SSUs_v1_p331_txt_00_13687f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 331, "page_end": 331, "section_path": ["CRRT", "Hypernatraemia", "Hypernatraemia"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Hypernatraemia", "keywords": [], "text": "Hypernatraemia\nNa >145\nMechanisms:\n•\nWhole body water loss: sweat, GIT, diabetes insipidus (central v nephrogenic), osmotic, impaired thirst mechanism\n•\nWater loss into cells: seizures, exercise\n•\nSodium overload: iatrogenic\nSSx: irritable, lethargy, seizures, coma, insulin resistance\nChronicity:\n•\nAcute: <48hrs\n•\nChronic: >48hrs\nManagement:\n•\nAcute:\no\nReplace water deficit with dextrose 5% + any ongoing losses (over 24 hours)\n•\nChronic:\no\nLower by <10mM / 24 hours i.e. <0.05mM/hour\no\nDextrose 5% (~1mL/kg/hour)\nOver-correction → cerebral oedema\nIf persistently high UO → DDAVP 0.4mcg IV q6-12hr (much less than vWD treatment)\nSee diabetes insipidus in neuro notes\n(Causes of nephrogenic DI: lithium, congenital, hyperCa2+, hypoK+, pyelo, PCKD, post-obstructive uropathy, myeloma,\namyloid/sarcoid)", "citations": [{"type": "pdf_page", "page": 331, "label": "p331"}]}
{"chunk_id": "SSUs_v1_p332_txt_00_2e0363", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 332, "page_end": 332, "section_path": ["CRRT", "Metabolic Acidosis", "Metabolic Acidosis"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Metabolic Acidosis", "keywords": [], "text": "Metabolic Acidosis\npH <7.35\nMechanism:\n•\nacid production\n•\nLoss of bicarb\n•\nDecreased renal acid secretion\nAnion gap = (Na+ + K+) – (Cl- + HCO3-)\nNormal = 8 – 16 (4 – 12 if not including K+)\nCorrect for albumin: by 2.5 for every 10g/L below 45\nRespiratory compensation: PaCO2 = 1.5 x HCO3 + 8\nDelta ratio = change in anion gap / change in bicarb\ni.e.\n(AG – 12) / (24 – HCO3)\nBecause normal anion gap is 12, and normal bicarb is 24\nDelta ratio:\n•\n0.4 = NAGMA\n•\n0.4-1.0: mixed HAGMA / NAGMA\n•\n>1.0 = HAGMA\n•\n>2.0 = HAGMA with pre-existing metabolic alkalosis\nCauses:\n•\nHAGMA:\no\nLactic acidosis\no\nKetoacidosis\no\nIngestion: EtOH, methanol, ethylene glycol, aspirin / salicylates, toluene, paracetamol, metformin, propylene\nglycol\no\nSevere renal failure (urea)\n•\nNAGMA / hyperchloraemic MA\no\nHCO3- loss: diarrhoea, type 2 RTA, carbonic anhydrase inhibitor, uretal diversion\no\nrenal acid excretion: mod renal failure, type 1 or type 4 RTA\no\nNormal saline / Cl-", "citations": [{"type": "pdf_page", "page": 332, "label": "p332"}]}
{"chunk_id": "SSUs_v1_p333_txt_00_328330", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 333, "page_end": 333, "section_path": ["CRRT", "Metabolic Alkalosis", "Metabolic Alkalosis"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Metabolic Alkalosis", "keywords": [], "text": "Metabolic Alkalosis\nCauses:\n•\nGIT H+ loss:\no\nVomiting or high NG aspirates (e.g. contraction alkalosis)\no\nCongenital chloride diarrhoea\n•\nRenal H+ loss:\no\nPrimary mineralcorticoid excess\n▪\nConn’s syndrome (i.e. primary hypoaldosteronism)\n▪\nCushing syndrome\n▪\nExogenous\no\nLoop or thiazide diuretics\no\nBartter syndrome (NaCl resorption in LoH)\no\nGitelman syndrome (NaCl resorption in DCT)\no\nPost-chronic hypercapnia\no\nLicorice\no\nLiddle syndrome\n•\nSevere hypoK+ with intracellular H+ shift\no\nVillous adenoma\no\nLaxative abuse\n•\nAlkali administration\no\nCalcium alkali\no\nHCO3\no\nCitrated blood products\n•\nContraction alkalosis\nRespiratory compensation: PaCO2 = 0.7 x HCO3 + 20", "citations": [{"type": "pdf_page", "page": 333, "label": "p333"}]}
{"chunk_id": "SSUs_v1_p334_txt_00_07f3db", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 334, "page_end": 334, "section_path": ["CRRT", "Guillain Barre", "Guillain Barre"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Guillain Barre", "keywords": [], "text": "Guillain Barre\nAcute demyelinating polyneuropathy\nSSx:\n•\nMonophasic i.e. continues to worsen\n•\nAscending symmetrical weakness (flaccid areflexic paralysis)\n•\nCN involvement\n•\nAutonomic instability\n•\nSensory sparing\nLikely autoimmune, usually follows prodrome (e.g. respiratory, gastrointestinal or viral infection)\nLack of fever at onset\nMonitoring: ICU not always needed\n•\nSpirometry / PFTs: suggestive of resp function\no\nFVC <20mL/kg\no\nPEF <250L/min\no\nMax insp pressure <30cmH2O\no\nMax exp pressure <40cmH2O\nIx:\n•\nLP: protein\n•\nImaging: mainly helpful to rule out other causes\n•\nNCS: velocity and prolonged distal latencies\nMiller-Fisher Syndrome:\n•\nOphthalmoplegia\n•\nAreflexia\n•\nAtaxia\nIx: possible antiganglioside GM1 antibodies\nRx: supportive +/-\n•\nPlasma exchange: usually 5 sessions\n•\nIVIg\nNo evidence for:\n•\nSteroids\n•\nEarly tracheostomy\nNeuromuscular +\no\nSevere lower back pain – adequate analgesia\no\nMechanical ventilation: FVC <20mL/kg, bulbar involvement, resp failure on blood gases\no\nLabile BP due to autonomic instability, sensitive to vasopressors", "citations": [{"type": "pdf_page", "page": 334, "label": "p334"}]}
{"chunk_id": "SSUs_v1_p335_txt_00_090914", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 335, "page_end": 335, "section_path": ["CRRT", "Encephalitis & Meningitis", "Encephalitis & Meningitis"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Encephalitis & Meningitis", "keywords": [], "text": "Encephalitis & Meningitis\n30% mortality.\nDetermining organism - consider:\n•\nGeographical location\n•\nImmune status\nMeningitis\nEncephalitis\nDefinition\nInflammation of meninges\nInflammation of brain\nSSx\nFever, headache, neck stiffness, altered mental\nstatus (95% will have 2 / 4) +/- focal deficits\nRash associated with Neisseria meningitidis\nFever, headache, altered mental state, focal deficits,\nseizures\nCauses\n•\nBacterial:\no\nStreptococcus pneumoniae main cause in\nadults (risk factors HIV, hyposplenism, EtOH,\nchronic liver / kidney disease)\no\nNeisseria meningitidis (main organism in\nadolescents)\no\nOthers: Listeria, Staph aureus\n•\nViral: less severe\no\nMost common: enterovirus, HSV, VZV\nCauses:\n•\nInfectious\n•\nPost-infectious\n•\nAuto-immune\nTreatment\nBacterial meningitis:\n•\nMedical emergency\n•\nInitiate treatment within 1 hour – do not delay\ntherapy for diagnostic interventions\n•\nAbx choice based on likely organisms, local\nresistance patterns, and age of patient\n•\nSteroids: hearing loss, neurological sequelae\n•\nTherapeutic hypothermia not recommended\n•\nInsufficient evidence: prophylactic anti-\nepileptics, hyper-osmolar therapy\nStart treatment within 6hr – ideally after CSF\nsampling and neuroimaging.\nIx:\n•\nBlood cultures within 1hr presentation – very useful if LP is CI\n•\nImaging: imaging prior to LP if concerns for ICP\no\nIndications: focal deficits, papilloedema, seizures, GCS <12\n•\nLP:\no\nCSF lactate useful for bacterial v viral – lactate <2mM essentially rules out bacterial disease\no\nCI to LP: ICP, bradycardia/HTN, focal neuro signs, abnormal posturing, pupil pathology, papilloedema, shock,\ndoll’s eye movements, extensive purpura, abnormal coags, local infection at LP site, compromised resp fx\n•\nHIV test\n•\nEEG if concern for seizure activity", "citations": [{"type": "pdf_page", "page": 335, "label": "p335"}]}
{"chunk_id": "SSUs_v1_p336_txt_00_c55ea7", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 336, "page_end": 336, "section_path": ["CRRT", "Tetanus", "Tetanus"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Tetanus", "keywords": [], "text": "Tetanus\nClostridium tetani:\n•\nObligate anaerobic, spore-forming Gram-positive bacillus\n•\nTetanus spores enter the body through contaminated trauma\n•\nIncubation period of 3 - 21 days, bacteria divide and release tetanus toxin\n•\nTravels from peripheries to spinal cord → inhibits neurotransmitter release\nSSx:\n•\nFirst signs: stiff neck, sore throat, trismis\n•\nOther: muscle rigidity, spasms, autonomic dysfunction\n•\nRisk of apnoea from laryngospasm or chest wall rigidity\nResp failure leading cause of death\nDiagnosis:\n•\nLargely clinical\n•\nSpatula test – induced masseter spasm\n•\nWound culture may grow 30% of time\n•\nSerum antitoxin level: low levels demonstrate susceptibility\nTreatment:\n•\nABCs\n•\nDisable toxin: immunisation (toxin already within CNS will have no effect)\n•\nKill bacteria: metronidazole + benpen\n•\nSurgical debridement\n•\nControl spasms: paralysis or benzo infusion\n•\nSNS: labetalol, MgSO4", "citations": [{"type": "pdf_page", "page": 336, "label": "p336"}]}
{"chunk_id": "SSUs_v1_p337_txt_00_47b329", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 337, "page_end": 337, "section_path": ["CRRT", "Botulism", "Botulism"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Botulism", "keywords": [], "text": "Botulism\nClostridium botulinum:\n•\nUbiquitous, obligate anaerobe, spore- forming Gram-positive bacillus\n•\nAnaerobic environment → spores germinate and grow into exotoxin-producing bacteria\n•\nBotulinum toxin enters presynaptic nerve cells of voluntary muscles and ANS\n•\nPrevent ACh release\nSSx:\n•\nCN palsies\n•\nDescending symmetrical flaccid paralysis characteristic of botulism (prox before distal)\no\nConsider if MG or Guillain barre a possibility\nDiagnosis:\n•\nAfebrile\n•\nAcute onset of one of: vision changes, difficulty speaking, change of voice, secretion issues, thick tongue\n•\nSigns at least one of: ptosis, extraocular palsy, facial paresis, pixed pupils, descending paralysis\n•\nLab test for toxin (gold standard is mouse bioassay)\nManagement:\n•\nABCs\n•\nAntitoxin\n•\nWound debridement\n•\nVaccination (high risk only)\n•\nNo evidence for any drugs other than antitoxin including abx, cholinergics", "citations": [{"type": "pdf_page", "page": 337, "label": "p337"}]}
{"chunk_id": "SSUs_v1_p338_txt_00_6f575b", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 338, "page_end": 338, "section_path": ["CRRT", "Peptic Ulcer Disease", "GI Haemorrhage"], "specialty_tags": ["CRRT", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "GI Haemorrhage", "keywords": [], "text": "GI Haemorrhage\nCauses:\n•\nVariceal:\n•\nNon-variceal:\no\nUlcerative\no\nMass lesion\no\nVascular\no\nTraumatic\nIx:\n•\nHistory: haematemesis (frank v coffee ground), melaena, haematochezia\n•\nExamination: volume status\n•\nIx: full bloods + G&H\no\nUrea:Cr ratio >30\n•\nEndoscopy\nManagement: No role for TXA\n•\nResus + ABCs + correct coagulopathy\n•\nSpecific:\no\nAcid suppression: pantoprazole 80mg IV load then 8mg/hour (or BD dosing)\no\nSource control:\n▪\nEndoscopy\n▪\nCT angiography / angioembolisation\n▪\nDouble-balloon enterscopy\n▪\nSB tube\nVariceal Bleeding\nManagement: (above +)\n•\nPharmacological\no\nOctreotide 50mcg loading then 50mcg / hour (same as carcinoid)\no\nTerlipressin 2mg IV q4 hourly\no\nCorrect coagulopathy\no\nCirrhosis: prophylactic antibiotics – ceftriaxone (mortality, SBP, rebleeding)\n•\nProcedural:\no\nBanding\no\nSclerotherapy\no\nCryoacrylate injection\no\nTIPS\no\nEmergency shunt surgery\nPeptic Ulcer Disease\nManagement: (above +)\n•\nOctreotide if refractory, of endoscopy CI, or delayed (50mcg\nthen 25mcg/hour)\n•\nIntervention:\no\nEndoscopic:\n▪\nGrade Ia to IIb have high re-bleeding risk →\ntreat\n▪\nDilute adrenaline injection\n▪\nThermal coagulation / argon plasma coagulation\n▪\nHaemoclip\n▪\nFibrin sealant\no\nSurgery\no\nInterventional angiography / embolisation\nForrest Classification\nGrade\nDescription\nRebleeding\nRisk\nWithout\nintervention\nIa\nActive arterial\nbleed\n55%\nIb\nOozing without\nvisible vessel\n55%\nIIa\nNon-bleeding\nvisible vessel\n43%\nIIb\nAdherent clot\n22%\nIIc\nFlat spot\n10%\nIII\nClean ulcer base\n5%", "citations": [{"type": "pdf_page", "page": 338, "label": "p338"}]}
{"chunk_id": "SSUs_v1_p339_txt_00_a89e6e", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 339, "page_end": 339, "section_path": ["CRRT", "Acute Liver Failure", "Acute Liver Failure"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Acute Liver Failure", "keywords": [], "text": "Acute Liver Failure\nDefinition:\n•\nAcute liver injury\n•\nHepatic encephalopathy\n•\nImpaired synthetic function (INR ≥1.5)\nSee liver failure notes\nManagement:\n•\nA/B:\no\nIntubate early\no\nPaCO2 35 – 40 for neuroprotection\no\nLung protective ventilation\n•\nC: hyperdynamic circulation with low SVR\no\nFluid resus with balanced crystalloid / albumin\no\nVasopressor for MAP >65 (>80 if raised ICP) – norad, vasopressin\n▪\nCPP >60 if cerebral oedema\no\nHydrocortisone for adrenal insufficiency\n•\nD:\no\nNeuroprotective measures\no\nMonitor for seizures\no\nNormoglycaemia\no\nHigh volume plasma exchange\n•\nE:\no\nControl fever\no\nMonitor for infection\no\nAntibiotics for grade III and IV encephalopathy\n•\nF:\no\nFB euvolaemia / slightly -ve\no\nSodium 145 – 150, serum osmols <320\no\nConsider CRRT: high dose, avoid citrate\n•\nG:\no\nGlucose IV – aim BSL >4 (high concentration to free water)\no\nEarly enteral feeding\no\nPPI stress ulcer prophylaxis\no\nElectrolyte correction\n•\nH:\no\nHb >70\no\nVitamin K 10mg daily for 3 days\no\nDo not treat INR unless bleeding or invasive procedure\n•\nL:\no\nCVC, art line, IDC, NGT, vascath +/- PiCCO\nSpecific management:\n•\nAntidotes:\no\nParacetamol +/- other: NAC\no\nWilson’s disease: D-penicillamine\no\nMushrooms: silibilin, penicillin G and NAC\no\nAntivirals\no\nAutoimmune hepatitis: steroids\n•\nOther:\no\nPlasma exchange\nComplications:\n•\nSepsis (now leading cause of death)\n•\nElectrolyte abnormalities\n•\nHepatic encephalopathy\n•\nCerebral oedema (previously most common cause of death) → mannitol, hyperventilate, barbiturate coma\n•\nSeizures: phenytoin\n•\nRenal failure\n•\nPulmonary oedema", "citations": [{"type": "pdf_page", "page": 339, "label": "p339"}]}
{"chunk_id": "SSUs_v1_p340_txt_00_0c7ffe", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 340, "page_end": 340, "section_path": ["CRRT", "Chronic Liver Failure"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Chronic Liver Failure", "keywords": [], "text": "Liver Transplant\nAcute Liver Failure\nKing’s College Criteria:\n•\nParacetamol induced:\no\nArterial pH <7.3, lactate >3 after 24 hours or\no\nGrade III/IV encephalopathy, PT >100s and Cr >300nmol/L\n•\nNon-paracetamol induced:\no\nPT >100s (INR >6.5) or\no\nAny 3 of:\n▪\nAge <10yo or >40yo\n▪\nUnfavourable aetiology (wilson’s disease, drug reaction, non-hep A/B/viral\n▪\nJaundice >7 days before encephalopathy i.e. not hyperacute\n▪\nPT >50s (INR >3.5)\n▪\nBili >300\nChronic Liver Failure\nMELD:\n•\nChronic liver disease\n•\nLife threatening complications\n•\nMELD-Na score >15\no\nAge\no\nBili\no\nINR\no\nCr\no\nSodium\nContra-indications to liver transplant:\n•\nIrreversible brain injury\n•\nMalignancy\n•\nUncontrolled sepsis\n•\nLack of social support / non-adherence to therapy", "citations": [{"type": "pdf_page", "page": 340, "label": "p340"}]}
{"chunk_id": "SSUs_v1_p341_txt_00_ee76da", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 341, "page_end": 341, "section_path": ["CRRT", "Acute Pancreatitis", "Acute Pancreatitis"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Acute Pancreatitis", "keywords": [], "text": "Acute Pancreatitis\nDiagnostic criteria:\n•\n2 out of 3:\no\nAcute onset of severe epigastric pain\no\nElevated amylase / lipase >3x ULN\no\nImaging studies\nClassification:\n•\nMild: no local or systemic complications\n•\nModerate:\no\nTransient organ failure ≤24 hours\no\nLocal or systemic complications\n•\nSevere: persistent organ failure ≥48 hours\nCauses:\n•\nGallstones 40 – 70%\n•\nEtOH 25%\n•\nHypertriglyceridaemia 10%\n•\nPost-ERCP\n•\nDrug-induced\n•\nTrauma – blunt / penetrating\n•\nHypercalcaemia\n•\nInfection\n•\nVasculitis\n•\nCF\nSeverity:\n•\nRanson’s criteria - mortality\n•\nApache II\nManagement: supportive care\n•\nResuscitation: initial required for HD stability → 5-10mL/kg/hour\n•\nAnalgesia\n•\nMonitoring:\no\nVitals\no\nUO\no\nElectrolytes (especially Ca2+, glucose, renal function)\n•\nNutrition:\no\nNBM\no\nEarly oral feeding as tolerated\no\nEnteral / parenteral feeds\n•\nAntibiotics only if suspected infection\nTreat underlying cause:\n•\nGallstones: ERCP, cholecystectomy\n•\nTriglycerides: apheresis, insulin\nLocal Complications\nSystemic Complications\n•\nPeripancreatic fluid collections\no\nConservative\n•\nNecrosis (sterile or infected)\no\nAbx, debridement, perc drainage\n•\nPseudocyst\no\nObserve v drain\n•\nWalled off\n•\nPortosplenomesenteric venous thrombosis\n•\nAbdominal compartment syndrome\n•\nShock / sBP <90\n•\nAPO PaO2 <60mmHg\n•\nRenal failure\n•\nGI bleeding\n•\nDIC\n•\nSevere hypocalcaemia", "citations": [{"type": "pdf_page", "page": 341, "label": "p341"}]}
{"chunk_id": "SSUs_v1_p343_txt_00_d87490", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 343, "page_end": 343, "section_path": ["CRRT", "Post-Intensive Care Syndrome", "Post-Intensive Care Syndrome"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Post-Intensive Care Syndrome", "keywords": [], "text": "Post-Intensive Care Syndrome\nEpidemiology:\n•\n≥50% will have some component + QoL\no\nCognitive 25%\no\nPsychiatric up to 60%\no\nPhysical up to 75%\nRFs:\n•\nPre-existing: cognitive dysfunction, mental health, functional disability, frailty\n•\nDuring illness: delirium, sedation, sepsis, shock, hypoxia, ARDS, mechanical ventilation, traumatic experience\n•\nAfter illness: early anxiety, depression, PTSD\nPresentation:\n•\nCognitive: cognition (concentration, memory, mental speed, executive function)\n•\nPsychiatric: anxiety, depression, PTSD\n•\nPhysical:\no\nICU acquired weakness\no\nContractures\no\nMalnutrition\no\nPoor lung function\no\nInsomnia / poor sleep", "citations": [{"type": "pdf_page", "page": 343, "label": "p343"}]}
{"chunk_id": "SSUs_v1_p344_txt_00_da7263", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 344, "page_end": 344, "section_path": ["CRRT", "Withdrawal of Care", "Withdrawal of Care"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Withdrawal of Care", "keywords": [], "text": "Withdrawal of Care\nReasons:\n•\nImminent death\n•\nLikely poor outcome\n•\nLethal underlying condition\nCapacity:\n•\nACD\n•\nGuardian or legal authority\n•\nConsult stakeholders (e.g. family)\nCommunication:\n•\nMDT\n•\nFamily + patient i.e. “shared decision making”\no\nConsider culture, religion, language, life-stage\no\nAffirm non-abandonment\no\nAllow time for questions\nProcess:\n•\nPrepare:\no\nInform family and explain process\no\nSpiritual + cultural care\no\nPrivate room\no\nSocial work\no\nPalliative care referral\n•\nAssess and manage symptoms\no\nPain, agitation, secretions, distress, dyspnoea, delirium\no\nTitrate management to effect – avoid oversedation\n•\nDiscontinue treatment\no\nNon-comfort treatments\no\nContinue O2 if relieves symptoms\no\nReligious visit / priest\no\nOrder:\n▪\nFluids + antibiotics\n▪\nCVS support\n▪\nVentilatory support\no\nTurn off monitors and alarms\no\nOngoing support\n▪\nSocial work / grievance counsellor\n▪\nALO if indigenous\n▪\nFormal debrief", "citations": [{"type": "pdf_page", "page": 344, "label": "p344"}]}
{"chunk_id": "SSUs_v1_p345_txt_00_41b628", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 345, "page_end": 345, "section_path": ["CRRT", "Brainstem Death Testing", "Brainstem Death Testing"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Brainstem Death Testing", "keywords": [], "text": "Brainstem Death Testing\nBrain death:\n•\nUnresponsive coma\n•\nAbsence of brainstem reflexes\n•\nAbsence of resp centre functions\n*Clinical setting compatible with irreversibility\nOR demonstrated absence of intracranial blood flow\nPreconditions:\n•\nMinimum 4 hr of observed unresponsive coma, unreactive pupils, absent cough / tracheal reflexes, no spont resp effort\n•\nCore temp >36\n•\nsBP >100mmHg\n•\nNo drug, toxin or sedative (>24 hours)\n•\nAbsence of severe electrolyte, metabolic or endocrine disturbance\n•\nIntact neuromuscular function\n•\nAbility to examine brainstem reflexes\n•\nAbility to perform apnoea testing\no\nSatisfactory gas exchange / normoxia\nExamination findings: tests\n•\nComa\n•\nAbsent brain-originating motor response\no\nPain above the neck\no\nSeizure\no\nDecorticate or decerebrate posturing\nTesting: tested in sequence\n1. Unresponsive coma:\na. Painful stimulus: supraorbital pressure, nailbed in 4 limbs (may be spinal reflexes not elicited by SO pressure)\n2. Brainstem reflexes:\na. Pupillary light: CN II, III\nb. Corneal reflex: CN V, VII\nc.\nVestibulo-ocular reflex: CN III, IV, VI, VIII\ni. Head at 30 degrees, ice cold water into the ear, watch eyes for 60s, in brain death will remain midline\nd. Gag reflex: CN IX, X\ne. Cough reflex: CN X\n3. Apnoea: pre-ox FiO2 100% 5 mins → switch off ventilator, supply O2 via manual BVM with PEEP valve – recommended\nT-piece → observe for 10 minutes\na. After 10 mins: ABG (apnoea persisting with PaCO2 >60mmHg or 20mmHg above baseline, pH <7.3)\ni. If patient becomes hypoxic a couple of mandatory breaths permitted to continue process\nObservations:\n•\nCompatible with brain death: spinal reflexes, ext/flex UL/LL, undulating toes, Lazarus, deep tendon reflexes, head\nturning, sweating, blushing\n•\nIncompatible with brain death: decorticate, decerebrate, true ext/flex response to painful stimuli, seizures, attempted\nbreathing\nWhen clinical / apnoea testing cannot be performed (i.e. no access to one eye / ear, high SCI, severe hypoxia, HD unstable):\n•\nRadiological confirmation of no flow: DSA, MRA, CTA, transcranial doppler\n•\nEPS\nBrain death mimics:\n•\nLocked in syndrome\n•\nParalysis\n•\nHypothermia\n•\nDrug intoxication / metabolic derangement\nTests all CN apart from I, XI, XII\nAdditional:\n•\nIf cause is cardiorespiratory\narrest must wait 24 hours\npost-ROSC\n•\nAge:\no\nAbove applies after 30\ndays of age\no\nPrior to 30 days old\nperiod of observation\nis 48 hours, not 24\nhours\no\nPremature babies <36\nweeks old, brainstem\ndeath testing cannot\nbe performed with\ncertainty", "citations": [{"type": "pdf_page", "page": 345, "label": "p345"}]}
{"chunk_id": "SSUs_v1_p346_txt_00_d3e500", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 346, "page_end": 346, "section_path": ["CRRT", "Management Prior to Organ Retrieval"], "specialty_tags": ["CRRT"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Management Prior to Organ Retrieval", "keywords": [], "text": "Management Prior to Organ Retrieval\nMonitoring:\n•\nRoutine ANZCA + temp, UO, BSL\n•\nBloods\nTargets:\n•\nBloods: Hb >70, normal sodium, BSL 6-10mM\n•\nCVS: MAP 60-110mmHg\n•\nResp: LPV, prevent VAP (head up 30 degrees, pulmonary toilet)\n•\nEndo: manage central DI (vaso, desmopressin), steroids, thyroid replacement\n•\nNormothermia\nComplications whilst awaiting organ donation:\n•\nHypertensive autonomic storm\n•\nVasodilatory shock\n•\nCardiogenic shock\n•\nDiabetes insipidus\n•\nVAP\nMust support family\nAbsolute CI donation:\n•\nActive cancer last 3y (exc non-melanoma skin cancer and primary brain tumours)\n•\nHaem cancer\n•\nUntreated systemic infection\n•\nCJD\n•\nHIV disease (not infection)\nNo longer age limits\nDCD Donation:\n•\nDoes not meet criteria for brain death\n•\nNo hope of viable recovery\n•\nExpected to die <60 mins after withdrawal of supports", "citations": [{"type": "pdf_page", "page": 346, "label": "p346"}]}
{"chunk_id": "SSUs_v1_p347_txt_00_df6fe2", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 347, "page_end": 347, "section_path": ["VASCULAR AND INTERVENTIONAL", "Peripheral Vascular Disease", "Peripheral Vascular Disease"], "specialty_tags": ["VASCULAR AND INTERVENTIONAL"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Peripheral Vascular Disease", "keywords": [], "text": "Peripheral Vascular Disease\n•\nAsymptomatic\n•\nSymptomatic:\no\nClaudication\no\nCritical limb ischaemia: (5Ps pain, pulselessness, pallor, parasthesia, paralysis) – 5y mortality 50%\n▪\nPain at rest\n▪\nUlceration / gangrene\nIx:\n•\nABI ≤0.9 (normal 0.9 – 1.2, abnormally high if non-compressible - mortality)\n•\nDuplex US\n•\nCTA / MRI (best for run offs)\n•\nInvasive angiogram\nManagement:\n•\nCVS risk factor modification +\no\nRx: statin\no\nBP (<140/90, <130/80 if diabetic)\n•\nExercise (improves claudication, no mortality benefit)\n•\nRx:\no\nAntiplatelet: single unless stent (CAPRIE clopidogrel > aspirin CVS endpoints)\no\nPCE3 inhibitors\no\n5HT2 inhibitors\n•\nRevascularisation\nCo-morbidities: CAD 60%, HTN, COPD 50%, CKD, obesity, diabetes, chronic pain, smokers\nComplications of PVD: wound dehiscence, post-op MI / stroke, renal failure\nCARP no evidence for PCI unless indicated\nPre-op:\n•\nFunction + RCRI (non-exercise ST)\n•\nModifiable RFs\nIntra-op:\n•\nMonitoring: 5-lead + art line\n•\nContrast → hydration\n•\nManage reperfusion\nPost-op:\n•\nMonitor for complications:\no\nGeneral: MINS / MACE, acute renal injury +/- contrast induced nephropathy, respiratory complications\no\nVascular: haematoma, graft failure, wound infection, re-stenosis, pseudoaneurysm", "citations": [{"type": "pdf_page", "page": 347, "label": "p347"}]}
{"chunk_id": "SSUs_v1_p348_txt_00_2b8f76", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 348, "page_end": 348, "section_path": ["VASCULAR AND INTERVENTIONAL", "Carotid Endarterectomy", "Carotid Endarterectomy"], "specialty_tags": ["VASCULAR AND INTERVENTIONAL"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Carotid Endarterectomy", "keywords": [], "text": "Carotid Endarterectomy\nIndications:\n•\nSymptomatic stenosis >50% (greatest ARR within 2/52 of last event)\n•\nAsymptomatic stenosis >60%\nCI: asymptomatic 100% occlusion, high medical risk\nComplications: CVA/embolisation, cerebral hyperperfusion syndrome,\nICH, MACE, CN / cervical nerve injury (RLN, SLN, hypoglossal,\nmandibular), haematoma +/- airway compromise + general\nGALA trial: no difference at 30 days for stroke, AMI, death (risk of\nselection bias as LA patients often older + more comorbid). Higher\nshunt rate for GA.\nPre-op:\n•\nSymptom timeline\n•\nMedical management:\no\nAntiplatelets:\n▪\nAsymptomatic: aspirin\n▪\nSymptomatic: DAPT\no\nStatin therapy\n•\nContralateral carotid flow\n•\nBlood pressure control\n•\nModifiable RFs\n•\nNeurological deficits\nIntra-op:\n•\nMode:\no\nAwake: superficial cervical plexus + /- sedation (precedex)\no\nGA: TIVA, south rae\n•\nMonitoring: 5-lead, art line\no\nNeuro-monitoring: BIS+EEG+DSA, SSEPs\n•\nImportant moments BP:\no\nInduction (baseline +/- 20%)\no\nDissection (stop, LA, atropine)\no\nClamp (baseline + 20%) → do not touch anaesthetic\n▪\nHeparin prior\no\nUnclamp: sBP <140\no\nEmergence\no\nPACU\n•\nNeuroprotection\n•\nParalyse – no cough\n•\nBlood management\n•\nRapid emergence\nPost-op:\n•\nQ1 hourly neuro obs\n•\nHypertension: headache, vision\no\nRx: labetalol, clonidine\n•\nBleeding +/- airway:\no\nSlow: oedema → AFOI nasal v oral?\no\nFast: tracheal deviation, release haematoma → normal oral\nStent v CEA:\n•\nrisk periprocedural stroke and death\n•\nrisk of MI, CN palsy, haematoma\n•\nNo difference in ipsilateral stroke after procedure\n•\nElderly: CEA > stent (consider ongoing DAPT) –\nindications institution specific", "citations": [{"type": "pdf_page", "page": 348, "label": "p348"}]}
{"chunk_id": "SSUs_v1_p349_txt_00_eda2ed", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 349, "page_end": 349, "section_path": ["VASCULAR AND INTERVENTIONAL", "Carotid Endarterectomy"], "specialty_tags": ["VASCULAR AND INTERVENTIONAL"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Carotid Endarterectomy", "keywords": [], "text": "Modality\nMethod\nBenefits\nLimitations\nIndication for Shunt\nAwake\nassessment\nAssess clinical\nsigns\n•\nDirect\nEvidence of cerebral\nischaemia i.e. agitation,\nslurred speech,\ndisorientation, weakness\n**contralateral hand grip\nCarotid\nartery\nstump\npressure\nNeedle inserted\ninto distal\ncommon carotid\nand measures\npressure post XC\n•\nEasy\n•\nCheap\n•\nLow sensitivity (high\nfalse negative)\n•\n<40mmHg\nEEG\nAlgorithmic\nanalysis of EEG\n•\nEasy\n•\nCheap\n•\nLow sensitivity (high\nfalse negative)\n•\nCortical region only\n•\nGA alters results\nMAC <0.5 required\n•\nReduction of BIS >30%\nindicates hypoperfusion\n•\nDelta / theta waves\n•\nDisorganised rhythm\nSSEPs\nTranscutaneous\nelectrical stimulus\nto assess pathway\nfrom peripheral\nnerve to sensory\ncortex\n•\nDetects subcortical\nischaemia\n•\nLow sensitivity (high\nfalse negative)\n•\nGA alters results\n•\namplitude by 50% (peak\nto trough)\n•\nlatency by 10%\n(stimulus to peak)\nTranscranial\ndoppler\nInfers CBF from\nblood flow velocity\n•\nMonitors flow and\npresence of emboli\n•\nVery operator\ndependent\n•\nClose to operating\nfield\n•\nNarrow acoustic\nwindow\n•\nMCAvel reduction >60%\n•\nFlow <25cm/s\nNIRS\nDifferential\nabsorption of\ninfrared light of\noxyHb and\ndeoxyHb\n•\nHigher sensitivity\n•\nFrontal lobe only\n•\nPredominantly local\nvenous O2 sats\n•\nSources of error: eg\ninterference,\nextracranial blood,\nambient light\n•\nHigh variability – no\n‘normal values’ data\n•\nFall ≥20%\n•\nAbsolute ≤50%\n(Generally not an indication\nto shunt alone – use to O2\nand blood pressure)\nLocal Anaesthetic\nGeneral Anaesthetic\nBenefits\n•\nAwake + direct neuro examination\n•\nEEG unaffected\n•\nPreserved CNS autoregulation\n•\nincidence of MI in hospital\n•\nshunt rate\n•\noperative site bleeding\n•\nLOS\n•\nMotionless patient + optimised surgical field\n•\nSecure airway\n•\nAvoids emergency conversion to GA\n•\nAvoid regional / local anaesthetic risks\n•\nDecreased CMRO2\n•\nPatient comfort\nDisadvantages\n•\nNot suitable if NESB / hearing impairment /\nmovement disorder / patient unwilling\n•\nVertebral artery injection (seizure)\n•\nSubarachnoid injection (LOC)\n•\nHorner’s syndrome\n•\nBlockade of phrenic n. or RLN\n•\nNeed for emergency conversion to GA (~4%)\n•\nReliance on indirect neuromonitoring\n•\nshunt rate\n•\nintra-op hypotension\n•\npost-op hypertension", "citations": [{"type": "pdf_page", "page": 349, "label": "p349"}]}
{"chunk_id": "SSUs_v1_p350_txt_00_d639d6", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 350, "page_end": 350, "section_path": ["VASCULAR AND INTERVENTIONAL", "Limb Amputation", "Limb Amputation"], "specialty_tags": ["VASCULAR AND INTERVENTIONAL"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Limb Amputation", "keywords": [], "text": "Limb Amputation\nType: primary – no attempt at revascularisation, secondary – after failed revascularisation\nIndications: ischaemia (unsalvageable), trauma, infection, malignancy, frostbite, compartment syndrome (failed management)\n30 day mortality 17% (AKA > BKA) 2’ cardiac, sepsis pneumonia, DVT/PE\nTypes of post-amputation pain:\n•\nSurgical stump pain\n•\nPhantom sensation: still feels like part of the body ~100%\n•\nPhantom-limb pain: pain in missing part 30 – 85%\nRFs for post-op pain: high pre-op pain, catastrophising, chemo/radiotherapy, age\nSurgical post-amputation pain\nPhantom limb pain 80%\nIntra-operative\n•\nPharmacological:\no\nParacetamol\no\nParecoxib\no\nDexmedetomidine\n•\nRegional:\no\nAKA: sciatic + femoral\no\nBKA: sciatic\n•\nEpidural (good for acute pain)\n•\nGabapentin\n•\nKetamine\nPost-operative\n•\nParacetamol\n•\nNSAID\n•\nPCA\n•\nCatheters\n•\nDaily APS review\nBack pain common:\n•\nTENS\n•\nHeat therapy\n•\nAcupuncture\n•\nGabapentin\n•\nKetamine\n•\nCalcitonin (acute not chronic)\n•\nTramadol\n+/- spinal cord stimulator – case reports\n•\nNon-pharm - consider:\no\nMirror therapy\no\nSensory discrimination training\no\nMotor imagery\nNo evidence for: amitriptyline, botox A, memantine, IV lignocaine\nPre-op:\n•\nPain specialist\n•\nModifiable RFs\nIntra-op:\n•\n1st on list associated with mortality\nPost-op:\n•\nPersistent stump pain 10%: infection, wound dehiscence, arterial insufficiency, OM, bone spur, haematoma, poor fitting\nprosthesis, neuroma, heterotopic ossification (calcium in stump tissue)", "citations": [{"type": "pdf_page", "page": 350, "label": "p350"}]}
{"chunk_id": "SSUs_v1_p351_txt_00_798823", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 351, "page_end": 351, "section_path": ["EVAR", "rEVAR", "Abdominal Aortic Aneurysm"], "specialty_tags": ["EVAR"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Abdominal Aortic Aneurysm", "keywords": [], "text": "Abdominal Aortic Aneurysm\nDefinition\n•\nWidening >1.5x normal diameter (all wall layers, any vessel) OR\n•\n>30mm absolute diameter\nRFs:\n•\nDevelopment: >65yo, male, COPD, PVD, FHx, ↑lipids, HTN, smoking\n•\nRupture: ↑size, ↑rate of expansion (diabetes protective), symptomatic, >60yo, female, HTN, smoking\nSmoking most important in both\nCause: atherosclerosis (main), rarer - Marfan syndrome, Salmonella, Brucellosis, TB, Takayasus\nNon surgical management:\n•\nSmoking cessation: slows growth by 20% + improves surgical outcomes\n•\nStatins (↓peri-op MI)\n•\nAspirin\n•\nConsider BB and ACEi\nRisk of rupture:\n•\n<5.5cm: <1%/yr\n•\n>5.5cm: 18% /yr for F, 12%/yr for M\nIndication for surgery: >5.5cm M, >5.0 F, symptomatic, rapid expansion", "citations": [{"type": "pdf_page", "page": 351, "label": "p351"}]}
{"chunk_id": "SSUs_v1_p351_txt_01_6b5cb0", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 351, "page_end": 351, "section_path": ["EVAR", "rEVAR", "EVAR"], "specialty_tags": ["EVAR"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "EVAR", "keywords": [], "text": "EVAR\nRequirements: neck >1.5cm, minimal plaque, disease-free iliacs, 1x fem a. >8mm (stent 7.5mm)\nEVAR v open:\n•\nBenefits: ↓peri-op morbidity / LOS / blood loss (650mL v 1600mL), short term mortality\n•\nDisadvantages: graft related, need for reintervention\nNo difference in long-term mortality\nPre-op:\n•\nBreath hold\n•\nCheck bilateral BP\nIntra-op: stable haemodynamics until aneurysm secure\n•\nLines on RIGHT (emergency balloon catheter from L axillary artery)\n•\nMonitoring: 5-lead, art line\n•\nHyoscine: ↓intestinal motility\nPost-op:\n•\nComplications: LL ischaemia / chol embolisation, stent displacement, endoleak, post-implantation syndrome\nrEVAR (EVAR for Rupture)\nrEVAR v open: ↓LOS, QoL, more cost effective\n•\nIMPROVE trial: no difference in 30 day or 3-year mortality\nIntra-op:\n•\nLA v GA: 30-day mortality\n•\nIf agitation or back pain: consider LA + sedation to facilitate REBOA prior to GA\n•\nIf retroperitoneal haematoma may have respiratory insufficiency", "citations": [{"type": "pdf_page", "page": 351, "label": "p351"}]}
{"chunk_id": "SSUs_v1_p352_txt_00_a29963", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 352, "page_end": 352, "section_path": ["EVAR", "Open Ruptured AAA", "Open Elective"], "specialty_tags": ["EVAR", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Open Elective", "keywords": [], "text": "Open Elective\nPre-op:\n•\nFunctional, RCRI\n•\nMust be on statin, aspirin + well controlled BP\n•\nModifiable RFs\n•\nConsent: peri-op mortality 1-10%\n•\nX-clamp assessment / TTE: location of clamp, CI to clamp ?severe AR\nIntra-op:\n•\nNeuraxial: post-op MI\n•\nMonitoring: 5-lead, art line, CVP, temp, UO\n•\nCLAMP ON: massive afterload – Anrep effect\no\nHeparin 100iu/kg + circ\no\nSNiP +/- GTN bolus pre-clamp\no\nSTOP lower body warmer\no\nHigh risk MI: Hb 90-100, avoid excessive tachycardia\n•\nCLAMP OFF:\no\nFluid load prior (CVP >12-15)\no\nPrepare for ischaemic reperfusion injury\n▪\nCO2 (hyperventilate)\n▪\nInsulin dextrose ready\n▪\nDefib pads on\n▪\nDilute adrenaline\nPost-op:\n•\nMonitor for ischaemic effects of X-clamp:\no\nUO / AKI: intra-op UO not correlated, dialysis rates similar supra- & infra-renal X clamp – no evidence for\ndiuretics", "citations": [{"type": "pdf_page", "page": 352, "label": "p352"}]}
{"chunk_id": "SSUs_v1_p352_txt_01_b80988", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 352, "page_end": 352, "section_path": ["EVAR", "Open Ruptured AAA", "Open Ruptured AAA"], "specialty_tags": ["EVAR", "crisis"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Open Ruptured AAA", "keywords": [], "text": "Open Ruptured AAA\nAbove +\nPre-op:\n•\nReverse anticoagulation\n•\nsBP 90\n•\nEarly blood products\n•\nAvoid TXA\n•\nREFER: haematology, ICU\n•\n+/- REBOA (seldinger via fem a.)\nIntra-op:\n•\nSurgeons scrubbed prior to GA (TMP)\n•\nsBP 90-120 (lowest recorded BP correlates 30-day mortality)\n•\nMajor haemorrhage bundle:\no\nMTP/ROTEM, sheath, level 1 tubing + rapid infuser, cell salvage\no\nCoagulopathy: minimise crystalloid, warm, iCa\nPost-op:\n•\nMonitor:\no\nAbdominal compartment syndrome\no\nIschaemic colitis", "citations": [{"type": "pdf_page", "page": 352, "label": "p352"}]}
{"chunk_id": "SSUs_v1_p353_txt_00_97fc14", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 353, "page_end": 353, "section_path": ["EVAR", "Open Aneurysm Repair", "Thoracic / Thoracoabdominal Aortic Disease"], "specialty_tags": ["EVAR"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Thoracic / Thoracoabdominal Aortic Disease", "keywords": [], "text": "Thoracic / Thoracoabdominal Aortic Disease\nIndications for surgery:\n•\nRupture or dissection\n•\nSymptomatic enlargement\n•\nEnlargement >1cm/yr or rapid increase\n•\nAbsolute size >6.5cm (or >6.0cm in CT disease)", "citations": [{"type": "pdf_page", "page": 353, "label": "p353"}]}
{"chunk_id": "SSUs_v1_p353_txt_01_0c234c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 353, "page_end": 353, "section_path": ["EVAR", "Open Aneurysm Repair", "tEVAR"], "specialty_tags": ["EVAR"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "tEVAR", "keywords": [], "text": "tEVAR\nAs for EVAR +\n•\nSpinal cord protection: 2% SCI (risk  length of graft)\no\n?lumbar drain", "citations": [{"type": "pdf_page", "page": 353, "label": "p353"}]}
{"chunk_id": "SSUs_v1_p353_txt_02_5c3a2f", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 353, "page_end": 353, "section_path": ["EVAR", "Open Aneurysm Repair", "Open Aneurysm Repair"], "specialty_tags": ["EVAR"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Open Aneurysm Repair", "keywords": [], "text": "Open Aneurysm Repair\nPre-op:\n•\nFunctional, RCRI\n•\nCompression of adjacent structures:\no\nStridor or dyspnoea from tracheal or bronchial compression\no\nDysphagia from oesophageal compression\n•\nBaseline neuro exam\nIntra-op:\n•\nMonitoring: 5-lead, 2x art lines – right radial + femoral, CVC, temp, UO\n•\nDLT\n•\nNeuromonitoring:\no\nMEPs: anterior columns (anterior spinal a.) - avoid NMBA or volatile >0.5 MAC\no\nSSEPs: posterior columns\n•\n?Partial left heart bypass\no\nCBF via native vessels + distal aorta via CBP (ensures blood flow to distal organs + XC afterload)\n▪\nCannulation LA/pulmonary vein → return distal aorta\n▪\nNo oxygenator\n▪\nACT 200 – 300\n▪\nT 34 (cerebral perfusion maintained)\n•\nSpinal cord perfusion:\no\nSequential clamping + re-implantation of intercostals/lumbar segmental vessels\no\nLumbar drain\n•\nX CLAMP as per AAA notes\n•\nCell salvage\nPost-op:\n•\nMonitor for ischaemia\n•\nCSIC", "citations": [{"type": "pdf_page", "page": 353, "label": "p353"}]}
{"chunk_id": "SSUs_v1_p354_txt_00_39c86a", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 354, "page_end": 354, "section_path": ["EVAR", "Type B", "Dissection"], "specialty_tags": ["EVAR"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Dissection", "keywords": [], "text": "Dissection\nIntimal tear → false lumen formation\nPresentation:\n•\nSSx: acute onset chest / back pain 90%\n•\nEnd organ hypoperfusion:\no\nCNS: stroke, syncope, Horner’s syndrome\no\nCVS: AMI if obstructed coronary ostia, heart failure / aortic regurg,\ntamponade, differential BP\no\nSpinal cord: paraplegia\no\nGut: mesenteric ischaemia\no\nAKI\no\nLimb ischaemia\nIx:\n•\nECG: may show ischaemia if coronary ostia involved\n•\nCXR: widened aortic silhouette, pleural effusion\n•\nTOE: dissection flap, lumens (F/F), thrombus, coronary arterial involvement, pericardial effusion, AR\n•\nCT-A/MR-A: show same as TOE + entry/re-entry points\nIndications for emergency surgery:\n•\nAscending aorta involvement\n•\nDescending aorta with compromised organ blood flow\n•\nFailed medical management\nManagement:\n•\nAnti-impulse therapy:\no\nHR <60\n▪\nEsmolol 0.5mg/kg load → 25 – 50mcg/kg/min\n▪\nLabetalol: 20mg IV → 0.5 – 2mg / min\no\nsBP 100-120mmHg\n▪\nSNiP: 0.25 – 0.5mcg/kg/min\n•\nAnalgesia – IV opioids\nType A\nPre-op:\n•\nAssess organ hypoperfusion above\nIntra-op: supine + midline sternotomy\n•\nDeep hypothermic circulatory arrest\n•\nMonitoring: 5-lead, RIGHT radial art line, CVC, temp, UO\no\nNeuro: NIRS\nType B\nIntra-op:\n•\nLateral decubitus + left lateral thoracotomy + DLT", "citations": [{"type": "pdf_page", "page": 354, "label": "p354"}]}
{"chunk_id": "SSUs_v1_p355_txt_00_495b8c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 355, "page_end": 355, "section_path": ["EVAR", "Fistula Formation", "Fistula Formation"], "specialty_tags": ["EVAR"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Fistula Formation", "keywords": [], "text": "Fistula Formation\nIndication:\n•\nStage 5 CKD\n•\nStage ≤4 but rapidly progressive\nNative vein arteriovenous fistula - commonest\nSub-types:\n•\nRadiocephalic: 1st line, lowest flows\n•\nBrachiocephalic: increased steal\n•\nBrachiobasilic transposition: highest risk of steal (usually due to failed distal fistulas)\n1 – 4mo maturation. Within 1cm of skin for easy cannulation. Non-dominant arm.\nArterial-venous graft: used when unable to approximate artery and vein, or when previous fistulas have exhausted vessels\n•\nPros: ease of cannulation, short maturation time\n•\nCons: poor long-term patency, 4x salvage procedures, 6x thrombosis, 10x infection\nTypes of graft:\n•\nForearm loop graft\n•\nBrachioaxillary graft\n•\nFemoro-femoral graft\nPre-op:\n•\nDialysis + AEIOU status\nIntra-op:\n•\nPadding to preserve current fistulas (document pre and post thrill)\n•\nIVC away from future sites\n•\nRegional: axillary brachial plexus + T2 +/- surgeon infiltration\no\nConsiderations:\n▪\nUraemic platelet dysfunction\n▪\nPotential prolonged heparin after dialysis\n▪\nVasodilation 2’ regional → higher vessel flow (predicts successful formation)\n▪\nPitfalls: intercostobrachial n. / T2 needs to be blocked separately", "citations": [{"type": "pdf_page", "page": 355, "label": "p355"}]}
{"chunk_id": "SSUs_v1_p356_txt_00_8add3c", "source_id": "Fellowship_Exam_SSUs", "doc_title": "Fellowship Exam - SSUs", "version": "v1", "page_start": 356, "page_end": 356, "section_path": ["EVAR", "Thorascopic Sympathectomy", "Thorascopic Sympathectomy"], "specialty_tags": ["EVAR"], "periop_phase_tags": ["all_phases"], "content_type": "text", "modality": "text", "title": "Thorascopic Sympathectomy", "keywords": [], "text": "Thorascopic Sympathectomy\nDisruption of sympathetic outflow at level of spinal cord:\n•\nT1 – T2: head & neck\n•\nT1 – T4: thoracic viscera\n•\nT2 – T5: upper limbs\nIndications:\n•\nHyperhidrosis\n•\nCRPS\n•\nIschaemic symptoms (including angina)\n•\nCongenital long QTc\n•\nIntra-arterial injection\nNo longer for Raynaud’s as vasodilatory effects are transient\nPre-op:\n•\nIndication\nIntra-op: usually GA\n•\nMonitoring: art line + 5 lead ECG if for long QTc (+ avoid QT prolonging medications)\n•\nPartial lung collapse:\no\nDLT\n•\nMonitor for tension capnothorax\n•\nCautious positioning to avoid brachial plexus injury\nPost-op:\n•\nCXR to exclude residual PTx", "citations": [{"type": "pdf_page", "page": 356, "label": "p356"}]}
